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Abstract 
Background 
Low Back Pain (LBP) is the principal cause of disability globally (Buchbinder et al. 2018; 
Hartvigsen et al. 2018).  Research and packages of care have strived to reduce levels of LBP, 
but globally it continues to rise (Foster et al. 2018).  There is debate as to the role of 
acupuncture in LBP care pathways and research on acupuncture is of varying quality and not 
conclusive (SAR, 2018).  Previous research of acupuncture has not effectively used trial 
design to produce high quality, robust and convincing evidence. 
Aims 
To investigate if acupuncture and manual therapy are indicated as appropriate treatments for 
the treatment of LBP and consider if their combination may be viable and effective. 
To determine the international LBP recommendations for acupuncture and manual therapy. 
To establish which RCT design could best evaluate acupuncture and manual therapy for the 
treatment of LBP and to trial this in a pilot study. 
To ascertain if high-quality research compares and combines acupuncture with manual 
therapy for LBP. 
Methods 
To review the international clinical practice guidelines and their approach to acupuncture and 
manual therapy for LBP.  To consider a range of clinical trial designs and establish a preferred 
design.  To conduct a trial investigating acupuncture and manual therapy alone and in 
combination for LBP, using a cohort study with nested factorial RCT.  To conduct a 
systematic review, comparing acupuncture with manual therapy for LBP. 
Results 
Further evidence is indicated in the study of acupuncture and manual therapy for LBP.  
Clinical practice guidelines are inconsistent in their interpretation of evidence and the 
recommendation of acupuncture.  A cohort study with nested factorial RCT is an effective 
design for recruitment, retention and to evaluate acupuncture and manual therapy for LBP.  
97% of participants accepted the interventions offered and 100% of individuals completed 
the RCT interventions and 100% returned (97% completion of primary outcomes measures) 
of follow-up questionnaires.  Zero attrition was achieved with this pilot study (95% CI 0.0, 
6.3).  Manual therapy may be superior (-1.4, 95% CI -3.8, 1.0, P=0.24) to usual care, but the 
results are not statistically significant.  Manual therapy appears favourable in an SR and meta-
analysis of manual therapy versus acupuncture; the results were limited by the 
methodological quality of the studies included.  
Conclusions 
A full-scale definitive trial of acupuncture and manual therapy using a cohort design, with 
nested factorial RCT is needed. 
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Glossary of terms 
Acupuncture - Acupuncture is ancient therapy with its history in Chinese 
medicine.  It translates ‘to puncture with a needle’ (World Health 
Organisation (WHO), 1991) involving the insertion of fine needles into the 
body, treating holistically (whole body).  In Chinese philosophy illness is 
considered an imbalance of energy sources in the body, acupuncture strives 
to recreate balance and harmony (Vera et al. 2018; Chong et al. 2015).  In 
western medicine, acupuncture is considered in physiological terms and is 
understood to stimulate blood flow, activate nerve activity (Kim et al. 2016; 
Li et al. 2013; Uchida and Hotta, 2008; Inoue et al. 2005) and stimulate 
specific areas of the brain to release pain-relieving chemicals (Jin et al. 2016; 
He et al. 2015; Bradnam 2011; Lewith, White and Pariente, 2005). 
Central Sensitization pain – Central sensitization pain occurs due to the 
dysfunction of neural (nerve) pathway signals of the central nervous system, 
resulting in a heightened (warning) neural response to painful stimuli (Tatta, 
2017). 
Cytokines – Are small proteins released by cells in the body, which interact 
with other cells.  They trigger an inflammatory response and respond to 
infection  (Shiel, 2018). 
Disability adjusted life years (DALYs) – One lost life year due to disability 
(WHO, 2018).  
Global burden of disease (GBD) – is a comprehensive regional and global 
research programme of disease burden that assesses mortality and disability 
of disease, injury and risk factors (WHO, 2018). 
Idiopathic – is pain of unknown origin. It is a term used to describe long-term 
chronic pain without an identifiable cause (Jacques, 2018). 
Low back pain (LBP) - is defined as pain, soreness, tension, muscle spasm 
or stiffness located between the costal margins (bottom of the ribs) and the 
gluteal folds (top of the legs) presenting with or without leg pain (sciatica) 
(McIntosh et al, 2011). 
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Low back pain: Non-specific - is identified as being benign and caused by 
structures in the back such as joints, discs, ligaments, tendons, muscle and 
other connective tissues (NICE, 2009). 
Low back pain: Specific - Specific LBP would be classified as being caused 
by malignancy, inflammatory disorders, infections or fractures (NICE, 2009). 
Manual therapy – is the movement of joints and /or soft tissue by the therapist 
hands.  Manual therapy includes techniques including spinal manipulation, 
spinal mobilisation and massage (NICE 2009). 
• Spinal manipulation = ‘a low amplitude high velocity movement at the 
limit of joint range taking the joint beyond the passive range of 
movement’ (NICE, 2009).  
• Spinal mobilisation = ‘joint movement within the normal range of 
motion’ (NICE, 2009). 
• Massage = ‘manual manipulation / mobilisation of the soft tissues’ 
(NICE, 2009).   
National Institute of Health and Clinical Excellence (NICE) – An 
organisation in England and Wales, which provides national guidance and 
advice to improve health and social care (NICE, 2018). 
Neuropathic pain – damage or disease affecting the somatosensory nervous 
system (Murnion, 2018). 
Nociceptive pain – pain attributed to the stimulation of peripheral receptors 
(nociceptors) of the primary afferent neurons due to noxious stimuli 
(chemical, mechanical, thermal) of non-neural tissues (Smart et al. 2010).   
World Health Organisation (WHO) – A specialised agency of the United 
Nations concerned with international public health (WHO, 2018). 
 17 
1.  Introduction 
Low Back Pain (LBP) presents a major challenge worldwide; it affects 
individuals from every aspect of society and its economic and personal impact 
continues to grow, rising by more than 50% since 1990 (Clark and Horton, 
2018; Cholangitis, 2018).   
Lifetime prevalence in industrialised countries was reported at between 60 - 
80% (World Health Organisation, 2013; Maniadakis and Gray, 2000) and 
global lifetime prevalence was reported at 40% (Hoy et al. 2012).  The 
National Institute of Health and Clinical Excellence (NICE) (2016) proposes 
that LBP impacts upon more individuals globally than any other medical 
condition, and it is now reported as being the primary cause of disability 
globally (Hartvigsen et al. 2018; Vos et al. 2016).  
LBP is the principal cause of activity limitation and work absenteeism 
throughout much of the world, impacting greatly upon global disability and 
the global economy (Hartvigsen et al. 2018; Thelin, Holmberg and Thelin, 
2008; Lidgren, 2003). 
Although in recent years the availability of medical interventions for LBP has 
increased significantly (Deyo et al. 2014) and there are a multitude of 
healthcare interventions and resource dedicated to LBP, there appears not to 
have been a corresponding reduction in the negative impact of LBP upon 
individuals and society (Foster et al. 2018; Deyo et al. 2014).   
LBP is a complex disorder with multiple aspects; it is a heterogeneous 
condition encompassing a broad range of symptoms and pain presentations 
e.g. nociceptive, neuropathic or central pain (Nijs et al. 2015).  Patients 
present to clinicians with a variety of symptoms, which are often not 
consistent, and currently there is great variation in clinicians’ approaches to 
LBP’s management (Duthey, 2013).  Although national and international 
guidelines exist, to date, no consistent approach in the management of LBP 
has been accepted or adopted by clinicians locally or internationally (Duthey, 
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2013).  O’Sullivan and Lin (2014) argue that if the management of LBP was 
more closely aligned with the evidence, the burden of LBP could be 
decreased. 
Existing evidence and clinical guidelines support the use of diagnostic 
techniques, self-care, manual therapy, exercise and possibly acupuncture, to 
address LBP (Qaseem et al. 2017; Wong et al. 2017; NICE 2016; Nijs et al. 
2015; Koes et al. 2010).  Debate does however exist surrounding the role of 
acupuncture.  Some international guidelines support the use of acupuncture, 
for example: America (Qaseem et al. 2017 and Chou et al. 2007), Scotland 
(SIGN, 2013) Canada (Cutforth et al. 2011), Belgium (Nielens et al. 2006), 
and previously England and Wales (NICE, 2009).  Other international 
guidelines do not recommend acupuncture, for example: England and Wales 
(NICE, 2016), Europe (Airaksinen et al. 2006), France (Agence, 2000) and 
Italy (Negrini et al. 2006) and other guidelines overlook the intervention: the 
Netherlands (KNGF, 2013; CBO, 2003).   
The UK’s National Institute of Health and Clinical Excellence (NICE) LBP 
guidelines illustrate this variation.  NICE supported the use of acupuncture in 
their 2009 publication (NICE, 2009) but withdrew support for acupuncture in 
their more recent guidelines (NICE, 2016) despite apparently no new 
contradictory evidence being produced; this policy change will be discussed 
further within chapter two.  Due to the variable viewpoints surrounding the 
use of acupuncture for LBP, further research is required to establish the role 
of acupuncture and this thesis will investigate this further. 
In this chapter, I consider the academic and, policy and practice context of 
the role of acupuncture and manual therapy for Low Back Pain (LBP).  
Acupuncture and Manual therapy were selected for this thesis in response to 
their recommendation in the 2009 NICE guidance; this will be discussed 
further in section 1.5.  The specific parameters used to define LBP are 
reflected upon within this thesis and are outlined within section 1.1.  The 
epidemiology and economic burden of low back pain upon the global society 
will be presented within section 1.2 and 1.3 respectively.  The prognosis of 
LBP in section 1.4 and management of LBP will be presented in section 1.5.  
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An outline of the current evidence and clinical guidance for treatments 
available for LBP and how these have changed over time, with specific focus 
upon acupuncture and manual therapy will be given.  Consideration to LBP 
being a complex condition, treated with complex intervention and the 
difficulties in assessing these will be discussed in section 1.6.  This chapter 
will demonstrate a clear need for the research undertaken for this PhD, and 
the research questions it aims to answer will be presented in section 1.7. A 
thesis chapter plan will be outlined in section 1.8. 
1.1 Definition: Low Back Pain 
Defining the term ‘Low Back Pain’ (LBP) presents challenges.  Establishing 
a definition and description for LBP is inherently complex and requires 
extensive explanation because as an applied medical diagnostic term, LBP is 
poorly classified.  The World Health Organisation (WHO) states: 
“Low back pain is neither a disease nor a diagnostic entity of any 
sort.  The term refers to pain of a variable duration in the area of 
anatomy afflicted so often that it has become a paradigm of 
responses to external and internal stimuli” 
WHO (2003), page 671 
While the term LBP is frequently used as a diagnostic term, it should perhaps 
be more accurately used as a diagnostic descriptor, a global term to describe 
a heterogeneous group of symptoms.  Clinically LBP represents a collection 
of symptoms, such as pain, stiffness or discomfort in the region of the lower 
back, caused by a variety of structures and therefore the term LBP does not 
provide any specificity as to an exact anatomical structural or causal 
diagnosis.  Low Back Pain (LBP) is defined as: 
“…pain, muscle tension, or stiffness, localised below the costal 
margin to the inferior gluteal folds, with or without referred or 
radicular leg pain (sciatica).” 
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McIntosh and Hall (2011), page 2 
This definition provides no precision as to the actual anatomical structure or 
injury causing the condition; it only describes generalised sensations in a 
generalised region.  
The NICE guidelines define LBP as: 
 “...the area bounded by the bottom of the rib cage and the buttock 
creases.  Some people with non-specific low back pain may also feel 
pain in their upper legs, but the low back pain usually predominates.  
Several structures, including the joints, discs and connective tissues, 
may contribute to symptoms.” 
NICE (2009), page 10  
Consequently, there is a significant lack of clarity for generalised pain in the 
lumbosacral region and little consensus in defining LBP (NICE, 2016; 
Parthan, Evans and Le, 2006).  This lack of clarity in the definition and thus 
diagnosis of LBP, may contribute to the variety that exists in the management, 
treatment and research of the condition (Duthey, 2013; Forward, Wallace and 
Hughes, 2008). 
 Specific and Non-Specific Low Back Pain 
For research and clinical purposes, it is important to differentiate between two 
categories of LBP: Specific LBP and Non-Specific LBP, as they constitute 
quite considerably different conditions with varying care pathways as detailed 
below.   
Initial diagnostic activity in relation to LBP is conducted by means of a 
thorough medical assessment.  Clinicians utilise clinical red flag screening 
tools to exclude or identify any serious pathology.  Identification of a serious 
or specific pathology would indicate the need for onward specialist referral 
and further investigations, whereas the exclusion of a specific pathology 
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would indicate a conservative treatment pathway for non-specific LBP 
(NICE, 2016; O’Sullivan and Lin, 2014; Duthey, 2013).  
Specific LBP: 
LBP is considered specific when a specific pathology is identified as a cause 
of the LBP.  Specific LBP constitutes 5 - 15% of LBP cases within primary 
care in the UK (Hollingworth et al. 2002).  LBP caused by serious pathology 
is very rare, less than 1% of LBP sufferers in primary care will receive a 
diagnosis of cancer for example (Henschke et al. 2013).   
Serious LBP with a definitive diagnosis is referred to as ‘Specific’ low back 
pain, due to its specific diagnosis.  It has been identified by NICE as: 
“Specific causes of low back pain = malignancy, infection, fracture, 
ankylosing spondylitis and other inflammatory disorders”        
(NICE, 2009, page 10) 
The diagnosis of ‘specific LBP’ encompasses a collection of conditions, 
which are generally more severe in their nature as identified above; they 
require complex invasive investigations and interventions by specialist 
physicians.  The specific diagnosis allows for a distinct care pathway to be 
adopted within primary care for the identified condition. 
The complex nature and requirement of intensive investigations, treatments 
and care pathways for specific LBP by their nature determine them to be 
beyond the remit of this study, they are often life-threatening conditions.   
Non-specific LBP: 
LBP is identified as non-specific because a specific cause cannot be 
conclusively established (Riksman, Williamson and Walker, 2011), it is 
suggested that it may occur due to a variety of biologic and behavioural 
influences (Deyo et al. 2014).  Non-specific LBP accounts for the majority of 
LBP, with 85 – 95% of LBP being diagnosed as non-specific, not caused by 
a specific or identifiable pathology (Hollingworth et al. 2002). 
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While a variety of definitions exist for non-specific LBP, NICE’s (2009) 
classification manages to encompass the key components of non-specific 
LBP, including the varied nature of structures involved and the exclusion of 
specific causes, they provide a descriptive narrative:  
“Non-specific LBP is tension, soreness and/or stiffness in the lower 
back region for which it isn’t possible to identify a specific cause of 
pain.  Several structures in the back, including joints, discs, and 
connective tissues, may contribute to symptoms.  The diagnosis of 
non-specific low back pain is dependent on the clinician being 
satisfied that there is not a specific cause for their patient’s low back 
pain”   
(NICE, 2009, page 9) 
Sensory nerves innovate several spinal structures within the low back, the 
sensory nerves allow the individual spinal structures to be pain generating and 
thus produce pain in the lower back.  Currently despite the advancement in 
imaging technology and medicine, it is not possible to identify the specific 
causes of sensory nerve stimulated pain (NICE, 2016) and thus it is 
considered as non-specific. 
Significant heterogeneity occurs amongst non-specific LBP, however 
duration-based categorisation has been used conventionally and continues to 
be used often in attempt to classify it further; three categories have 
traditionally indicated divergent treatment pathways for LBP (NICE, 2009): 
• Acute LBP – is classified as LBP incidence within the first six weeks 
• Sub-acute LBP – is classified as LBP for between six to twelve weeks 
• Chronic LBP – is classified as LBP lasting longer than six to twelve 
weeks or recurrent back pain that continues to affect an individual 
constantly or intermittently over a period of time  
(Duthey, 2013) 
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Though international medical pathways and extensive research studies have 
adopted these categories, the most recent UK NICE LBP guidelines (NICE, 
2016) recommended adopting a new approach. They consider LBP as a 
continuum and recommend attempting to identify risk of recurrence and 
chronicity to categorise LBP, as opposed to duration-based time frames.  In a 
break from convention they advocate identifying risk factors to be a more 
appropriate indicator of the risk of chronicity, and thus may guide care 
pathways and treatment requirement for LBP more appropriately, rather than 
categorisation of LBP by the duration of symptoms (NICE, 2016).  This 
approach has not currently been adopted internationally. 
In addition to the lack of diagnostic clarity, multiple terms are currently used 
interchangeably as descriptors for LBP without a specific cause; the clinical 
community have currently not converged upon one term (figure 1.1). 
 
Figure 1.1: Diagnostic terms for LBP (adapted from NICE, 2016; Duthey, 2013; 
Forward et al. 2008) 
The focus throughout this thesis will be to explore Non-specific LBP of at 
least a six-week duration (beyond the acute phase).  For consistency and 
Low	Back	Pain
Non-specific	LBP
Simple	LBP
Mechanical	LBP
Idiopathic	LBP
Musculoskeletal	LBPSciatica
Discogenic	LBP
Muscular	LBP
Radiculopathy
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clarity, where LBP is used within the thesis, it will be referring to sub-acute 
and chronic ‘Non-specific LBP’.  
1.2 Epidemiology of Non-Specific Low Back Pain 
1.2.1 Aetiology and risk factors of Non-Specific LBP 
Non-specific LBP can be described as idiopathic in nature with an individual 
being unable to identify a specific cause or incident resulting in their LBP.  
Identifying a specific anatomical pain source can thus prove problematic, in 
turn posing difficulty in diagnosis and subsequent treatment (Deyo et al. 
2014; Riksman et al. 2011).   
As LBP is considered as a pain in the region of the lumbosacral region of the 
spinal column, it can occur for a variety of reasons and from a variety of 
structures.  The soft tissues involved in LBP include the muscles, vertebral 
discs, spinal and peripheral nerves, joint capsules, soft connective tissue, 
ligaments and blood vessels (NICE, 2016).  Many of these structures are often 
involved with non-specific LBP with some or all being involved or affecting 
pain simultaneously within the course of an LBP episode.  LBP is described 
frequently in medical practice as a result of overuse of a muscle, a strain of 
the soft tissues or a repetitive injury suffered over time (Parthan et al. 2006). 
When a tissue structure becomes a trigger for the LBP through a sprain, strain, 
pull or stretch it becomes inflamed producing chemicals such as cytokines, 
these chemicals initiate the physiological process of swelling within the local 
tissues and its surrounding structures.  Swelling, though required for the 
healing process can inadvertently limit blood flow and the delivery of key 
nutrients for healing.  The swelling can also limit the flow and removal of 
inflammatory products, thus causing further irritation to the region.  If 
inflammation is not reduced, a cycle of pain and inflammation can occur, 
leading to chronicity of pain (Duthey, 2013; Forward et al. 2008).  
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Though it is generally considered that the establishment of a specific cause 
for non-specific LBP is not possible, Deyo and Weinstein (2001) proposed 
that the anatomical origin of non-specific LBP could be sub-divided further 
into the following (figure 1.2): 
 
Figure 1.2: Anatomical origin of non-specific LBP (Deyo and Weinsein, 2001) 
This approach however, was unable to establish a cause for 70%, which was 
categorised as ‘unknown aetiology’ for LBP (figure 1.2).  Additionally, MRI 
and CT scans have determined facet joint disease, disc prolapses, and disc 
degeneration can often be a normal part of the aging process and non-
symptomatic (Tonosu et al. 2017; Brinjikji et al. 2015; Lateef and Patel, 
2009).  The anatomical origin presented therefore, may not be the root cause 
of a person’s LBP, thus limited information is provided to guide diagnostic 
causation of pain or in the guidance of following a specific treatment pathway. 
Various risk factors have been associated with LBP; these include incorrect 
and sustained postures, manual work, trauma (i.e. car accident), sporting 
injuries, repetitive strains and socio-demographic factors including height, 
weight, lifestyle, age, smoking, physical fitness, and psychological influences 
(NICE, 2009).   
70%10%
4% 3% 13%
Anatomical	origin	of	non-specific	
LBP
Unknown	aetiology	(non-specific)Degenerative	discs	andfacet	jointsProlapsed	discs	withnerve	root	painSpinal	stenosis
Other	non-specific	causes
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Globally it was proposed that 37% of LBP could be attributed to occupational 
incidences. Various occupations expose individuals to sustained standing or 
sitting positions, (including occupational drivers), and activities involving 
vibrations or manual work with excess lifting, and are commonly linked with 
an increased risk of LBP (Duthey, 2013). 
Inequalities within society have also been reported to impact LBP, with 
disadvantaged groups having a higher reported incidence of LBP, but 
receiving a lower onward referral rate for interventions or investigations than 
non-disadvantaged groups (DoH, 2006). 
1.2.2 Global Burden of Disease 
The Global Burden of Disease (GBD) study in 2017 included 345 diseases 
and injuries, including musculoskeletal disorders, from 195 countries.  The 
global study provided estimates of the impact and burden of each condition.  
Of the 345 conditions studied, LBP was positioned globally as the leading 
cause for years lived with disability (YLD) and listed as second for overall 
burden of disease in terms of disability-adjusted life years (DALYs) in high 
socio-demographic countries (WHO, 2018).  This is an increase in the burden 
of LBP from the 2010 GBD study when LBP was sixth in terms of DALYs. 
Hoy et al. (2014) ranked the YDLs and DALYs for LBP globally and across 
individual regions for the 2010 study, demonstrating the burden of LBP 
internationally, and identifying the regional variation (table 1.1).  LBP 
impacts greatly upon society internationally and it is suggested that when 
considering the reported number of cases and the burden of disease in terms 
of DALYs, LBP has a more profound impact upon society than HIV, road 
injuries, tuberculosis, lung cancer, and chronic obstructive pulmonary disease 
(Hoy et al. 2014; Lozano et al. 2012). 
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Region YDL ranking 
DALY 
ranking Region 
YDL 
ranking 
DALY 
ranking 
Globally 1 6 Central Latin America 2 7 
Central Asia 2 7 Southern Latin America 1 2 
East Asia 1 5 Tropical Latin America 1 3 
Southeast Asia 1 2 North Africa / Middle east 1 2 
Australasia 1 1 North America High income 1 3 
Caribbean 4 13 Oceania 2 14 
Central Europe 1 3 Central sub-Saharan Africa 3 23 
Eastern 
Europe 1 3 
Eastern sub-Saharan 
Africa 3 17 
Western 
Europe 1 1 
Southern sub-
Saharan Africa 4 15 
Andean Latin 
America 2 5 
Western sub-
Saharan Africa 2 13 
Table 1.1: Regional LBP YDL and DALY ranking out of 291 conditions in 
2010 (adapted from Hoy et al. 2014) 
In a 2005 study of medical consultations (not solely emergency visits) in the 
United States of America (USA), LBP accounted for approximately 14 
million consultations with physicians across the country (Snider et al. 2008).  
LBP was also estimated to account for 2.5% - 3% of emergency department 
visits within the United States, which equates to 2.63 million consultations 
(Friedman et al. 2010). 
Within England there has been a growing trend of hospital admissions and 
surgical procedures for LBP, over a 15-year period, with the greatest 
increases seen in the older population (Sivasubramaniam et al. 2015) as 
detailed in the figure 1.3 and 1.4.  The data was collected retrospectively using 
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Hospital Episode Statistics of lumbar spine disease cases in England between 
1999 and 2013 (Sivasubramaniam et al. 2015). 
 
Year 
Figure 1.3: Hospital admission for LBP by age group in England (adapted 
from Sivasubramaniam et al. 2015) 
 
Year 
Figure 1.4: Number of surgical procedures for degenerative lumbar spine 
disease by age group in England (adapted from Sivasubramaniam et al. 2015) 
Hospital admissions were reported to have risen from 127 to 216 per 100,000, 
with surgical procedures rising from 25 to 49 per 100,000, reflecting a 
significant cost and burden to the NHS and society within England 
(Sivasubramaniam et al. 2015). 
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1.2.3 Global Incidence of Low Back Pain 
Incidence of LBP, the measurement of newly diagnosed cases within a 
specific time period, is frequently measured over a one-year period and relies 
greatly upon the accuracy of reporting.  Measuring the rate of new cases 
treated may in some contexts be a more practical measure of incidence, as 
this figure is more often known and recorded, whereas the incidence of 
untreated or unreported cases is commonly unknown (Greenberg et al. 2005).   
Comparing estimates of incidence can be problematic due to heterogeneity of 
information collected across studies, some measure first incidence of LBP 
and other studies include recurrent events.  The expense of longitudinal 
studies required for incidence measurement means that fewer data studies are 
available for incidence, comparative to prevalence data detailed below within 
section 1.2.4 (Hoy et al. 2010). 
International incidence: 
Internationally the incidence of LBP is significant, there are variations from 
region to region and Western Europe has the highest incidence of LBP 
worldwide (Hoy et al. 2014). 
In Germany a nationwide computer assisted telephone interview (CATI) of 
8318 individuals indicated incidence at approximately one in four adults 
(25%) over the age of 30 years reports chronic LBP each year and LBP is one 
of the major causes of disability in Germany (Neuhauser, Ellert and Ziese, 
2005).   
In Denmark it is reported that although 60% to 90% of the population are 
expected to experience LBP during their life, the annual incidence is reported 
at 5%, considerably lower than other countries within Europe, however the 
data was collected in 1988 (Bekkering et al. 2003; Frymoyer, 1988).   
No large longitudinal population studies existed within the USA, however 
using a National Electronic Injury Surveillance System of registered cases of 
LBP presenting to emergency departments, it was estimated that 2.06 million 
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cases of LBP were reported in a population of 1.48 billion, equating to an 
incidence of 1.4 per 1,000 person-years (Waterman, Belmont and Schoenfeld, 
2012).  
No international consensus on measuring the incidence of LBP appears to 
exist.  It is difficult therefore to determine if the international differences in 
incidence of LBP are real, are likely linked to lifestyle and access to 
healthcare, or if the variation may in part be due to the variation in 
measurement and data collection approaches (Bohman et al. 2014). 
UK incidence: 
A population survey conducted by the Department of Health (DoH) in the 
United Kingdom (UK) in 1998, reported incidence of LBP at 40% within the 
preceding 12 months (DoH, 1999) this was calculated using data reported to 
the Health and Safety Executive (HSE) under the Reporting of Injuries, 
Diseases and Dangerous Occurrences (RIDDOR) scheme.  While no further 
current UK data is available from the DoH specific to LBP incidence, within 
the UK over 200 different types of musculoskeletal disorders are registered 
and reported, and LBP was reported by the DoH to account for more than 
40% of all musculoskeletal disorders as reported to the HSE within the UK 
(DoH, 2006).   
More recent data are available from the UK Health and Safety Executive 
(HSE) (2017) on the working population; this data was collected using the 
Labour Workforce Survey (lFS) and RIDDOR reporting.  A report on work 
related disorders in 2017 reported 194,000 (590 cases per 100,000 workers) 
cases of LBP across the labour workforce between 2016 and 2017, with an 
associated incidence rate of 150 per 100,000 (95% CI). 
The National Institute for Health and Clinical Excellence (NICE) an 
organisation, which provides national guidance for healthcare improvement 
in England and Wales, has suggested that nearly everyone within the UK 
would be affected by LBP at some point within their lifetime (NICE, 2009. 
Cholangitis, 2018; Clark and Horton, 2018).  A lifetime incidence of between 
58 – 84% was estimated by Bernstein et al. (2017) and Parsons et al. (2011) 
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based on data from Dionne in 1999, collected via the ‘House Survey for 
England’ and the ‘General Household Survey’, a national survey conducted 
in England and Wales on behalf of the Department of Health (DOH).  
Milczarek (2009) reported approximately 62% of sufferers still live with their 
LBP after twelve months, contributing to the chronicity of the condition. 
1.2.4 Global Prevalence of Low Back Pain 
Prevalence is the measure of live cases of LBP at a specific time point and 
thus is more easily estimated than incidence.  Period prevalence is the 
measure between two time points and point prevalence is measured at a 
specified time point (Greenberg et al. 2005).  Cross sectional studies are used 
to measure prevalence.  However analysing global prevalence over time is 
fraught with difficulty due to the complexities of obtaining accurate 
population estimates, significant methodological heterogeneity, variations in 
studies measurement of LBP and the recall periods required by participants 
across studies (Edwards et al. 2016; Hoy, et al. 2010; Konstantinou and Dunn, 
2008). 
International prevalence: 
A systematic review (SR) of the global prevalence of LBP reported a total 
mean prevalence was 31.0% ±0.6%, with a one-year prevalence of 38.0% ± 
19.4% and a lifetime prevalence of 39.9% ±24.3 (Hoy et al. 2012). The point 
prevalence of 11.9% ±2.0% was also reported with a one-month prevalence 
of 23.2% ±2.9% (following adjustments for inconsistencies in methodology), 
substantiating LBP as a significant consideration on a personal and a global 
level (Hoy et al. 2012). 
Global lifetime prevalence data was collected by the Global Burden of 
Diseases Study and reported LBP at 40%, with Western Europe having the 
highest prevalence (Hoy et al. 2014).  Lifetime prevalence increases 
significantly to 60 – 80% in western industrialised countries (WHO, 2013. 
Maniadakis and Gray, 2000).  The range across countries is marked however; 
the point prevalence was estimated at 10% of the adult population in 
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Denmark, based the Danish National Health survey, vastly lower than the 
majority of Europe, (KJøller and Rasmussen, 1995; in Dufour et al. 2010).  
France reported an estimated prevalence of 50% with hospital fees accounting 
for a large portion of the cost of LBP based on a National survey and Hospital 
attendance data (Rossignol, 2009; Konstantinou and Dunn, 2008).  
Prevalence in Germany was unknown until a prevalence study was conducted 
in 2005 using a nation-wide computer-assisted telephone interview (CATI), 
it was reported one in four adults over the age of 30 years reported chronic 
LBP (Neuhauser, Ellert and Ziese, 2005).  
There are various possible explanations for the international variations in LBP 
prevalence such as; varying reporting and recording of data, country specific 
interpretation of data, lifestyle and cultural differences, and variations in 
medical and self-care (Hoy et al. 2012; Hoy et al. 2010). 
LBP affects a diverse range of populations across the globe, impacting upon 
the young through to the very old, although the prevalence and burden 
internationally increases during the sixth decade of life (Hoy et al. 2012; 
Breivik et al. 2006).  Prevalence was found to be higher in men (mean 10.1%, 
95% CI 9.4 – 10.7) than women (mean 8.7%, 95% CI 8.2 -9.3) with this 
pattern translating globally (Hoy et al. 2014). 
UK prevalence: 
The Department of Health (DoH) survey also reported prevalence within the 
UK, reporting a lifetime prevalence of 80% (DoH, 2006) no further current 
data is available from the DoH specific to LBP prevalence within the UK 
general population. 
The HSE in their report on work related disorders in 2017, stated that of all 
conditions reported, LBP was the highest, with 590 cases per 100,000 workers 
reported from 2016 to 2017.  The prevalence of LBP was reported to be 
greater for men than women in the working population (720 per 100,000, 580 
per 100,000, from 2014 - 2017) and a total of 194,000 cases of LBP were 
reported within the UK workforce between 2016 and 2017 (HSE, 2017). 
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While the majority of data is derived from the working-age population it is 
suggested that LBP is most prevalent in the seventh decade of life in the 
England and Wales (NICE, 2016). 
1.2.5 LBP epidemiological data 
A dearth of epidemiological data on LBP has long existed, however in 2000 
epidemiological research into the area of LBP was reported to be growing 
(Walker, 2000).  In 2010, Hoy et al. stated that further research was required 
into the epidemiology of LBP, they also established that there was a need for 
epidemiological studies to adopt a more standardised approach to each other 
across the research spectra to aid data comparisons of LBP epidemiology 
internationally (Hoy et al. 2010).   
These views were echoed again in 2015 and recommendations for 
epidemiological studies of LBP to follow the National Institutes of Health 
(NIH) pain consortium task force guidance were encouraged (Deyo et al. 
2014), with minimum data sets advised.  A lack of research was also identified 
within developing countries, with the majority of studies focused upon 
European society with Caucasian individuals, reducing the global 
generalizability of studies and current data sets (Meucci, Fassa and Faria, 
2015).   
The lack of standardised tools for diagnosing LBP, further complicates data 
collection; often research data of LBP relies upon self-reported episodes 
(Parthan et al. 2006).  Significant heterogeneity in data collection and 
objective measures continues to be present across LBP studies globally 
causing international comparisons to be complex (Hoy et al. 2014).   
There continues to be limited epidemiological research specific to LBP 
relative to the significant burden it places upon society.  It is also suggested 
that though LBP is widespread and impacts greatly upon individuals and 
society, it continues to be relatively under-funded and under prioritised for 
treatment, investment and research comparative to other conditions of similar 
or lower prevalence (Buchbinder et al. 2018).  This may possibly be explained 
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by LBP often being considered comparatively trivial, as it is not a life limiting 
condition (Hoy et al. 2014; Hoy et al. 2010). 
1.3 Economic Burden of Low Back Pain 
The economic burden of LBP is the estimated total associated cost to 
individuals and society; including any resource use which would not have 
occurred if the condition were not present (Dagenais, Caro and Haldeman, 
2008).  The costs of LBP can be divided into three categories; direct costs, 
indirect costs and intangible costs (Odole et al. 2011). 
• Direct costs: include the cost of medical appointments, investigations, 
medications, interventions and all associated medical costs for a 
condition. 
• Indirect costs: incorporate productivity loss for industry, earnings lost 
to individuals and family members, cost of paid support, 
transportation for appointments and sustenance purchases, 
premature death may also be incorporated into this calculation for 
disease limiting indirect costs. 
• Intangible costs: are often unquantifiable and difficult to measure, but 
can include the effect of disease on third party individuals, examples 
could include, if an individual were on long term sick with LBP, this 
can impact on the morale of the colleagues having to cover additional 
workload, or activities or important events missed by family members 
due to parental incapacity with LBP. 
(Odole et al. 2011) 
International economic burden: 
The burden of LBP upon international communities and economies is 
considerable (Costa et al. 2009).  The WHO (2013) determined LBP to be the 
leading cause of activity limitation and absence from work throughout the 
world.  As with other healthcare measures the measures of burden upon 
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economies between countries and within individual countries is varied, with 
limited consistency in measurement of data (Hoy et al. 2010). 
In the USA in 2002 annual direct health care costs related to back pain care 
specifically were estimated at $17.7 billion, (Mychaskiw and Thomas, 2002).  
An alternative estimate calculated the economic cost to be $105.4 billion (Van 
der Roer et al. 2005).  Both these estimates used data from the Medical 
Expenditure Panel Survey (MEPS) and the principle explanation for the 
difference in estimates, is the latter study reported all healthcare costs for 
individuals suffering LBP, as opposed to direct healthcare cost specifically 
attributable to LBP (Parthan et al. 2006).   An alternative estimate of direct 
healthcare costs of LBP was $85 billion dollars nationally in 2005, which 
reflected a vast increase from the 2002 $17.7 billion estimate and a reported 
65% increase in cost from 1997 (Martin et al. 2008).  In 2010 it was suggested 
that LBP was the fifth most common reason to access health care in the USA 
with an annual spend of $30 – $50 billion on LBP treatment specifically 
(Waterman et al. 2010; Chou and Chekelle, 2010). 
Lost revenue in the USA, due to indirect costs and lost working days was 
estimated at $22 billion in 2005, this estimate included medication costs, 
medical consultations and hospitalisation (Parthan et al. 2006), while an 
earlier estimate of the annual productivity loss was at $34 billion, the estimate 
included costs of health care utilisation, wage estimates and productivity and 
disability (Rizzo, Berger and Abbott, 1998).  Additional to lost revenue 
approximately 2% of the work forces within the USA were financially 
compensated for their occupational back pain injuries annually (Della-
Giustina, 2015).  The total inclusive costs related to LBP were estimated to 
be in excess of $100 billion per year (Crow and Willis, 2009). 
In Germany LBP was reported as one of the major causes of work 
absenteeism and disability in the country (Neuhauser et al. 2005).  Another 
German study measured their economic costs on a per patient basis, with 
annual direct costs estimated at 7000 euros per person for LBP sufferers and 
work absenteeism accounting for 75% of total per patient cost of LBP in 
Germany (Juniper, Le and Mladsi, 2009).  
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In Sweden a study calculated that in addition to direct costs, the indirect costs 
were extensive for those with LBP.  Direct costs were estimated at 3,100 
euros, whereas indirect costs were estimated at 17,600 euros per LBP patient 
(Ekman et al. 2005). 
Maniadakis and Gray (2000) stated over 17 years ago there was a lack of 
economic and incidence data on LBP, a condition whose impact was so 
extensive and costly.  Though further data has become available there 
continues to be limited exploration on this subject and a lack of consistent 
measurement and reporting of economic data (Hoy et al. 2014). 
UK economic burden: 
LBP accounts for 11% of the total disability within the UK population, 
implicating LBP as the greatest singular source of incapacity of a non-fatal 
condition within the UK (Greenough, 2016; Sivasubramaniam et al. 2015).  
Year Estimated Cost Area measured Reference 
1998 £1632 million Direct healthcare costs to the NHS 
Maniadakis and 
Gray, 2000 
1998 £11 billion Indirect and direct costs in the UK 
Maniadakis and 
Gray, 2000 
2001 £12.3 billion 
Associated societal cost. 
(2.5 million individuals in the UK 
were reported to have back pain on 
every single day of the year, 22% 
of UK healthcare spend) 
PCC, 2010 
2002 £69 million 
Retrospective cohort study in 
UK primary care, determined 
4.6 million GP appointments 
(equivalent of 793 fulltime GP 
roles) 
Belsey, 2002 
2003 
£481 million 
£197 million 
Per year to NHS 
Private consultations 
PCC, 2010 
2007 £1.1billion NHS Critchley et al. 2007 
Table 1.2: Estimated cost of low back pain in the UK 
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Economic cost and healthcare cost estimates vary greatly across studies due 
to their dependence upon cost-of-illness approximations, fundamental 
suppositions, and the differing study methodologies and measurement 
analyses used across the data sets (Phillips, 2006).  Various annual estimates 
have been identified, detailed in table 1.2; however there appears to be a lack 
of agreement.  The estimated cost discrepancies may in part be due to the 
varying data collection methods used. 
Current reported NHS cost data for LBP within the UK is lacking, however 
economic analysis data is available from other organisations and government 
departments, detailed in table 1.3. 
Year Estimated Cost Area measured Reference 
2017 
3.2 million  
working days lost due to LBP,  
16.5 working days were lost on 
average to each LBP case 
Reported 194,000 
cases of LBP existed 
within the labour 
workforce in 2016/17 
The Health 
and Safety 
Executive 
(HSE) 
2008 
33% of LBP sufferers had a 
recurrence of symptoms that 
caused their repeated absence 
from work  
An occupational 
survey in Northern 
Ireland 
NIAO, 2008 
2007 
Five million working days were 
lost each year 
Half a million people receive a 
long-term state incapacity benefit 
Chartered Society of 
Physiotherapy (CSP) 
report 
CSP, 2007 
2003 
£1.4 billion 
estimated the cost of benefits paid 
to individuals afflicted by LBP 
£3.8 billion 
additional lost productivity 
estimated 
The Department for 
Work and Pensions 
(DWP) 
PCC, 2010 
Table 1.3: Estimated economic cost of low back pain in the UK 
No further updates on LBP have been reported or are available from the 
Office of National Statistics (2017) or NHS digital (2017).   
An often-additional cost and impact upon society are what are described as 
“hidden costs”, an example of this is the nature and quality of care provided 
in general practice being variable across the UK.  Some patients are referred 
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to physiotherapists, orthopaedic consultants or to a pain management team, 
while others are given advice and prescribed medication with no onward 
referral (Fritz, 2012).  The implications for this variability to subsequent 
healthcare costs for delayed onward referral and thus chronicity of conditions 
is unknown, however it is suggested that the costs could be extensive (Care 
Quality Commission (CQC), 2017).Despite the extent and impact of LBP 
within the UK, there appears to be inconsistent measurement of LBP and its 
economic burden upon society.  Consistent data records would provide more 
accurate and current measures of the economic burden of LBP; however, 
burden of disease is often not a principle driver for decision making, data on 
the cost of improving quality and length of life is more usually focused upon 
(Kennelly, 2017).  
Interestingly though of all the economic analysis studies undertaken of all 
conditions, it was reported that LBP was found to be one of the costliest 
conditions to the UK economy.  A finding also reflected internationally (Fritz, 
2012). 
1.4 Prognosis of Low Back Pain 
Individuals with their first incidence of LBP have a relatively good prognosis, 
with 60 – 70% recovering within six weeks and 80 – 90% improving within 
twelve weeks.  The 10 – 20% who do not recover by twelve weeks (chronic 
LBP) have an uncertain outcome, with treatment and prognosis amongst this 
group being variable (Forward et al. 2008; Anderson, 1999; Frank et al. 
1996). 
Chronic LBP sufferers have a poor prognosis of full recovery, with 62% 
having LBP for beyond twelve months (Milczarek, 2009).  Recurrent injuries 
occur for these individuals and 33% experiencing a recurrence requiring their 
absence from work (Milczarek, 2009; NIAO, 2008). 
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1.5 Management of Low Back Pain 
Accessing the appropriate treatment at a suitable time can be key to improving 
the prognosis of an individual’s LBP, and extensive literature and advice is 
available to encourage self-care and treatment, for LBP (CSP, 2017; Fritz, 
2012).  However, accessing the most appropriate advice specific to an 
individual can be inherently difficult, due to limited access, limited 
knowledge and the variety of information available (CQC, 2017).  As 
mentioned previously it is noted that those from disadvantaged groups have 
been reported to be less likely to be offered treatments or diagnostic 
interventions and thus suffer a poorer prognosis (Hartvigsen et al. 2018; 
Sharim et al. 2017; DoH, 2006). 
If individuals attempt to access treatment independently of the NHS, there are 
various professionals who offer treatment for LBP e.g. doctors, 
physiotherapists, chiropractors, osteopaths, acupuncturists, massage 
therapists, healing therapists (NICE, 2016) and various treatments are 
available e.g. exercise, education, physiotherapy, manual therapy, ultrasound, 
acupuncture, CBT, magnet therapy, hypnosis (Parthan et al. 2006).  These 
diverse disciplines and treatments offer techniques with varying underlying 
principles, evidence and likely effectiveness; however, the public may find it 
difficult to discern which is the appropriate treatment to aid their condition.  
On-line access to information and social media provides greater information 
resource but this can also be misleading in guiding treatment and prognosis, 
as presented information may inflate claims of effectiveness or be untrue 
(Advertising Standards Authority (ASA), 2010). 
Several treatment interventions are researched, available and used globally 
for LBP (see figure 1.5). 
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Figure 1.5: Interventions for LBP (adapted from Parthan et al. 2006) 
Comprehending the vast expanse and quality of research available for all LBP 
interventions is impossible for professionals, many of whom rely upon 
systematic reviews and clinical guidelines to summarise the key information 
(Vale et al. 2015). 
In England and Wales, the NICE guidelines are one source of information 
often used to guide clinical staff in relation to best available evidence and 
practice.  NICE guidelines for LBP were produced in 2009 and updated in 
2016 (NG88 2009 & NG59 2016). The change in recommendations between 
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Physical	therapy	/physiotherapy
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Spinal	manipulation
Hot/cold	packs
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these two guidelines and the removal of acupuncture from the 2016 guideline 
recommendations is discussed further in Chapter two. 
1.6 Combining a Complex Condition with Complex interventions 
LBP has long been considered a complex condition with multiple facets.  As 
such, some argue that it should be treated aggressively using a 
multidisciplinary approach, with treatment aiming to address all aspects of 
the condition including the physical symptoms, psychological aspects and 
functional restoration (Salerno, Browning and Jackson, 2002).   
Many of the individual interventions used for LBP are also considered 
complex in their nature and teasing out the therapeutic effectiveness of 
specific single interventions remains challenging.  Defining the actual 
components (which are active, and which are inert) of a complex intervention 
is possibly the most challenging part of evaluating a complex intervention 
(Campbell et al. 2000). 
Complex interventions are used widely within healthcare and are considered 
as interventions with several interacting components.  Acupuncture and 
manual therapy are two such interventions, which will be considered within 
this thesis due to their recommendation in the NICE LBP guidelines in 2009 
as presented in chapter two, section 2.6. Evaluating the complexities of these 
interventions is challenging for researchers with many RCT methodologies 
lacking the sensitivity to comprehend the causal relationships and their 
intricate associations (MRC, 2008).   
The Medical Research Council (MRC) established a framework and guidance 
for developing RCTs for complex interventions in 2000 and updated their 
guidance in 2006 (MRC, 2008), the MRC are currently updating the guidance 
and this is due to be published in 2019 (Skivington et al. 2018). The adoption 
of this framework is widely considered to be good practice when researching 
the development and effectiveness of complex interventions and the 
framework was current at the time of conducting the trial for this thesis.  The 
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MRC guidance highlighted the concept of ‘Process Evaluation’ of complex 
interventions, partly due to the effect sizes within RCT’s not providing policy 
makers with substantial information for replication in clinical practice (Moore 
et al. 2015).  Recognising the importance of process evaluation was 
established within the updated MRC guidelines, as it: 
“can be used to assess fidelity and quality of implementation, clarify 
causal mechanisms and identify contextual factors associated with 
variation in outcomes.”  
(Craig et al. 2008, page 3) 
Prior to the development of the MRC framework, researchers generally 
focused upon a uni-faceted approach, often comparing single interventions to 
usual care, various forms of placebo or considering a single intervention in 
head to head comparisons for LBP. 
Understanding complex interventions is an on-going area of research and 
development.  The MRC recognises the need to understand how complex 
interventions work and are currently funding investigations of causal models 
of complex interventions in an attempt to determine how the mechanisms of 
action of interventions occur and how the variables of a mechanism influence 
one another (MRC, 2018). 
In clinical practice, healthcare professionals rarely deliver single 
interventions but rather a package of interventions.  The combination 
approach adopted by many is commonly considered more useful and may 
incorporate for example; exercise, advice, manipulation, massage and 
acupuncture, all within a single treatment session (Salerno et al. 2002).  
Establishing which components are therapeutic and which are inert continues 
to be open to debate (Gleiss, 2017).  Adopting a pragmatic inclusive approach 
to the research process for LBP and combining interventions within research 
studies may deliver results more closely mapped in clinical practice.  Thus far 
current research design may be failing to reflect current clinical practice 
(Salerno et al. 2002) and has not provided definitive statement on treatments 
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to enable the development of a comprehensive, effective pathway of care for 
LBP. 
A complex condition like LBP may be suited to a multi-faceted package, 
combining complex interventions; this may be a more useful approach and 
may prove to be a more successful resolution for the treatment of LBP 
(Salerno et al. 2002).  Therefore this thesis and the associated pilot RCT will 
investigate the comparison and combination of acupuncture and manual 
therapy treatments for LBP; this will be outlined in chapter four. 
1.7 Conclusion 
This chapter has provided an introduction and described the condition of LBP, 
highlighting its burden upon society.   The impact of LBP both on the 
population and the economy internationally is substantial (Clark and Horton, 
2018) and necessitates the need for further investigation. 
With the aetiology of LBP frequently remaining unclear, a variety of 
treatment options are currently adopted by clinicians (Parthan et al. 2006), 
gaining some clarity regarding the most effective treatment pathways for LBP 
through further research would be clinically useful. 
This chapter has started to build the case for continued research into the area 
of LBP.  It has highlighted the need to consider research design for complex 
interventions, which may also better reflect clinical practice.  Considering an 
approach to incorporate both acupuncture and manual therapy individually 
and combined may provide guidance into the most effective and clinically 
useful interventions for LBP and this will be explored in chapter two and 
three.   
1.8 Thesis Research Questions:  
• Are acupuncture and manual therapy and their combination 
approporiate and viable treatments of LBP? 
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• What are the international LBP recommendations for acupuncture 
and manual therapy? 
• Which RCT design could best evaluate acupuncture and manual 
therapy in the treatment of LBP? 
• Is high quality research available comparing and combining 
acupuncture and manual therapy for LBP? 
1.9 Structure of the thesis 
Chapter one:  I discussed LBP, its epidemiology, economic burden, causes 
and prognosis. I described some of the current treatments available for LBP.  
I outlined the complexities of assessing complex interventions for a complex 
condition and concluded with key research questions to be considered 
throughout this thesis. 
Chapter two:  In this chapter I present a review of systematic reviews of 
acupuncture and manual therapy for LBP and investigate if any available 
evidence compared or combined acupuncture with manual therapy.  I also 
review the systematic reviews of international clinical practice LBP 
guidelines, and the source international clinical practice guidelines, 
considering them in relation to the UK NICE guidelines and their 
recommendations specific to acupuncture and manual therapy.  The chapter 
critically examines the NICE LBP guidelines from 2009 and 2016, and I 
report upon the changes over time, and their evidence and recommendations 
of manual therapy and acupuncture.  I discuss the removal of acupuncture 
from the recent NICE guidelines (2016) and the uncertainty around its 
provision.  In this chapter I start to consider if acupuncture and manual 
therapy are appropriate interventions for the treatment of LBP. 
Chapter three:  I consider the strengths and weaknesses of RCT designs and 
the most appropriate design for a trial of acupuncture and manual therapy for 
LBP.  I provide the rationale for the use of a cohort design with a nested 
factorial RCT, exploring the impact of retention and recruitment to trials.  
Discussion and justification for using an active control group rather than a 
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placebo or sham arm within the trial is also given.  In this chapter I establish 
the basis for deciding which RCT design could best evaluate acupuncture and 
manual therapy for the treatment of LBP. 
Chapter four: In this chapter I justify the need for a pilot study, the 
professional group to take the lead on a study of LBP and which LBP outcome 
measures to utilise. I detail the aims, methodology and scientific procedures 
of the cohort investigation and embedded pilot RCT, which forms a major 
part of this thesis.  I present the recruitment rates, study documentation, 
justification for the choice of study population and inclusion and exclusion 
criteria.  The randomisation process and trial interventions are detailed, and 
the monitoring and methods of analysis are also presented. 
Chapter five:  I report the results of the pilot study and the use of the cohort 
study for recruitment to the nested factorial RCT. Providing a descriptive 
review of the information and participant data gained and the outcomes of the 
trial.  I present an exploratory analysis, though it was not planned for the pilot 
to be powered to demonstrate effectiveness within the RCT.  
Chapter six: In this chapter I discuss the results of the pilot study.  I consider 
recruitment for the trial, acceptance and retention rates and any issues arising 
from the RCT.  I discuss the results of the primary and secondary outcomes, 
the exploratory regression analysis and the comparison analysis of the two 
outcome measures, the results of the ancillary data and the sample size 
calculation.  I discuss the design of the RCT for evaluating a population with 
LBP, the new findings from this pilot and I conclude in a discussion of the 
strengths and weaknesses of the RCT and what impact this information will 
add to future investigations in this area of research. 
Chapter seven: I present a systematic review of acupuncture and manual 
therapy for LBP, which includes a meta-analysis including the data from the 
pilot RCT conducted for this thesis.  I present a GRADE quality assessment 
and recommendations, and a discussion of the available research and its 
quality.  The strengths and limitations of the review and the need for further 
evidence on acupuncture and manual therapy are discussed. 
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Chapter eight: Constitutes a summary of the thesis, I discuss key findings and 
identify limitations of the thesis and the pilot RCT.  I reflect upon proposed 
future research identified from this study, highlight what has been contributed 
to the research knowledge base and consider what a future study may 
constitute.  The chapter ends with conclusions from the thesis. 
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2 A literature review of acupuncture and manual 
therapy and a review of Clinical Guidelines for LBP 
2.1 Introduction 
In chapter one, I introduced the subject of LBP and laid the foundation for the 
study of this thesis.  In this chapter I present a review of systematic reviews 
(SRs) of acupuncture and manual therapy for LBP and investigate if any 
available evidence compared or combined acupuncture with manual therapy, 
to inform a potential pilot trial for this thesis.  I also present the current clinical 
LBP guideline recommendations internationally and I contextualise the 
international guidelines with the UK NICE LBP guidelines.  I critically 
examine the NICE guidelines for LBP from 2009 and the updated version in 
2016, and I discuss the disparities between the NICE guidelines, explore 
changes over time and reflect upon the most recent recommendations for the 
management and treatment of LBP.  Specific focus of the evidence provided 
for acupuncture and manual therapy is given. 
2.2 Literature review 
2.2.1 Aims and methods of literature review 
Aim of the literature review: 
• To review systematic reviews of acupuncture and manual therapy for 
LBP and to investigate if any available evidence compared or 
combined acupuncture with manual therapy for LBP 
Prior to conducting a pilot trial for this thesis, I conducted a literature review 
in March 2010 from the databases listed (Box 2.1).   The plan of this literature 
review was to inform a potential planned pilot trial of the current evidence 
base.  For the purpose of presenting this thesis, the search conducted in 2010 
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of systematic reviews, was repeated in 2018, to ensure all information 
provided in this thesis was updated, current and accurate.   
Box 2.1: Sources searched for previous systematic reviews of acupuncture 
and manual therapy, and their comparison or their combination for the 
treatment of LBP: 
 
• The Cochrane Library 
• The Cochrane Database of systematic Reviews 
• The Database of Abstracts of Reviews of Effects 
(DARE) 
• The Cochrane Database of Methodology Reviews 
• Health Technology Assessment (HTA) Database 
• NHS Economic Evaluation Database 
• PROSPERO International prospective register of 
systematic reviews 
• NIHR Health Technology Assessment Website 
http://www.ncchta.org 
• Centre for Reviews & Dissemination Website 
http://www.york.ac.uk/inst/crd 
• Pubmed (Medline) 
• The internet, including Google scholar  
(Montori et al. 2005) 
This search was conducted to establish the current available evidence.  All 
SR’s found, which considered acupuncture or manual therapy individually for 
LBP are detailed in sections 2.2.2.1 and 2.2.2.2 (tables 2.1 and 2.2). 
Since the aim of my thesis was to investigate if acupuncture versus manual 
therapy and their combination could be considered as effective treatments for 
LBP, the databases were also searched for systematic reviews, protocols and 
publications of acupuncture versus manual therapy, and acupuncture 
combined with manual therapy for LBP (section 2.2.2.3).   
 49 
I wanted to identify and explore if any existing systematic reviews, protocols 
or studies comparing or combining acupuncture with manual therapy were 
registered or currently planned, to avoid duplication and derive any lessons 
learned from the previously conducted systematic reviews.  Any similar or 
associated reviews were reviewed to see if they were current, comprehensive 
(including all the available evidence) and to review any limitations. 
2.2.2 Results of the literature review 
My literature review revealed that although reviews existed for acupuncture 
and manual therapy used separately for LBP, no systematic reviews compared 
acupuncture with manual therapy or combined acupuncture with manual 
therapy for LBP (section 2.3.3).  This indicates a potential need for further 
research in this area.   
The SRs identified were checked to see if any included RCTs compared or 
combined acupuncture with manual therapy for LBP and if any existed, they 
were reviewed and reported upon.    
2.2.2.1 Summary of systematic reviews of acupuncture for LBP  
Table 2.1 summarises the SR’s I found and further detail is provided within 
the narrative of this chapter. 
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Authors and Date Title 
Parameter 
dates 
Number of 
Studies Authors conclusions 
Liu, Skinner, 
McDonough, 
Mabire, Baxter 
(2015) 
Acupuncture for 
LBP: An overview 
of SR’s 
From 
database 
inception to 
February 
2014 
16 SRs 
Acupuncture as an adjunct to 
conventional therapy 
provides short term pain 
relief and functional 
improvement, further 
research required 
Zeng, Chung  
(2015) 
Acupuncture for 
chronic nonspecific 
low back pain: An 
overview of 
systematic reviews 
January 2003 
to May 2014 17 SRs 
Appears to be strong 
evidence for the 
effectiveness and moderate 
evidence for the cost 
effectiveness for the use of 
acupuncture in LBP 
Lam, Galvin and 
Curry (2013) 
Effectiveness of 
acupuncture for 
nonspecific chronic 
low back pain: a 
systematic review 
and meta-analysis 
From 
database 
inception to 
May 2012 
25 RCTs 
Reported acupuncture was 
favourable for self-reported 
pain however exerted 
caution in interpreting the 
results 
Lee, Choi, Lee, 
Lee, Shin, Lee, 
(2013) 
Acupuncture for 
acute low back pain: 
a systematic review 
From 
database 
inception to 
June 2011 
11 RCTs 
Determined the evidence 
was encouraging for 
favouring acupuncture over 
medication or sham but 
determined further evidence 
was required 
Furlan, Yazdi, 
Tsertsvadze, Gross, 
Van Tulder, 
Santaguida, 
Gagnier, 
Ammendolia, 
Dryden, Doucette, 
Skidmore, Daniel, 
Ostermann, 
Tsouros, (2012) 
A Systematic 
Review and Meta-
Analysis of 
Efficacy, Cost-
Effectiveness, and 
Safety of Selected 
Complementary and 
Alternative 
Medicine for Neck 
and Low-Back Pain 
From 
database 
inception to 
February 
2010 
147 RCTs 
Demonstrated short to 
medium effects of the CAM 
interventions compared to 
usual care, inconclusive 
results when compared to 
other interventions and 
negative results when 
compared to sham 
Standaert, CJ. 
Friedly, J. Erwin, 
MW. Lee, MJ. 
Rechtine, G. 
Henrikson, NB. 
Norvell, DC. (2011) 
Comparative 
effectiveness of 
exercise, 
acupuncture, and 
spinal manipulation 
for low back pain 
From 
database 
inception to 
December 
2010 
1 RCT 
Concluded insufficient 
evidence in this area 
Furlan, A. van 
Tulder, MW. 
Cherkin, D. 
Tsukayama, H. 
Lao, L. Koes, BW. 
Berman, BM. 
(2005) 
Acupuncture and 
dry-needling for low 
back pain 
1996 to 
February 
2003 
35 RCTs 
No firm conclusions of the 
effectiveness of acupuncture, 
some evidence for 
acupuncture being a useful 
adjunct to other treatments 
for LBP 
Ernst, White 
(1998) 
"Acupuncture for 
Back Pain: A Meta- 
Analysis of 
Randomized 
Controlled Trials." 
From 1969 to 
1996 12 RCTs 
Concluded acupuncture 
superior to various control 
interventions, insufficient 
evidence of superiority to 
placebo 
Table 2.1: Summary details of acupuncture SR’s included in literature search 
Two reviews (SR) were published in 2015.  Liu et al. (2015) conducted a 
computer-aided systematic literature search of databases, and reviewed SRs 
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of acupuncture for LBP to February 2014.  They included 16 SRs, and 
extracted the methodological qualities of the original RCT studies with 
judgement from the SR authors.  The external validity of the SRs was assessed 
using the revised STRICTA reporting guidelines (MacPherson et al. 2010) 
and quality assessment was conducted using an AMSTAR checklist.  They 
reported overall the methodological quality was low and external validity was 
weak of the included SR and the primary studies.  This review presented 
comprehensive methods and report of the results. They concluded 
acupuncture as an adjunct to conventional therapy provides short term pain 
relief and functional improvement, but concluded further knowledge was 
required, and additional effort required to improve the quality of both RCTs 
and SRs in this area (liu et al. 2015) their conclusions appeared appropriate 
to the literature presented.   
Zeng and Chung (2015) searched data from January 2003 to May 2014, for 
reviews published in English or Chinese in the Cochrane library, Allied and 
Complementary Medicine Database, Scopus and the Chinese Academic 
Journal (CAJ).  They included 17 SRs and assessed the methodological 
quality of the reviews using the Overview Quality Assessment Questionnaire 
(OQAQ) (the 17 SR were rated as 7 x 9/9, 3 x 7/9, 3 x 6/9, 1 x 5/9, 1 x 4/9 
and 2 x 2/9).  They reported all the SRs held positive findings for acupuncture 
in LBP, and concluded “there appears to be strong evidence for the 
effectiveness and moderate evidence for the cost effectiveness of the use of 
acupuncture”.  However the review presented limited methodological 
information, and while they presented the evidence of varying quality of the 
studies, they did not report how the quality of the studies impacted upon their 
conclusions.  Thus their positive conclusions of strong evidence for 
acupuncture for LBP appeared to be overstated, as only small to moderate 
effect sizes were reported, at least two SRs had presented inconclusive 
findings and one of the most recent SRs (Hutchinson et al. 2013) reported no 
difference between acupuncture and sham acupuncture in their review. 
Lam, Galvin and Curry (2013) reviewed research to May 2012 and examined 
25 individual studies.  They used the Cochrane risk of bias tool and identified 
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low methodological quality in many of the included studies and substantial 
heterogeneity across the studies.  Comprehensive methods, results and meta-
analysis were presented.  They reported acupuncture had clinically 
meaningful reductions of self-reported pain compared to sham (mean 
difference 16.75, 95% CI, -33.33 to -0.19), and improved function when 
compared to no treatment (standard mean difference = 0.94, 95% CI, -1.41 to 
-0.47), however they exerted caution in interpreting the results due to the 
limitations and the heterogeneity of the included studies.  The conclusions of 
this SR appeared to be a fair representation of the RCTs included. 
Lee et al. (2013) conducted a SR for acute LBP and identified 11 RCTs for 
consideration.  They reported significant methodological limitations in the 
RCTs.  The methods and results reported were reasonable but a meta-analysis 
was not conducted.  They reported that the evidence was encouraging for 
favouring acupuncture over medication or sham but they recommended that 
further evidence was required.  The author’s findings were positive and 
broadly representative of the RCTs reviewed. 
Furlan et al. (2012) conducted an extensive SR considering several areas of 
complementary and alternative medicine for low back and neck pain.  This 
SR considered studies published until February 2010, including 147 studies 
and the analysis reported pain intensity and disability.  Risk of bias was 
assessed using the Cochrane Collaboration Back Review Group (CCBG) 
criteria and their methods and results were comprehensively presented.  The 
review included 33 RCTs of acupuncture and 23 manual therapy 
(manipulation and massage) RCTs but noted the quality of the studies was 
low.  The results demonstrated short to medium effects of the CAM 
interventions compared to usual care, inconclusive results when compared to 
other interventions and negative results when compared to sham 
interventions.  Within the SR, one study of acupuncture versus manipulation 
for LBP (Giles and Muller, 2003) and its pilot study (Giles and Muller, 1999) 
were reported and their data were pooled as a sub-analysis of this review, it 
concluded that manual therapy was superior to acupuncture.  The SR was 
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comprehensive, including many types of intervention and the conclusions 
appeared to be a fair representation of the RCTs included. 
Hutchinson et al. (2012) reviewed acupuncture research for low back pain 
from 1950 to 2011, they identified 82 RCTs but only seven were included in 
the SR based on their inclusion criteria, reporting 72 studies were excluded 
based on including pregnant ladies and the elderly in their RCTs.  
Comprehensive information on the methods and results were presented, 
though no meta-analysis was conducted.  They indicated there was some 
evidence to suggest acupuncture was more effective than no treatment, but 
reported no conclusions could be drawn about its effectiveness over other 
modalities due to the conflicting evidence and poor quality of the studies. The 
author’s findings appeared to be representative of the RCTs reviewed. 
In 2011 a review attempted to investigate RCTs that compared the 
effectiveness of exercise, acupuncture, and spinal manipulation for low back 
pain. The review searched studies on MEDLINE and The Cochrane Library 
up to December 2010.  They found one study comparing exercise to spinal 
manipulation; however, they were unable to find evidence that compared 
acupuncture with spinal manipulation or exercise and concluded there was 
insufficient evidence in this area (Standaert et al. 2011). 
The systematic reviews listed below (also see table 2.1), were available in the 
March 2010 literature review and helped inform the planned pilot study for 
this thesis. 
Furlan et al. (2005) investigated the treatment of acupuncture for LBP from 
1996 to February 2003, they included 35 RCT with comparators of placebo, 
other interventions, no treatment or alternative acupuncture.  The methods 
and reporting of the SR and meta-analysis was comprehensive and concluded 
no firm conclusions could be made regarding the effectiveness of 
acupuncture, but found some evidence for acupuncture being useful in 
adjunct to other treatments for LBP.  Their conclusions appeared 
representative of the RCTs presented. 
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An earlier systematic review and meta-analysis by Ernst and White, 1998, of 
acupuncture for LBP searched databases from 1969 to 1996; 12 RCTs were 
included.  The methods and reporting of the SR and meta-analysis was 
comprehensive, while they identified an assessment of quality criteria there 
was no report of the assessment results.  It concluded that acupuncture was 
superior to various control interventions but there was insufficient evidence 
of its superiority to placebo (Ernst and White, 1998).  Their conclusions 
appeared representative of the RCTs presented. 
 55 
2.2.2.2 Summary of systematic reviews of manual therapy for LBP 
Table 2.2 summarises the SRs I reviewed; further detail is provided within 
the narrative of this chapter. 
Authors and 
Date Title 
Parameter 
dates 
No. of 
Studies Authors conclusions 
Furlan, 
Giraldo, 
Baskwill, Irvin, 
Imamura, 
(2015) 
Massage for low 
back pain 
From 
database 
inception to 
August 2014 
25 RCTs 
Reported having very little 
confidence in the effectiveness 
of massage for LBP 
Kumar, Beaton 
and Hughes, 
(2013) 
The effectiveness of 
massage therapy for 
the treatment of 
nonspecific low 
back pain: a 
systematic review of 
systematic reviews 
January 2000 
to December 
2012 
9 SRs 
Concluded that an emerging 
but very small evidence base 
existed, but indicated there was 
some evidence massage was 
effective for LBP in the short 
term 
Hidalgo, 
Detrembleur, 
Hall, 
Mahaudens, 
Nielens, (2014) 
The efficacy of 
manual therapy and 
exercise for different 
stages of non- 
specific low back 
pain: an update of 
systematic reviews 
From January 
2000 to April 
2013 
11 RCTs 
Concluded manual therapy to 
be effective and favoured it as a 
treatment when combined with 
exercise 
Slater, Ford, 
Richards, 
Taylor, 
Surkitt, 
Hahne, (2012) 
The effectiveness of 
sub-group specific 
manual therapy for 
low back pain: a 
systematic review 
From 
database 
inception to 
2010 
7 RCTs 
Concluded that manual therapy 
was effective for the treatment 
of LBP when compared to 
other treatment 
Rubinstein, 
Terwee, 
Assendelft, de 
Boer, van 
Tulder, (2012) 
Spinal manipulative 
therapy for acute 
low-back pain 
From 2000 to 
March 2011 20 RCTs 
Concluded manipulation was 
no more effective than inert 
interventions, sham or other 
recommended therapies 
Kuczynski, 
Schwieterman, 
Columber, 
Knupp, Shaub, 
Cook, (2012) 
Effectiveness of 
physical therapist 
administered spinal 
manipulation for the 
treatment of low 
back pain: a 
systematic review of 
the literature 
From 
database 
inception to 
May 2012 
6 RCTs 
Concluded spinal manipulation 
was safe delivered by physical 
therapists, the evidence 
supports its use, with 
improvement of clinical 
outcome 
Assendelft, 
Morton, Yu, 
Suttorp, 
Sheklle, (2004) 
Spinal Manipulative 
Therapy for Low 
Back Pain 
From 
database 
inception to 
January 2000 
39 RCTs and 
Q-RCTs 
Determined no clinically 
relevant difference between 
spinal manipulation and other 
interventions for LBP 
Table 2.2: Summary details of manual therapy SR’s included in literature search 
Furlan et al. (2015) conducted a SR of massage for LBP, reviewing databases 
to August 2014, (updating the 2008 SR of massage) they included 25 RCTs 
and the methods, results and meta-analysis presented were comprehensive.  
 56 
The authors stated that the quality of the studies was low and reported having 
very little confidence in the effectiveness of massage for LBP.  Their 
interpretation appeared representative of the RCTs presented. 
A systematic review of SRs of massage for low back pain (Kumar, Beaton 
and Hughes, 2013) searched databases from January 2000 to December 2012 
and included nine SRs.  They reported significant methodological flaws in the 
primary research and concluded that an emerging but very small evidence 
base existed.  A meta-analysis was not conducted.  They indicated there was 
some evidence massage was effective for LBP in the short term. With the 
poor quality of some of the included SRs and primary research and the 
negative results of many of the SR, the conclusions of this SR appeared 
generous in nature.  
Hidalgo et al. (2014) reviewed evidence for manual therapy from 2000 to 
2013 and reported upon 11 RCT of medium to high quality with a low risk of 
bias.  The methods and results were comprehensive, and they concluded 
manual therapy to be effective and favoured it as a treatment when combined 
with exercise.  No meta-analysis was conducted but the conclusions appeared 
to be a fair representation of the studies included. 
Slater et al. (2012) searched databases for manual therapy for LBP to 2010, 
and included seven studies.  The methods and results were comprehensive, 
no meta-analysis was conducted, and they reported the quality of evidence 
was very low.  They concluded that manual therapy was effective for the 
treatment of LBP when compared to other treatment.  Their conclusions 
appeared not to consider the low quality of the RCTs and thus need 
interpreting with caution.    
Rubinstein et al. (2012) updated their 2004 systematic review of spinal 
manipulative therapy for acute LBP in 2012, they included 20 RCTs, the 
quality of the studies was assessed using GRADE, one third of the RCTs were 
considered high methodological quality but the remaining studies were 
considered low and very low quality.  The methods, results and meta-analysis 
of the SR were comprehensive, and they concluded spinal manipulative 
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therapy was no more effective than inert interventions, sham or other 
recommended therapies.  The conclusions reached appeared to be 
representative of the RCTs included. 
Kuczynski et al. (2012) conducted a SR of manipulation delivered by physical 
therapists (physiotherapists) they searched databases to May 2012 and 
included six RCTs for analysis.  The methods and results of the SR were 
comprehensive, and they concluded the use of spinal manipulation was safe 
when delivered by physical therapists and the evidence supported its use, with 
improvement in clinical outcome.  However they did note there was a lack of 
a true control group and a risk of bias across all the included studies. A meta-
analysis was not conducted.  The conclusions appeared to be a fair 
representation of the results presented. 
The SR shown below (also see table 2.2) was also available in the March 2010 
literature search and helped inform the planned pilot study for this thesis. 
Assendelft et al’s (2004)  review of spinal manipulation for low-back pain 
searched databases up to January 2000, and 39 RCTs and quasi-randomised 
trials, with comparators of other manual therapies or no treatment were found.  
They reported that quality varied, but quality improved in more recent studies.  
The methods, results and meta-analysis were comprehensive, and they 
determined there was no clinically relevant difference between spinal 
manipulation and other interventions for LBP; they did not consider 
acupuncture in their review.  The findings appeared representative of the 
RCTs presented. 
2.2.2.3 Acupuncture versus manual therapy for LBP 
One systematic review was found which attempted to compare exercise, 
acupuncture and manual therapy for LBP (Standaert et al. 2011, detailed in 
section 2.3.3), however it uncovered only a single publication for its review, 
which compared spinal manipulation with exercise for LBP.  They concluded 
insufficient evidence was available in this area.   
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No systematic reviews or primary research were found combining 
acupuncture with manual therapy for LBP.   
There were no protocols comparing or combining acupuncture with manual 
therapy for LBP registered in 2010, and this remained the case in 2018, with 
no new or current review protocols registered.  While no protocols compared 
or combined acupuncture with manual therapy; one SR protocol of 
acupuncture only for (sub) acute non-specific LBP (Furlan et al. 2011) was 
found on the Cochrane database, and one SR protocol of manipulation only 
for LBP (Blanchette et al. 2015) was found on the BioMed Central (BMC) 
database.   
Three individual studies (Giles et al. 2003; Cherkin et al. 2001; Giles et al. 
1999) were identified from this literature review.  The three studies compared 
acupuncture with manual therapy for LBP, and these studies all reported 
manual therapy to be favourable to acupuncture.  These three studies are 
detailed in full in chapter seven, as part of the systematic review conducted 
for this thesis.   
2.2.3 Evidence summary and conclusions 
As detailed above, eight acupuncture SRs for LBP from 1998 to 2015 were 
reviewed.  Two (Liu et al. 2015; Furlan et al. 2005) indicated acupuncture as 
an adjunct to conventional therapy was effective, and six (Liu et al. 2015; 
Zeng et al. 2015; Lam et al. 2013; Lee et al. 2013; Furlan et al. 2012; Ernst et 
al.1998) reported acupuncture to be effective when compared to usual care, 
medication or other interventions, but inconclusive when compared to sham.  
One (Furlan et al. 2005) concluded no firm conclusions could be drawn 
regarding the effectiveness of acupuncture for LBP (Furlan et al. 2005) and 
one reported insufficient evidence comparing acupuncture with spinal 
manipulation and exercise (Standaert et al. 2011).   
Of the seven manual therapy SRs for LBP from 2004 to 2015 reviewed, two 
concluded manual therapy (Hidalgo et al. 2014: Slater et al. 2012) and one 
concluded manipulation (Kuczynski et al. 2012) were effective; two 
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(Rubinstein et al. 2012: Assendelft et al. 2004) reported manipulation was no 
more effective than other interventions or sham.  One stated small but positive 
evidence for massage (Kumar et al. 2013) and one reported little confidence 
in the effectiveness of massage (Furlan et al. 2015).   
The primary research across all the acupuncture and several of the manual 
therapy reviews (Furlan et al. 2015; Kumar et al. 2013; Slater et al. 2012; 
Rubinstein et al. 2012; Kuczynski et al. 2012; Assendelft et al. 2004) was 
reported as low quality with a high risk of bias, and significant 
methodological flaws.  Only one manual therapy SR reported including 
medium to high quality studies with a low risk of bias in their review (Hidalgo 
et al. 2014).  Meta-analyses were conducted in only four acupuncture (Lam 
et al. 2013; Furlan et al. 2012; Furlan et al. 2005; Ernst et al.1998), and three 
of the Manual therapy SRs (Furlan et al. 2015; Rubinstein et al. 2012; 
Assendelft et al. 2004), therefore the increased statistical power of combining 
results, and the improved estimates of effect sizes associated with meta-
analyses, and thus greater confidence in the results, was not afforded to those 
SRs. 
No SRs comparing acupuncture with manual therapy or combining the 
interventions were found in 2010.  In 2018, one SR was found but as 
discussed, they concluded insufficient evidence existed (Standaert et al. 
2011).  Three individual studies (including one pilot study) comparing 
acupuncture with manual therapy were discovered in the initial 2010 search, 
these were conducted between 1999 and 2003.  No further individual studies 
comparing the interventions were found in 2018. 
No SRs or studies combining the acupuncture or manual therapy were found 
in 2010 or 2018 (other than the 2014 pilot study for this thesis).   
At the time of my 2010 literature search only two acupuncture SRs (Furlan et 
al. 2005; Ernst et al. 1998) and one manual therapy SR (Assendelft et al. 2004) 
were available to inform the planning of the pilot RCT.  Very limited evidence 
was available comparing acupuncture with manual therapy for LBP and no 
evidence available combining acupuncture with manual therapy for LBP.  In 
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addition much of the evidence was based on studies with significant 
methodological limitations and risk of bias.  Therefore from this review I 
determined there was a requirement for a further high quality RCT study into 
the effectiveness of acupuncture and manual therapy for LBP.   
The additional research identified in 2018, after my 2010 review, remained 
limited in the comparison and combination of acupuncture and manual 
therapy for LBP, and the methodological and bias limitations persisted.   
Further research of high quality and rigorous methodological design was 
indicated in this area, to contribute to the knowledge base. 
In the following sections of this chapter, I shall consider the international 
clinical practice guidelines, and how the available evidence for acupuncture 
and manual therapy was interpreted to inform the guidelines. 
2.3 Clinical practice guidelines 
Healthcare is a complex field with vast quantities of research of varying 
quality.  Clinical guidelines are introduced and developed to provide guidance 
in the treatment of conditions, promote best evidence-based practice, reduce 
variation in treatment delivery, minimise the use of low-value interventions 
and thus improve patient care (O’Connell et al. 2017; Koes et al. 2010).  They 
guide clinical practice, but are not necessarily intended to dictate clinical 
practice or to become regulatory for healthcare.  Nevertheless they have had 
a tendency to become a prescription for best practice with one size fits all 
pathways, which can inevitably fail some individuals (Ault, 2018).  However, 
NICE does refer to the responsibility of a treating practitioner:  
“…the guideline does not override the individual responsibility of 
healthcare professionals to make decisions appropriate to the 
circumstances of the individual patient…” 
(NICE, 2016b, page 2; NICE, 2009c, page 1) 
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Early guidelines for LBP were less than popular amongst healthcare 
practitioners.  In the USA the Agency for Health Care Policy and Research 
(AHCPR) produced a LBP guideline in 1994, which was opposed by 
powerful professional and commercial forces, to the detriment of the health 
service they intended to advise and support.  Individuals demanded access to 
all interventions, as per the guideline and litigation suits and claims of sub-
standard treatment ensued, a costly and lengthy process for the Health Service 
and Government (De Jong, 1995).   
Delegated authority for guideline development in the USA was subsequently 
established and significant progress in the acceptance of guidelines ensued.  
Progress, in part, has occurred due to the involvement of healthcare 
professionals in the process, improvement and continually evolving guideline 
development process, peer review, improvement in the standards of 
guidelines, the quality and quantity of research, and advancements in medical 
interventions (WHO, 2014; Pillastrini et al. 2012; Bouwmeester, van Enst and 
van Tulder, 2009).  Further efforts to support guideline acceptance remain a 
priority and efforts are continuing (Ault, 2018; O’Connell et al. 2017; Fischer 
et al. 2016; Glasgow et al. 2012).   
Once developed, the implementation of guidelines is then required, which 
constitutes another hurdle.  It is suggested that integrating recommendations 
from guidelines into clinical practice takes time, with the passage of time 
dependent upon the adaptations required by services and current clinical 
practice (NICE, 2016b).  NICE (2016b) recommend aligning changes in 
recommendations to local priorities for the most effective outcome and 
transition of recommendations into clinical practice. 
The process for disseminating clinical practice guideline recommendations is 
described as passive (Gad El-Rab, Zaïane and El-Hajj, 2017) with further 
support required for extracting information and facilitating it through to the 
clinical decision-making process needed (Gad El-Rab et al. 2017; O’Connell 
et al. 2017; Birch, Alraek, Lee, 2016; Ament et al. 2015). 
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A recent pilot survey of GP’s concluded that their decision to offer access to 
acupuncture did not reflect their awareness of available guidelines; and 
reported acupuncture was most often accessed for pain relief for various 
musculoskeletal conditions including LBP.  The study concluded that GP’s 
often expected recommendations in guidelines when they were not in fact 
made (Czarnawska-Iliev et al. 2016). 
As with all clinical practice, it is essential for healthcare professionals to take 
into account the most recent evidence, to inform their decision-making 
process in the delivery of care for LBP (O’Connell et al. 2017).  However 
there remains uncertainty over the most appropriate management of LBP 
(Darlow et al. 2014).  It would be anticipated that guidelines based on the 
same international evidence base would be similar, however 
recommendations can be conflicting (Koes et al. 2010).  The production of 
over 39 different clinical guidelines for LBP, were reported internationally 
(Lonnemann et al. 2012).   
Over time the general development and methodological quality of the 
guidelines has improved (Pillastrini et al. 2012), however there is a continued 
need to improve the development and quality of clinical guidelines (Pillastrini 
et al. 2012).  It has been suggested that clinical practice guidelines are based 
on RCT evidence and expertise from solely wealthy countries and focus on 
treatment such as medication, and surgery and do not focus upon prevention 
and long term solutions.  There is movement however for the redesign of 
treatment pathways and focus upon prevention to reduce LBPs impact and 
disability (Foster et al. 2018). 
Healthcare professionals often assume consistency in recommendations 
across clinical practice guidelines.  In section 2.4, I report my review of SRs 
of international clinical practice guidelines and consider the similarities and 
differences across the published international guidelines. 
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2.4 Systematic Reviews of International Clinical Practice 
Guidelines 
With the existence of many international guidelines there have subsequently 
been systematic reviews comparing clinical practice guidelines for low back 
pain and these are discussed below. 
Prior to reviewing the international clinical practice guidelines, I conducted a 
search of available SRs of clinical practice guidelines to appraise the current 
evidence. 
2.4.1 Aims and methods 
Aim of the review: 
• To review systematic reviews of clinical practice guidelines for LBP  
In 2018, I conducted electronic database and internet searches for systematic 
reviews of clinical practice guidelines, for the period of 2000 to 2017.  The 
SRs needed to include LBP guidelines, including information on the 
diagnosis and treatment of LBP.  I extracted data regarding the included 
guidelines, the diagnosis and treatment of LBP and the methods of the SRs. 
2.4.2 Results of SRs of clinical practice guidelines 
Three SRs were identified and included in my review and are detailed below. 
Koes et al. (2001, 2010):  In 2001, a review included the clinical practice 
guidelines from 11 countries, published between 1994 and 2000.  One 
guideline for each country was included; if multiple updates had occurred the 
most recent publication was included.  Systematic review methods were used, 
using electronic databases and the methods were comprehensive and 
appeared robust.  Four authors were used to extract data from three or four 
guidelines, they reported using the same data categories of their 2001 review, 
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however limited detail was provided and no information regarding 
consistency or any disparities between the authors extraction was given, 
limiting the transparency of the review.   
The review established that similar recommendations were found between the 
diagnostic classification and therapeutic interventions.  However, 
discrepancies between recommendations on exercise therapy, spinal 
manipulation, muscle relaxants and patient information were found (Koes et 
al. 2001). 
In 2010, the 2001 systematic review was updated and included 13 national 
clinical guidelines and two international clinical guidelines from Europe, (one 
for acute LBP and one for chronic LBP) (Koes et al. 2010).  The search 
extended the previous review from 2000 to 2008 and guidelines from the 2001 
review were also checked for updates.  One guideline was selected for each 
country; the selection was based upon the most recent guidelines published.  
Table: 2.3 lists the guidelines included within the 2010 systematic review. 
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Country Title Author 
Australia, 2003 
Australian acute musculoskeletal pain 
guidelines. 
Evidence-based management of acute 
musculoskeletal pain. 
Bowen Hills: Australian 
Academic Press; 2003 
Austria, 2007 
Evidence and consensus based Austrian 
guidelines for management of acute and 
chronic nonspecific backache 
Friedrich, M. Likar, R. 
2007 
Canada, 2007 
An interdisciplinary guideline development 
process: The Clinic on Low-back pain in 
interdisciplinary Practice (CLIP) low-back 
pain guidelines 
Rossignol et al, 2007 
European 
guidelines, 2004 
European guidelines for the management of 
acute nonspecific low back pain in primary 
care 
van Tulder et al, 2006 
European 
guidelines, 2004 
European guidelines for the management of 
chronic nonspecific low back pain Airaksinen et al, 2006 
Finland, 2008 Low back pain among adults.  An update within the Finnish current care guidelines Malmivaara et al, 2008 
France, 2000 
Guidelines department, diagnosis and 
management of acute low back pain (<3 
months) with or without sciatica & diagnosis, 
management and follow-up of patients with 
chronic low back pain 
Agence Nationale 
d’Accreditation et 
d’Evaluation on Sante 
(Agence, 2000) 
Germany, 2007 Recommendations for treatment of low back pain Drug, 2007 
Italy, 2006 
Diagnostic therapeutic flow-charts for low 
back pain patients: the Italian clinical 
guidelines 
Negrini et al, 2006 
New Zealand, 
2004 New Zealand Acute Low back pain Guide NHC, 2004 
Norway, 2007 New clinical guidelines for low back pain Laerum et al, 2007 
Spain, 2005 
Lumbalgia Inespecifica. Version espnola de 
la Guia de Practica Clinica del Programa 
Europeo COST B13 
Spanish Back Pain 
Research Network (2005) 
The Netherlands, 
2003 
Clinical guideline for non-specific low back 
pain 
Dutch Institute for 
Healthcare Improvement 
(CBO) 2003 
United Kingdom, 
2008 Back pain (low) and sciatica 
Clinical knowledge 
summaries (CKS) NICE, 
2008 
United States, 
2007 
Diagnosis and treatment of low back pain: a 
joint clinical practice guideline from the 
American College of Physicians and the 
American Pain Society 
Chou et al, 2007 
Table 2.3: Systematic review of clinical guidelines 2010 (Koes et al. 2010) 
Koes et al. (2010) reported their expectation was to discover similar guideline 
recommendations, as the guidelines were all based on the same international 
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evidence.  Similar recommendations remained in place from the 2001 review, 
with specific diagnostic triage and classification, following a red flag 
diagnostic process and physical examination (though European guidelines 
advocate a limited neurological screen comparative to the other guidelines).  
Diagnostic imaging was not recommended for routine cases in any guidelines.  
Recognition of psychosocial factors (yellow flag systems) was seen across all 
the guidelines, though variation in the detail of assessing these factors was 
seen.  Table 2.4 summarises the common diagnostic recommendations:   
Common Recommendations for Diagnosis of Low back pain 
Diagnostic triage  
(non-specific low back pain, radicular syndrome, serious pathology) 
Screen for serious pathology using red flags 
Physical examination for neurological screening  
(including straight leg raise test) 
Consider psychosocial factors  
(yellow flags) if no improvement 
Routine imaging not indicated for non-specific low back pain 
Table 2.4: Summary of recommendations for diagnosis of LBP (Koes et al. 2010) 
Therapeutic interventions recommended are summarised in table 2.5, across 
all the guidelines these included the discouragement of bed rest, the 
recommendation of multidisciplinary team approaches, chronic pain 
supervised exercise programmes and cognitive behavioural therapy.  
Though significant consistency is seen across the international guidelines, 
variations were reported. Discrepancies concerning prescription medication 
remain across the guidelines.  Paracetamol was generally recommended along 
with non-steroidal anti-inflammatories, however vast differences were seen 
for the recommendation of opioids, muscle relaxants, benzodiazepines and 
anti-depressants despite the evidence base being consistent.  It is suggested 
that cultural norms of medication use in each country may explain the 
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variation (Koes et al. 2010).  Spinal manipulation remained variable from the 
previous review in 2001.  Across the guidelines some recommended 
manipulation or advised it as a short-term therapeutic option, and others did 
not recommend it.  This was attributed to evidence not being robust enough 
for consistent recommendation, allowing interpretational differences at 
guideline committees (Koes et al. 2010).   Koes et al. (2010) noted the 
differences were less than may be anticipated when considering varying 
cultures and healthcare systems, and they attributed the differences to 
disparities in local care systems and lack of robust evidence for some 
interventions.   
Common Recommendations for the Treatment of Low back pain 
Acute or Sub-acute Pain  Chronic Pain  
Reassure patient 
(favourable prognosis) 
Ultrasound & electrotherapy -          
not recommended 
Recommended to remain active Medication – short term use 
Medication as indicated Manipulation – short term use 
Bed rest discouraged Supervised exercise therapy -
recommended 
Supervised exercise programmes –   
not recommended 
Cognitive behavioural therapy - 
recommended 
 Multidisciplinary approach - 
recommended 
Table 2.5: Summary of recommendations for the treatment of LBP (Koes et al. 2010) 
The included guidelines were based on scientific evidence, consensus from 
committee discussion and expert opinion.  However the guideline reports did 
not disclose detail of which decisions were influenced by committee 
consensus or expert opinion and did not publish the committee or expert 
discussions, limiting transparency of the guidelines in the review.  
Additionally, limited focus on whether cost effectiveness data influenced 
decisions was not reported across the guidelines (Koes et al. 2010). 
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The Koes et al. 2010 update established there had been minimal changes to 
the guideline recommendations a decade on.  The key developments included 
no longer recommending MRI and CT scans for routine cases and taking a 
more robust approach in the consideration of psychosocial factors to prevent 
chronicity.  Therapeutically, exercise therapy held a firmer position in the 
recommendations, along with remaining active and returning to work as soon 
as possible.  Some clarity regarding primary and secondary medication 
approaches and when to refer to primary or secondary care were provided but 
overall the management of LBP since the 2001 review remained consistent.  
It may be that LBP was being managed appropriately as per the earlier 
guidelines, or that sufficient new evidence had not been established for 
amendments to be made to the recommendations (Koes et al. 2010). 
Koes et al (2010) reported all the included guidelines were based on a 
comprehensive literature reviews (Cochrane library, Medline, Embase, 
PEDro) using systematic review methods, with most guidelines adopting a 
weighting of the strength of evidence and rating of evidence to determine their 
recommendations.  Three committees (Austria, Germany and Spain) based 
their evidence entirely or in part on the European LBP guidelines.  Previous 
guidelines and literature reviews are reported as more frequently becoming 
the starting point for new searches and guidelines (Koes et al. 2010). 
The 2010 review by Koes et al. (2010) presented only national 
multidisciplinary guidelines and did not include an exhaustive list of all 
clinical guidelines, and many guidelines therefore were not included within 
this review.  This review was an update of the 2001 review however no 
planned follow up of the review is reported. Koes et al. (2010) acknowledged 
this as a limitation of their review.   An additional limitation transpires due to 
all the included guidelines originating from wealthy industrialised countries 
limiting the reviews global generalisability. 
Pillastrini et al. (2012): Pillastrini et al. (2012) conducted a systematic review 
including 13 clinical practice guidelines for LBP from eight separate 
countries and one European guideline. SR methods were used, and the 
methods appeared explicit and robust.  Electronic databases were searched 
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for clinical practice guidelines from 2002 to 2010.  Table 2.6 shows the 
included guidelines.   
Country Title Author 
United States, 
2005 
Institute for clinical systems improvement 
(ICSI): United States  ICSI, 2005 
United States, 
2007 
Diagnosis and treatment of low back pain: a 
joint clinical practice guideline from the 
American College of Physicians (ACP); 
American Pain Society low back pain 
guidelines panel (APS) 
Chou et al, 2007 
Canada, 2009 Guidelines for the evidence – informed primary care management of low back pain 
Institute of Health 
Economics, towards 
optimized practice (TOP) 
program, 2009 
Canada, 2007 Clinic on low back pain in interdisciplinary practice (CLIP) guidelines;  Rossignol et al, 2007 
Australia, 2002 Low Back Pain 
New South Wales 
Therapeutic Assessment 
Group Inc (NSW TAG) 
2002 
European 
guidelines, 2004 
European guidelines for the management of 
chronic nonspecific low back pain Airaksinen et al, 2006 
Italy, 2006 
Diagnostic therapeutic flow-charts for low 
back pain patients: the Italian clinical 
guidelines 
Negrini et al, 2006 
The Netherlands, 
2003 
National practice guideline for the 
physiotherapeutic management of patients 
with low back pain 
Bekkering et al. 2003 
United Kingdom, 
2009 
Low back pain: early management of 
persistent non-specific low back pain. 
National Collaborating Centre for Primary 
Care and Royal College of General 
Practitioners 
Savigny et al, 2009 
United Kingdom, 
2006 
Clinical guidelines for the physiotherapy 
management of persistent low back pain. 
Chartered Society of Physiotherapy 
Mercer et al. 2006 
Austria, 2007 Centre of Excellence for Orthopeadic Pain Management Speising (CEOPS) Friedrich & Likar, 2007 
Germany, 2007 Recommendations for the treatment of low back pain. 
Drug Committee of the 
German Medical Society, 
2007 
Germany, 2003 
The German College of General Practitioners 
and Family Physicians (DEGAM) low back 
pain guideline 
Becker et al. 2003 
Table 2.6: Systematic review of clinical guidelines 2012 (Pillastrini et al. 2012) 
The guidelines selected by Pillastrini et al (2012) in their review differed from 
those included by Koes et al. (2010) and appeared to focus more on specific 
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professional association guidelines as opposed to national guidelines, for 
example they included the Chartered Society of Physiotherapy Clinical 
Practice guidelines (CSP, 2007).  It was also the first review to include 
interventions such as acupuncture, hydrotherapy etc.   
As part of the review, three authors assessed the methodological quality of 
the identified clinical guidelines independently, using the Appraisal of 
Guidelines for Research and Evaluation (AGREE) tool.  13 guidelines were 
reported to be satisfactory, using effective literature review methods, scope 
and clarity, with adequate critical appraisal of the evidence and thus were 
included within the review. 
This review reported a strong consensus across the guidelines regarding 
diagnostic triage and prognostic factors, and an increased alignment of 
therapeutic interventions; which included exercise therapy, multidisciplinary 
approaches and combined physical and psychological interventions.  An 
improvement in the quality of chronic pain guidelines was noted in this 
review (Pillastrini et al, 2012). 
This review included guidelines which: 
• Addressed the clinical management of non-specific chronic LBP in 
primary care 
• Were published by a professional group 
• Were available in English, Italian or German languages 
• Stated recommendations for therapeutic interventions explicitly 
(Pillastrini et al. 2012) 
It is of interest that this review opted for guidelines published by professional 
groups, as this potentially may have excluded National guidelines if they were 
produced by a guideline development committee and not produced by a 
professional body such as the Chartered Society of Physiotherapy, or the 
Royal College of General Practitioners.  It may have been they were 
attempting to focus primarily upon clinical interventions delivered by 
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healthcare professionals, but Pallastrini et al. (2012) do not offer any rational 
or discussion to allow for understanding of their selection criteria. 
Pillastrini et al. (2012) determined the diagnostic recommendations continued 
to be consistent with Koes et al. (2010) findings, with no differences found, 
he also clarified the unified approach across the guidelines of focus upon 
identifying risk factors to prevent chronicity. 
Therapeutic recommendations were reported as more varied across the 
guidelines and this was attributed to the significant involvement of multiple 
disciplines in the management of LBP (Pillastrini et al. 2012) table 2.7 
summarises the key recommendations.  
Recommendations for the Treatment of Low back pain 
Educational interventions - recommended 
Manipulation – recommended or therapeutic option or not recommended 
Supervised exercise therapy - recommended 
Cognitive behavioural therapy - recommended 
Multidisciplinary approach - recommended 
Tens, biofeedback, lumbar supports, ultrasound, electro, laser therapy and 
traction – not recommended 
Table 2.7: Summary of recommendations for the treatment of LBP (Pillastrini 
et al. 2012) 
Pillastrini et al. (2012) discussed that although there was an array of 
conservative interventions available from physiotherapists, few were 
routinely recommended across the guidelines due to a varied evidence base.  
A strong consensus and evidence for exercise interventions was reported but 
advised a lack of clarity in type of or prescription of such exercises across the 
guidelines.  Consensus also existed in recommending combined physical and 
psychological interventions across the guidelines (Pillastrini et al. 2012).  
Spinal manipulation continued to not be consistently recommended across the 
guidelines, which Pillastrini et al. (2012) attributed to the continued 
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underlying conflicting evidence and the interpretation from the guideline 
development committees, he endorsed the need for future consensus on 
precise recommendations for manual therapy.  
Limiting their review to professional group publications only limited the 
scope of this review and thus the inclusion of the most current guidelines was 
not included within the review.  Additionally, two different clinical guidelines 
from the USA, Canada, the UK and Germany were included in the review, 
questioning the breadth of the review and limiting the international 
generalisability and detail of the review.  Pillastrini et al. (2012) offered no 
insight into their methodological reasoning and identified no limitations of 
their review.  They focused solely on the limitations and recommendations of 
the included guidelines.  Pillastrini et al. (2012) recommended future 
guidelines should adopt the GRADE framework to grade evidence and inform 
recommendations (GRADE, 2004) to limit confusion and allow international 
consistency and collaboration.  No planned review date was reported within 
the review.  
Wong et al. (2017): More recently, Wong et al. (2017) conducted a systematic 
review of clinical practice guidelines for LBP.  Systematic review methods 
were used, and the methods were comprehensive and appeared rigorous.  
They searched electronic databases from 2005 to 2014.   
13 guidelines were discovered from five different countries and two European 
guidelines.  The systematic review included more than one guideline from 
each country and also included multiple editions of guidelines (Wong et al. 
2017) thus limiting the geographical scope of the review. 
The guidelines were critically appraised, using the AGREE II criteria by 
independent reviewers.  Ten of the clinical practice guidelines were selected 
and recorded as having a low risk of bias and high methodological quality, 
nine of the ten high quality guidelines focused of low back pain (without 
diagnostic specificity) and were included within the review.  The tenth high 
quality guideline was specific to lumbar disc herniation with radiculopathy; 
this guideline was not included in the review due to its condition specificity 
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to one type of LBP (Wong et al. 2017).  All included guidelines used robust 
literature review methods and adequate criteria for critically appraising of the 
evidence (Wong et al. 2017).  Table 2.8 shows the guidelines included in the 
review. 
Country Title Author 
European 
guidelines, 2004 
European guidelines for the management of 
chronic nonspecific low back pain Airaksinen et al. 2006 
European 
guidelines, 2004 
European guidelines for the management of acute 
nonspecific low back pain in primary care van Tulder et al. 2006 
Belgium 2006 Chronic low back pain (KCE report) Nielens, 2006 
United States, 
2007 
Diagnosis and treatment of low back pain: a joint 
clinical practice guideline from the American 
College of Physicians (ACP); American Pain 
Society low back pain guidelines panel (APS) 
Chou et al. 2007 
United States, 
2009 
An evidence based clinical practice guideline from 
the American Pain society Chou et al. 2009 
United Kingdom, 
2009 
Low Back Pain: Early management of persistent 
non-specific LBP NICE, 2009 
United States, 
2011 
A joint clinical practice guideline from the 
American College of Physicians and the 
American Pain Society 
Livingston et al. 2011 
Canada, 2011 
Alberta health technology assessment (HTA) 
Canada: Multidisciplinary clinical practice 
guideline low back pain  
Cutforth et al. 2011 
Scotland, 2013 Scottish intercollegiate guidelines network (SIGN) Management of chronic pain SIGN, 2013 
Table 2.8: Systematic review of clinical guidelines 2017 (Wong et al. 2017) 
Wong et al (2017) excluded guidelines if they were deemed to have poorly 
conducted systematic literature review searches or if inadequate critical 
appraisal methods of the evidence were evident.  The three low 
methodological quality guidelines identified included a guideline from the 
Phillippines (PARM, 2011), the American physical therapy guideline (Delitto 
et al. 2012) and an Ottawa clinical practice guideline (Brosseau et al. 2012), 
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and these were excluded from the review for not fulfilling the quality 
standards of the review (Wong et al. 2017). 
In this review, individual countries within Europe appear to have been 
omitted with the exception of the UK and Belgium.  The European guidelines 
were however included.   
The authors concluded that some methodological improvements were 
apparent from earlier reviews, but suggested updates were required to many 
guidelines, and limitations existed across the guidelines, notably in guideline 
applicability, (including facilitators and barriers), resource implication and 
monitoring criteria upon implementation were reported as not being 
adequately addressed.  They reported evidence of consensus in 
recommending education, activity and exercise, manual therapy and 
paracetamol or NSAIDs as first line treatments for LBP (Wong et al. 2017).  
Wong et al. (2017) recommended many guideline developers needed to 
further address the implementation of the guideline recommendations and 
also the involvement of the end user in the development of future guidelines. 
Wong et al. (2017) reported some limitations of their review, which included 
selecting only English language guidelines (limiting the external validity).  
They also reported the differing use of LBP classifications (i.e. acute, sub-
acute, chronic) limited their ability to ensure misclassification did not occur 
in their synthesis.  No planned review date was reported within the review. 
2.4.3 Summary of the systematic reviews: 
Allowing for differences in the dates completed, it could be anticipated that 
the SRs of the clinical practice guidelines for LBP would consider similar 
guidelines and countries.  However across the three SRs presented (Koes et 
al. 2010, Pillastrini et al. 2012, Wong et al. 2017) only two clinical practice 
guidelines (United States, Chou et al. 2007 and European, Airaksinen et al. 
2006) were common across all three SRs.  Recommendations did appear 
similar with some changes in the treatments recommended over time. 
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Across the various guidelines the recommendations of acupuncture and 
manual therapy were inconsistent, section 2.5 reviews the international 
clinical practice guidelines and considers the recommendations for 
acupuncture and manual therapy and the inconsistencies across the 
guidelines.   
2.5 International Guidelines – Recommendations for Acupuncture 
and Manual therapy 
2.5.1 Indication for a review of international clinical practice guidelines, 
recommendation of acupuncture and manual therapy 
Various countries have developed national clinical practice guidelines in 
attempt to manage LBP.  As all the guidelines are based upon the same 
international clinical evidence, it would be anticipated that the guidelines 
would provide similar recommendations for diagnosis and treatment 
interventions.  The review published in 2010 reported the guidelines to be 
similar regarding diagnostic classification and therapeutic interventions, 
however significant differences existed across countries (Koes et al. 2010). 
The guidelines and systematic reviews of guidelines discussed above debate 
the evidence for manual therapy but there is minimal discussion or 
acknowledgement of acupuncture, when it could be reasoned that the 
evidence for acupuncture is no less controversial than the evidence for manual 
therapy. 
While RCTs of acupuncture have generally demonstrated poor quality (Li et 
al. 2016), there are several RCTs assessing the efficacy of acupuncture, which 
have been assessed as having high methodical quality using the Cochrane 
Collaboration Back Review Group (CBRG) quality assessment for RCT's.  
These studies have reported that acupuncture can significantly reduce pain 
intensity in patients with LBP (Liang et al. 2017; Brinkhaus et al. 2006; 
Thomas et al. 2006; Leibing et al. 2002; Molsberger et al. 2002). 
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A recent meta-analysis of chronic pain demonstrated acupuncture to be 
effective at reducing chronic pain (Vickers et al. 2018b) and it was also shown 
to have lasting effects beyond 12 months for relieving pain (MacPherson et 
al. 2017b).  A Cochrane review in 2005 concluded that acupuncture was more 
effective for pain relief than no treatment or sham acupuncture for the 
treatment of chronic LBP at a three-month follow up.  While acupuncture was 
not shown to be more effective than other conventional therapies; when it was 
added to other conventional therapies, it was shown to improve pain and 
function better than conventional therapies alone (Furlan et al. 2005; 
Dascanio et al. 2015e). 
There is limited high quality evidence for the efficacy of acupuncture for the 
treatment of LBP, many publications include case studies / series and 
intervention studies with methodological designs that are inadequate for 
assessing efficacy.  Lewis and Abdi (2010) suggested the quality of studies 
conducted in more recent years have improved; however effectiveness of 
acupuncture remains to be conclusively demonstrated.  The available 
evidence for acupuncture is discussed further in section 2.7.2 of this chapter. 
2.5.2 Aims and methods 
Aim of the review: 
• To review the clinical practice guidelines for LBP and their 
recommendations of acupuncture and manual therapy.  
In 2018, I conducted electronic database and internet searches for 
international clinical practice guidelines, for the period of 2000 to 2017.  I 
also searched the reference lists and included guidelines in the SRs detailed 
in section 2.4, and checked the reference lists of any guidelines found.  For 
inclusion in the review, the guidelines needed to be national guidelines for 
LBP, and include information on the diagnosis and treatment of LBP.  Only 
one guideline from each country was included, the most current guideline was 
reported upon, however the previous edition of the guidelines was considered 
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to evaluate any changes which may have occurred in the recommendations 
over time.  I extracted data regarding the methods of the guidelines and the 
recommendations of acupuncture and manual therapy. 
2.5.3 Results of SRs of clinical practice guidelines 
Clinical practice guidelines from eight countries and one European guideline 
were identified and included in my review and are detailed below. 
USA:  The American College of Physicians (ACP) produced an updated 
guideline in 2017 (Qaseem et al. 2017).  The updated guideline focused upon 
non-invasive pharmacologic and non-pharmacologic treatments of LBP.  The 
target population included adults (>18 years) with acute, sub-acute and 
chronic LBP, radicular LBP or symptomatic spinal stenosis.  Published 
studies between January 2008 and November 2016 were included along with 
earlier studies identified by their inclusion in the 2007 American Pain 
Societies systematic review. 
The ACP policy also detailed if guidelines were not updated within five years 
they are automatically withdrawn, ensuring their guidelines are always 
current and up to date (Qaseem et al. 2010).  The development process for 
this guideline appeared to be fully transparent and robust, thus providing 
confidence in its recommendations.  
Qaseem et al. (2017) determined the guideline development process to be of 
high quality, it was developed and established by the American College of 
Physicians (ACP) and the methods of the development process were fully 
transparent, (summarised in the guideline, included fully as an appendix of 
the guideline and also published separately).  The guideline development 
followed a multistep process, included a systematic review methodology of 
the evidence base, deliberation of the evidence by the committee, summary 
recommendations with evidence and recommendation grading (Qaseem et al. 
2010).  The guideline underwent a peer review process and a consultation 
process (including public) prior to the final guideline publication (Qaseem et 
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al. 2017).  Throughout the guideline the recommendations are linked to the 
evidence and the evidence is graded, with the strength of the guideline 
recommendation also indicated. 
The most significant modification in the updated American guideline 
publication was that the guidelines recommended first line treatment should 
consider non-drug therapy, in an attempt to move away from reliance upon 
pharmaceutical treatments for LBP.  For chronic LBP they recommended: 
“exercise, multidisciplinary rehabilitation, acupuncture, 
mindfulness-based stress reduction (moderate quality evidence) tai 
chi, yoga, motor control exercise, progressive relaxation, 
electromyography biofeedback, or spinal manipulation (low-quality 
evidence).”  
(Hackethal, 2017, page 3) 
For chronic LBP that was non-responsive to the above non-drug therapy 
interventions, NSAIDS were recommended as a first line medication. This 
was followed by tramadol, duxetine, with opioids only considered if first and 
second line drug therapy was ineffective.  Not offering drug therapy, as first 
line treatment was a considerable shift in the approach within primary care 
internationally.  However it was suggested that the approach was due to 
limited choices of pharmacology, and to the progression in approach aiming 
to prevent LBP becoming a chronic condition (Atlas, 2017). 
In their conclusions, the ACP summarised that there was no evidence to 
suggest one therapy was clearly better than any other, though more recent 
evidence supported mindfulness-based stress reduction techniques, tai chi for 
chronic LBP and acupuncture for acute LBP (Qaseem et al. 2017). 
Canada: The Institute of Health Economics developed the clinical practice 
guidelines for LBP with a multidisciplinary team of clinicians and 
researchers: Towards Optimized Practice (TOP) program in 2015 (TOP, 
2015) and updated with minor revisions in 2017 (TOP, 2017).  The guideline 
focused upon diagnosis and conservative non-surgical interventions for LBP.  
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The target population included adults (>18 years) with LBP of any duration 
(excluding pregnant women). 
To ensure the guidelines remain current, a scoping search of the literature to 
inform the guidelines is conducted annually to assess if the guidelines require 
updating, if two or more new good quality SEED (clinical practice) guidelines 
were identified then an update of the guidelines was commenced.  This 
maintained the currency and accuracy of the guideline, in line with the best 
available evidence. 
The Canadian guidelines appeared to be of high quality with comprehensive 
methods and reporting, using systematic review methods.  The methods of 
the Canadian guidelines appeared comprehensive with a background 
document, supporting documents and a process description document, all 
published as supportive documentation.  Two committees were involved, a 
Steering Committee (SC) tasked with collection and collation of research and 
operational oversight, and the Guideline Update Committee (GUC) who 
reviewed the 2nd edition of the guideline and revised the recommendations in 
the 3rd edition to reflect the current research in LBP management.  The 
guidelines were peer reviewed by various stakeholders, professionals with 
experience and interest in pain management, their colleagues, and patients 
with acute and chronic LBP. 
Decisions and recommendations were made based on the collective 
professional opinion of the committees and analysis of the relevant evidence.  
Limited information was provided regarding the professional opinion of the 
guideline development committee, while they state expert opinion was used 
when evidence was older the seven years, no information is provided to 
support the discussions or opinions.  It was not possible to clarify if 
recommendations were influenced by professional opinion or the weight 
given to the professional opinion, comparative to the evidence.  Potentially 
allowing professional bias to influence the guideline recommendations and 
thus they lacked transparency in this area. 
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The Canadian guideline relied profoundly upon SEED guidelines from other 
countries to inform its guideline.  No reviews of original evidence or studies 
were conducted for this guideline.  Thus the guideline committees did not 
assess the quality of the empirical evidence directly, and any recently 
published evidence was not necessarily incorporated into the guideline, 
limiting the opinion and the strength of the information provided.   
The SEED guidelines were critically appraised on their methodology and 
reporting using the AGREE tool (Appraisal of Guidelines for Research 
Evaluation, (AGREE, 2009) and only those rated as average or good were 
included.  SRs of new interventions not covered by the previous Canadian 
guidelines, or other SEED guidelines were critically appraised by the GUC, 
though no detail is provided.   
Throughout the guideline however evidence for individual recommendations 
were referenced to other guidelines and evidence, i.e. acupuncture for chronic 
pain references supporting evidence of SRs from the previous Canadian 
guidelines and the Scottish guidelines.  A comprehensive evidence list for 
each individual condition was not provided in the updated guidelines, limiting 
the information provided. 
In similarity to the America clinical practice guideline, the Canadian 
guideline recommended both acupuncture and manual therapy for LBP.  
However the Canadian guidelines recommend manual therapy (spinal 
manipulation) for acute LBP, but did not recommend for or against 
acupuncture or massage due to insufficient evidence.  For chronic LBP the 
guideline recommends acupuncture, recommends massage but did not 
recommend for or against spinal manipulation due to insufficient evidence 
(TOP, 2017).  Therefore disparities in the recommendations of acupuncture 
and manual therapy exist between the American and Canadian guidelines.  
Europe: The European guidelines for the management of chronic low back 
pain were published in 2006 (Airaksinen et al. 2006).  The guideline focused 
upon the diagnosis, treatment and management of chronic LBP across 
Europe; an age demographic was not specified for the guideline target 
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population.  The guidelines were developed to inform groups who were 
intending to develop new or review current guidelines, indirectly informing 
the public, health care providers, industry and policy makers in Europe.   
The guidelines have not been updated since 2006 and thus not current in there 
evidence base.  No information is afforded regarding planned reviews or 
subsequent editions of the guidelines, and this is a significant limitation of the 
European guideline, which was intended to inform the development of other 
national clinical practice guidelines. 
The guideline Working Committee (WC) consisted of experts in the field of 
LBP research and developed the guideline within the COST ACTION B13 
(2006) framework LBP guidelines issued by the European Commission.  A 
draft guideline was produced and reviewed by members of the management 
committee of COST B13 before the full guideline was published.  While 
drafts were circulated to the committee and the working group, no external 
peer review or public consultation of the document occurred, limiting its 
editorial independence and transparency.  
The guideline used systematic reviews of SRs, RCTs and searched existing 
national guidelines.  The quality of evidence was assessed for systematic 
reviews using the Oxman and Guyatt index (Oxman and Guyatt, 1991) and 
for RCTs a methodological quality assessment, with criteria related to internal 
validity (van Tulder et al. 1997).  The guideline rated evidence from A (strong 
evidence) to D (no evidence) and their recommendations were based on 
evidence with a quality rating of A or B.  The quality assessment techniques 
used for the European guidelines were outdated and may not be as informative 
as more recent assessment criteria.   
Committee discussion was used to consider the evidence and inform the 
recommendations though no information was provided outlining the 
discussions or their influence on the recommendations, limiting the 
transparency of this process and subjecting the guidelines to potential bias 
from committee members. 
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The guideline concluded no single intervention is likely to be effective in the 
treatment of LBP and that effect sizes of therapeutic interventions were rather 
modest.  The guidelines considered the available evidence for acupuncture, 
but were unable to recommend it as a treatment option, due to the conflicting 
evidence surrounding acupuncture and sham acupuncture and limited 
evidence when compared to other interventions.  While they acknowledged 
the evidence for manual therapy (including spinal manipulation) was not 
conclusive due to the low quality of many studies within systematic reviews, 
they concluded they were able to recommend a short course of manipulation 
/ mobilisation as a treatment option for chronic LBP.  They were unable to 
recommend massage due to insufficient evidence (Airaksinen et al. 2006). 
Belgium: The guidelines in Belgium were published in 2017 (Van Wambeke 
et al. 2017) updated from their previous guideline in 2006 (Nielens et al. 
2006), by the KCE (Belgium Health Care Knowledge Centre) an organisation 
part funded by the public service.  The guideline focused on the evaluation 
and management of LBP.  An age demographic was not specified for the 
guideline target population, however due to them following the NICE 
guideline they do refer to the NICE target population of those >16 years with 
LBP of any duration.  
No guideline update or review was conducted of the 2006 guideline until the 
publication of the 2017 guideline, however in their current guideline they 
recommend the guideline would ideally be reviewed at five years following 
publication to ensure it is current.  However no process is documented to 
outline how any future review process will occur. 
The Guideline Development Group (GDG) consisted of multidisciplinary 
healthcare professionals and KCE researchers.  The guideline development 
process appeared to be robust and of high quality, it was developed and 
published as a separate document and was fully transparent.  The guideline 
was produced following a standard methodology based on a systematic 
review of the evidence and they searched for previous clinical practice 
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guidelines.  All clinical practice guidelines were appraised using the AGREE 
II checklist (AGREE, 2017). 
The KCE guidance noted that their recommendations were based largely on 
the NICE guidelines (2016) which they reviewed in depth and referred 
specifically to them throughout as part of their guideline development, 
however they did not follow all the recommendations made by NICE, 
outlining any differences and justifications for their decisions.  Similarly in 
there 2006 guideline where they referred to the European Clinical Practice 
Guidelines (Airaksinen et al. 2006) as an important source of evidence for its 
guideline but did not follow all its recommendations.  This approach limited 
the GDGs assessment of the source data and published evidence. 
The guideline recommendations were circulated to professional associations 
and clinical experts for external peer review, though no open review or public 
consultation was conducted, limiting the scope of the external review.  
Comments were gathered and discussed before the final external validation 
of the guideline, by two clinicians and the methods reviewed against the 
AGREE II checklist. 
The published guideline clearly indicated the levels of evidence for each 
recommendation and if expert opinion was used.  While it is useful to know 
the basis for the recommendations, no information on the expert opinion or 
discussions is detailed regarding their influence on the recommendations, 
limiting the transparency of the recommendations and the potential for 
committee bias to be introduced. 
Recommendations in the 2017 guideline were similar to the 2006 guideline 
(except for acupuncture and medication) in which they concluded remaining 
active and minimal time missed from work is essential.  They favoured 
conservative treatments with moderate and high-quality evidence over 
surgery or invasive procedures and recommended both acupuncture and 
manual therapy.  The guidelines also recommended against bed rest, lumbar 
supports and paracetamol (Van Wambeke et al, 2017; Nielens et al. 2006).  
They reported low quality evidence was available to recommend massage, 
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TENS, and hydrotherapy.  Moderate quality evidence was reported for 
recommending Back schools, educational programmes for self-care, spinal 
manipulative / mobilisation therapy (and acupuncture in 2006).  High quality 
evidence was reported for recommending the modest effectiveness of 
exercise programmes, multi-disciplinary bio-psychosocial rehabilitation, 
CBT (Van Wambeke et al, 2017; Nielens et al. 2006). 
In their updated 2017 guidelines they recommended considering 
manipulation, mobilisation and soft-tissue techniques but only as part of a 
multimodal treatment with supervised exercise, the level of evidence ranged 
from high to very low, with the strength of the GDG recommendation being 
weak.  For acupuncture the guideline committee reported a recommendation 
could not be formulated, due to the conflicting evidence and the recent change 
in the NICE guideline recommendations.  They did not follow the NICE 
guideline by not recommending it but instead took a neutral position, stating 
‘No recommendation on acupuncture has been formulated’, this was a change 
from their 2006 guideline in which they recommended both acupuncture and 
manual therapy (Van Wambeke et al, 2017; Nielens et al. 2006). 
Netherlands: The KNGF (Koninklijk Nederlands Genootschap voor 
Fysiotherapie) produced the Dutch clinical practice guideline for patients 
with low back pain in 2013 (KNGF, 2013), updating its previous guidelines 
from 2003.  An age demographic was not specified for the guideline target 
population.   
No information is afforded regarding the process for updating the guidelines.  
The Dutch college of general practitioners also produced a guideline for LBP 
however this dates back to 1996 with no recent updates.  The KNGF guideline 
was focused upon diagnostics and treatments of patients with non-specific 
LBP by a physical or manual therapist.   
The guideline followed SR methods, but limited information regarding the 
methodological process of developing the guidelines was available limiting 
its transparency.  However Pillastrini et al. (2012) considered it to be a high-
quality guideline, considering evidence from systematic reviews and meta-
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analyses.  No information regarding the quality of assessment of evidence 
was provided and no direct links were made to the evidence in their 
recommendations, limiting the depth and critical information in the guideline. 
A multidisciplinary committee was formed to develop the guidelines and their 
opinion was used within the guidelines, though no information regarding the 
weight of professional opinion to the evidence was provided limiting the 
transparency of the recommendations and potentially allowing for bias from 
committee members.  No external peer review or public consultation was 
conducted in the production of these guidelines, limiting the editorial 
independence of the review. 
The primary advice for the KNGF guideline was patient reassurance and 
maintaining and increasing activity levels, and they recommended the 
consideration of manual therapy (joint mobilisation, manipulation or 
massage) (KNGF, 2013).  However Acupuncture was not considered within 
the Dutch physiotherapy guidelines in 2003 or 2013, this was potentially due 
to the guidelines being produced by the Dutch physiotherapy association and 
physiotherapists not being permitted to practice acupuncture in their country, 
unless they have completed an additional full-time three-year degree in 
acupuncture and thus acupuncture is not commonly practiced by 
physiotherapists in primary care.   
France: The French guidelines were published in 2016 (Petit et al. 2016) and 
focused on the prevention of low back disorders in the working population, 
though an age demographic was not specified for the guideline target 
population. 
The guideline development committee consisted of a multidisciplinary team 
of 24 experts.  The guideline methods followed the Clinical Practice guideline 
methods proposed by the French National Health Authority.  SR methods 
were followed, and the evidence was assessed providing a grade for strength 
of each recommendation in relation to the evidence or expert opinion.  Clear 
indication of when expert opinion was used in recommendations was given 
though no detail regarding the discussions or opinions is available, limiting 
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the transparency.  A committee of 50 experts completed the peer review, 
though no external peer review or public consultation was conducted, limiting 
the editorial independence of the review. 
The French guidelines advised there was no evidence to recommend one form 
of manual therapy over another but recommended manual therapy, in line 
with the European guidelines.  They reported being unable to recommend 
acupuncture due to conflicting evidence and lack of strong evidence to 
support the intervention (Petit et al. 2016). 
Italy: The Italian guidelines were financed by the Italian Health Ministry and 
published in 2006 (Negrini et al. 2006).  They focused upon the diagnosis and 
therapeutic input for LBP of any duration, and produced flow diagrams for a 
variety of LBP conditions.  Age demographic was not specified for the 
guideline target population. 
The guidelines state a review and a further literature search would be 
anticipated by 2008, however no evidence of a review of the guidelines is 
apparent, thus the guideline does not include the current evidence base due to 
its publication in 2006. 
A committee of multidisciplinary health professionals developed the 
guideline, and an epidemiologist performed the ‘bibliographic research’, 
evaluated the methodological quality and synthesised the data into tables for 
the committee.  No information regarding the epidemiologist is provided to 
determine their expertise in the various areas of LBP research.  No 
information regarding peer review or public consultation is evident, limiting 
the editorial independence of the guideline.  
SR methods were used, they considered SRs, RCTs and clinical practice 
guidelines, though limited information regarding the methods was provided.  
An epidemiologist conducted a ‘critical methodology quality evaluation’ of 
the literature, though the quality evaluation process is not transparent within 
the guideline.  Evidence was graded as ‘A’ a strong recommendation, through 
to ‘C’ there is deep uncertainty pro or versus the recommendation.  They 
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reported their grading system did not conform strictly to the levels of 
evidence, thus limiting the interpretation of the evidence grading.  
Additionally while an evidence rating is given there is no corresponding 
evidence linked to the guideline, so it is not possible to establish which 
evidence was considered to provide the rating.  No information is afforded 
regarding the committee’s opinion in any decision making on the guidelines, 
limiting its transparency. 
The guideline did not recommend acupuncture, for acute sciatica with an 
evidence rating of ‘A’ = a strong recommendation there was no evidence of 
efficacy for acupuncture.  For chronic LBP they do not recommend 
acupuncture with evidence rating of ‘B’ = there are doubts as to whether the 
procedure should always be recommended. However they did recommend 
manual therapy, manipulation and massage for sub-acute LBP with an 
evidence rating of ‘C’ there is deep uncertainty, but reported for acute sciatica 
it was contraindicated or not useful.  For chronic LBP patients’ manual 
therapy was recommended with evidence rating of ‘B’ (Negrini et al. 2006).   
Scotland: Within the UK, the Scottish Intercollegiate Guidelines Network 
(SIGN) in Scotland develops guidelines and healthcare policies independent 
to England and Wales and is funded by the NHS Quality Improvement, 
Scotland.  SIGN produced a guideline for chronic pain in December 2013, 
which encompassed the assessment and treatment of chronic LBP (SIGN, 
2013). 
The guideline methodology states it should consider if guidelines should be 
reviewed after a period of three years, though they state having a fixed review 
time may not be appropriate due to evidence being published at different rates.  
No reviewed or updated guideline has been published since 2013 limiting the 
current evidence status of the guidelines. 
The guideline development committee developed the guidelines; they 
consisted of a group of relevant professionals and patient representatives.  SR 
methods were used, and equality impact was assessed, using the AGREE 
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criteria.  The methods were transparent and published as a separate document.  
The guideline stated its editorial independence from the funding body. 
The evidence within the guideline was given a level from 1++ to 4 and was 
also graded from A to D; A = At least one meta-analysis SR or RCT rated as 
1++ (high quality with a very low risk of bias) or a body of evidence 
consisting principally of studies rated as 1+.  D = evidence from non-
analytical studies or expert opinion.  In addition good practice points were 
given if recommended best practice was based on the clinical experience of 
the GDG.  Peer review and public consultation was conducted to review the 
draft of each guideline.  The guidelines clearly outlined the evidence used to 
inform each decision and recommendation.   
SIGN used the term manual therapy as an umbrella term for various forms of 
hands on therapy.  They acknowledged extensive research for manual therapy 
but noted it was generally of poor quality.  SIGN recommended manual 
therapy should be considered for short-term relief of LBP, with evidence 
graded as ‘B’ (SIGN, 2013). 
SIGN identified systematic reviews incorporating RCTs of varying quality, 
showing small clinically relevant benefits of acupuncture for LBP compared 
to waiting list controls.  A meta-analysis of acupuncture versus no 
acupuncture showed overall benefit for LBP.  SIGN recommended 
acupuncture should be considered for short-term relief of LBP with evidence 
graded as ‘A’ (SIGN, 2013). 
Ireland: No Irish guidelines exist for LBP; it is indicated that Irish healthcare 
adopts the European clinical practice LBP guideline and their 
recommendations (Fullen et al. 2007).  However, research suggested that 
though General Practitioners were consistent with prescribing medications, 
there was less consistency for onward referral than recommended by the 
European guidelines (Fullen et al. 2007). 
United Kingdom: The National Institute of Health and Care excellence 
(NICE) are a government-funded organisation in the UK whose objective is 
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to improve outcomes of individuals using the NHS, and other public and 
social care services, and part of their remit is to produce clinical practice 
guidelines (NICE, NG59, 2016).  The focus of the guideline was on the 
diagnosis, treatment and management of non-specific LBP in primary and 
secondary care.  The target population was individuals >16 years of age with 
LBP and/or sciatica of any duration, those whom were pregnant or had 
consistent LBP following surgery were excluded. 
NICE state their guidelines are reviewed for an update every two years with 
a guaranteed review at least every four years, to ensure their currency and 
accuracy is maintained in line with the best available evidence.  The guideline 
was reconsidered in 2018 and no new evidence was found to prompt a review 
or impact its recommendations (NICE, 2018). 
The Guideline Development Committee (GDC) was a multidisciplinary team 
of 12 healthcare professionals and two lay members, who discussed the 
evidence to develop the draft recommendations of the guideline.  SR methods 
were adopted, and the methods were detailed and transparent, with supporting 
methodological documentation published separately.  The National Clinical 
Guideline Centre (NCGC) team conducted literature searches (with RCTs 
given primacy) and prepared systematic reviews and economic analyses.  
Whenever possible randomised and prognostic data was meta-analysed and 
reported in GRADE profile tables.  Evidence summaries and the GRADE 
assessments to assess quality of the evidence were produced, for the 
committee to consider. The committee also invited experts in the field to 
present at their meetings.  The NICE guideline detailed the strength of 
recommendation within the guideline linked to the strength of evidence 
presented and reviewed. 
However limited information was provided regarding the strength of 
professional opinion of the guideline development committee or expert 
opinions, no information is presented detailing how discussions or opinions 
informed decisions.  It is not possible to clarify if recommendations were 
influenced by professional opinion, or the weight given to the professional 
opinion comparative to the evidence considered.  This potentially allows the 
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guideline recommendations to be influenced by professional bias of the 
committee and thus lack transparency. 
Prior to publication, a draft version of the guidelines was produced, submitted 
for review by registered stakeholder groups, and revised if appropriate before 
the final document was agreed and peer reviewed internally by NICE and 
ratified.  A comprehensive patient and public consultation was not conducted 
as part of the guideline development process, which was a criticism of the 
guidelines, however NICE are currently consulting on improving public 
consultation in the development of their guidance (NICE, 2019).  The lack of 
editorial independence of the NICE LBP guideline remains a limitation, with 
it scoring 42 out of 100 on the AGREE II assessment conducted for the 
Canadian guideline (TOP, 2017). 
The NICE (2016) guideline recommended manual therapy, including spinal 
manipulation and massage for LBP.  In a change from their NICE 2009 LBP 
guideline however, they removed their recommendation for acupuncture 
based on insufficient evidence above sham, and due to not being able to 
justify the cost of implementation with the limited available evidence.  The 
NICE guideline recommendations are discussed further in section 2.6. 
2.5.4 Summary of the clinical practice guidelines 
Table 2.9 summarises the key information regarding the scope and methods 
of the international guidelines as discussed above (section 2.5.4). 
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Table 2.9: Summary of the scope and methodology of the international 
guidelines 
Title Country & Year 
Scope of 
guideline Methodology 
Peer & 
public 
review 
Committee 
opinion 
Grading 
of 
evidence 
Clinical 
Practice 
Guideline 
LBP 
USA 
2017 
(2007) 
>18 years 
Acute, sub-acute, 
chronic, radicular 
LBP, symptomatic 
spinal stenosis 
Systematic 
review 
Yes 
Yes 
Yes Yes 
HTA 
guideline   
LBP 
Canada 
2017 
>18 years 
LBP of any 
duration 
Excluded 
pregnancy 
Systematic 
review 
Yes 
Yes 
Yes Not directly 
European 
Guideline 
LBP 
Europe 
2006 
No age 
demographic 
specified 
Chronic LBP 
Systematic 
review 
No 
No 
Yes Yes 
KCE 
Report 
287 
Belgium 
2017 
>16 years 
LBP of any 
duration 
Systematic 
review 
Yes 
No 
Yes Yes 
Dutch 
National 
practice 
Guideline 
Netherlands 
2013 
(2003) 
No age 
demographic 
specified 
Non-specific LBP 
Systematic 
review 
No 
No 
Yes No 
French 
Good 
Practice 
Guideline 
LBP 
France 
2016 
No age 
demographic 
specified 
LBP in the 
working 
population 
Systematic 
review 
Yes 
No 
Yes Yes 
Italian 
Clinical 
Guideline 
Italy 
2006 
No age 
demographic 
specified 
LBP of any 
duration 
Systematic 
review 
No 
No 
Yes Yes 
SIGN 
Chronic 
Pain 
Guideline  
Scotland 
2013 
Chronic pain 
including LBP >12 
weeks 
Systematic 
review 
Yes 
Yes 
Yes Yes 
NICE   
LBP 
Guideline 
NG59 
England 
& Wales 
2016 
>16 years 
LBP of any 
duration 
Excluded 
pregnancy and 
post-surgical 
Systematic 
review, 
GRADE, 
Meta-
analysis 
Yes 
Some 
Yes Yes 
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Title Year Country Acupuncture Recommended 
Manual Therapy 
Recommended 
Clinical 
Practice 
Guideline LBP 
2017 USA Yes Yes 
Clinical 
Practice 
Guideline LBP 
2007 USA Yes Yes 
HTA LBP 
Guideline 2017 Canada Yes Yes 
European LBP 
Guideline  2006 Europe No Yes 
KCE Report  
287 
2017 Belgium 
A 
recommendation 
could not be 
formulated 
Yes 
KCE Report  
Vol 48C 
2006 Belgium Yes Yes 
Dutch National 
practice 
Guideline 
2013 Netherlands Not considered Yes 
Dutch National 
practice 
Guideline 
2003 Netherlands Not considered Yes 
French Good 
Practice LBP 
Guideline  
2016 France No Yes 
Italian Clinical 
LBP Guideline 2006 Italy No Yes 
SIGN Chronic 
Pain Guideline 2013 Scotland Yes Yes 
NICE LBP 
Guidelines 
NG59 
2016 England & Wales No Yes 
NICE LBP 
Guidelines 
NG88 
2009 England & Wales Yes Yes 
Table 2.10: International recommendations of acupuncture and manual 
therapy for LBP 
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The disparity internationally between the recommendation of acupuncture 
and manual therapy for LBP discussed in section 2.5.4, is summarised in table 
2.10.  Table 2.10 also highlights if any changes in recommendations between 
the same guideline occurred over time. 
2.5.5 Reasons for the International guideline differences 
There are potentially many reasons for the inconsistences that occur across 
international clinical practice guidelines and these shall be considered further 
below.  Understanding these differences is important to interpreting the 
clinical practice guidelines and the incorporation of their recommendations 
into clinical practice. 
It could be suggested the variation observed between international guidelines 
may exist due to the date of publication, lapse of time between the writing of 
the guidelines and changes driven by the publication of new evidence 
(O’Connell et al. 2017).  However, the Belgium guidelines from 2006 
(Nielens et al. 2006), the Canadian guideline from 2017 (TOP, 2017), the 
Scottish guidelines from 2013 (SIGN, 2013), and USA guidelines from 2017 
(Hackethal, 2017) all recommend acupuncture and these four guidelines alone 
span an eleven-year time period.  During a similar time period the European 
guidelines from 2006 (Airaksinen et al. 2006), and the French guidelines from 
2016 (Petit et al. 2016) and the UK NICE guidelines (2016) did not 
recommend acupuncture.  Lack of conclusive evidence of acupuncture 
beyond sham, was quoted as the reason for not recommending acupuncture, 
within these three guidelines.  The disparity in recommendation from 2006 to 
2017, suggests that it is not the time frame and publication of new research 
evidence that determined any recommendation in the case of acupuncture and 
manual therapy. 
The influence of one international guideline upon another is evident 
especially with the Belgium 2017 guideline using the NICE 2016 guidelines 
extensively to inform their guideline.  This highlights the importance and 
need for guidelines to be fully transparent and independent.  While 
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international guidelines consider each other’s guidelines, it is evident 
however they do not always follow the same conclusions. 
There are vast differences in quality across the research base for LBP and 
GDGs are required to generate recommendations when uncertainty of 
interventions is evident.  There is extensive scope for interpretive variation 
within GDGs and these may be influenced by expertise, personal opinion, 
public opinion and previous and other guideline recommendations.  For 
example, the American guideline recommended spinal fusion whereas the 
Canadian and UK NICE guideline did not, and the UK NICE guideline 
recommended radiofrequency nerve denervation whereas the Canadian and 
American guidelines established there was insufficient evidence to 
recommend the intervention (O’Connell et al. 2017; Qaseem, 2017; Juch et 
al. 2017; Hasenbring, Rusa and Turk, 2012). 
The guideline development directive and scope of a guideline may be 
determinants for the variation, for example effectiveness or efficacy may be 
a motivating factor.  With acupuncture, both the American and Canadian 
guidelines recommend acupuncture based on comparisons with usual care or 
no treatment (effectiveness).  Whereas NICE (2016) do not recommend 
acupuncture based on comparisons with clinical effect above sham 
acupuncture (efficacy) (O’Connell et al. 2017).  In addition to this the Dutch 
guideline (KNGF, 2013) simply do not acknowledge acupuncture within their 
guideline.   
The size of treatment effect threshold expected may also contribute to 
research being viewed positively or not.  In the case of the NICE guidelines 
2009 and 2016, the 2009 guideline considered the treatment effect in the 
effectiveness of acupuncture over usual care not efficacy over sham.  Whereas 
in the 2016 guideline, the minimal clinically important difference (MCID) of 
treatment effect was increased to 1.0 over sham was introduced (Cummings, 
2017), and this changed the threshold of expectation within the research that 
had previously been included, this is discussed further in section 2.8.  
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Additional considerations for the differences between the guidelines may 
include; local traditions, cultural norms, public expectations, local healthcare 
provision, commissioning, funding, and variations in the guideline 
development processes (O’Connell, 2017; Dascanio et al. 2015f; Hasenbring 
et al. 2012).   
It may be advantageous internationally for future research to attempt to 
standardise some of the disparities between the guidelines, to afford more 
consistency across the guideline recommendations.  Pillastrini et al. (2012) 
for example advocated for future guidelines to adopt the GRADE framework, 
to aid international comparison and reduce any discrepancies.  However, 
guidelines within countries continue to have differences and are conflicting, 
therefore gaining some standardisation nationally may aid an initial approach.  
Such national internal differences will be discussed further in section 2.6, 
where the differences between the NICE LBP guidelines of 2009 and 2016 
are discussed. 
2.6 Review of NICE LBP guidelines of 2009 and 2016 
This thesis and the pilot study conducted (see chapter four and five) were 
inspired by the 2009 / NG88 LBP guidelines.  The 2016 / NG59 guidelines 
were published during the writing of this thesis and thus have been included 
in the below analysis and discussion, to explore the changes and the 
implications these have on future research planning.  The consideration of 
both these guidelines is key to this thesis as they inform current clinical 
practice in England and Wales, and will impact upon the requirement of future 
research into acupuncture and manual therapy for LBP. 
Guidelines for clinical practice in England and Wales are developed by the 
National Institute for Health and Care excellence (NICE).  Guideline 
development committees develop the guidelines by consideration of best 
evidence surrounding the condition or intervention (Czarnawska-Iliev and 
Robinson, 2016).  
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The NICE LBP guidelines are complex documents covering various aspects 
of LBP management; however they summarise the care pathway with an 
algorithm shown in figure 2.1.   
  
Figure 2.1: Low back pain and sciatica management algorithm (NICE, 2016) 
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The 2016 NICE guideline is an update of the 2009 guideline, there are some 
significant differences between the two, as detailed in table 2.11.  The more 
recent 2016 guideline presented the guidelines using a different format to the 
2009 and the divergence between the guidelines will be discussed below. 
The 2009 guidelines scope covers the assessment and management of non-
specific LBP in adults over the age of 18 years, while the 2016 guidelines 
scope covers the assessment and management of non-specific LBP and 
sciatica in adults over the age of 16 years, thus extending the target 
population.  No justification for this change is given within the guideline, they 
simply state:  
“….they hope to address inconsistent provision and 
implementation….” 
(NICE, 2016, page 23) 
The 2009 guideline provided guidance for the early management of non-
specific chronic LBP with a duration of longer than 6 weeks up to one year.  
Whereas the 2016 guideline includes all LBP from the first episode, 
(including acute (less than six weeks), sub-acute (six – twelve weeks) and 
chronic (more than twelve weeks)) with no cut off time point.  Their rationale 
here is to identify the risk of chronicity using the recommended risk 
stratification tool.  This is a novel approach to LBP, moving away from the 
international norm of timescale classification.  The American College of 
Physicians (ACP) state that while included in their guideline, acute and sub-
acute LBP resolves spontaneously for the majority of individuals (Qaseem et 
al. 2017). 
The 2016 guideline also introduced a section on return to work programmes, 
with the aim of assisting individuals back into work (table 2.11).  Key 
treatment changes have been made regarding medications, most significantly 
with paracetamol, which is no longer recommended in the 2016 guideline 
(table 2.11) (Bernstein et al. 2017). 
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Interventions considered 
within the NICE LBP 
guidelines 
NICE LBP guidelines (NG88) 
(2009) 
NICE LBP and sciatica 
guidelines (NG59) (2016) 
Risk assessment & risk 
stratification tools Not considered in guidelines Recommended 
Imaging Not routinely recommended Not routinely recommended 
Self-management Recommended Recommended 
Exercise 
(individual & group sessions) – including 
aerobic activity, movement instruction, muscle 
strengthening, postural control and stretching 
Recommended Recommended 
Orthotics & Lumbar 
supports Not recommended Not recommended 
Manual Therapy 
(including spinal mobilisation, spinal 
manipulation and massage techniques) 
Recommended Recommended 
Traction Not recommended Not recommended 
Acupuncture Recommended Not recommended 
Electrotherapies  
(including ultrasound, percutaneous, 
transcutaneous electrical nerve stimulation, 
PENS, TENS, laser therapy and 
interferential) 
Not recommended Not recommended 
Psychological therapy Not included in guidelines Recommended 
Combined physical and 
psychological treatment 
programmes 
Recommended Recommended 
Return to work 
programmes Not included in guidelines Recommended 
Pharmacological 
therapies 
Variations in recommendations: 
Paracetamol – Recommended 
NSAIDs – Recommended 
Weak opioids – Recommended 
Strong opioids – recommended 
Tricyclic antidepressants - 
recommended 
Variations in recommendations:  
Paracetamol – Not recommended 
NSAIDs – Recommended 
Weak opioids – Recommended 
Strong opioids – not recommended 
Tricyclic antidepressants – not 
recommended 
Injections of therapeutic 
substances Not recommended Not recommended 
Radiofrequency 
denervation Not recommended Recommended 
Epidurals Not included in guidelines Recommended 
Surgery 
Spinal decompression - Not 
included in guidelines       
Spinal fusion – Recommended 
Disc replacement - Spinal fusion 
- Not included in guidelines 
Spinal decompression – 
Recommend 
Spinal fusion – Not recommended 
Disc replacement – Not 
recommended 
Table 2.11: Interventions considered by NICE for LBP Guidelines 
Interestingly in the 2009 NICE guidelines, shown in table 2.11, they do not 
recommend offering a psychological treatment programme as an individual 
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intervention for those with LBP, despite some evidence showing them to be 
efficacious (Gatchel and Rollings, 2008; Turk, Swanson and Tunks, 2008; 
Chou and Huffman, 2007; Hoffman et al. 2007; van Tulder et al. 2000).  They 
do however recommend the combination of physical treatment with 
psychological therapy in a combined approach with the aim to address the 
psychosocial component of LBP for patients.  New evidence regarding the 
psychological element impacting LBP (Pillay, 2016; O’Sullivan et al. 2014; 
Sadeghian, Hosseinzadeh and Aliyari, 2014; Pincus and McCraken, 2013; 
Main and George, 2011) has also been published since the 2009 guidelines 
and psychological therapies as an individual intervention were thus included 
within the 2016 guidelines.  The psychological element of LBP is an 
extensive and complex area of research and while it is acknowledged, it does 
fall outside the remit of this thesis.  
Another distinct change in the 2016 guidelines was considering and 
recommending radiofrequency nerve denervation, which was not 
recommended in 2009.  Additionally, acupuncture was recommended in the 
2009 guidelines but no longer recommended in the 2016 guideline.  The 
evidence for acupuncture was re-evaluated and the recommendation for 
acupuncture withdrawn (table 2.11).  Of note was that the NICE guidelines 
for LBP amended their guidance for acupuncture following the consideration 
of a wider range of research, with some new small-scale studies and more 
historic research considered and reinterpreted the research with altered 
parameters, which is discussed further in sections 2.7 and 2.8 of this chapter.  
Cost delivery of acupuncture was sighted, as one of the main factors but 
considering an alternative cost-effective delivery model by combining 
interventions proposed by the pilot study for this thesis was not considered.  
Poor quality research with questionable results was another of the key reasons 
for the reinterpretation of the acupuncture evidence.  Manual therapy 
continued to be recommended across both the guidelines. 
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2.6.1 The influence of NICE guidelines in developing the foundations of this 
PhD:  
The NICE (2016) guideline conclusions, made finding a trial design to 
address the quality issue for acupuncture studies and a design that eliminated 
as many potential biases as possible, a more significant need for the future of 
acupuncture research (see section 2.7.2). 
The long-term management of LBP by conventional medical treatments has 
been shown to be of limited effectiveness (O’Sullivan et al. 2014) and a 
comprehensive technology assessment and evidence report published in 2010 
(Furlan et al. 2010) suggested complementary and alternative therapies 
should be considered for future interventions, perhaps alongside conventional 
medicine.  The 2010 report considered spinal manual therapy, massage and 
acupuncture as the three most widely used alternative therapies for LBP 
internationally (Furlan et al. 2010) and its recommendations were noted to 
inform the pilot study for this thesis. 
The interventions of interest specific to this PhD; manual therapy and 
acupuncture, were selected in part due to their inclusion within the “Key 
priorities for implementation” section of the NICE guidance (2009), which 
included the principle recommendations: 
“Offer one of the following treatments, taking into account patient 
preference: 
• An exercise programme 
• A course of manual therapy 
• A course of acupuncture 
Consider offering another of these options if the chosen treatment 
does not result in satisfactory improvement.” 
(NICE, NG88, 2009, page 2) 
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Though three treatment interventions were recommended within the NG88 
2009 guidelines, other than considering patient preference, no indication as 
to sequential preference of which intervention to offer first was given, nor in 
which order to offer if multiple interventions were indicated, this was perhaps 
due to insufficient evidence of superiority of the recommended interventions.  
The guidelines simply advised that if one intervention did not provide 
satisfactory improvement, offer another of the treatment options (NICE, 
2009). 
The lack of clarity and preference within the guidelines potentially leads to a 
costly approach to NHS healthcare, with patients potentially following 
several unparalleled treatment pathways.  An individual may receive nine 
manual therapy sessions, followed by ten acupuncture sessions and / or eight 
sessions of group or personalised exercise programmes (Dascanio, 2015d).  
No evidence was presented comparing the treatment options to one another, 
to provide guidance of preferential primary treatment options.  No 
consideration or evidence was given for the potential of combining the 
recommended treatments options together within one session for a patient.  
Providing two or three interventions simultaneously within a treatment 
session would offer considerable cost savings to the NHS compared to 
offering several separate courses of treatment, as the 2009 NICE guidelines 
recommend (Dascanio, 2015b).  This thesis will aim to investigate this 
possibility. 
Could providing two of the treatments in combination provide an additional 
benefit to patients and save costs?  Could providing one specific therapy first 
provide preferable results and reduce referral for onward treatment?  Is there 
any benefit of providing additional therapy if one specific intervention has 
not been successful?  All questions, which remain, unanswered by the NICE 
LBP guidelines (2009) and thus the objective and intention of this PhD was 
born. 
After consideration and planning and with the limited resources of this PhD, 
the recommendation of an exercise programme was not considered for the 
pilot study.  An exercise programme for LBP falls within part of routinely 
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delivered care provided by physiotherapists and there are many schools of 
thought on exercise approaches.  Therefore its consideration and investigation 
falls outside the resources and remit of this PhD.  The pilot study focused 
upon the remaining recommended treatment options of manual therapy and 
acupuncture and their combination, to investigate the potential for a future 
full-scale trial. 
2.6.2 NICE (2009) definition of acupuncture and manual therapy 
Acupuncture – is defined as ‘the insertion of a solid needle into any 
part of the human body for disease prevention, therapy or 
maintenance of health’ (Acupuncture Regulation Working Group 
(ARWG) 2003. NICE, 2009, page 28). 
Manual Therapy – is defined as a treatment that involves 
‘manipulation, massage, soft tissue and joint mobilisation.’  It is ‘a 
general term for treatments’ performed by chiropractors, osteopaths 
and physiotherapists.  (NICE, 2009, page 34). 
2.7 Evidence informing NICE - NG88 2009 and NG59 2016 
The following section will consider the supporting evidence across both the 
2009 and 2016 NICE guidelines for manual therapy and acupuncture. 
The 2016 NICE guideline stated; 
“The GDG agreed that where interventions have been compared to 
sham, the sham must be for the intervention of interest e.g. a 
comparison between acupuncture and sham acupuncture would be 
accepted however acupuncture compared to sham massage would 
not.” 
(NICE, 2016, page 43) 
They went on to say that: 
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“….if there was a lack of placebo or sham-controlled evidence, 
evidence against usual care will be given priority when decision 
making.” 
(NICE, 2016, page 452) 
In addition they stated: 
“The GDG is required to make decisions based on the best available 
evidence of both clinical effectiveness and cost-effectiveness.  
Guideline recommendations should be based on the expected costs 
of the different options in relation to their expected health benefits 
(that is their cost-effectiveness) rather than the total cost alone.” 
(NICE, 2016, page 55) 
Table 2.12 provides a summary of the research considered for manual therapy 
and acupuncture for NG 88 (2009) and NG 59 (2016). 
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 NICE 2009 NG 88 NICE 2016 NG 59 
Manual 
Therapy 
Classification 
Spinal manipulation 
Spinal mobilisation 
Massage 
Soft Tissue technique 
Traction 
Manipulation / Mobilisation 
Mixed modality manual therapy 
Research 
studies 
7 studies -1x high quality 
1x moderate quality 
5 x low quality – high risk of bias 
48 single intervention studies 
Research 
studies 
continued 
Massage  
1x systematic review containing 8 
papers 
1 study – high quality 
18 dual intervention studies 
Cost Utility 
economic 
evaluation 
Two evaluations 
One Manual therapy cost effective 
One Massage not cost effective 
Cost and QALY data provided 
 
Five evaluations – all cost effective 
All with significant limitations 
Cost and QALY data provided 
 NICE 2009 NG 88 NICE 2016 NG 59 
Acupuncture 
Insertion of solid needle 
Acupuncture and Dry needling 
Insertion of solid needles 
TCM and Western acupuncture 
Research 
studies 
1 x systematic review – high quality 
1 x high quality RCT 
2 x moderate quality RCTs 
1 x low quality RCT 
29 RCTs 
3 x combined therapy RCTs 
2 x Cochrane reviews – not included as 
did not match protocol criteria 
Cost Utility 
economic 
evaluation 
One evaluation – cost effective 
Cost and QALY data provided 
One evaluation – cost effectiveness 
Cost and QALY data provided 
Table 2.12: Summary of acupuncture and manual therapy research for 2009 
and 2016 NICE LBP guidelines  
2.7.1 Evidence for manual therapy 
NICE guidelines 2009: 
Manual therapy interventions are intended to improve mobility, function and 
pain and are usually delivered by a therapist’s hands affecting the 
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neuromuscular system by the movement of joints and /or soft tissue (NICE 
2016; NICE 2009). 
Three types of manual therapy techniques were reviewed for the 2009 NICE 
guidelines and included:  
• Spinal manipulation: A Low amplitude high velocity movement at the 
limit of joint range, taking it beyond the passive range of movement, 
(NICE, 2009)  
• Spinal mobilisation: A joint movement within the normal range of 
motion, (NICE, 2009) 
• Massage: Manual manipulation / mobilisation of the soft tissues, 
(NICE, 2009) 
The 2009 guidelines were informed by evidence from seven RCTs on 
manipulation and mobilisation techniques, one systematic review and one 
RCT on massage therapy.  NICE (2009) used systematic review methods in 
accordance with ‘The Guideline Manual’ (NICE, 2006) to review and assess 
the quality of the evidence. 
SRs had been published on manipulation and mobilisations for LBP, however 
these were excluded from the 2009 NICE guidelines due to issues of 
heterogeneity between studies, the appropriate studies were however selected 
from the systematic reviews and considered individually for the guideline 
(NICE, 2009). 
Of the seven RCTs on manipulation / mobilisation techniques, only one was 
considered to be of high quality with a low risk of bias (UKBEAM, 2004) and 
another was considered a well conducted RCT with a low risk of bias 
(Cherkin et al. 1998).  However, five of the trials were considered to be low 
quality, at high risk of bias. Three of these five low quality studies found no 
difference between the intervention and control (Hurwitz et al. 2006; 
Anderson et al. 1999; Doran and Newall, 1975), one found improvement 
following a two-week follow-up (Triano et al. 1995) and one found 
significant results but was subject to high attrition (Goldby et al. 2006).  The 
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risk of bias in these five trials centred around the lack of power of the studies, 
the small sample sizes reducing the precision of any estimated treatment 
effect, the lack of detailed methodology, the lack of transparency regarding 
the randomisation process, and the high attrition rate. 
Evidence used to support massage included a systematic review of eight 
international RCTs (Furlan et al. 2002).  Though all the studies had small 
participant numbers, the outcome of the SR suggested a beneficial effect of 
massage at one year, when compared to sham or self-care education, and an 
effect equal to the use of corsets.  Additionally, one included RCT (Little et 
al. 2008) judged to be high quality at low risk of bias, found significant 
improvements between massage and usual care at three months but not at 12 
months.  While this was a large trial of 579 participants, the participants were 
randomised to eight separate treatment groups considerably reducing the 
power of the study; only 75 participants populated the massage group.  When 
considering only the massage group versus the control group (72) this 
substantially reduced the size of this sub-study and analysis, with the primary 
investigation considering the Alexander technique. 
Although NICE state the evidence suggests manual therapy is more effective 
overall than usual care, and more effective or the same as other interventions 
there appeared to be a lack of recent good quality evidence to support the 
recommendation of manual therapy within the 2009 NICE guidelines. 
NICE guidelines 2016: 
The types of manual therapy techniques considered by the 2016 NICE 
guidelines included: 
• Spinal manipulation  
• Spinal mobilisation (including therapy (SMT) and Maitland 
technique) 
• Soft tissue technique 
• Traction 
• Mixed modality manual therapy (soft tissue technique +/- traction +/- 
manipulation / mobilisation 
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(NICE, 2016, page 352). 
48 studies of single interventions (reported in 55 research papers) and 18 
studies (25 research papers) considering the combination of non-invasive 
interventions with manual therapy as an adjunct were included in the review.  
This represents a considerable increase in research since 2009, with 22 
additional recent studies included, and a greater number of historic papers 
added which were not included in the 2009 guidelines (NICE, 2016). 
NICE (2016) used the GRADE framework to review and assess the quality 
of the evidence.  The outcomes of the studies were summarised individually 
across the studies, these included pain severity, function, healthcare 
utilisation, adverse events, psychological distress and Quality of Life (QoL) 
(NICE, 2016). 
Five cost-utility economic evaluations of manual therapy were considered 
across the range of interventions, all five were considered to have potentially 
serious limitations but provided cost and QALY data (NICE, 2016). 
The recommendations from NICE 2016 were to not offer traction for LBP, 
but consider offering manual therapy, but only as part of a treatment package 
including exercise with or without psychological therapy (NICE, 2016, page 
452). 
The GDG acknowledged there was variable evidence for manual therapy and 
the wide scope of the intervention as a technique added to the difficulty in 
assessing it.  They reported functional outcomes did not correlate with QoL 
outcomes.  As individual interventions evidence was limited for soft tissue 
techniques (based mainly on massage), spinal manipulation and mixed 
modality therapies compared to sham with only short term benefit for some 
studies (not seen beyond four months).  When compared to usual care the 
evidence was again contradictory and benefits shown were inconsistent 
across the studies.  They did report however a large multi-centred trial 
reported benefit in QoL and function when manual therapy was combined 
with self-management and exercise (NICE, 2016). 
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The GDG concluded the evidence did not allow them to recommend manual 
therapy as an independent intervention, but it could be considered as part of 
treatment packages as an optional intervention alongside exercise (Bernstein 
et al. 2017. NICE, 2016). 
2.7.2 Evidence for Acupuncture 
NICE guidelines 2009: 
The NICE guidelines made their recommendations on the clinical evidence 
from one systematic review, four RCTs and one cost utility study.  NICE 
(2009) used systematic review methods in accordance with ‘The Guideline 
Manual’ (NICE, 2006) to review and assess the quality of the evidence. 
The SR was considered of high quality with low risk of bias; it followed SR 
methods and used the Cochrane Back Review Group (CBRG) guideline (van 
Tulder et al. 2003) to assess methodological quality of the included studies.  
It reported acupuncture compared to sham provided some short-term pain 
relief, and acupuncture compared to no treatment provided some pain relief 
and functional improvement (Furlan et al. 2005). 
One RCT of moderate quality and low risk of bias, reported significant 
improvement of pain when compared to no treatment, but no significant 
improvement when compared to minimal acupuncture (Brinkhaus et al. 
2006). 
The cost utility study found acupuncture to be cost effective (Ratcliffe et al. 
2006). 
NICE guidelines 2016: 
The types of acupuncture intervention considered by the 2016 NICE 
guidelines included: 
• Traditional chinese acupuncture  
• Western medical acupuncture 
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29 studies (reported in 32 papers) were reviewed; a considerable increase 
compared to the evidence considered for the 2009 guidelines.  These included 
nine historic papers (published in 1976, 1980 x2, 1986, 1999, 2002 x2, 2003) 
and eleven more recent (mostly small-scale studies) publications from 2007 
to 2014.  
As mentioned, NICE (2016) used the GRADE framework to review and 
assess the quality of the evidence.  The outcomes of the acupuncture studies 
were summarised individually across the studies, these included pain severity, 
function, healthcare utilisation, adverse events, psychological distress and 
Quality of Life (QoL) (NICE, 2016). 
They reported, one study and two large studies assessed as moderate to high 
quality evidence, found clinically important benefit of acupuncture.  Eight 
studies showed no clinically significant difference for short or long term pain 
and a sensitivity analysis of eight studies reported no clinically significant 
difference between acupuncture and sham.  One study showed improvement 
in healthcare utilisation and another in function (both moderate quality) and 
a further six studies ranging from low to high quality demonstrated no 
difference over sham for function (NICE, 2016). 
Two high quality studies demonstrated benefit of acupuncture versus usual 
care for QoL and pain.  A sensitivity analysis of eight studies reported clinical 
benefit of acupuncture but this analysis was rated as very low quality.  All 
evidence comparing acupuncture to active comparisons or as an adjunct to 
other interventions were assessed as very low quality very small-scale studies 
(NICE, 2016). 
The recommendations from NICE 2016 were to not offer Acupuncture for 
managing LBP with or without sciatica based on the evidence reported.  The 
GDG discussed the need to demonstrate specific intervention effects, over 
and above placebo.  Though the GDG acknowledged a clinically important 
improvement in QOL and pain compared to usual care, but as sham evidence 
is available the sham evidence informs the decision-making and noted no pain 
relief was achieved beyond four months.  The GDG stated that although a 
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significant number of trials of acupuncture were reviewed the evidence was 
not consistent in demonstrating a treatment-specific effect.  While 
acupuncture was seen to be superior to usual care, it had not shown significant 
effect compared to sham, they therefore concluded the improvement was 
likely to be the result of a contextual or placebo effect.  They concluded that 
extensive evidence ranging from very low quality to high quality evidence 
was reviewed and that further research was unlikely to alter their conclusions.    
2.8  The removal of acupuncture from NICE NG59 (2016) 
The removal of acupuncture from the NICE guidelines (2016) occurred 
following changes in guideline expectations and a re-evaluation of the 
evidence, with the inclusion of some new (mostly small-scale) studies and 
historic studies not considered by the 2009 guidelines.  For both acupuncture 
and manual therapy, NICE (2009) considered a small number of studies 
comparative to the 2016 guidelines.  Many of the very low quality and low 
quality studies were not reported in the 2009 guidelines but were included 
and considered in the 2016 guidelines. 
Cost delivery of acupuncture was sighted as one of the reasons for not 
recommending acupuncture, due to the high cost to the NHS without evidence 
of benefit above the context effect.  The costs quoted in the guideline for 
acupuncture were £37 - £56 per hour (NICE, 2016, page 492), at a substantial 
cost to the NHS of £24,366,000 (NICE, 2009).  In respect of this, as 
mentioned previously one of the considerations I aim to consider with this 
thesis is the delivery of acupuncture combined with manual therapy in one 
treatment session, thus a single cost to the NHS.  By comparison manual 
therapy was reported at £51 for an assessment and £39 for a follow-up 
appointment (NICE, 2016, page 448).   
Discussion has occurred regarding acupunctures removal.  Some have been 
pleased as they consider acupuncture as a ‘theatrical placebo” (Colquhoun 
and Novella, 2013; Cummings, Hróbjartsson, and Ernst, 2018) and others 
have been less than happy.  Of NG59 one such author suggested that: 
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“…different levels of evidence were used for different interventions, 
with a perceived bias favouring conventional practice.” 
(Cummings 2017, page 1)  
Cummings (2017) argued that acupuncture was required to demonstrate 
effectiveness of needling plus context effect versus gentle needling plus 
context, rather than needling against context of needling.  He continued to 
state that exercise was compared to no exercise, with no context control (usual 
care) (Cummings, 2017).  MacPherson (2017a) supported this view, 
suggesting the guidelines were compromised by: 
“The inconsistent application of the criteria between interventions.” 
(MacPherson, 2017a, page 248). 
NICE reviewed their process for their 2016 guideline to implement 
consistency with other NICE guidelines (NICE, 2016) and their expectation 
of a minimal clinically important difference (MCID) of 1.0 on the visual 
analogue scale (VAS) preferably over sham was applied to their evidence 
review.  This was not conducted for the 2009 guideline. 
Some felt however this change of expectation was not universally applied 
(Macpherson, 2017a; Cummings, 2017; Bovey, 2017; Weeks, 2016; Birch et 
al. 2016).  Cummings, (2017) explained that when compared to usual care, 
acupuncture achieved 1.61 improvement in pain on the VAS, and when 
compared to sham, acupuncture achieved a 0.8 improvement in pain on the 
VAS.  Due to the 0.8 improvement being below 1.0, acupuncture received a 
negative recommendation, despite the improvement of 1.61 above usual care.  
Whereas comparatively exercise achieved a 0.74 improvement in pain at four 
months on the VAS above usual care, and exercise received a positive 
recommendation. (Cummings, 2017; Bovey, 2017; NICE, 2016).   
Though statistically these figures are accurate, NICE (2016) debated that 
sham exercise was not possible to achieve and that remaining active and 
exercise had been shown to be effective for LBP.  NICE reported they were 
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dubious to support a technique (acupuncture) with inconclusive evidence that 
may discourage some individuals from remaining active, exercising and 
caring for themselves (NICE, 2016).  This justification did not quiet the critics 
however and the Acupuncture Now Foundation (ANF) (Weeks, 2016) and 
others have described the NICE guidelines as ‘evidence-biased medicine’ due 
to the discrepancies in their recommendations (Birch et al. 2017; Weeks, 
2016). 
The comparison of acupuncture to sham acupuncture as oppose to usual care 
(as for exercise) created another contentious issue in the recommendations 
(Birch et al. 2016).  It was suggested that the GDG did not provide 
reassurance on their understanding of sham acupuncture not always being 
inert within some RCTs (Cummings et al. 2018; Macpherson, 2017a: 
MacPherson et al. 2017c; Cummings, 2016a; Weeks, 2016; Lin et al. 2012; 
Campbell, 2006).  The difference between sham acupuncture and real 
acupuncture continues to be poorly understood due to the somatosensory 
tactile component of acupuncture often being included in sham techniques 
(Makary et al. 2018). 
It was argued that due to the physiological mechanism of acupuncture, just 
moving a needle away from a specific point (non-point needling, often 
considered sham), or shallow needling or attempting non-penetrating with a 
Streitberger needle (Strietberger and Kleinhenz, 1998) did not negate the 
active component of acupuncture treatment and actually has a physiological 
effect on the body.  Sham acupuncture techniques actually have a 
physiological effect on the tissues they contact due to the innervation of those 
tissues (Nishiwaki et al. 2018; Chen et al. 2017; Cummings, 2016; Zhu et al. 
2013; Lin et al. 2012; Moffet, 2009; Lund and Lundeberg, 2006; Campbell, 
2006).  Sham acupuncture is discussed further in section 3.5.1.1.  
Some studies have shown sham acupuncture to be as effective as true 
acupuncture (Lowe, 2017; Moffet, 2009), and it has been argued that this is 
due to acupuncture not being an effective intervention, but merely a good 
placebo (Cummings et al. 2018; Lowe, 2017; Colquhoun and Novella, 2013).  
However an alternative argument is that sham acupuncture often maybe an 
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active treatment (Cummings et al. 2018; Cummings, 2017; Wang, 2017; 
Lundeberg et al. 2011; Moffet, 2009; Lund, Näslund and Lundeberg, 2009; 
Lund and Lundeberg, 2006).   
Sham acupuncture has been shown to be more effective than usual care, many 
conventional medications and other interventions (Cummings, Hróbjartsson 
and Ernst, 2018; Cummings, 2017; Cummings, 2016b; Lundeberg et al. 2011; 
Moffet, 2009).  Until an inert sham for acupuncture can be established, 
referring to non-TCM and non-point acupuncture techniques as sham 
acupuncture would be inadvisable for research practice and this is discussed 
further in section 3.5.1.1. 
In addition, it has been suggested that conflicts of interest held by the 
Guideline Development Committee (GDC) Chair and one other member of 
the committee were not satisfactorily managed in the public’s best interest 
(Cummings, 2017).  It was noted that both members had private practices, 
which would benefit financially from the recommendation for radiofrequency 
nerve denervation by the guideline.  As previously noted, the technique had 
previously not been recommended in the 2009 or by other international 
guidelines based on lack of evidence.  Both individuals were new to the 
committee and took part in the discussion of this intervention and its 
recommendation (Cummings, 2017; Cummings, 2016).  When challenged on 
the subject, NICE responded advising they felt the declaration of interest 
made by the individuals was sufficient not to influence the GDGs decision on 
the matter (Cummings, 2017), even though it received a positive 
recommendation, despite the inconclusive evidence and other guidelines not 
supporting the intervention (Juch et al. 2017; O’Connell et al. 2017; 
Hasenbring et al. 2012). 
2.9 Discussion 
The literature review I conducted highlighted a lack of high quality evidence 
investigating the comparison or combination of acupuncture and manual 
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therapy for LBP.  Highlighting the need for further high quality evidence in 
this area. 
It is evident that from the same body of international evidence, a variety of 
guidelines can interpret the evidence in a variety of ways.  Over 39 different 
international LBP guidelines were reported to exist, and all had 
inconsistencies to each other across their recommendations, with GDG 
interpretation of the evidence playing a significant role (O’Connell et a. 2017; 
Lonnemann et al. 2012).  It poses the question are all these guidelines 
necessary?  Would an international collaboration for guidelines be in the best 
interest of evidence based medicine?  How does the research community and 
GDGs ensure transparency and consistent interpretation of the same clinical 
evidence? 
The disparity across international guidelines in their recommendation of 
acupuncture is evident, some countries recommend it, other countries do not 
recommend it and some countries simply do not acknowledge it within their 
guidelines (Birch et al. 2016).  The significant variation in the 
recommendation of acupuncture may be explained by a variety of factors; the 
country of origin of the guideline, the type of healthcare practiced / expected, 
the scope of the guideline, the guideline methods used, how the evidence was 
appraised, the use of effectiveness or efficacy in the guideline criteria, the 
minimum threshold of an effect expected above sham / usual care, the 
research available at the time of writing the guidelines, the influence of 
conclusions from other published guidelines, the influence of GDC and expert 
advisers, the transparency of the decisions, and if peer and public review were 
used.  These factors may have a significant influence of the development of 
guidelines, and the international community should consider how some of 
these potential differences could be resolved and coordinated to achieve 
greater international consistency. 
Acupuncture is used widely in society, but its use remains controversial 
(Vickers et al. 2018b).  Caution needs to be exercised in assuming 
acupuncture is effective or not, from reviewing the guidelines, research is 
currently contradictory, and further high quality research is required.  
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Establishing the effectiveness of acupuncture in high quality studies and its 
use in combination with other interventions would add value to the 
knowledge base.   
In the case of acupuncture within the UK, since the 2016 NICE guidelines 
many physiotherapy NHS departments have seen acupuncture for LBP no 
longer authorised for practitioners, impacting upon the clinician’s clinical 
autonomy and decision-making abilities for their patients (Davis, 2016; 
Dascanio, 2015b; Dascanio et al. 2015f).  This thesis aims to consider 
acupuncture and manual therapy independently and in combination for LBP 
initially through a pilot study, but aims to inform a full-scale study to provide 
some clarity in the knowledge base and the recommendations in clinical 
practice guidelines. 
The change in recommendation for acupuncture in the NICE 2016 guidelines 
continues to be a contested decision with the suggestion of a different 
assessment and expectation approach for different interventions.  The 
effectiveness and use of acupuncture for LBP remains controversial, and the 
poor quality of acupuncture studies and cost were cited as a reason for its 
removal and exclusion from the NICE LBP guidelines (NICE, 2016).   
Acupuncture and manual therapy are considered as complex interventions 
and as discussed in chapter one (section 1.6), the design of conducted trials 
in some cases may not have been sensitive to accommodate their complexity.  
This may in part explain why many effectiveness studies are inconclusive, 
present challenges and are of poor quality.  Robust trial design is imperative 
in determining the effectiveness of these interventions. 
The need to understand the best trial design to assess acupuncture and 
improve the quality of acupuncture research, so a decision upon effectiveness 
can be determined, is apparent.  The following chapter will consider the 
various types of RCT’s and aim to recommend a best-fit design to achieve 
these objectives and thus a trial design for a pilot RCT for this PhD. 
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3 Randomised Controlled Trials (RCTs) 
3.1 Introduction 
Thus far I have considered LBP and its impact upon society highlighting the 
need for further evidence.  I have conducted and presented a literature review 
and identified and discussed systematic reviews of international guidelines 
for LBP, demonstrating the disparity between the guidelines, their 
recommendations and lack of conclusive evidence.  The NICE guidelines for 
England and Wales and their update in 2016 have been reviewed and their 
recommendations for acupuncture and manual therapy discussed.  
Chapter two discussed the uncertainty remaining over the use of acupuncture 
for LBP and the dispute over its removal from the NICE LBP guidelines 
(2016).  Poor quality evidence was sighted as a significant reason for the 
removal of acupuncture from the NICE LBP guidelines (2016).  Many studies 
in research will fall victim to a random or systematic error (Henderson and 
Page, 2007).  The literature for acupuncture studies has been described as 
variable, of poor methodological quality, difficultly in interpretation, 
inconsistent reporting, issues with internal and external validity and high 
levels of attrition (SAR, 2018; Liu et al. 2015; Qiu et al. 2016; Norvella, 2015; 
Lee et al. 2012).  These issues have often occurred due to poor trial design 
and the execution of the studies.   
The uncertainty that remains surrounding the effectiveness and efficacy of 
acupuncture is in part due to these issues with study design.  Without high 
quality trials designed for acupuncture, it will not be possible to conclusively 
analyse it and recommend it for inclusion or exclusion from future clinical 
practice guidelines and thus the commissioning of current clinical practice. 
This chapter will consider RCTs and their intended use, present types of bias 
and critically review potential RCT designs, in an attempt to understand the 
strengths and weaknesses of specific designs in relation to bias.  It will relate 
the RCT designs to a potential study of acupuncture and manual therapy 
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aiming to identify and offer justification for a single design option, which will 
enable a good quality evaluation and eliminate as many biases as possible to 
improve future quality studies.  Thus potentially offering a solution to rectify 
the poor quality previously seen in many acupuncture and manual therapy 
trials as presented by NICE (2016). 
The RCT is considered to be the ‘Gold Standard’ methodology for research 
evidence (figure 3.1) and randomisation reinforces the validity of the trial.  
Randomisation reduces selection bias by ensuring any between group 
differences occur simply due to chance and not due to specific selection of 
participants (Bondemark and Ruf, 2015; Henderson and Page, 2007).  Non-
randomised trial designs, by comparison, have inherent sources of bias so 
limiting internal validity (Kunz and Oxman, 1998). 
  
 
Figure 3.1: The hierarchy of evidence (Adapted from: 
http://www.create.ac.uk/blog/2014/07/29/evidence-quality-in-intellectual-property-research-a-comparison-with-
the-medical-sciences/) 
The essential reason for conducting an RCT is to determine causation.  The 
rigour of the RCT design aims to prevent selection bias, account for 
regression to the mean, counter temporal changes, and provide a valid basis 
for statistical inference.  However, despite the extensive benefits and 
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enhanced validity of the RCT, there are potential biases that can be introduced 
into an RCT, especially if trial design is not rigorous and well executed.  All 
biases need to be attenuated as far as possible to ensure trial internal validity 
and reduce the risk of a biased treatment estimate (Torgerson and Torgerson, 
2008).  Koletsi et al. (2011) reported in their study of RCTs that while 112 
studies identified themselves as RCT’s only 33 (29.5%) could be classified 
as RCTs through their demonstration of adequate random number generation 
and allocation concealment, concluding there is a clear need for the 
improvement of accurate reporting of RCTs.   
RCTs have also been shown to be onerous in their planning, funding and 
execution, with recruitment often being a significant problem encountered.  
In a review of 114 RCTs, delay in the commencement date occurred in 41% 
of trials and recruitment problems were experienced in 63% of trials.  Less 
than 31% fulfilled their targeted recruitment reducing the power of the trials 
and 53% of the trials used a recruitment extension (McDonald et al. 2006). 
3.1.1 Explanatory and pragmatic trials   
RCTs can be an explanatory or pragmatic in their design, with each design 
addressing differing research questions (White et al. 2002a). 
Explanatory trial: An explanatory trial aims to explain the specific effects 
and mechanism of an intervention under ‘ideal’ conditions (Thorpe et al. 
2009), tightly controlling for all non-specific elements.  These trials compare 
an intervention to a placebo control and are often used in drugs trials and the 
early development of interventions.  Explanatory trials have high internal 
validity however lack external validity and the ability to generalise to clinical 
practice (Sedgwick, 2014a; Greenhalgh, Howick and Maskrey, 2014; 
MacPherson, 2004). 
Pragmatic trial: Pragmatic trials aim to establish the effectiveness, risks and 
costs of an intervention within its routine environment, without separating out 
the specific and non-specific effects of the treatment (Thorpe et al. 2009).  
These trials have a greater population inclusion, with fewer inclusion criteria 
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and exclusion criteria, they have a wider potential range of study sites, they 
are less tightly controlled, allowing a wider view of an intervention and they 
utilise approaches to improve effectiveness as would be the case in clinical 
practice. These attributes afford greater external validity, more closely 
reflecting and informing intervention use within clinical practice, however 
this can be at the expense of the internal validity compared to explanatory 
trials, (Ford and Norrie, 2016). 
3.2 Potential bias in an RCT 
Bias within trials can alter our estimate of the true effect of the investigated 
intervention.  In scientific research, bias implies the observation of an effect 
that occurs due to a systematic error.  An example would be if an individual 
were encouraged or selected (in a recognised or unrecognised way) one of the 
investigated outcomes over the others due to influence on their judgement 
(Pannucci and Wilkins, 2010).  The effect of bias can occur in both directions 
to overestimate or underestimate the true intervention effect (Cochrane, 
2018), it is important to understand the risk of bias and eradicate it as far as 
possible within RCTS. 
In the following section the potential biases that occur within an RCT will be 
discussed and how these impact upon the research process. While other biases 
do exist for example commercial bias (Ahn et al. 2017), and there is extensive 
evidence to suggest that trials and other studies can be very biased, the 
following section will focus upon the bias that can be controlled for, in a study 
for this PhD. 
3.3 Sources of bias in RCTs 
3.3.1 Selection bias 
Selection bias occurs when baseline characteristics are systematically 
different between intervention arms.  Differences that occur within study 
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arms need to occur due to chance not due to an outside intervention.  Adequate 
allocation concealment and effective randomisation can reduce this bias 
(Cochrane, 2018; Henderson and Page, 2007).    
3.3.2 Performance bias 
Performance bias is the systematic unintended differences occurring between 
intervention arms, often due to lack of blinding.  An example would be if a 
therapist knew they were delivering the true intervention they maybe more 
positive in their delivery and communication than if they knew they were 
delivering a placebo treatment.  Equally if a participant thought they were 
receiving the true intervention they may be more encouraged than if they 
believed they were receiving a placebo (McCambridge et al. 2014; Rubinstein 
et al. 2014).  Adequate blinding in placebo trials or equivalence of 
interventions in comparison trials can reduce this bias. 
3.3.3 Detection bias 
Detection bias refers to the process of outcome assessment and how these 
may differ if not standardised or outcome assessors not blinded.  Detection 
bias does tend to be less of an issue for pragmatic RCTs as standardised 
outcome measure tools are used, however this does not always eradicate the 
problem and blinding outcome assessors can be an effective solution 
(Viswanathan et al. 2013). 
3.3.4 Attrition bias 
Attrition is the loss of participants during a trial that cannot be incorporated 
into the trial analysis.  Attrition of between 0 - 5% is not considered to 
substantially affect the trial results to any degree of significance.  However, 
attrition levels are purported to average approximately 20% and are generally 
poorly reported or addressed (Dumville, Torgerson and Hewitt, 2006).  
Though some differential attrition is likely to occur within all trials, non-
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random attrition across trial arms is the key concern.  The non-differential 
attrition within trials can significantly reduce the validity of trials (Strite, 
2010).   
Various reviews have reported a range of attrition rates ranging from 4 – 28% 
(Hewitt et al. 2010) and 7 – 67% of attrition within trials (Dumville et al. 
2006; Leon et al. 2006); these substantial rates are likely to influence the 
outcome of their trial.  A study of CBT for LBP reported an attrition rate of 
18% (Glombiewski, Hartwich-Tersek and Rief, 2010); a trial of manipulation 
and exercise for LBP reported 3 – 6% attrition (Evans et al. 2018).  A study 
of acupuncture and sham acupuncture for LBP reported a 4% attrition rate, 
however a loss of 10 and 11 participants from the acupuncture and sham 
acupuncture arms and a loss of 25 participants from the conventional therapy 
arm was seen (Haake et al. 2007).  While some reported attrition figures are 
low, if disproportionate attrition occurs across the intervention groups it may 
introduce post-randomisation selection bias, potentially altering the direction 
of the treatment effect, leading to a misinterpretation of the trial results. 
If random attrition occurs and the loss to follow up rate is similar between 
intervention arms, any potential attrition bias is minimised (though the 
reduction in numbers will reduce the statistical power of the study). Further 
attrition bias can be reduced by thorough efforts to follow up all participants 
and retain participants even if they do not elect to continue with their 
randomised intervention.  The utilisation of an intention to treat analysis 
would aim limit any bias resulting from attrition and selection bias (Torgerson 
and Torgerson, 2008).  
The majority of attrition often occurs within the early stages of a trial, usually 
between the collection of baseline data and the first follow-up point 
(Torgerson and Torgerson, 2008).   The MRC/BHF (2002) trial of antioxidant 
vitamin supplements for the prevention of cardiovascular disease reported 
almost one third of the total participants dropped out within the first time 
period (a run-in period) of their trial.  A trial investigating McKenzie 
physiotherapy for low back and neck pain, with a 12 month follow up period, 
reported 75% of the attrition occurring within the first follow up period (6 
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weeks), with 18% of participants being lost.  The accumulative attrition at 6 
and 12 months increased from the reported 18% to 23% and 24% respectively 
but a further increase of only 5% and 1% attrition (Klaber-Moffett et al. 
2006).  Three further trials on back pain reporting attrition, investigated spinal 
manipulation (UKBEAM, 2004), cognitive behavioural therapy (Lamb et al. 
2010) and Yoga (Tilbrook et al. 2011) and presented similar rates of attrition 
at 25%, 22% and 13% respectively.   
Scope for potentially limiting and reducing attrition in the early phase of a 
trial may be achieved by the use of a run-in period or a trial nested within a 
cohort study; these designs are discussed in section 3.4.5 (run-in trials) and 
section 3.4.7 (cohort design with nested RCT). 
3.3.5 Reporting bias 
Reporting bias signifies the differences between reported and unreported 
results.  The reporting occurs within studies due to the investigators reporting 
the significant differences in publications, but less likely to report differences, 
which are not significant  (Cochrane, 2018).  Chan (2005) suggested this was 
the most common form of bias within RCTs.  Publication of all trial results 
both positive and negative should be encouraged and supported to reduce this 
bias (Mlinaric et al. 2017; Goodchild, 2015).  
3.3.6 Resentful demoralisation 
Participant preferences can introduce an outcome bias.  It is thought that an 
individual’s treatment preference may alter their outcome and therefore the 
trial results (Bowling and Ebrahim, 2008).  This can occur in two ways, a 
participant may be very encouraged by their randomised intervention and 
approach the trial with a positive attitude to the intervention they wanted, as 
the key motivator for entering a trial may be to receive the trial intervention.  
This overtly positive approach may influence the treatment effect, thus 
potentially more positively skewing their results.  Alternatively, if not 
allocated to an intervention they wished for, participants may be despondent 
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and exhibit resentful demoralisation bias (Brewin and Bradley, 1989), or even 
drop out of the trial contributing to attrition bias of the results. 
UKBEAM (2004) reported compliance to the manipulation intervention at 
92% but a lower rate at 63% for the exercise intervention.  Potentially 
indicating participants entering this trial had a preference for the manipulation 
intervention, or that the intervention may potentially be easier to adhere to.  
Another trial of active treatment interventions for neck pain demonstrated 
participant preference did affect their outcome (Klaber-Moffett et al. 2005).  
However, a trial of exercise for LBP offering participant preference for 
exercise versus usual GP care indicated no difference in outcome of 
participants who preferred the exercise intervention with those who were 
indifferent to their randomised intervention (Klaber-Moffett et al. 1999).  A 
trend of reduced compliance or indifference to an exercise intervention may 
be an area of further exploration, as if resentful demoralisation does have 
greater impact on exercise comparative to other active interventions, having 
an exercise comparator in effectiveness trials could potentially lead to an 
inaccurate reporting of the treatment effect within those trials.   
A systematic review conducted by a research collaborative in 2008 reported 
participants assigned to their preferred intervention having a greater effect 
size than those who were indifferent or who received their undesired 
treatment.  It concluded prior to randomisation, participant preferences should 
be undertaken (PCRG, 2008).  Offering participant preference within a trial 
is one potential method to reduce resentful demoralisation and other bias.  
Participant preference trials are discussed further in section 3.4.4. 
3.3.7 Outcome ascertainment 
Outcome ascertainment is triggered when investigators over report the effects 
of one intervention of a trial over the other, this can occur consciously or 
unconsciously.  If this occurs bias will be introduced into the results and could 
lead to the over or under inflation of a reported treatment effect. 
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A systematic review of 21 trials analysed ascertainment bias of blinded and 
non-blinded outcome assessors on their assessment of treatment effects.  It 
reported an over-estimate of odds ratios by an average of 36% by non-blinded 
assessors of subjective binary outcomes, demonstrating substantial bias in the 
estimation of effects of non-blinded assessment (Hróbjartsson et al. 2012). 
Ascertainment bias can be limited by the blinding of assessors or by collecting 
the results from a number of sources, i.e. having two doctors assessing a 
blinded condition post intervention or alternatively the use of patient reported 
outcome measures independent of the practitioner and researcher 
(MacPherson et al. 2008).   
3.3.8 Hawthorne effects 
The Hawthorne effect is the improvement a participant gains as a direct result 
of being part of a trial or experiment (Sedgwick, 2012b).  This was recognised 
in an experiment on factory workers where productivity improved, whether 
working conditions were either improved or worsened, improvements in 
productivity resulted due to being part of an experiment and the influence 
monitoring (Silverman, 1998). 
The Hawthorne effect can be minimised by using a sham or placebo 
intervention, or alternatively through the comparison of the intervention to an 
alternative intervention in an effectiveness trial.  The objective being to 
ensure comparability across groups, thus the Hawthorne effects would be 
anticipated to be the same for all and any effects counterbalanced (Torgerson 
and Torgerson, 2008). 
3.4 Trial Designs  
In the following section I consider and discuss potential RCT designs, with 
the aim to identify the advantages and disadvantages of each trial design with 
reference to minimising the biases described above.  The trial designs 
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considered; placebo, crossover, factorial, and preference RCTs, RCTs with 
run-in periods, adaptive cohorts and cohorts with nested RCTs. 
3.4.1 Placebo randomised controlled trials 
Placebo randomised controlled trials are generally respected as the ‘gold 
standard’ of RCT design in health care research.  They are considered as the 
most reliable method for evidence-based medicine and play an invaluable role 
in the development of healthcare (Spieth et al. 2016; Kaptchuk, 2000).  They 
are increasingly becoming an expectation of guideline developers, such as 
The National Institute for Clinical Excellence (NICE) in the UK and also by 
national regulators such as the Advertising Standards Authority (ASA).   
In addition to the advantages attributed to all well designed RCTs, placebo 
RCTs are considered a preferential design due to their ability to reduce or 
eliminate potential post randomisation biases including: ascertainment bias 
(through blinding); Hawthorne effect (all patients receiving the same level of 
care); resentful demoralisation (as patients are blind to their allocation) and 
potentially attrition bias (as individuals are unaware of their allocation so any 
attrition should be random and theoretically evenly spread across trial arms).  
Consequently, their robust nature of limiting bias increases the validity of the 
results, making them the trial design of choice and the reason many in 
healthcare assign credibility only to RCTs with placebo design (Torgerson 
and Torgerson, 2008). 
The strength of placebo RCT partly lies in its design eradicating the ‘placebo 
effect’ in the assessment of a drug or intervention.  Effectively there is 
blinding of trial clinicians and participants, affording increased the internal 
validity and reliability of the trial results (Relton et al. 2010).  
The history of placebos dates back to the 18th century (Jütte, 2013), and it is 
reported that placebos, due to limited knowledge of disease aetiology, may 
have been significantly improved the health of many (Munnangi and Angus, 
2019).  Placebos have been used extensively throughout research studies and 
are reported to work on mechanisms modulated by the brain, such as pain, 
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and are stated to make participants feel better but not cure them (Kaptchuk 
and Miller, 2018).  A placebo or sham intervention is a ‘fake’ medical 
treatment or procedure designed to convince a participant in a clinical 
experiment they have received the real treatment.  A placebo is proposed to 
cause a psychological improvement rather than a physiological one and the 
placebo effect occurs when a participant’s condition improves (or 
deteriorates) in response to a placebo treatment (Munnangi and Angus, 2019).  
Though some in research contests this theory, they believe the psychological 
can affect the physiological and this is discussed further below. 
Blease (2012) argues that the placebo effect should be re-termed the “positive 
care effect”, as all interventions occur in the ‘context of care’ and this can 
have a powerful effect on an individual.  The ‘context of care’ incorporates 
all the aspects associated with an intervention but not the intervention itself, 
i.e. the method of delivery, the location of the intervention, the interpersonal 
relationships between the patient and the therapist, the patient’s belief in the 
treatment, the therapist’s belief and communication regarding the 
intervention (Blease, 2012).  The expectations of a patient are known to play 
a significant role in the success of a placebo effect (Benedetti, 2013).   
The strength and effect of a placebo has been shown to vary for individuals 
and conditions, with four areas reported to be involved in a placebo effect, 1) 
The expectation and conditioning, 2) The placebo effect on the brain, 3) 
Psychoneuroimmunology (the effect of brain activity on the immune system), 
4) Evolved health regulation (the body’s ability to respond to illness).  
Placebos have been shown to be effective in many situations and have also 
been demonstrated to improve the effect of current treatments (Newman, 
2017).  Beecher (1995) used the term ‘The Powerful Placebo” due to its 
positive effect in many clinical trials.   
In the medical field if an intervention emerges as equivalent to a placebo 
treatment it attracts dismissal or refutation by the research community, 
however this view may be changing.  Scientific research has shown that in 
addition to the modification of subjective (psychological) symptoms, 
placebos can elicit specific relevant regions of the brain to be stimulated and 
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various neurotransmitters (e.g. endorphins, dopamine, cannabinoids) are 
released, giving placebos a valid legitimacy (Kaptchuk and Miller, 2018).  
Research has shown that placebo effects account for more than unexplained 
recovery or regression to the mean (Katchup et al. 2008).  Some researchers 
are starting to investigate how to harness the placebo effect for interventions, 
rather than dismissing or trying to minimise its effects (Newman, 2017).  
Critical questions are therefore raised; should placebo treatments be 
embraced, can placebo treatments be used legitimately in some cases, rather 
than potentially harmful medicines.   
Despite their many advantages however, placebo-controlled trials have been 
criticised.  Justification for using placebos when valid treatments are readily 
available is ethically questionable and concerns regarding participants 
understanding of placebos have been raised.  Although they offer high 
internal validity, they are often explanatory trials in nature and may have 
limited external validity.  Their controlled nature reduces the ability to 
emulate ‘normal’ environments and thus limits their generalisability to 
clinical practice (Blease, Bishop and Kaptchuk, 2017; Frieden, 2017; Ford 
and Norrie, 2016; Spieth et al. 2016; Keränen et al. 2015; Greenhalgh et al. 
2014; MacPherson and Thomas, 2007).   
Enrolling a participant into a placebo trial may not reflect usual clinical 
practice where both the patient and the clinician are fully informed of the 
treatment being offered, limiting the clinical application of a placebo-
controlled trial (Blease et al. 2017; Ricker et al. 2015).  Clinicians may also 
consciously or unconsciously promote the ‘placebo’ effect within everyday 
practice as an additive effect to complement and enhance the psychological 
and physiological effects of treatment.  Tightly controlled placebo RCTs do 
not allow this natural enhancement to occur and the effectiveness of a therapy 
as it would occur in clinic may be underestimated (Bystad, Bystad and Wynn, 
2015).  Additionally there is significant heterogeneity in the placebo 
interventions used in trials, limiting standardisation and analysis across trials.  
The effect sizes of placebos and sham techniques have been shown to vary 
with some potentially having active treatment components (MacPherson et 
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al. 2017c) (discussed further in section 3.5.1), and inconsistencies in placebo 
effects have been demonstrated in some NICE network analyses (White and 
Cummings, 2012). 
Placebo RCTs are explanatory trials in their nature, and establishing 
effectiveness of a clinical intervention may well be served better with an 
alternative design.  Pragmatic trials have been suggested as potential 
alternatives to placebo RCTs, they can limit bias while still retaining the 
characteristics of clinical practice, allowing the wider application and external 
validity of any findings (Ford and Norrie, 2016; Relton et al. 2010). 
While there are arguments for and against the use of placebo RCTs, it is 
important to recognised that in research or clinical practice, all real or sham 
interventions are delivered in the context of care with the routine of treatment, 
and these context effects and routines need to be considered in research 
(Kamper and Williams, 2013).  The full theory and study of placebo is a vast 
subject area and as such beyond the realms of this PhD, an introduction and 
key principles of placebo are considered here and further discussion of 
placebo RCTs is presented in section 3.5.1. 
3.4.2 Randomised crossover trials 
A trial design widely used by pharmaceutical companies is the crossover 
design (Mills et al. 2009).  Participants act as their own control in crossover 
RCTs, they receive both interventions but in a random order.  Commencing 
in one group, then after a specified time period to allow for washout, crossing 
over to the other intervention.  This may consist of an intervention and a 
control, or two or more interventions.  A benefit of this design is that a paired 
data comparison can be made (participants compared with themselves), 
reducing the variability and thus increasing power.  Fewer participants are 
required, as they act as their own controls.  These can only be used for chronic 
conditions however where treatment is for symptom relief, not cure (Senn, 
1993).   
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Crossover trials have been shown to be useful for chronic pain trials of 
medication.  Pain relieving drugs have a wash out period therefore after a 
short delay appropriate to the carry over effect; the implementation of the 
alternative treatment can be administered (figure 3.2) (Sibbald and Roberts, 
1998).  With all participants receiving the same treatment regime just in a 
varied order an added advantage is establishing if treatment response is 
influenced by participant characteristics. 
 
Figure 3.2: Design of a crossover trial (adapted from Bowling and Ebrahim, 2005) 
Crossover trials are recommended for stable and chronic conditions, such as 
arthritis, their use is usually for interventions with short lasting effects (Mills 
et al. 2009).  One issue with cross over trials is the potential ‘carry over’ (and 
differential carryover) effect of an intervention or the lack of wash out of the 
intervention.  The wash out periods can increase trial length and create ethical 
concerns for any trial participants who potentially are without treatment for a 
period of time (Yang and Stufken, 2008). 
In trials of medicinal products physiological measures via blood testing can 
help ensure the washout effect has occurred.  This is more difficult to 
determine in non-pharmaceutical interventions, it is not known what the wash 
out effect of active interventions are, and no test exists to measure clinical 
effects.  MacPherson et al (2017b) reported the effect from acupuncture trials 
remaining at 12 months.  It would thus be difficult to establish if any treatment 
effects had been completely eradicated before the commencement of an 
alternative active treatment intervention.  Crossover trials would not therefore 
Treatment	A Outcome OutcomeTreatment	BWash	out	periodTreatment	B Outcome	 OutcomeTreatment	A
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be recommended for the comparison of complex active interventions with an 
unknown period of the washout effect. 
3.4.3 Factorial RCT design 
A factorial RCT design allows for two or more interventions to be analysed 
against a control separately and also in combination (table 3.1).  It also allows 
for the potential assessment of an interaction between interventions (Pocock, 
1983).  An advantage of this design is the reduced cost; the factorial design 
will enhance the cost effectiveness and efficiency of a trial by allowing the 
analysis of two interventions concurrently while still including a control arm, 
effectively delivering two trials for the relative cost of one (Finlay et al. 2003). 
Table 3.1 demonstrates the factorial design, with the central four cells 
indicating the treatment groups for allocation.  The margins highlight how the 
comparison analysis of the results would occur. 
Interaction between treatments and over usual care can also be detected with 
this design, analysing for synergy (or additive effects), or negative effects of 
a combination of treatments.  This makes it an effective method for comparing 
complex interventions while still maintaining a control arm. 
 Treatment B No Treatment O Margin 
Treatment  
A 
AB AO 
All A - 
AB & AO 
No Treatment  
O 
BO OO 
All non-A - 
BO & OO 
Margin 
All B - 
AB and BO 
All non-B - 
AO and OO 
 
Table 3.1: Factorial 2 x 2 trial design, with analysis at the margins  
It has been suggested that this design is under used and should be adopted 
more widely (Torgerson and Torgerson, 2008) however possibly due to its 
more complex design and analysis, researchers have not embraced it.  It has 
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also been shown that many factorial RCTs are often underpowered for the 
interaction analysis, limiting their validity (McAlistair et al. 2003). 
3.4.4 Preference trials 
Preference trials are designed to offer participants a choice of interventions, 
providing the preferred intervention to those who have a preference and 
randomising any participant who has no preference (Brewin and Bradley, 
1989).  Offering a preference aims to decrease resentful demoralisation and 
maintain participation by providing the participants their choice of treatment 
with the intention of minimising any crossover effects to usual care and 
dilution bias  (Bowling and Ebrahim, 2008).  
Preference trials however, do require a greater sample size and have an 
increase cost.  A substantial number of the participant population can receive 
their preferred intervention but be lost for analysis from these studies, because 
if they chose their preferred treatment and had a strong preference, they are 
not able to be randomised, only participants with no preference are 
randomised in these designs, potentially also reducing the external validity of 
the trials (Torgerson and Torgerson, 2008). 
However Bradley-Gilbride and Bradley (2010) consider that offering 
preference could increase the external validity of an RCT.  They suggest the 
preference design increases inclusivity of the population, with a greater range 
of individuals agreeing to enter a trial because those with a strong preference 
who would often refuse to enter an RCT have less fear of receiving unwanted 
interventions would agree to enter.   
Preference participants are often not included in the analysis of the trial 
interventions as they have psychological expectations of the intervention, 
which may introduce bias, including selection bias.  One solution to this is to 
determine individual preference but continue to randomise all participants, 
this permits analysis of whether an original preference influences outcome.  
An example of this design was the SPRINTER trial (2005) (figure 3.3). 
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Figure 3.3: Flow diagram of SPRINTER 
preference trial results  
(Modified from www-users.york.ac.uk/~djt6/lecture-preference-trial.ppt) 
The SPRINTER trial results demonstrated that those who preferred the brief 
intervention had a greater clinical improvement than those who preferred 
usual care.  Participant preference to an intervention was shown to impact 
upon the trial results, with analysis demonstrating interaction (SPRINTER, 
2005).  
Though all participants being included in the trial analysis increases the 
external validity of this design, resentful demoralisation and attrition may be 
increased reducing the internal validity.  As individuals are asked for their 
preference then randomised, and thus not necessarily given their preferred 
treatment choice, being asked for their preference and then potentially given 
something else could potentially increase resentful demoralisation further 
(Torgerson, Kaber-Moffet and Russell, 1996). 
Zelen’s method or Pre-randomised consent: 
Zelen’s method and pre-randomised consent are types of preference trials.  
Their approach potentially deals with post-randomisation biases as they 
specifically focused upon participant preference.   Zelen’s method is a design 
in which participants only consent to treatment after randomisation has 
occurred. However, this poses difficulty for some in the research community 
SPRINTER	TRIAL	
Brief	intervention	(BI)
Indifferent-1.007 Prefer	BI-2.811 Prefer	UC0.567
Usual	care	(UC)
Indifferent-3.094 Prefer	BI-2.142 Prefer	UC-2.75
Overall 12-month 
improvement  -0.840 
Overall 12-month 
improvement  -2.825 
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who feel this is an unethical approach (Relton et al. 2010; Campbell et al. 
2005; Stevens et al. 2001). 
Participants, who consent to treatment post randomisation and have been 
allocated to the intervention, receive the intervention, those who do not 
consent to treatment even, if allocated, receive standard care.  The intention 
to treat (ITT) principle should be used in Zelen’s design, so all participants 
are followed up in the study in the intervention group they were allocated to, 
regardless of the intervention they received, consented to or crossed over to, 
thus avoiding selection bias (Yelland et al. 2015; Gupta, 2011; Adamson et 
al. 2006).  
Consenting post randomisation in this design does risk participants refusing 
their allocated treatment and thus may introduce a dilution of the treatment 
effect following the ITT principle.  However, ITT is not always used in 
designs of this nature (which itself would introduce selection bias) and a 
review of trials using Zelen’s methodology showed 29% did not follow the 
ITT principle, and thus reported potentially biased results (Adamson et al, 
2006).   
Zelen’s design also aims to prevent resentful demoralisation and subsequently 
reduce attrition, with those participants randomised to the control group / 
standard care not being advised of their allocation, that they are in a control 
group or even part of a trial.  This provides an alternative to a patient 
preference trial design (Torgerson and Torgerson, 2008). 
Disadvantages of this design are that participants may cross over.  If a 
participant is randomised to receive an active treatment, they may refuse the 
treatment when it is offered, therefore crossing over into the usual care or 
control group. This was reported to occur for 10 - 36% of participants, a 
significant percentage of crossover (Altman et al. 1995).  This can lead to 
crossover attrition and following the intention to treat analysis model would 
impact on treatment findings, causing dilution bias and reducing the power of 
the study.   
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Additionally, ethics committees are not supportive of this design, considering 
it unethical not to inform the participant which treatment group they have 
been allocated to or that they are even part of a trial (Torgerson, 2001).  For 
these reasons Zelen’s method is rarely used (Adamson et al. 2006). 
3.4.5 Run-in period, delayed-start or pre-randomisation time period trials 
Run-in periods, delayed start or pre-randomisation time periods can be 
incorporated into trial design.  They provide time for evaluating participant’s 
symptoms or disease and thus evaluate the interventions actions upon those.  
Thus the time element of the study can help to distinguish whether a reduction 
of the symptoms or modifying of a diseases progress is significant.  The 
design has been used successfully in studies of Alzheimer’s or Parkinson’s 
(D’Agostino, 2009).  The run-in trial is another trial design that can aid the 
reduction of attrition within RCTs.  Participants are recruited to a trial but not 
randomised until after their first follow-up period has been completed.  
Previous trials have shown that the majority of attrition occurs within the first 
follow-up phase and therefore randomising participants after this time point, 
should reduce attrition rates and selection bias (Torgerson and Torgerson, 
2008).  
The MRC/BHF study group (2002) used this design when considering 
vitamin supplements for high-risk individuals with heart disease.  They 
reported during their run-in period almost one third of participants dropped 
out of the trial.  Randomisation after the run-in period reduced their attrition 
and potential bias, thus improving the validity of the outcome of the trial. 
It could be argued that this approach may lead to the selection of only the 
more willing participants and hence provide an overestimation of the 
population treatment effects of a trial, reducing the external validity.  
However participants otherwise included would be lost prior to 
randomisation, and those lost may be of similar persona, potentially reducing 
the diversity of the trial population.  The participants lost are likely those who 
would have likely dropped out of the trial after randomisation and their results 
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would then follow the ITT principle, potentially diluting the overall treatment 
effect and outcome.  Though trying to retain participants and include a diverse 
population is important, the reduction of attrition would arguably be most 
beneficial in trials (Dascanio, 2015c). 
A disadvantage of a design with a run in period or delayed start is that some 
participants may lose interest while waiting for an extended period following 
their acceptance into the trial, thus attrition during the run-in period may be 
considerably higher, comparative to studies that randomise to the intervention 
at the acceptance into the trial (Velengtas, Mohr and Messner, 2012). 
An additional concern is that the use of run-in periods may lead to an 
overestimate of the impact of the treatment on the population, as in a trial 
situation some participants would, when offered the intervention, refuse or 
drop out.  However, in a clinical setting, the clinician could be recommending 
the intervention to the patient and they may be more likely to follow a 
clinician’s advice.  Also, if a treatment were offered on the NHS on the basis 
of a trial using a run-in period, the results are based on the participants waiting 
for run-in period before receiving the intervention and for a similar accurate 
effect the patients may also need to wait for the set period prior to receiving 
their recommended intervention to reproduce the trial outcomes.  NHS 
waiting times however may render this less of a problem.  
Trials with run-in periods and those without may produce conflicting results.  
If significantly different levels of attrition occurred between trials, greater 
attrition and following ITT principle would inevitably lead to a dilution bias 
of the trial results, thus providing conflicting estimates of effect. 
3.4.6 Adaptive cohort design 
An adaptive cohort design is a study that facilitates modifications to occur to 
the interventions and / or statistical process during the study period, while 
maintaining the reliability and validity of the study (Chow and Chang, 2008).  
They are ‘standard’ RCTs but with built in processes to allow planned 
changes to occur.  They were designed primarily for the pharmaceutical 
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industry in response to cost and time concerns for the evaluation of medicines.  
They aid the examination of several medicines and allow the implementation 
and withdraw of medications as the results during the trial indicate, thus 
providing vast cost saving on trials and accelerating the evaluation process 
(Mahajan and Gupta, 2010).   Maintaining a sufficient cohort size and 
statistical power within these studies can prove challenging but prior study 
data from previous phases can be used during statistical analysis (Lestini, 
Dumont and Mentré, 2015).   
Adaptive cohort designs can be very useful if one is testing several promising 
interventions and the design enables the trial to be finished early in the event 
of futility, inferiority or superiority.  They have an advantage of flexibility of 
pre-planned modifications (set at protocol stage and approved by ethics) that 
can be applied to the trial, for example; increasing the dose of a treatment, 
adapting the treatment duration, providing additional input (Lestini et al. 
2015).  
The adaptive cohort design may benefit a participant with an aggressive 
disease, where clinicians are looking for immediate responses to therapies.  
Additionally, if an intervention is deemed to be ineffective or detrimental then 
the intervention arm can be ceased early (Mahajan and Guptal, 2010).  
Adaptive cohort designs have included the introduction or withdrawal of 
interventions during the course of a trial.  This was used in the STAMPEDE 
trial (James et al. 2008), a cohort version of the adaptive RCT design.  
STAMPEDE was developed for the treatment of prostate cancer, comprising 
of six arms and five phases, this design methodology was used to answer 
research questions as quickly and reliably as possible (James et al. 2008).   
When one form of medication was deemed ineffective during the trial, it was 
withdrawn and not offered to any further recruited participants.   
With some adaptive designs if a new medication becomes available during 
the trial it can be added to the trial and incorporated into the randomisation 
process for new participants.  The nature of this design allows it to be very 
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flexible and adapt to the current and new treatments available for conditions 
(Sydes et al. 2009).   
There are however significant challenges in the practicality of the adaptive 
cohort design and the statistical analysis of such a complex design, due in 
part, to the changing variable parameters and any early stopping.  The 
multiple layers of the design increase the studies complexity and the results 
can become difficult to interpret (Chow and Chang, 2008).  Sydes et al. (2009) 
reported that effective planning and statistical expertise can overcome the 
challenges to ensure the design provides effective evaluation, they argue these 
designs though complex should be more widely adopted. 
Disadvantages of the adaptive cohort design include the possible 
overestimation of the benefit (or harm) if a trial is ceased early due to 
superiority or inferiority, as regression to the mean may have exaggerated any 
effects (Bassler et al. 2007).  The statistical analysis involved in these trials is 
very complex and requires expertise to ensure accuracy.  Multiple interim 
analyses may also jeopardise the integrity of the study (Mahajan and Guptal, 
2010; Sydes et al. 2009).  Also due to the nature of the design and over 
recruitment, if the trial runs to fruition, the increased length of recruitment 
and sample size is usually larger than an average trial and runs for longer thus 
making it potentially costlier than a conventional RCT (Lansberg et al. 2016). 
3.4.7 Cohort design with nested RCT 
The cohort design with nested RCT combines the strengths of a randomised 
trial with an observational epidemiology study (Loannidis and Adami, 2008) 
as shown in figure 3.4. 
This design has the potential to address issues of recruitment, attrition, 
resentful demoralisation, patient preference, ethical challenges, eliminating 
the need for advising participants they are in the control group and allowing 
treatment comparisons (Bibby et al. 2018; Relton et al. 2010), they may 
therefore provide a solution to many of the issues highlighted in the other 
designs. 
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In this design, only compliant participants are randomised into the RCTs thus 
reducing attrition.  As previously discussed, attrition is commonplace in the 
early phases of trials; in this design the RCT is nested within the cohort and 
participants will have completed at least one follow-up questionnaire prior to 
the RCT commencing.  Therefore, any non-compliant participants are likely 
to drop out prior to randomisation.  Reduction of attrition reduces the sample 
size requirement and there is also less need for the over inflation of sample 
size, often used to account for any attrition (Relton et al. 2010). 
 
 
Figure 3.4: Flow diagram of cohort study with nested RCT 
Resentful demoralisation can be reduced with this design (Bibby et al. 2018).  
Enrolling participants into a cohort allows for some participants to be advised 
and some not to be advised of their randomised allocation.  In the case of 
allocation to usual care (and not to a placebo or alternative intervention), those 
randomised to this group and who otherwise may experience resentful 
demoralisation are not advised of their allocation.  These individuals know 
they are continuing in a cohort and may enter a trial at some future time point, 
they continue unaware they had been randomised to usual care for the trial 
Source	population
Cohort	Study
Remain	in	cohort	due	to	consent	or	ineligiblity Enter	Nested	RCT	Randomised	
Cohort	participants	complete	first	follow-up	questionnaire
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and therefore will not be resentful of not receiving an active intervention.  
Ethics surrounding this approach has been questioned, as participants are not 
fully informed at each stage of the study, however the methodology provides 
a resolution to the many issues affecting trials and limits bias within RCTs 
(Bibby et al. 2018; Kim, Flory & Relton, 2018). 
Although rarely used until more recently, the cohort design with nested RCT 
is starting to be adopted more in the UK and internationally (Kim et al. 2018).   
In the UK it was used in a study of transition from child to adult mental health 
services, allowing a flexible time frame for entering the nested RCT (Singh 
et al. 2017).  It was used in the Yorkshire Health study cohort, which allowed 
for participant recruitment to 22 RCT’s (including studies for first aid, 
depression and herbal medicine) from the cohort (Holding et al. 2017; 
Viksveen, Relton and Nichols 2017; Deakin and Tsai, 2017), and it was used 
within the York trials unit for RCTs within a falls cohort study (Rodgers et 
al. 2018; Cockayne et al. 2017).   
Trials within Cohorts have also been completed in Australia (LBP), Canada 
(HIV. Mental Health, Scleroderma and Diabetes), Finland (Meniscal injuries) 
and the Netherlands (Cancer studies), so it is gaining in its popularity (Relton, 
2016). 
There are few disadvantages to the nested cohort design, but critiques of this 
design have been conducted. They have predominated around the concern of 
ethical issues surrounding recruitment and consent to this trial design (Kim, 
et al. 2018; Biddy et al. 2018; Weijer, Goldstein and Taljaad, 2017; Relton et 
al. 2016) and suggestions and adjustments have been reported and 
implemented (Vickers et al. 2018; Weijer et al. 2017; Relton et al. 2016). 
Though the design is useful for prevalent conditions it would not be 
appropriate for incident conditions, as participants afflicted with a condition 
are selected from a cohort for the nested trial.  Investigating incident 
conditions like fractures would be inappropriate with this design as a cohort 
would need to be extremely large for sufficient participants to suffer from a 
fracture and be eligible for any nested trial.  The large numbers and extended 
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time period required to achieve an effective sample size would make the 
design unworkable for incident conditions.   
It is possible that recruitment to a cohort may prove more problematic than a 
routine RCT and the actual take up of the RCT by the cohort participants may 
be reduced.  The additional cost of following up the cohort as well as the RCT 
participants may also be a consideration, due to the increased time, effort and 
cost required comparative to a trial with a run-in period (Dascanio, et al. 
2014), however the administrative requirement to collect data from the cohort 
could be designed to minimise cost and time.  Greater costs may also 
potentially be incurred to encourage response rates of participants to a cohort 
study comparative to a ‘standard’ RCT (Boyd et al. 2015).    
Research has not currently been conducted to assess the fidelity of this design, 
to determine if and when this design should be used in preference to a 
‘standard’ RCT (Relton et al. 2015). 
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3.4.8 Strengths and Weaknesses of RCT designs 
A summary of the strengths and weaknesses of the RCT designs discussed 
are presented within the table 3.2. 
RCT Design Strengths Weaknesses 
General 
strengths and 
weaknesses 
true to all 
RCT designs 
Gold standard methodology 
Enhanced internal validity 
Abolishes selection bias 
Manages temporal changes 
Manages regression to the mean 
Provides basis for statistical inference 
Eliminates Hawthorne effects 
Limited external validity 
Bias can be introduced 
Perceptive to attrition and resentful 
demoralisation (without design input) 
Perceptive to outcome ascertainment 
(without design input) 
Time, effort & cost required for design 
Placebo RCT 
Eradicates placebo effect 
High internal validity 
Increased reliability of trial results 
Eliminates ascertainment bias & 
Eliminates resentful demoralisation 
(blinding) 
Eliminates Hawthorne effect 
Limited application to clinical 
practice 
Limited for complex interventions 
Difficult to develop a true and 
effective placebo for complex 
interventions 
High cost 
Pragmatic 
RCT 
Evaluate intervention in real world 
setting 
Greater external validity and 
generalisability 
Reduced internal validity 
Negative results cannot infer 
treatment effectiveness under 
optimal conditions 
Challenging design & analysis  
Greater time and resource required 
Randomised 
crossover 
trials 
Requires fewer participants 
Participants act as own control 
Less variable results, paired data 
comparison 
Effective for pharmaceutical trials 
Carry over of treatment effect 
Washout period increases trial term, 
ethical issues - non-treatment period 
Unsuitable for complex 
interventions 
Pre-
randomised 
consent 
Or Zelen’s 
method 
Eliminates resentful demoralisation 
Reduces attrition 
Cross over of participants = attrition 
Risk of dilution bias, reduced power 
if follow ITT and crossover occurs 
Ethical concerns 
Patient 
preference 
trials 
Eliminates resentful demoralisation 
Offers participant choice to limit 
cross over 
Reduced external validity due to 
selection bias, with participants 
choosing not to be randomised 
Limited comparison across trial arms 
Factorial     
RCT design 
Comparison of multiple interventions, 
combinations to each other & UC 
Reduced cost 
Complex design & analysis required 
Underpowered for interaction tests 
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Run in or time 
periods pre-
randomisation 
trials 
Reduces attrition & selection bias 
Enhanced validity of outcome 
Overestimate of population effects 
Participant loss of interest - wait period 
Adaptive 
cohort design 
Design flexibility and adaptability 
Compares active treatments 
Introduces and withdraws treatment 
if superior, inferior or futile. 
Combines research designs 
Potential for over estimation of 
results due to regression to the mean 
Costly over extended period of time 
and with over recruitment 
Complex design 
Cohort design 
with nested 
RCT 
Reduces attrition & thus sample size 
Reduces resentful demoralisation 
Randomise only compliant 
participants 
Useful for prevalent conditions 
Increased cost with cohort follow up  
Recruitment to a cohort may be 
problematic 
Reduced take up of treatment  
Inappropriate for incident conditions 
Table 3.2:  Strengths and weaknesses of RCT designs 
3.5 Trial designs and their application to a study of acupuncture 
and manual therapy for low back pain 
Selecting the most appropriate trial design for an RCT is imperative to 
providing confidence in the results of a trial.  As discussed in chapter two, 
research into acupuncture and manual therapy has been criticised for a lack 
of quality and unconvincing results, the poor quality of the trials in fact 
sighted as the reason for not recommending the intervention in clinical 
practice guidelines (NICE 2016; Liu et al. 2015). 
It is imperative that consideration is given to trial design and execution. 
Acupuncture and manual therapy as complex interventions, require a design 
to accommodate their complexity, assess them with impartially and evenly, 
provide adequate analysis, and thus produce a high quality trial, with evidence 
of effectiveness.  In the following sections I shall utilise the information 
discussed previously for trial designs (section 3.4) and apply them to a 
potential study of acupuncture and manual therapy. 
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3.5.1 Placebo RCT and Complex interventions 
Placebo controlled trials are excellent designs for testing medication when a 
placebo pill can be given (Kaptchuk, 2000).  Offering a placebo pill in drug 
trials is relatively straight forward, establishing an inert placebo however has 
proved problematic for more complex interventions when a therapist 
interaction is involved (MRC, 2008).  Placebo effects are the responses 
surrounding the intervention and have been shown to have considerable 
effects on clinical, physiological and brain outcomes for individuals (Wager 
and Atlas, 2015). 
The investigative difficulty in research lies in where the effect size of various 
placebo interventions differ significantly, resulting in varying estimations of 
effect of the studied intervention, thus a placebo with a higher effect size 
would potentially underestimate the effect size of the tested intervention.  
When comparing the effectiveness of interventions in placebo-controlled 
studies the effect size and effectiveness of the placebo intervention is a key 
consideration.  Trial results may potentially vary and could be 
underestimating the true effect of an intervention if studies are comparing the 
investigated intervention to a placebo / sham with a large effect size.  There 
is variation in the size of effect for different placebos / shams and some may 
be more active and have significant treatment effects.  In recent placebo 
surgery studies for example, a placebo shoulder surgery was reported to be as 
effective as the investigated surgery and the results led to it being argued that 
the investigative surgery should no longer be conducted (Lehtinen et al. 
2018).  While showing an intervention is no more effective than a placebo 
may be a very valid undertaking, there needs to be confidence the results are 
a true representation of the tested interventions.  In the studies (Paavola et al. 
2018; Beard et al. 2018), the placebo surgery was a very similar procedure to 
the investigated surgery.  Therefore large numbers of participants, an 
appropriate methodology and effective analytical techniques would be 
required for the sensitivity to detect a difference in effect size between two 
very similar interventions, (which could potentially present very similar 
outcomes and effect sizes) and this was not the case in the studies.  
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In the Paavola et al. (2018) publication, the study was conducted from 2005 
to 2015 and involved placebo surgery which anesthetised the participant, 
arthroscopically entered the shoulder via four arthroscopic portholes and used 
saline within the joint to investigate anatomical structures.  While considered 
a placebo surgery for the study, it is a routinely used surgical investigative 
procedure in clinical practice.  It is a very involved procedure, which 
conducted all but the specific component (arthroscopic sub-acromial 
decompression, ASD) of the investigative surgery, and both surgeries had a 
positive and similar effect on the long-term outcome of participants at 24 
months (Paavola et al. 2018).  It may be that the hypothesised additional 
component of the sub-acromial decompression (ASD) as a mechanism of 
action was no more effective above the ‘placebo surgery’ as the results 
indicate.  Or perhaps the placebo surgery may in itself be an effective 
procedure (and not a true placebo) and thus the study not sensitive or powered 
sufficiently to detect a difference.  The placebo surgery may have a greater 
effect size than other potential placebos, while the true intervention had an 
intervention mechanism over and above the placebo surgery (the ASD), if the 
placebo surgery had a large effect size and similar outcome to the ASD 
surgery, as mentioned previously, the RCT would require an extensive sample 
size with appropriate methodological design and analysis to detect any 
potential differences between the two interventions.  However this study was 
not planned or powered to consider additive effects of the surgical 
intervention and the interventions were compared parallel in a three-arm trial.  
The study also had a limited sample size of 59 participants receiving the ASD 
and 63 receiving the diagnostic arthroscopy (DA), which did not meet the 
sample size required to power the study.  While designed as a three armed 
trial, the comparison of ASD to exercise therapy was treated as a secondary 
outcome and reported that though a small significant difference was seen in 
favour of the ASD the predetermined minimal clinically important difference 
was not achieved (Paavola et al. 2018). 
Beard et al. (2018) conducted a similar parallel three-armed trial between 
2012 and 2015 and produced similar results and recommendations.  However 
they reported an attrition rate of 23% (ASD), 42% (DA) and 12% (no 
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treatment) of individuals not receiving their allocated intervention by six 
months.  While an intention to treat analysis was reported, a dilution bias may 
have been introduced with the level of attrition and disparity across the 
groups.  The outcome data reported on 88, 93, 84 participants in the ITT 
analysis, as opposed to 106 (ASD), 103 (DA), 104 participants who entered 
the trial, but 72, 65 and 64 in the per-protocol analysis.  Thus attrition and a 
dilution bias may have been introduced into the study due to the systematic 
differences between the groups, with the greatest overall attrition in the DA 
arm (103 – 93 – 65) and then the no treatment arm (104 – 84 – 64) an 
overestimation of the intervention group may have been apparent.  The 
sample size calculated at 85 participants per treatment group for the three-
armed trial to power the study was also not achieved.   
Beard et al. (2018) reported that while both surgical groups showed a small 
benefit over no treatment, the differences were not clinically significant.  
They stated the differences between the surgical groups and no treatment 
could have been the result of a placebo effect (both surgeries) and / or the 
postoperative physiotherapy.  The headline interpretation from both placebo 
studies is the addition of ASD over DA is not shown to be effective (Lehtinen 
et al. 2018), however both surgeries were effective over no treatment and this 
possibly requires further assessment and research. 
There are ethical constraints surrounding placebo surgery, which does limit 
the types of procedures possible in research (Savulescu, Wartolowska and 
Carr, 2016).  Thus using a well-established investigative operation (DA) with 
a potentially significant effect size as a placebo, in an RCT that is not 
adequately powered or an appropriate methodological design to assess 
additive effects may have limited the sensitivity of the RCT to evaluate and 
provide a definitive explanation and result for surgery. 
The placebo RCT design is more difficult to utilise with complex active 
interventions (as discussed in section 1.6), like surgery, acupuncture and 
manual therapy, due to the ethical constraints surrounding the placebo and 
also it often proves difficult to disentangle the inert, psychological and 
treatment effects (MRC, 2008; Relton et al. 2010). 
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The difficulty in disentangling the therapeutic effect can limit the ability to 
decide on an inactive placebo (MRC, 2008) and it is somewhat difficult 
therefore to develop a true and effective placebo for an intervention.  
Especially if the boundaries of the treatment specific effects are blurred and 
a placebo device is not truly inert, this has been true in attempts to provide 
placebo or sham interventions for acupuncture and manual therapy trials (Lin 
et al. 2012; Lundeberg et al. 2011) as discussed previously in section 2.8 and 
further explored below in sections 3.5.1.1 and 3.5.1.2. 
With the growing public knowledge of treatments and understanding of 
research, it is proving increasingly difficult to blind participants or offer 
placebo interventions, as many patients have an awareness of the appearance 
and potential effects of a treatment (Ricker et al. 2015).  The applicability of 
placebo control trials is therefore becoming more of a challenge for complex 
interventions. 
In the next section I shall highlight the placebo type of interventions 
previously attempted for RCTs of acupuncture and manual therapy and 
provide a commentary on how effective and accepted these were. 
3.5.1.1 Placebo interventions for Acupuncture: 
Acupuncture is a multi-facetted therapeutic intervention (Makary et al. 2018).  
Establishing an effective placebo or sham control for acupuncture trials 
remains a major methodological challenge.  Many attempts to develop 
effective placebos / sham controls for the investigation of acupuncture have 
been made, though none thus far have proved to be conclusively inert or 
superior (Makary et al. 2018; Wang et al. 2017; Zhu et al. 2013).  
In their consideration of research for acupuncture, the NICE (2016) LBP 
guideline committee included many studies using sham techniques including 
both needle penetrating and non-needle penetrating techniques (section 
2.7.2).  The results of these studies and the lack of a MCID of 1.0 on a VAS 
scale of acupuncture over sham acupuncture contributed to their decision not 
to recommend acupuncture for LBP as discussed in section 2.8).  However 
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many of the included studies had significant methodological issues, were poor 
quality, with a high risk of bias, but were nonetheless included in NICE’s 
meta-analyses of evidence, apart from Marignan (2014).  Table 3.3 
summarises the sham acupuncture studies included by NICE (2016), these 
studies are detailed further in the text below. 
Author     
Year 
Participants 
Intervention Sham intervention Outcome Measure / Results 
Marignan 
2014 
12 
Auricular (ear) 
acupuncture 
One off treatment, 
immediate follow-
up post treatment 
Acupuncture 
needling delivered at 
non-acupuncture 
points in the ear 
VAS – Pain 
 Acup mean = -0.6  
(95% CI, 1 to -3) 
Sham mean = -4.3  
(95% CI, -1 to -6) 
VAS 
et al. 2012 
275 
Acupuncture 
Five sessions, 
over two weeks 
Sham = acupuncture 
needling at non-
acupuncture points 
Placebo = pressure 
with semi-blunted 
needle with guide 
tube at acupuncture 
points 
RMDQ – relative risk to 
conventional therapy 
Acupuncture = 5.04  
(95% CI, 2.24 – 11.32),  
Sham = 5.02  
(95% CI, 2.26 – 11.16),  
Placebo = 2.57  
(95% CI, 1.21 – 5.46) 
GERAC 
trial 
Haake 
et al. 2007 
1162 
Acupuncture 
Ten sessions, over 
6 – 9 weeks 
Needled avoiding 
acupuncture points or 
meridians bilaterally 
Von Korff Chronic Pain Scale 
Inter group difference: 
Acup vs Conventional therapy 
20.2 (13.4 to 26.7 P< 0.001) 
Acupuncture vs sham  
3.4 (-3.7 to 10.3. P = 0.39) 
Sham vs Conventional therapy 
16.8 (10.1 to 23.4. P<0.001)  
Kwon  
et al. 2007 
50 
Acupuncture 
12 sessions, over 
four weeks 
Needles insert into 
non-acupuncture 
points (10-20mm 
from acupuncture 
point) 
VAS – Pain 
Acup baseline = 52.24±19.76, 
FU = 33mm (SD 15.75) 
Sham baseline = 51.28 ±21.42 
FU = 35.52mm (SD 15.22) 
not statistically significant 
Brinkhaus 
et al. 2006 
301 
Acupuncture  
12 sessions, over 
eight weeks 
Non-acupuncture 
points, needled  
bilaterally using 
superficial insertion 
VAS – Pain 
Acup mean = 28.7mm (+/- 
30.3mm SD) 
Minimal (sham) mean = 
23.6mm (+/- 31.0mm SD) 
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Wait list mean = 6.9mm (+/- 
22.0mm SD) 
Molsberger  
et al. 2002 
186 
Acupuncture 
12 sessions, 3x 
per week, over 
four weeks 
Needles inserted but 
applied superficially 
at non-acupuncture 
points 
VAS – Pain 
Acup mean = 23mm (SD 20) 
Sham mean = 52mm (SD19) 
Edelist 
et al. 1976 
30 
Acupuncture 
Three treatments, 
over six days 
Acupuncture needles 
inserted at non-
acupuncture points 
Global evaluation – responder 
criteria 
Acup 46% improvement 
Sham 40% improvement 
Hasegawa 
et al. 2014 
80 
Acupuncture 
Five sessions, no 
duration 
information 
provided 
Non-penetrating 
needles on same 
acupuncture points 
VAS – Pain 
Acup mean =1.98cm (SD 2.12) 
Sham mean =3.38cm (SD 2.26) 
Cho 
et al. 2013 
130 
Acupuncture 
2x per week, over 
six weeks 
Semi-blunt needle on 
non-acupuncture 
points 
VAS – Pain 
Acup mean =2.78cm (SD 2.32) 
Sham mean =4.06cm (SD 2.19) 
Cherkin 
et al. 2009 
638 
Acupuncture 
Seven weeks  
Simulated 
acupuncture using 
toothpick in needle 
tube, tapped and 
twisted toothpick on 
acupuncture point 
RMDQ –function 
Individualised acup mean 4.4 
Standardise acup mean 4.5 
Sham acup mean 4.4 
Usual care mean 2.1 
(P<0.001) 
Kennedy  
et al. 2008 
48 
Acupuncture 
Three to 12 
sessions, over 4- 6 
weeks 
Park Sham device 
non-penetrating 
needle but needle and 
guide tube contacted 
skin at acupuncture 
point 
VAS – Pain 
Acup VAS mean = 28.3 ± 5.2,  
95% CI, 17.9 – 38.6)  
Sham VAS mean = 38.9 ± 5.1, 
(95% CI, 28.5 – 49.2) 
Inoue  
et al. 2006 
31 
Acupuncture 
One off treatment 
Guide tube tapped 
onto the skin at the 
most painful points 
and acted as though 
needle was inserted 
VAS – Pain 
Acup mean = -15±9 (SD) 
Sham mean = -5±9 (SD)  
(P= 0.02) 
 Table 3.3: Acupuncture sham and placebo studies in LBP trials (included 
within NICE, 2016) 
Sham acupuncture techniques have included non-point needling (placing 
needles in non – acupuncture points or in points not specific to disease 
according to Traditional Chinese Medicine (TCM)) and minimal / shallow 
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needing (needles inserted superficially).  Trials using comparisons of these 
sham techniques with acupuncture showed relatively modest differences seen 
in effect sizes (MacPherson et al. 2017c).  However these control 
interventions all include needling the skin and may have had an active 
treatment needle insertion component in the sham intervention, as evidence 
has shown there is a physiological effect on the innervated tissue when it is 
needled (MacPherson et al. 2017c; Chen et al. 2017; Cummings, 2016; Zhu 
et al. 2013; Lin et al. 2012; Moffet, 2009; Lund, Näsland and Lundeburg, 
2009; Campbell, 2006).  In Japanese acupuncture for example, many types of 
the acupuncture technique employ shallow insertion of needles, of varied 
location or also non-insertion techniques (toya hari method) (Birch and Felt, 
1999).  Understanding the physiological mechanism of acupuncture in 
investigative studies is crucial before an effective study can be designed or an 
appropriate sham control intervention. 
Summary of sham (needle insertion) acupuncture studies for LBP (also see 
table 3.3): 
Marignan (2014) trial conducted a one off treatment of auricular (ear) 
acupuncture for low back pain versus placebo acupuncture (selecting 
acupuncture points in the ear that did not correspond with low back pain 
points).  12 participants were split evenly between the two groups and 
assessed before and after the intervention on the VAS scale.  They reported 
the acupuncture group had an average decrease of pain of -4.3 (-1 to -6) and 
reported this result as highly significant P<0.002 and the placebo group 
experiencing a decrease of 0.6 (1 to -3. P>0.28).  The study compared 
auricular acupuncture points, which corresponded with LBP in TCM 
principles, with auricular acupuncture points, which did not correspond with 
acupuncture points in TCM principles.  Thus they were comparing 
acupuncture with acupuncture, just different prescriptions.  It is interesting 
the sham treatment is interpreted as a sham intervention and also to observe 
the significant difference between the two groups, however the small sample 
size was very small within this study, it included only a single treatment of 
acupuncture, and conducted a before and after analysis, the methodology of 
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this study was very low quality, with a very high risk of bias, thus limiting 
the interpretation of the results. 
Vas et al. (2012) conducted a multi-centred trial with 275 participants across 
four arms.  Acupuncture, sham acupuncture (acupuncture needling at non-
acupuncture points), placebo acupuncture (pressure with semi-blunted needle 
with guide tube at acupuncture points) and conventional treatment.  The 
participants received five treatments across a two-week period, and the 
primary outcome was reduction in RMDQ score of 35% or more, two weeks 
after the interventions and the acupuncture interventions were measured as 
relative risks to conventional therapy.  Acupuncture = 5.04 (95% CI, 2.24 – 
11.32), Sham = 5.02 (95% CI, 2.26 – 11.16), Placebo = 2.57 (95% CI, 1.21 – 
5.46).  They reported all three acupuncture interventions were superior to 
conventional care but there was no significant difference between three 
acupuncture groups, and reported the results imply acupuncture was not better 
than sham or placebo acupuncture.  The study was well conducted with a low 
risk of bias.  While all the acupuncture interventions showed improvement 
over conventional care, no difference was found between the interventions 
and this may be explained by acupuncture merely being a good placebo 
treatment and any effect seen simply that of a placebo effect (Lowe, 2017; 
Colquhoun and Novella, 2013).  Or alternatively it may be explained in part 
by the adequacy (or inadequacy) of the interventions used.  Five intervention 
sessions over a two week period may not have been sufficient to establish a 
treatment effect versus the context of a treatment effect and it also could be 
viewed as minimal for the treatment of LBP, for example the NICE guidelines 
(2009) recommended ten sessions over a ten to twelve week period.  
MacPherson et al. (2013) reported the treatment dose and duration of 
treatment were shown to effect treatment outcomes, with lower dose and 
duration showing smaller treatment effects, and this view also supported by a 
review of 24 chronic pain studies (Chen et al. 2019).  In addition the use of 
the RMDQ as the primary functional outcome measure may have limited the 
sensitivity of the results presented, as it may be limited in its ability to 
measure significant functional change over a short period of time, and the 
RMDQ is reported to be a less sensitive measure if disability is likely to 
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remain high in a trial (Deyo et al. 1998).  In studies of acute conditions, with 
very short treatment periods, a measure of pain e.g. the VAS may provide a 
more sensitive outcome measure (Gould et al. 2001). 
The GERAC (Haake et al. 2007) large trial with 1162 participants compared 
verum TCM acupuncture with Sham acupuncture (superficial needling at 
non-acupuncture points) and conventional therapy (medication, 
physiotherapy and exercise), for ten 30-minute sessions over five weeks.  At 
six months a questionnaire response rate of 47.6% (acupuncture), 44.2 (sham) 
and 27.4% (conventional), attrition bias would have been introduced due to 
the high levels and disparity across groups.  An intention to treat analysis was 
used though a dilution bias may have been introduced and the lower response 
rate in the conventional therapy could exaggerate the effect of the 
acupuncture groups, thus potentially overestimating their effect.  For 
acupuncture vs conventional therapy they reported between group differences 
of 20.2% (95% CI, 10.1% to 23.4% P< 0.001) for the acupuncture versus 
sham 3.4% (95% CI, -3.7 to 10.3% P=0.39) and for sham vs conventional 
therapy 16.8% (95% CI, 10.1% to 23.4% P<0.001).  Reporting acupuncture 
and the sham acupuncture were almost twice as effective than conventional 
therapy.  The study was well conducted with a low risk of bias. The results 
were quickly interpreted and reported as acupuncture being ineffective and 
no different to sham (Ernst, 2008) with no discussion of the sham intervention 
used.  Lowe, 2017, and Colquhoun and Novella (2013) support this view and 
argue that acupuncture is purely a good placebo and any treatment effect seen 
is that of a placebo effect.  They feel this principle was demonstrated clearly 
in several studies with the sham acupuncture and the true acupuncture effects 
being closely aligned.  Others however, have an alternative argument, that the 
sham was in fact a milder form of acupuncture and questioned the 
interpretation of the results (Shih, Costi and Teixeira, 2008; Wand and 
O’Connell, 2008; Bausell, 2009).  This study was delivering two types of 
acupuncture technique, and both acupuncture and sham (non TCM point) 
acupuncture performed significantly better than conventional therapy in the 
study.  It is possible our understanding of the mechanisms of acupuncture 
remains limited, and the study design using TCM principles in research 
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comparing them to non-TCM needling may be misleading.  The act of 
needling may be the active component of acupuncture (Cummings, 2016; Lin 
et al. 2012; Choi et al. 2012; Campbell, 2006), and thus when comparing the 
two, sham acupuncture may have diluted the estimate of the effectiveness of 
true acupuncture.  The need to follow TCM principles or perhaps even the 
need for a TCM practitioner to deliver acupuncture may thus not be necessary, 
in research or clinical practice (Dascanio, 2015b). 
Kwon et al (2007) conducted a study comparing acupuncture with placebo 
acupuncture, which involved acupuncture needling on non-acupuncture 
points, with 50 participants across both groups.  Treatment was for 20 minutes 
three times weekly for four weeks.  The authors concluded acupuncture (VAS 
baseline 52.24±19.76, FU 33mm (SD 15.75) was more effective than the 
placebo (VAS baseline 51.28 ±21.42, FU 35.52mm (SD 15.22) though the 
results were not significant.  There was limited information on allocation 
concealment or blinding and the methodological quality was poor for this 
Korean study and as discussed acupuncturing non-acupuncture points as a 
form of placebo has been refuted as the sham acupuncture may dilute the 
estimate of the effectiveness of the true acupuncture, (MacPherson et al. 
2017c; Chen et al. 2017; Cummings, 2016; Zhu et al. 2013; Lin et al. 2012; 
Moffet, 2009; Lund et al. 2009; Campbell, 2006). 
Brinkhaus et al (2006) conducted a study of 301 participants, comparing 
acupuncture for LBP with minimal acupuncture, and a waiting list control.  
Their minimal acupuncture technique involved using acupuncture needles but 
placing them on non-acupuncture points and not inserting them as deeply as 
the acupuncture points in the acupuncture group.  12 treatment sessions were 
conducted over an eight-week period and the VAS was used to measure pain 
intensity.  At eight weeks the difference between acupuncture and the waitlist 
control was 21.7mm (95% CI, 13.9 – 30.0mm) and the difference between 
acupuncture and minimal acupuncture was 5.1mm (95% CI, -3.7 to 13.9mm).  
Both acupuncture and minimal acupuncture performed significantly better 
than no treatment, but no significant differences were found between 
acupuncture and minimal acupuncture at eight, 26 or 52 weeks.  The study 
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was of high quality with a low risk of bias giving confidence in the results.  
While the minimal acupuncture intervention was not referred to as a sham 
acupuncture intervention in the study or publication (as the authors 
determined it as an minimal form of acupuncture) critics were quick classify 
it as a sham technique, and reported the results as demonstrating no difference 
between acupuncture and sham acupuncture for LBP (Parsons, 2006).  Lowe 
2017, and Colquhoun and Novella (2013) argue that no difference between 
acupuncture and sham acupuncture further demonstrates that acupuncture 
works principally as a placebo treatment, and any effect seen is simply that 
of a good placebo effect.  An alternative argument, as discussed previously, 
is that the study delivered two types of acupuncture technique, and both 
acupuncture and minimal acupuncture performed significantly better than no 
treatment in the study.  It may be possible that the physiological mechanisms 
of acupuncture are poorly understood, and research studies comparing TCM 
and non-TCM acupuncture could be a flawed from the outset, due to the 
misinterpretation that TCM points are the active component of acupuncture, 
thus comparing TCM with non-TCM in research will potentially fail to show 
the effectiveness of acupuncture.  The sham studies potentially demonstrate 
that the ‘effect of the needling’ (rather than the TCM point location) may need 
to be considered with greater importance in research and clinical practice.  
Thus future sham studies should possibly not follow TCM / non-TCM 
principles of acupuncture as this may dilute the estimate of the effectiveness 
of true acupuncture, and they should contemplate other options for sham 
techniques. 
Molsberger et al. (2002) compared acupuncture combined with conservative 
orthopaedic management, versus sham acupuncture (needles inserted 
superficially at non-acupuncture points) combined with conservative 
orthopaedic management, versus conservative orthopaedic management, with 
186 participants across the three groups.  Both acupuncture (VAS mean 
23mm (SD 20) and sham (mean 52mm (SD19) performed better than with 
conservative orthopaedic management, and they found a significant 
difference between acupuncture and sham (P<0.001) on VAS, though found 
no difference in the functional mobility or medication use of participants 
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within the study.  They concluded acupuncture could be an important addition 
to conservative orthopaedic management, however their study methodology 
was low quality and the results had a high risk of bias limiting the 
interpretation of the study outcomes.  The sham technique delivered a form 
of acupuncture treatment and thus the study may have been comparing a true 
acupuncture treatment with a potentially slightly inferior acupuncture 
treatment, as opposed to comparing to a sham / placebo technique, thus the 
sham acupuncture may have diluted the estimate of the effectiveness of true 
acupuncture.  As discussed above, this might indicate that the TCM point 
specificity may not be the key principle in the mechanism of acupuncture, or 
alternatively it may be that the effect seen in the acupuncture group is merely 
that of a placebo effect (Lowe, 2017; Colquhoun and Novella, 2013). 
Edelist, Gross and Langer (1976) highlighted the use of Sham needling in 
their study over 40 years ago.  The methods and analysis were limited in this 
study when compared to the standards of RCTs conducted today, but 
demonstrated the historic principle of trying to address the issue of placebo / 
sham within studies.  30 participants were enrolled in the study, and allocated 
to acupuncture or sham acupuncture, (which involved needling 15cm away 
from the spine at the level of L4-5 and in the posterior leg 10cm below the 
popliteal fossa).  Treatment was conducted three times at two-day intervals.  
The assessment criteria reported in the study was limited with an orthopaedic 
surgeon and the patient determining if the patient had improved or not.  15 
patients from each group, seven in the acupuncture group improved, 8 did 
not, six in the sham group improved, 9 did not.  They reported a 46% 
improvement in the acupuncture group and a 40% improvement in the sham 
group.  This was a low quality study with a high risk of bias and thus the 
results need to be interpreted with caution.  The technique used for sham 
needling demonstrated the belief in the TCM principles of specific point, by 
just needling at an alternative sight to the true acupuncture group.  However, 
as discussed, many other TCM acupuncture points exist in the region used for 
the sham technique, trigger point needling techniques would utilise this 
region with needling to the Latissimus dorsi muscle and as previously stated 
the insertion of needles creates a physiological healing response.  It is possible 
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the study was actually just comparing two programmes of acupuncture 
treatment; thus the sham acupuncture may have diluted the estimate of the 
effectiveness of true acupuncture, and that TCM point specificity is perhaps 
not the causal treatment principle of acupuncture techniques.  An alternative 
view is that the study may be highlighting acupuncture as simply a good 
placebo treatment (Lowe, 2017; Colquhoun and Novella, 2013). 
Summary:  The studies using sham acupuncture with needle insertion provide 
information suggestive of a limited difference between acupuncture and sham 
needle acupuncture for low back pain, although probably more noteworthy 
was that both interventions improved comparative to usual care in most 
studies.   
It maybe that conventional care is inadequate, and thus both interventions 
present as effective.  However as discussed, the consistent finding of an 
apparent lack of difference between acupuncture and sham acupuncture is 
interpreted by some as meaning that acupuncture is just a very good placebo 
intervention and not an effective treatment at all (Cummings et al. 2018; 
Lowe, 2017; Colquhoun and Novella, 2013).  This is view is in part due to 
the expectation in research to see a dose response of assessed interventions, 
i.e. true acupuncture would present as better than placebo acupuncture, and 
placebo acupuncture would present as better than no treatment, if in fact true 
acupuncture was more effective than the placebo effect.  An alternative view 
is that the sham acupuncture techniques used are not inert or a true placebo, 
but actually an active form of acupuncture treatment (Cummings et al. 2018; 
Cummings, 2017; Wang, 2017; Lundeberg et al. 2011; Moffet, 2009; Lund et 
al. 2009; Lund and Lundeberg, 2006).  Kamper et al. (2013) argues that only 
when it is understood what elements a sham intervention actually control for; 
can it be established what is accountable for a between group difference in 
treatment effect.  Acupuncture may just simply be a very effective placebo 
intervention, however further rigorous assessment and research is required to 
explore this. 
MacPherson et al (2017c) argued that the appropriateness of many previously 
published sham controlled acupuncture studies, which used needle 
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penetration, were questionable.  He suggested the results of the studies he 
reviewed, indicate sham acupuncture (using penetrating needles) is not inert 
but an active, and influences the effect size seen in the studies, and thus 
concluded these sham techniques should not be employed when controlling 
for non-specific effects of acupuncture (MacPherson et al. (2017c).  Whereas 
Colquhoun et al. (2013) argued that acupuncture is merely a theatrical 
placebo, with no meaningful differences seen between acupuncture and sham 
acupuncture.  He questions whether the differences that may be seen in effect 
size may be the result of bias and lack of blinding in the studies, and stated 
that any benefits which may exist are simply too small to be clinically helpful 
to patients.  Alternatively, while Western Medical Acupuncture evolved from 
TCM it has adapted and no longer adheres to the Chinese principles, 
considering that acupuncture needling stimulates the nervous system and 
stimulates the body’s own pain relieving mechanisms (White et al. 2009).  
Thus offering an explanation as to why needling at non-TCM acupuncture 
points as a form of sham / placebo may not be demonstrating a significantly 
different effect in some research to the true acupuncture (Cummings, 2016).  
Some acupuncture points have been demonstrated to have greater point 
specificity on brain imaging studies (Zhang 2004), however great controversy 
remains over whether the specific location of Traditional Chinese Medicine 
(TCM) acupuncture points are in fact specific or accurate (Campbell, 2006).  
While some in the acupuncture community truly believe in true TCM point 
specificity, it is increasingly being demonstrated that the ‘act of needling’ 
may potentially be the active component of acupuncture not necessarily the 
location of the needle (point specificity).  Evidence suggests that the insertion 
of a needle anywhere in the body will elicit a physiological and potentially a 
treatment effect (Cummings, 2016; Lin et al. 2012; Choi et al. 2012; 
Campbell, 2006).  Further, Langevin and Yandow (2002) mapped TCM 
acupuncture points with the anatomical connective tissue planes of a human 
body and discovered over 80% of the acupuncture points corresponded with 
the location of inter-muscular or intramuscular connective tissue planes.  
They concluded the anatomical relationship between the two was relevant in 
explaining acupunctures mechanism of action.  This theory was supported by 
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a study demonstrating a reduction in the electrical impedance of needled 
tissue on anatomical connective tissue planes, which corresponded with some 
acupuncture points (Ahn et al. 2005). Also by a review literature proposing 
the acupuncture mechanism occurs through the sustained stretch of tissue by 
the manipulation of the needle, impacting upon the connective tissue 
plasticity and modulation of the peripheral sensory nervous system 
(Langevin, 2014). 
Western acupuncture, which is the most commonly practiced by 
physiotherapists and doctors in the UK focuses more on a physiological 
approach to acupuncture, in its specific effect on the connective tissues 
(langevin et al. 2007), the body in producing natural pain relieving chemicals, 
such as serotonin, melatonin and endorphins (da Silva et al. 2014; Wang et 
al. 2014; Wang, Kain and White. 2008; Stein et al. 2001) and its anti-
inflammatory effects by stimulating vagal modulation (Jin et al. 2017; 
Cummings, 2016; Lim et al. 2016; Torres-Rosas et al. 2014). 
The ‘act of needling’ being the active component is a view potentially also 
supported by other areas of medical research.  Benedetti (2008) reported that 
the act of inserting an epidermic needle without injecting any fluid, in post-
operative patients had a similar pain relieving effect as injecting specific pain 
relieving medication.  Indicating the act of needle insertion may potentially 
be the active component of treatment.  He also repeated this study with the 
injection of saline, and reported a similar outcome (Benedetti et al. 2009).   
Opioid (pain relieving) receptors involved in pain modulation have been 
shown to exist outside of the central nervous system and on the peripheral 
sensory nerves.  Stimulation of the peripheral nerve opioid receptors will 
therefore produce an analgesic effect.  The process stimulates the release of 
pro-inflammatory neuropeptides (e.g. endorphins) and the down regulation of 
neural excitability, resulting in pain reduction.  Environmental stimuli will 
stimulate the opioid receptors to produce an analgesic response (Makary et 
al. 2018; Campbell, 2006; Stein et al. 2001).  The insertion of a needle into 
the skin therefore will stimulate these peripheral nerves, a-delta and a-beta 
(responsible for detecting pain, pressure touch and movement) which are 
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located in the skin, producing a pain modulation response.  The local trauma 
or pressure of a needle induces nerve signals locally, which are also sent to 
spinal and central levels.  Therefore many argue that using shallow or non-
TCM point needling would not provide an inactive placebo for research 
investigation (Chen et al. 2017; Cummings, 2016; Zhu et al. 2013; Moffet, 
2009; Lund et al, 2009; Lund and Lundeberg, 2006; Campbell, 2006). 
The sham studies using needle penetration all exhibit significant limitations 
in their design methodologies, substantial heterogeneity of the dose of 
treatment, style of acupuncture and type of sham needling is apparent across 
the studies.  Many of the studies had small sample sizes, with low quality and 
high risk of bias, thus limiting the interpretation and significance in drawing 
conclusions from their results.  This is suggestive of the need for either, 
further high quality, adequately powered studies of sham RCTs, or further 
investigation and understanding of TCM point specificity of acupuncture and 
the design of adequate sham techniques in research studies. 
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Summary of sham (non-needle insertion) acupuncture studies for LBP (also 
included by NICE 2016): 
Toothpicks have been used as an alternative sham to needling and also sham 
acupuncture needles have been developed in an attempt to find an alternative 
to placebo needling; devices included the Streitberger, the Park and the 
Takakure.  A device, which uses a stage dagger mechanism, the needle does 
not penetrate the skin, but a blunt needle contacts the skin and upon a strong 
tap withdraws into the shaft of a guide tube.  These studies are summarised 
in table 3.3. 
Hasegawa et al. (2014) conducted a study of scalp acupuncture (needles in 
the head) compared to non-penetrating acupuncture needles (blunt retracting 
needle, blunt needle and shaft of the guide tube in contact with the participant) 
at the same acupuncture point locations as for the acupuncture intervention 
for acute LBP.  80 participants were randomised across two groups, and 
received five sessions and followed up at day 28.  The authors concluded 
scalp acupuncture (mean VAS 1.98cm (SD 2.12) was more effective than 
sham acupuncture (mean VAS 3.38cm (SD 2.26).  However limited 
information regarding the length of treatment and methods were given in this 
study, limiting its transparency, quality and potential bias within the study.  
Worth noting is this was the only study to use scalp acupuncture for acute 
LBP and thus may be less comparable with studies using body acupuncture.  
Additionally they consider acute LBP only, which is professed to resolve 
spontaneously for the majority of individuals (Qaseem et al. 2017) and thus 
the results may demonstrate an over estimation of the treatment effect.  
Cho et al. (2013) conducted a study across three Korean medical hospitals, 
recruiting 130 participants randomised to real or sham acupuncture (Blunt 
non-penetrating needles on non-acupuncture points).  Treatment was 
conducted twice weekly for six-weeks.  The authors reported acupuncture 
treatment (VAS mean 2.78cm (SD 2.32) was superior to sham acupuncture 
treatment (VAS mean 4.06cm (SD 2.19) at eight weeks (P=0.011).  However 
the quality of the study was low with a high potential risk of bias, limiting the 
interpretation of the results. 
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Cherkin et al. (2009) conducted a large four-arm study with 638 participants, 
comparing ten sessions over seven weeks of individualised acupuncture, vs 
standardised acupuncture (prescribed points) vs Sham acupuncture 
(Simulated acupuncture using a toothpick in a guide tube, including tapping 
and twisting the toothpick at the acupuncture point, the tube and toothpick 
were removed, but then the acupuncture point was stimulated again at ten and 
twenty minutes with the toothpick placed on the skin and rotated clockwise 
and anti-clock wise) vs usual care.  They reported all groups showed 
improvement at eight weeks, but the individualised, standardised and sham 
acupuncture groups all improved (4.4, 4.5, 4.4 points RMDQ) over usual care 
(2.1 P<0.001) and concluded that real acupuncture appeared to be no more 
effective than sham acupuncture, but both were superior to usual care.  
Limited information regarding allocation concealment was given for the 
study and treatment completion rates were 84%, 87% and 90% across the 
intervention arms, showing levels of attrition, with some variation across the 
groups.  A consideration for this study is the repeated stimulation of the 
acupuncture point by the sharp tip of the toothpick within the sham 
acupuncture group.  This technique is likely to have created a local trauma to 
the soft tissues (potentially may have been more uncomfortable than the 
acupuncture intervention and caused more trauma) and stimulated pain and 
the peripheral pain receptors/nerves, and thus perhaps may not have been an 
adequate inert sham technique.  Alternatively it may be that the effectiveness 
acupuncture seen may be simply that of a good placebo effect (Lowe, 2017; 
Colquhoun and Novella, 2013). 
Kennedy et al. (2008) conducted a feasibility study of 48 participants to 
investigate the feasibility of comparing acupuncture to sham acupuncture (at 
the same acupuncture points, using the ‘Park’ sham device, non-penetrating 
needle, blunt needle contacts the skin and then retracts into the guide tube).  
Participants received between three and twelve treatments within a 4-6 week 
period, though no detail regarding any differences in dosage occurring across 
groups is given.  After adjusting for baseline score, pain appeared to reduce 
in the acupuncture group (VAS mean 28.3 ± 5.2, 95% CI, 17.9 – 38.6) more 
than in the sham group (VAS mean 38.9 ± 5.1, 95% CI, 28.5 – 49.2) though 
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statistical significance was not achieved. No significant difference was found 
between the groups on the RMDQ.  As a small feasibility study, it was not 
powered for the results to reach statistical significance, therefore any 
inferences from the study need to be made with caution. 
Inoue et al (2006) conducted a small study of 31 participants, comparing 
acupuncture with sham (therapist tapped a guide tube on the patients most 
painful part and proceeded to act like they had inserted the needle).  The 
participants received one intervention and were assessed before and after the 
intervention.  They reported significant differences with improvement in the 
acupuncture group with a mean difference of -15±9 compared with the sham 
group -5±9 (P= 0.02).  While positive differences were reported this was a 
very small-scale before and after study, with limited generalisability, low 
quality and high risk of bias. 
While there appears to be some evidence of a difference between the 
effectiveness of acupuncture and sham (non-needle insertion) acupuncture, 
the majority of the studies are very small, of low quality, with high risk of 
bias.  The only large scale study (Cherkin et al, 2009) found no difference 
between acupuncture and sham, though both techniques were superior to 
usual care and the sham technique using toothpicks was questionable.  Further 
research is required in this area before conclusive understanding of sham and 
placebo techniques in acupuncture studies can be gained.  
A systematic review of literature supports the use of acupressure as a pain 
relieving technique (a therapist applies manual pressure to an acupuncture 
point on an individual’s skin) as an effective treatment for pain (Pan et al. 
2000).  Thus a blunt needle pressed upon the skin and a strong tap of a sham 
needle (with or without some local trauma from the device) and taping a sham 
needle in place with a plaster, sponge or tape, or applying the pressure of a 
needle or guide tube on a participants skin arguably provides a form of 
sustained acupressure (and potentially upon an acupuncture point, which 
some argue is an integral part of an acupuncture treatment).  It has previously 
been suggested that this contact with a participant’s skin has been able to elicit 
the activation of the peripheral sensory nerves (c-fibres) which are situated in 
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the superficial epidermal layers of the skin and receptive to pressure, pain, 
and touch, and thus have a physiological effect on stimulations received 
(Vrontou, et al. 2013; Lund and Lundeberg, 2006). 
While the theory of the development of sham acupuncture needle appears 
appealing on first assessment, there are reports of the devices often piercing 
the skin, creating erythema’s and the device requiring a strong physiological 
tap upon an acupuncture point which could be synonymous to acupressure (a 
healing technique utilises pressure rather than needles).  It has been argued 
that these devices are not inert in their effects (Cummings, 2017; Moffet, 
2009; Lund, et al. 2009).  A systematic review and meta-analysis considered 
the appropriateness of both sham and placebo acupuncture by comparing 
them to other routine treatments.  They found both statistically significant 
differences between sham or placebo acupuncture compared to routine care 
and waiting list (standardised mean difference for VAS -0.36 (95% CI -0.54 
to -0.18, and the chronic pain scale -0.35 (95% CI -0.49 to -0.20).  They 
concluded sham and placebo acupuncture are more efficacious for pain relief 
than routine or waiting list care and their appropriateness and use for 
acupuncture research was premature.  Recommending the evaluation of sham 
and placebo interventions as control methods to determine their specific effect 
and if acupuncture has a specific effect over them.  Guidelines to aid future 
research and standardisation are advocated (Xiang et al. 2018).  A systematic 
review and meta-analysis supported this view concluding these devices had 
not been rigorously tested, with questions surrounding blinding credibility 
and the variation in effect sizes seen across trials.  They reported the non-
penetrating needles were not adequate as inert controls for acupuncture trials 
and stated further research and development was required (Zhang et al. 2015). 
MacPherson et al. (2017c) in their meta-analysis of 29 studies reported that 
acupuncture was significantly superior to sham regardless of the sham 
intervention used, they also reported that studies with sham penetrating 
needles controls, reported smaller effect sizes for the true acupuncture groups 
than those studies where the sham comparator did not penetrate the skin, 
suggestive that the effect size of acupuncture was being influenced by the 
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type of control method used.  Of the 29 studies analysed, 18 compared 
acupuncture with non-acupuncture controls and 20 compared acupuncture 
with sham acupuncture.  They stated:  
“acupuncture was found to be statistically superior to all types of 
control intervention for all analysis (p<0.001).  Effect sizes were 
larger for the comparison between acupuncture and non-
acupuncture controls than for the comparison between acupuncture 
and sham acupuncture controls (0.37, 0.26 and 0.15 for comparison 
with sham controls vs 0.55, 0.57 and 0.42 for comparison with non-
acupuncture controls for musculoskeletal pain, osteoarthritis and 
chronic headache respectively).” 
(MacPherson et al. 2017c)  
They described greater effect sizes with acupuncture when compared to a 
sham non-penetrating needle intervention (0.43, 95% CI 0.01 to 0.85) than 
when compared to a sham needle penetrating technique (0.17, 95% CI 0.11 
to 0.23) (MacPherson et al. 2017c).  Though conventional levels of statistical 
significance between groups was not achieved. 
More recently however MRI studies have suggested that while both sham 
acupuncture and real acupuncture appear to be eliciting improvement in pain.  
Sham acupuncture was suggested to be stimulating the placebo circuitry 
within the brain, stimulating a response, whereas true acupuncture stimulates 
the primary somatosensory cortex modulating the body’s neurophysiological 
response (Maeda et al. 2017).  Thus potentially explaining why both 
techniques elicit positive responses.  Further exploration of the physiological 
and neurological processes of acupuncture and thus sham acupuncture are 
required to allow advancement in this area of study. 
In addition, sham acupuncture needles are considerably more expensive than 
acupuncture needles and while only a minor consideration for the purposes of 
research, at £425 per box of 100 single-use disposable needles (average of 10 
needles per session) comparative to £7.31 for 100 regular acupuncture 
needles.  It could be argued that with the ambiguity surrounding the 
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effectiveness of sham needles not being an inert placebo, it may be more 
ethical to use funds to finance alternative treatment comparators within 
acupuncture trials. 
Another technique previously used as a placebo or control for acupuncture 
was laser therapy (active and inactive) (Langevin et al. 2006).  Acupuncture 
is increasingly more commonplace, and growing as a treatment choice with 
more than 4 million treatments reported annually in 2012 (Hopton et al. 
2012).  Within studies participants are likely to know that a laser treatment is 
not a true acupuncture treatment (lund et al. 2009; Ricker et al. 2015). 
While uncertainty remains regarding the true effects of acupuncture across 
trials, a long-term analysis of trial results suggests the benefit of acupuncture 
compared to no acupuncture controls remains long after treatment has ceased.  
In their meta-analysis of 20 studies, MacPherson et al. (2017b) considered the 
long-term effect of acupuncture on chronic pain and from their central 
estimate were able to report 90% of the benefit of acupuncture appeared to 
remain at 12 months comparative to non-acupuncture controls.  A 50% 
treatment benefit was sustained at 12 months comparative to sham 
acupuncture controls in the analysis.  Thus reporting a continued benefit of 
acupuncture beyond the end of treatment time period appears to be evident.  
They did report significant heterogeneity across their studies and also 
reported studies including fewer acupuncture treatments across a shorter 
duration had poorer outcomes, further indicating the need for a more 
standardised approach across acupuncture research studies. 
Without knowledge and explanation of the true specific effects of 
acupuncture which current research has not successfully provided, it is very 
difficult to develop an effective inert placebo for the purposes of a placebo 
RCT.  The majority of acupuncture trials lack standardisation of needling 
location, depth, dosage, retention time, treatment frequency, number of 
sessions, all of which may have an influence on clinical effect, thus 
introducing further non-standardised sham techniques in various trials has 
further fuelled the uncertainty of acupuncture (Zhang et al. 2016).  As 
discussed above and in chapter two (section 2.8), sham acupuncture has, in 
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some trials, been shown to be as effective as true acupuncture (Lowe, 2017; 
Zhang et al. 2016; Moffet, 2009).  Further research and understanding of the 
acupuncture mechanism is needed to allow the analysis of the efficacy of this 
technique against placebo or sham acupuncture devices and establish if 
acupuncture is merely a very good placebo or if in fact sham / placebo 
acupuncture is not inert in its application. 
3.5.1.2 Placebo Interventions for Manual Therapy: 
In the field of manual therapy a variety of placebo / control interventions have 
been used.  These have included massage, sham massage, sham manual 
therapy and sham manipulation.  The assessment in some of the trials of the 
delivery of sham treatments was based on the clinician’s opinion ‘that they 
were not providing a full and effective treatment’, they perceived they were 
delivering a sham, or inferior treatment and thus controlling for time and 
attention (Cambron et al. 2011).  Sham or clinician perceived inferior 
treatments are dubious and subject to bias.  Outcome ascertainment would be 
a potential bias due to the inability to blind the clinician in a pragmatic trial.  
A clinician may possibly influence the outcome due to their opinions of the 
true or sham intervention and they may also display inconsistency in their 
delivery of any sham or true intervention. 
While a significant number of studies included by NICE LBP (2016) 
guidelines compared manual therapy to self-management, usual care or other 
interventions, many did utilise various sham manual therapy techniques, 
Table 3.4 summarises the sham manual therapy studies included by NICE 
(2016), these studies are detailed further in the text below. 
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Author     
Year 
Participants 
Intervention Sham intervention Outcome Measure / Results 
Ajimsha  
et al. 
2014 
80 
Soft tissue 
techniques 
(massage, 
myofascial 
release)  
24 sessions 
Hands placed gently 
over treatment areas 
McGill Pain 
 Intervention = mean outcome 
13.1 (SD6.9) 
Sham = mean outcome 18.3 
(SD7.5) 
Bialosky 
et al.  
2014 
110 
Mobilisation 
Six sessions, over 
two weeks 
Sham = Motion 
mimicking 
intervention but 
differing 
biomechanically 
Enhanced sham = 
Sham technique with 
instructional set to 
enhance expectation 
Pain sensitivity 
SMT mean = 18.56 ± 23 (SD) 
Sham mean = 23.64 ± 28.93 
(SD) 
Haas et al. 
2014 
391 
Manipulation 
18, 12 or 6 
sessions, over 6 
weeks 
Sham manipulation, 
consisted of light 
massage 
VAS 
Manipulation mean = 29.0 
(20.8 SD)  
sham mean = 37.9 (20.4 SD)   
Senna et al. 
2011 
93 
Manipulation 
12 sessions, over 
four weeks 
Manually applied 
forces with 
diminished 
magnitude 
Functional disability scale 
SMT mean = 29.83 (12.49 SD)  
Sham mean = 33.46 (12.68 
SD) 
Santilli et al. 
2006 
102 
Manipulation 
Treatment 5 days per 
week, for 5 minutes, 
up to 20 sessions, in 
1 month 
Soft muscle pressing, 
similar to 
manipulations but not 
following specific 
patterns or thrusts 
Functional disability 
SMT mean = 29.83 (12.49 SD)  
Sham mean = 33.46 (12.68 SD) 
Hoiriis et al. 
2004 
192 
Manipulation 
(Chiropractic) 
seven sessions, 
over two weeks 
Simulated position 
but light pressure 
only applied 
VAS 
Manipulation mean = 1.71 
(1.88 SD)  
Sham mean = 2.21 (2.02 SD) 
Triano et al. 
1995 
200 
Manipulation 
12 sessions, over 
two weeks 
Low force, high 
velocity thrusts 
VAS  
Manipulation mean = 1.33 
(1.59 SD)  
Sham mean = 2.17 (2.44 SD) 
Waagen 
1986 
29 
Manipulation 
(Chiropractic) 
Adjustment of spine 
with minimal force 
VAS  
Manipulation = +2.3  
sham = +0.6 
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2 -3 times weekly 
for two weeks 
Table 3.4: Manual therapy sham and placebo studies in LBP trials (included 
within NICE, 2016) 
Ajimsha et al. (2014) conducted a study of 80 participants in an Indian 
hospital, comparing a protocoled myofascial release (type of massage) with a 
sham technique (clinicians placed their hands over the same treatment areas 
but applied gentle maintained contact. They provided 24 sessions over an 
eight-week period.  They reported mean differences between the groups for 
the intervention 13.1 ± 6.9 (SD) and the sham 18.3 ±7.5 (SD) on the McGill 
pain inventory at 12 weeks.  No information on randomisation or allocation 
concealment was provided, limited methodological information is provided, 
the data from the six participants who dropped out was excluded from the 
results and ITT analysis was not used.  The quality of this study was low, with 
a high risk of bias. 
Bialosky et al. (2014) conducted a four-arm study of 110 participants 
comparing spinal manipulative therapy (SMT) with placebo SMT (which 
involved a thrust to the patient but in a neutral position rather than rotated), 
enhanced placebo SMT (included placebo SMT and commentary of 
successful technique to be used) all receiving six sessions over two weeks and 
a no treatment control group.  They assessed changes in pain sensitivity via a 
supra-threshold heat response and observed a mean decrease of LBP 10.27 ± 
18.22 (SD) across all participants regardless of their allocation and significant 
group dependent changes in pain were not observed, the mean differences 
between groups for SMT were 18.56 ± 23 (SD) and the sham were 23.64 ± 
28.93 (SD) at two weeks post intervention, though limited results and 
explanations were available.  The methodological, analysis and results 
information reported in this study is limited, no information on 
randomisation, allocation concealment or ITT analysis is afforded, limiting 
the quality and increasing the risk of bias of the study. 
Haas et al. (2014) considered if there was efficacy to the dosage of spinal 
manipulation, by comparing 100 participants to each of four groups, one 
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receiving 18 sessions of manipulation (15 minutes), one receiving 12 sessions 
and one six sessions and a sham group (light massage).  All participants 
received a hot pack before and five minutes of ultrasound therapy after their 
allocated intervention.  The intervention group receiving 12 sessions had the 
greatest outcome.  The mean difference for pain for the manipulation (12 
sessions) was 29.0 (20.8 SD) and for the sham 37.9 (20.4 SD).  This was a 
small study and the primary investigation of this study was dose of treatment, 
not assessing sham and they reflected in their discussion that the light 
massage intervention was technically a comparison control rather than a true 
sham intervention. 
Senna and Machaly (2011) compared 93 participants across three arms, 12 
treatments of SMT over one month followed by fortnightly treatments for 
nine months, vs 12 treatments of SMT, vs 12 sham SMT (manual forces 
applied with diminished magnitude with patient in neutral not rotated 
position).  They reported both the SMT intervention groups improved 
comparative to the sham intervention at a one-month follow up for functional 
disability with mean outcome for SMT 29.83 (12.49 SD) and for sham 33.46 
(12.68 SD).  This was a small study, with the sample size across three groups 
and the primary investigation not assessing sham. 
Hoiriis et al. (2004) conducted a three-arm study of 192 participants with sub-
acute LBP (4-6 week duration).  Chiropractic manipulation and a medical 
placebo, vs sham adjustments (light pressure applied to the participant in a 
neutral position, with no thrusts) and muscle relaxants, vs sham adjustments 
and a medical placebo.  They reported improvements in the intervention 
group with VAS mean for manipulation 1.71 (1.88 SD) and sham 2.21 (2.02 
SD).  Only 82.8% (159) of participants completed their allocated intervention, 
though the attrition was relatively evenly distributed across the groups (13, 
17, 13 respectively), ITT analysis was not used in this study and there was a 
high risk of bias in the study.  Additionally they considered sub-acute LBP 
only, which is professed to resolve spontaneously for the majority of 
individuals (Qaseem et al. 2017) and thus the results may demonstrate an over 
estimation of the treatment effect. 
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Triano et al. (1995) conducted a three-arm study with 209 participants, 
comparing manipulation vs a manipulation mimic (low force, high velocity 
thrust) performed daily for six days per week for two weeks and a back 
education programme.  At four weeks the mean difference on the VAS was 
1.33 (1.59 SD) for manipulation and 2.17 (2.44 SD), and on the functional 
disability was 10.6 (11.7 SD) for the manipulation group and 14 (11.7 SD) 
for the sham manipulation group.  They provided a very intensive course of 
treatment, which is unlikely to be available in clinical practice and the sham 
technique used a thrust technique in this study, which may have had a 
physiological effect on the participant and perhaps may not have been an inert 
sham, potentially affecting the effect size of the study.  81.3% of participants 
completed the study and missing data was identified in approximately 20% 
of the final follow-ups.  While the study appeared to be of moderate size to 
start with only 47 manipulation and 39 sham participants data was available 
in the four-week analysis, highlighting significant attrition and the ITT 
analysis not used.  This study had low quality and had a high risk of bias. 
Waagen et al (1996) conducted a small study of 29 participants comparing 
chiropractic manipulation with sham (adjustment of body using minimal 
force). Treatment was for 2 -3 sessions per week for two weeks, at two-week 
review using the VAS they reported manipulation mean +2.3 and sham +0.6.  
Though limited information regarding the results or the methods of the study 
was provided.  It was of very low quality with a very high risk of bias and 
thus interpreted with caution. 
The majority of sham / placebo manual therapy studies are small with low 
power, and not using ITT analysis, they have low quality and high risk of 
bias, limiting the interpretation which can be drawn from them.  A systematic 
review of manipulation versus sham, reports some evidence for manipulation 
having specific treatment effects over sham, though the review cautions 
taking strong inferences due to the few available studies, small study sizes, 
no practitioner blinding, high attrition and ITT analysis often not used 
(Ruddock et al. 2016).  
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Choosing massage as a placebo or sham intervention is questionable, as it is 
a manual treatment used by many clinicians including physiotherapists and 
while there is a limited evidence base, it is a recommended treatment for LBP 
by NICE (2016 and 2009) therefore if used as a sham or placebo would not 
be inert and may bias effect sizes of the interventions within the trials.  As 
discussed above for acupuncture, contact with the skin stimulates the 
activation of C fibres, therefore contact made for adjustments, performing 
high velocity movements or massaging would not provide an inert placebo or 
control (Lund and Lundeberg, 2006). 
Alternative placebo options for manual therapy have included the use of 
inactive ultrasound (sound wave therapy) (Bennell et al. 2010), detuned 
ultrasound or detuned interferential therapy (electrical nerve stimulation), 
controlling only for time and attention of the intervention (Koes et al. 1992).  
The use of a piece machinery as a placebo even if deactivated however would 
be evident to the participant, they would be aware they were not receiving the 
active manual therapy treatment intervention and potentially be subject to 
resentful demoralisation.  In a study on patients’ perception of care of manual 
therapy and placebo treatments, it was reported that the placebo intervention 
of a low level laser pad was not a successful placebo comparison to the active 
treatment groups (Cambron et al. 2011), thus limiting the effectiveness of 
using it as a placebo intervention against manual therapy. 
Further research is required into appropriate sham techniques or placebo 
interventions for manual therapy to provide further information in this area 
(Hawk et al. 2002). 
3.5.1.3 Summary of placebo RCTs for acupuncture and manual therapy 
The use of a placebo RCT would be very difficult to achieve when analysing 
multiple complex interventions for LBP.  Both manual therapy and 
acupuncture are complex interventions, which the physiologically processes 
of, are not yet fully understood, there is a lack of knowledge and explanation 
of their active treatment components, thus designing an inert placebo of either 
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intervention would be challenging (MacPherson et al. 2017c; Hawk et al. 
2002).   
The use of the placebo RCT trial therefore, would be unfeasible without 
further insight into the specific effects of the complex interventions studied.  
While the credibility of a placebo RCT results are convincing, an alternative 
robust method is required to substantiate the results of the intended trial for 
this study.  A pragmatic trial would arguably be a more acceptable and ethical 
choice for research in this area (Relton et al. 2010).   
3.5.2 Randomised Crossover trial for acupuncture and manual therapy 
Crossover trials are useful for investigating comparative medications for 
LBP, as the wash out period allows participants to cross from one medication 
to another.  It is unclear however what the wash out effect of acupuncture and 
manual therapy would be, but it is unlikely they occur quickly, completely or 
at the same rate.    
An acupuncture trial for allergic rhinitis reported the continued improvement 
of symptoms at six months following acupuncture treatment (Brinkhaus et al. 
2008), and MacPherson et al (2017b) synthesised the data from 29 
acupuncture trials using a network meta-analysis and reported the effect from 
acupuncture trials remaining at 12 months.  Potentially making a cross over 
trial with wash out effects unsuitable.  No crossover trials comparing 
acupuncture and manual therapy have thus far been conducted (Rubinstein et 
al. 2011).  
A complex condition, like LBP may be difficult to evaluate under these 
conditions.  If an active treatment such as manual therapy demonstrated effect 
in the first treatment period and a patient had gained improvement, assigning 
them to a comparative treatment like acupuncture in a cross over trial would 
be unwise.  The participant’s baseline markers would change for each 
intervention and an additive treatment effect may occur instead of an 
alternative treatment effect.  Consequently this design would not be useful for 
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the clinical evaluation of manual therapy or acupuncture in the treatment of 
low back pain for this study. 
3.5.3 Factorial RCT for acupuncture and manual therapy 
The Factorial RCT design allows for the comparison of more than one 
intervention with a reduced cost comparative to two separate trials.  Analysis 
of each intervention individually to usual care, to each other and in 
combination can occur.  The design provides a wealth of information and 
analysis, with the additional knowledge of additive effects and interactions 
occurring in well-powered studies. 
While the factorial RCT is considered a complicated design with a more 
complex analysis, it is a design that would suit the aims of a study for this 
thesis, considering acupuncture and manual therapy for LBP, with the added 
advantage of combining them and maintaining a usual care arm. 
3.5.4 Preference Trials for acupuncture and manual therapy 
Preference trials are excellent at offering participants choice and eliminate 
resentful demoralisation thus reducing attrition.  However inflated sample 
sizes are required, as participants with strong preferences, are not 
subsequently randomised and are not included within the trial analysis.   
The need for a greater sample size and increased cost of providing additional 
interventions make this design beyond the possibilities of the planned pilot 
study, however recording participant preference is an objective of any future 
trial. 
Zelen’s methodology:  
As discussed Zelen’s methodology is effective at eliminating resentful 
demoralisation, however if great numbers do not consent to their randomised 
intervention a dilution effect can occur and crossover of participants is likely 
with this design, influencing the trial results. 
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Though this design is not considered appropriate for the planned investigation 
of acupuncture and manual therapy for LBP, some characteristics of the 
approach would be very useful, i.e. the controls being unaware of their 
allocated intervention to prevent resentful demoralisation and limit attrition. 
3.5.5 Run-in period or pre-randomisation time period Trials 
The reduced attrition and selection bias afforded these trial results greater 
validity.  Improving the validity and quality of trials is a key consideration 
for interventions, whose history is shrouded with low quality RCTs. 
While participant drop out during the wait period may occur during these 
trials, it occurs prior to randomisation thus providing a pool of participants 
less likely to drop out and thus a reduction in attrition.  The suggested 
potential of an over estimation of the population effect should not impact the 
results as it is anticipated that participants who drop out would have 
nonetheless dropped out at some point during the trial. 
Reducing attrition and selection bias is vital in a trial, while not selected, 
many of the features of this design will positively influence the design chosen 
for this study. 
3.5.6 Adaptive cohort 
While comparing active treatments, the adaptive cohort provides design 
flexibility and combines several research designs, enabling it to adapt to 
advances in medicine withdrawing and introducing interventions as indicated, 
thus providing an insightful design.  As discussed earlier withdrawing 
interventions early may provide an over estimation of effect with regression 
to the mean.  This design and analysis are considered unnecessarily complex 
and costly for the planned study of acupuncture and manual therapy for LBP, 
and thus was not selected as it does not require such flexibility or adaptation 
during the study. 
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3.5.7 The cohort design with nested RCT 
As discussed in section 3.4.7, there are many advantages to the cohort design 
with nested RCT, including reduced attrition, reduced sample size, reduced 
resentful demoralisation and the randomisation of conforming participants 
only.  Due to design methodology and the benefits afforded, this design has 
been selected for the planned investigation of acupuncture and manual 
therapy for LBP.  Further details and methodology specific to acupuncture 
and manual therapy will be detailed below in section 3.6.  
3.6 A Cohort study with nested factorial RCT 
The distinct advantages and disadvantages of various trial designs were 
considered for this thesis study prior to establishing the chosen design format.   
A ‘cohort study with a nested factorial RCT’ has been selected for this study 
of acupuncture and manual therapy for LBP due to its methodological 
suitability and many advantages. 
This is relatively new and novel methodology, and has been suggested as an 
effective method for its use with chronic conditions such as LBP (Grant et al. 
2006).  LBP is a prevalent complex, often chronic condition and the planned 
interventions are complex interventions, therefore a primary objective in 
selecting the design was robust methods to maximise recruitment, minimise 
bias and ensure a study of high quality. 
By combining two investigative methods, (a cohort study and a nested 
factorial RCT) an observational study and a RCT, this design can address 
various issues, limit the introduction of bias and potentially solve many issues 
experienced and reported in previous RCTs (Bibby et al. 2018; Kim et al. 
2018; Relton et al. 2017; Relton, 2009).   
Recruitment: The objective of employing of a cohort study with a nested RCT 
was to utilise its methodology to enhance participant recruitment and 
retention thus reduce attrition, while maintaining the rigorous nature of the 
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randomised controlled trial to assess the interventions (Bibby et al. 2018; 
Relton, 2009) as shown in figure 3.5.  Previous studies of acupuncture and 
manual therapy have experienced significant recruitment and retention issues 
(as discussed in section 3.3.4). 
 
Figure 3.5: Cohort study with nested RCT flow diagram 
One of the fundamental and novel benefits of the cohort design is its use as a 
recruitment vessel to an RCT, maximising potential recruitment.   
Recruitment initially occurs to the cohort study with advice of potential 
onward referral to a nested RCT.  It is anticipated that having a cohort of 
participants to recruit for an RCT should prove beneficial, as the appropriate 
participants are available and have consented to the cohort and potentially the 
RCT. 
The recruitment process incorporates the benefits of a built in ‘Run-in period’ 
to the study, ensuring any attrition occurring in the early phase of the study 
would occur prior to randomisation.  It also enables the recruitment and 
randomisation of conforming participants only, to the RCT.  The potential 
reduction of attrition in the RCT reduces the sample size needed and 
importantly reduces the risk of attrition bias (Dascanio, 2015d).  
Observational	Cohort	StudyBaseline	Questionnaire Continue	in	cohort	if	ineligible	or	not	consentedFirst	Follow-up	completedEntry	to	Nested	RCTif	eligible	and	consentedParticipants	complete	the	nested	RCT	for	the	trial	period	and	then	continue	in	the	cohort
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Using the design for recruitment and retention also provides participant data 
across time and a non-RCT comparative group for the study.  This approach 
has not been undertaken previously for a study of LBP. 
Additionally this design has enabled the use of some of Zelen’s principles to 
aid the reduction of resentful demoralisation and crossover within the RCT.  
As participants are within a cohort, those whom are randomised to the usual 
care arm are not informed of their allocation and thus continue in the cohort, 
as they were prior to randomisation, unaware they have not been allocated an 
active intervention arm.  Additionally participants will be able to select if they 
do not wish to receive one of the study interventions but will still be able to 
be randomised to the preferred intervention or usual care. 
Limitations:  Some limitations of nested cohort study design do exist, and 
others will emerge as it becomes more commonly used and will be explored 
in this thesis.    
There are additional costs incurred in following up the full cohort not just 
those who enter the RCT with a run-in period (Boyd et al. 2015; Torgerson 
and Torgerson, 2008).  Recruitment as for all studies remains a requirement 
and can be problematic (De Hertogh et al. 2009. Howard and Donovan, 2008), 
it is unknown if there will be a difference in the uptake to a cohort with a 
nested RCT comparative to a ‘standard’ RCT.  Additionally participant 
recruitment from the cohort to the RCT is also unknown, this may prove lower 
than for a ‘standard’ RCT and will be explored as part of this study (Dascanio, 
2015c). 
The ethical implications and consent for this study design remain ambiguous 
and this full ethical approval will be obtained (Kim et al. 2018; Biddy et al. 
2018; Weijer et al. 2017; Relton et al. 2016). 
Additionally as this is a pragmatic study, it is not possible to blind the 
participant or the clinician.  The final outcome assessment is provided by the 
patient using an outcome measure tool but cannot be blinded (Ford and 
Norrie, 2016; Torgerson and Torgerson, 2008; MacPherson, 2004).  Thus 
blinding is not possible within this study. 
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Factorial design:  The use of a factorial RCT design has been selected for the 
nested RCT primarily due to the intention to conduct a pragmatic design with 
complex interventions.  The nested factorial design RCT will allow for more 
than one intervention to be compared, in combination and to a control group. 
An extensive evidence report reviewing complementary and alternative 
medicine (CAM) therapies (including acupuncture and manual therapy) for 
low back pain, recommended the need for well powered and well-designed 
trials investigating the use of CAM treatments against widely used active 
treatments, to help provide clinically relevant outcomes and conclusions 
(Furlan et al. 2010).  Using a factorial design RCT will enable this to occur 
with acupuncture and manual therapy while also maintaining a usual care 
control group and allowing their combination. 
3.6.1 Addressing bias in a cohort study with a nested factorial RCT 
Randomisation eliminates selection bias and the use of an intention to treat 
analysis both aid the validity of trials, making them more generalizable to 
clinical practice.  Both these principles will be used with the selected design, 
however there are also other biases that need to be avoided. 
Attrition: Attrition is one of the major threats to the internal validity of any 
trial and acupuncture and manual therapy studies historically have been 
victim to poor quality studies with high attrition levels (NICE, 2016; Li et al. 
2016; Liu et al. 2015).  Ensuring low attrition levels to improve the quality of 
this design is a key objective. 
The design of this study specifically aims to reduce that threat (Relton et al. 
2010).  Using a randomised cohort design will mean a period of three months 
will occur prior to randomisation, allowing the collection of baseline data and 
the first set of outcome data.  Only participants who return their three monthly 
data questionnaires (first set of outcome data) will be eligible for the RCT and 
randomisation.   
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As discussed, the majority of attrition occurs at the first period of follow-up 
of an RCT, it is anticipated subsequent attrition following randomisation 
should be minimal.  Dilution effects (i.e. some participants, randomised to 
intervention fail to accept the treatment) may impact of the study results, 
however it is anticipated this will be low due to nature of our design and the 
level of choice provided within the study.   
An attempt to reduce attrition will also occur through the provision of 
comprehensive explanations of the study and regular contact in the form of 
questionnaires to maintain regular contact with the participants throughout 
the study (Torgerson and Torgerson 2008). 
Resentful demoralisation: The cohort recruitment method will enable the 
limitation of resentful demoralisation in this study.  The design allows for 
those randomised to the usual care arm not to be advised of their allocation 
and this is conducted as ethically as possible, and informative explanations 
will be provided to the participants (Torgerson et al. 1996).   
From the outset participants are consenting to enter a LBP cohort study and 
advised that though they may be approached at a future date to take part in a 
trial within the cohort, only a proportion of participants may be offered active 
treatment.  Therefore any participants randomised to usual care will not be 
advised further of any allocation and continue in the cohort as they were prior 
to randomisation.  Not knowing they have entered a trial in the usual care arm 
aims to reduce any resentful demoralisation.   
Outcome ascertainment: Outcome ascertainment bias can be eliminated 
through blinding, however due to the pragmatic nature of this study blinding 
is not possible.  However using patient reported outcome measures 
throughout the study eliminates outcome ascertainment bias, as the 
investigators are not involved in the collection of the participant data (Gupta, 
2014; Hróbjartsson et al. 2012; MacPherson et al. 2008). 
Hawthorne effects, temporal changes and regression to the mean: 
Randomisation, the inclusion of a control group receiving usual care and the 
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inclusion of more than one treatment arm within this factorial RCT will 
eliminate the effects of the Hawthorne effect, temporal changes and 
regression to the mean.  Any potential effects will be balanced across all four 
groups (Torgerson and Torgerson 2008). 
Participant preference: At initial consent to the cohort study participants will 
be asked if they are interested in a variety of interventions for LBP.  At 
consent to the RCT participants will be asked if they are willing to receive 
either acupuncture or manual therapy.  If they select, they are happy to receive 
one intervention but not another, they will still be able to be randomised to 
their chosen intervention or usual care, allowing them to remain within the 
randomisation process.  Though this does not constitute a full preference trial, 
it does offer some ability to deselect an unwanted intervention, it aims to limit 
any participant preference bias, crossover of the trial participants and limit 
any dilution bias. 
3.7 Conclusion 
RCT’s are considered the gold standard of research and therefore are used to 
inform the planning and application of clinical practice.  There is an inherent 
responsibility on clinical trials to produce valid and accurate results to inform 
clinical practice. 
There is a distinct lack of evidence investigating acupuncture and manual 
therapy in comparison or in combination, and though there are studies of the 
interventions individually the quality of these studies has been questioned and 
resulted in the case of acupuncture in them being removed from clinical 
practice guidelines (NICE, 2016).  Conducting a well-designed study with 
high quality and validity was the objective of the planned study for this thesis. 
The cohort design with a nested factorial RCT was selected; as it combines 
the many benefits of previously discussed designs but limits the weaknesses 
other designs portray.  The cohort recruitment design will be used to review 
its effectiveness in recruiting and retaining participants to a pilot RCT, which 
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will assess acupuncture against manual therapy, against combined 
acupuncture and manual therapy, against a usual GP care in a factorial RCT 
design.   
This methodology was applied to enhance participant recruitment and 
retention while maintaining the rigorous nature of the RCT in assessing the 
selected interventions.  Combining two investigative methodologies and also 
using the factorial design to allow comparisons and combined interventions 
will aim to provide a robust informative study.   
The cohort study should provide the RCT with eligible compliant participants 
and reduce the level of attrition post randomisation.  The factorial model 
allows the comparison of alternative treatments in unison and also in 
combination, while maintaining the usual care group to control for any 
regression to the mean or Hawthorne effect. 
All trials should aim to minimise attrition and trials with superior designs 
should always be emulated, regardless of complexity.  The introduction of 
bias and errors in research studies can occur through various mediums.  
Exceptional design and execution of RCTs is required to ensure trials are able 
to fulfil the expectation lay upon them.  Further consideration by the research 
community of the selection of trial design is essential to limit bias and errors 
in RCTs. 
Gaining further knowledge on the selected design methodology is a key 
consideration in choosing the design.   Finding a way to achieve a reduction 
in attrition and considering how a run in period may be used without any 
additional loss through participant indifference will aim to provide greater 
knowledge to the research community. 
Following the consideration and analysis of all RCT designs, the cohort 
design with nested factorial RCT has been selected for this PhD study.  
Further information and the full study methods of this novel design are 
presented in chapter four of this thesis. 
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4 Detailed Plan of Investigation and Scientific 
Procedures 
4.1 Introduction 
In the thesis I have discussed the impact of LBP upon society and I have 
reviewed and presented the current research and international guidelines, and 
discussed why there is a need for more evidence for acupuncture and manual 
therapy for LBP.  The quality of previous acupuncture and manual therapy 
studies were presented to highlight the limitations and weakness of the 
studies, and I presented the strengths and weaknesses of various trial designs 
to establish a robust research design to aid future study.  A novel trial design 
was identified and selected, with the objective to realise the need to inform 
clinical practice and guideline development committees. 
In this chapter I will summarise the RCT design and complex interventions 
previously discussed in chapter three, and outline the justification for a pilot 
study.  I will then provide the detailed methods of the investigation and 
scientific procedures of the proposed pilot study; a cohort study with a nested 
factorial RCT of acupuncture and manual therapy for LBP.  I will also justify 
the use of chartered physiotherapists and the selected outcome measurement 
tools within the study.  
4.2 RCT design and complex interventions 
As discussed in chapter three, randomised controlled trials (RCTs) have long 
been acknowledged as the ‘Gold standard’ of evaluative research method in 
health sciences (Lilienfeld, 1982; Kang et al. 2008).  If wisely designed, 
conducted and analysed, RCTs provide the strongest evidence for the 
existence of a cause-effect relationship (Pocock, 1983).  RCTs allow 
understanding of the effects of interventions on participants by means of 
robust thorough scientific methods (Falagas et al. 2009). 
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The randomisation process separates the RCT from other forms of research 
methods and provides high internal validity and allows an RCT to control for 
selection, subversion or sabotage bias, and through the use of a control arm, 
it eliminates effect of the Hawthorne effect, temporal changes and regression 
to the mean.  An intention to treat analysis principle also provides the most 
robust analysis technique for preventing any introduction of bias (Torgerson 
and Torgerson 2008). 
Current treatments for LBP including acupuncture and manual therapy tend 
to be described as complex interventions (as described in section 1.6 and 
3.5.1).  The Medical Research Council (MRC) established a framework and 
guidance for developing RCTs for complex interventions (MRC, 2008). 
Though the MRC is updating its evidence base on these interventions (MRC, 
2018) and this is due to be published in 2019 (Skivington et al. 2018), the 
adoption of this framework is widely considered to be good practice when 
researching the development and effectiveness of complex interventions 
(MRC, 2008).   
A working group reviewing complex interventions reported that defining the 
actual components of a complex intervention is possibly the most challenging 
part of evaluating a complex intervention (Campbell et al. 2000).  
Establishing which components are therapeutic and which are inert continues 
to be open to interpretation, and research currently does not fully translate the 
replication of or to clinical practice (Moore et al. 2015). The understanding 
of how complex interventions work within clinical practice is essential to 
creating a comprehensive evidence base that can direct policy and clinical 
practice (Moore et al. 2015). 
Applying an appropriate research design and defining the components of the 
intervention where possible is crucial to the methods of the studies 
(Blackwood, 2006).  Standardisation of the process of the RCT and defining 
which components are fixed and which are variable can assist with assessing 
a complex intervention with an RCT (Broer, Bal and Pickersgill, 2016; Kühne 
et al. 2015; Hawe, Shiell and Riley, 2004).   
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Previous trials of complex interventions for low back pain have routinely 
compared interventions to usual care or various forms of placebo.  LBP is a 
multi-faceted condition and may require a more complex approach to its 
management than has previously been investigated.  The comparison of 
treatment interventions to one another and in combination may prove key in 
developing advancement in the management of this chronic condition. The 
pilot study methods to be outlined could potentially aid the establishment of 
preferential treatments and promote the consideration of added benefits in 
offering additional or combined treatments for LBP (Dascanio, 2015d).  In 
the following section I outline the justification for conducting a pilot RCT. 
4.3 Justification for a Pilot RCT 
What specifically constitutes a pilot study within social sciences can be 
difficult to determine, and many full-scale studies conducted within health 
sciences are relatively small, it has been suggested that many should perhaps 
be thought of as pilot or feasibility studies (Torgerson and Torgerson, 2008). 
The NIHR (2015) indicates that:  
“Pilot studies are a smaller version of the main study used to test 
whether the components of the main study can all work together. It 
is focused on the processes of the main study, for example to ensure 
that recruitment, randomisation, treatment, and follow-up 
assessments all run smoothly.” 
However in contrast the MRC state:  
‘A pilot study need not be a “scale model” of the planned main-stage 
evaluation, but should address the main uncertainties that have been 
identified in the development work.’             
(Craig et al. 2008)  
A methodological review of pilot studies within health care from medical 
journals from 2000 – 2001 was conducted (Lancaster et al. 2004).  The 
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authors concluded no formal description or definition could be established to 
clarify the specifics of a pilot trial (Lancaster et al. 2004).  It is generally 
agreed however that the principle objective of a pilot study is to facilitate and 
provide guidance to inform a full-scale RCT (Eldridge et al. 2016).  Pilot 
studies constitute an important role within research, as inadequate preparation 
and poor methodological process has previously led to poor trial outcomes in 
studies (Birch, 2004). 
A pilot study differs from a feasibility study.  A feasibility study often 
considers if a study can be done.  Feasibility studies may not randomise within 
the trial and are not necessarily intended to evaluate the outcome of interest; 
they are primarily to provide information on design parameters for a main 
trial  (NIHR, 2017). 
Achieving high quality research commences with the selection of an 
appropriate design of a trial.  A design that is able to incorporate multiple 
facets and situations experienced by those suffering with LBP and that can 
minimise bias and attrition.  Ultimately what is required is a long term, large-
scale, multi-regional phase III trial with extensive monitoring of individuals 
with LBP and their follow-up.  It is imperative however to test out the 
methods of any future full-scale trial, to ensure such methods are effective 
and appropriate (MRC, 2008).  A pilot study allows researchers to gain 
knowledge on the functioning of the trial and which adaptations if any would 
be required to improve a future full-scale study. 
Justifications and indications for conducting a pilot RCT include: 
• Assessment of the design methods to answer the research question 
• Testing of the scientific methods 
• Providing information to plan recruitment and assessing recruitment 
targets 
• Trialling the randomisation process 
• Testing of trial documentation 
• Determining the acceptance and use of the trial interventions 
• Surveying for the reporting of incidents 
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• Assessment of the appropriateness of the analysis technique 
• Testing of the most appropriate outcome measure 
• Establishing trial parameters to inform future trial power calculations 
(Eldridge et al. 2016; Torgerson and Torgerson, 2008; Salter et al. 2006; 
Lancaster et al. 2004) 
The aims (listed below) of the proposed pilot study were in line with the 
indications for a pilot study (listed above), i.e. providing information on 
recruitment, determining acceptance of the interventions, assessing the trial 
design and methods, testing the trial documentation and outcome measures, 
and establishing the trial parameters for a future trial.  The pilot study was 
therefore indicated as it aimed to address these to inform a full-scale study: 
• Recruitment rates of participants to a cohort study from GP practices 
• Recruitment rates of participants from the cohort study to a nested 
RCT 
• Consent rates and acceptance of the interventions by participants 
• Acceptance of the combination of interventions by therapists 
• Attrition rates of participants pre and post randomisation 
• The use of this design for evaluating a population with low back pain 
• Advise the selection of an appropriate outcome measurement tool 
• Informing a sample size calculation for a full-scale study 
(Dascanio, 2015d) 
RCTs are notoriously problematic in their execution, often with limited 
follow-up periods and other shortcomings of pragmatic trials, therefore 
ensuring the planning and execution is effective via pilot RCTs is imperative 
prior to a full-scale costly RCT (McDonald et al. 2006).   
A cohort study, used as a recruitment method to a nested factorial RCT, has 
never been used for the musculoskeletal condition LBP previously.    As this 
will be the first time this study methodology has been adopted for this 
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condition, the pilot study will investigate the employment of the investigative 
design to determine parameters for a full-scale multi-centred study.  
The outcome of this study would look to inform the methodological design 
of a national multi-centred trial aiming to establish the nature and course of 
LBP. Ultimately establishing the most effective interventions and a 
comprehensive treatment pathway of those suffering with LBP within the 
UK.  Aiming to develop a more informed evidence base to support individuals 
and inform healthcare policy. 
The proposed pilot study will evaluate many of the indicated reasons for 
conducting a pilot study, the aims of the pilot are detailed below in section 
4.4 and the results of the pilot are detailed in chapter five.  
This pilot study protocol has been published (Dascanio 2015d, see appendix 
A3), and is referenced where appropriate throughout this chapter. 
4.4 Aims and Objectives of the pilot study 
4.4.1 Primary aim 
The primary aim was to inform a full-scale study by conducting a pilot study 
to explore the methodological process of undertaking a cohort design study 
for the recruitment of participants to a nested factorial RCT, investigating 
manual therapy and acupuncture alone and in combination versus usual care 
for LBP (Dascanio, 2015d). 
4.4.2 Primary objectives 
The primary objectives of this study were to ascertain information to inform 
a full-scale trial in the following areas: 
• Recruitment rates of participants to the cohort from GP practices 
• Recruitment rates of participants from the cohort to the nested RCT 
• Consent rates and acceptance of the interventions by participants 
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• Management of the combination of interventions by practitioners 
• Attrition rates of participants pre and post randomisation 
• Inform  sample size calculation for a full scale study 
• Evaluate the use of the design for a population with low back pain 
4.4.3 Secondary objectives 
The secondary objectives of this study were to ascertain the most appropriate 
and clinically useful outcome measurement tool for a full trial. 
• Assess use / completion of Roland Morris disability questionnaire 
(RMDQ) and Modified Oswestry Disability Index (MODI). 
• Compare the objective measure tools (RMQD and MODI) to assess 
which would be most appropriate for a full-scale trial. 
• Assess use / completion of VAS, SF12, EQ-5D and healthcare 
utilisation questionnaire 
4.5 Justification for the selected outcome measure tools 
Patient Reported Outcome Measures (PROMs): PROMs can be generic or 
disease specific tool and collect ‘patient centred’ data at varying time points.  
The results provide an insight into patient opinion of their own condition, the 
treatment and how it has impacted upon their day-to-day life (Kyte et al. 
2015). 
 
A PROM can be defined as:  
“…any report of the status of a patient’s health condition that comes 
directly from the patient, without interpretation of the patient’s 
response by a clinician or anyone else.”  
(FDA, 2009) 
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Outcome measurement has been used in varying forms for more than one 
hundred years, with reports dating back to Florence Nightingale, who was 
reported to use a very simplified PROM, with a three-point outcome, simply 
patients categorised as either ‘relieved, unrelieved or dead’.  Despite 
substantial technological advances in modern medicine, some would argue 
that we haven’t actually progressed too far in terms of health care 
measurement (Appleby et al. 2004).   
PROMs were initially developed for their use within research field, to provide 
objective measures and demonstrate effectiveness of interventions.  They are 
viewed as providing reliable, measurable outcomes and are distinctly rooted 
within the research process.  However following a drive to demonstrate 
clinical and cost effectiveness in day-to-day healthcare provision and inform 
commissioning, PROMs have also become routine in clinical practice.   
Following the completion of this study, the Chartered Society of 
Physiotherapy (CSP) advocated the use of the EQ-5D-5L as a generic 
standardised quality of life questionnaire for data collection within the field 
of musculoskeletal physiotherapy, and audit data has been collected since 
2009 within physiotherapy practice in the NHS (Black, 2013).  The tool was 
selected due to its applicability to a variety of health conditions, its 
widespread use and based on advice from the Department of Health (DoH).  
NHS England PROMs team were considering the incorporation of this 
measure across the NHS (CSP, 2014). 
Two condition specific outcome measures have been selected for this study.  
The motivation for using two objective measure tools for LBP, was to 
consider which would be the most appropriate measure to use in a full-scale 
trial.  Although many objective measurement tools are in existence, there is 
still not consensus within the research community or within clinical practice 
which tool, if any, is the most effective for reliability, validity and sensitivity 
to clinically relevant changes (Longo et al. 2010).  Amongst RCTs of LBP 
the Roland Morris Disability Questionnaire (RMDQ) (Roland and Morris, 
1982) and the Modified Oswestry Disability Index (MODI) (Fairbank and 
Pysent, 2000) are the most commonly used (Morris et al. 2015) and are 
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recommended without preference by the Cochrane Back Review Group 
(CBRG).   
The planned sub-analysis of the comparison of the two outcome measures 
(RMDQ and MODI) is detailed in section 4.21.2, with the corresponding 
results presented in section 5.4.4 and 5.4.5 and discussed in section 6.6.3.  
Both measures have thus been selected for this study and the key 
characteristics are summarised in table 4.1. 
Questionnaire Time point reference 
No. of 
questions 
No. of 
response 
options 
Range of 
score 
Improvement 
indicated by 
Roland-Morris 
Disability 
Questionnaire 
Today 24 One 0 - 24 Reduction of score 
Modified 
Oswestry 
Disability Index 
Not 
specified 10 Six 0 – 100 
Reduction of 
score 
Table 4.1: Summary characteristics of the RMDQ and the MODI 
While two, condition specific outcome measures were selected for their 
comparison in the RCT, it was important to select one measure as the primary 
outcome measure for reporting of the trial.  Therefore the RMDQ was selected 
as the primary measure, due to its extensive use in LBP research (Longo et 
al. 2010). 
Roland Morris Disability Questionnaire (RMDQ):  The primary condition 
specific outcome measure chosen was the RMDQ, which was selected due to 
its extensive use within research studies of low back pain.  It was developed 
in 1983; Roland and Morris were reported to state that:  
“One of the problems in mounting a trial of treatment of back pain 
is the lack of suitable outcome measures”. 
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(Roland and Morris, 1983) 
They subsequently went on to develop and present the RMDQ LBP measure 
(Roland and Morris, 1983).  They developed the RMDQ questionnaire to be 
short, simple, sensitive, and reliable, advocating for it to be used in future 
trials of LBP.  Since its development it was subsequently been followed by 
the development and use of various alternative outcome measure tools, 
however the RMDQ has become one of the most commonly used LBP 
measures in research (Longo et al. 2010). 
When a low level of disability is anticipated at the end of a clinical trial, it has 
been suggested that RMDQ is the most useful tool.  It has also been shown to 
be effective in a primary care setting and is very easy to administer over the 
telephone, which may aid higher completion rates in trials, at minimal cost 
(Deyo et al. 1998).   
The RMDQ is a list of 24 statements of function and movement covering 
areas of daily living, physical wellbeing and mental health, with a yes or no 
tick to answer, the participant reports their response to the questions based on 
how they are feeling on the day the measure they complete the measure.  The 
RMDQ is scored out of 24 with 0 = no disability and 24 = severe disability 
(BPS, 2019).  A score of four or more on the RMDQ was seen an indication 
of symptoms differentiable from a dysfunctional to a functional state 
(Stratford and Riddle, 2016). 
The RMDQ has been shown to provide a good measurable, valid, and reliable 
outcome measure of disability related to LBP (Pawar et al. 2017. Chiarotto et 
al. 2016; Stevens et al. 2016; Bishop et al. 2010; Brouwer et al. 2004; Fritz 
and Irrgang, 2001).  The internal consistency was judged to be good 
(Cronbach’s a = 0.83 to 0.96) (Smeets et al. 2011; Spanjer et al. 2011; 
Mousavi et al. 2006; Stratford et al. 1996).  The test-retest reliability was good 
with a range of intra-class correlation coefficients (ICC) = 0.83 to 0.93 
depending upon the time period between the test and retest (BPS, 2019; 
Jordan et al. 2006; Brouwer et al. 2004; Davidson et al. 2002; Stratford et al. 
1996). 
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The RMDQ was reported to have a moderate to large correlation with other 
PROMS, e.g. ODI and the Quebec scale (QS) (Cohen, 1992) and a moderate 
to large correlation with pain intensity (r = 0.34 to 0.57) to the VAS, EuroQol 
and the Oswestry questionnaire (Kovacs et al. 2004).  Its responsiveness 
against global perceived effect scales is rated as good (area under the curve = 
0.77), and this was comparable with other scales (ODI and QS) (Davidson et 
al. 2002).  It was also reported to have a moderately high correlation when 
compared to physical measures of active functional tests (0.55 P = 0.001) 
(Caporaso et al. 2012). 
There are some limitations to the RMDQ.  It was reported by Frost et al (2008) 
that the RMDQ was less responsive to overall change in disability than the 
ODI questionnaire and Davidson et al. (2002) concluded the RMDQ lacked 
adequate reliability and scale width for the clinical setting, with poorer test-
retest reliability over longer time periods.  While the RMDQ is reported to be 
a useful tool if a low level of disability was anticipated at the end of a clinical 
trial, by contrast it was therefore less sensitive if disability is likely to remain 
relatively high throughout a trial (Deyo et al. 1998).   
Additionally the measure is only applicable to LBP and the design of the 
measure (completing the questionnaire based on how ones feels today) could 
also be viewed as a limitation of the RMDQ, as for individuals with 
fluctuating symptoms, like LBP, this limits the account of the episodic 
variation of a participant’s symptoms.   Completing the questionnaire based 
on how an individual feels on that day only for a condition such as LBP may 
afford varying and potentially inconsistent results. Participants may be 
experiencing a particularly good or a particularly bad day when they complete 
the questionnaire, potentially not giving an accurate estimate of their standard 
LBP symptoms over time. Which may affect the estimate of effect being 
diluted or reduced, and could impact upon achieving the minimum entry 
threshold into a trial, the adequacy of score reported and the accuracy of 
scores between the study time-points. 
Minimum clinically important difference (MCID):  Statistical significance in 
trial results does not automatically imply clinical importance, very small 
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treatment effects, too small to be meaningful to participants, may be 
statistically significant in studies with large sample sizes, and contra-laterally 
large clinically important treatment effects may fail to reach statistical 
significance if sample sizes are small (Katz, Paillard and Ekman, 2015).  The 
MCID was established to determine if a treatment effect is clinically 
important (Man-Son-Hing et al. 2002).   
While differences of 4 – 5 on the RMDQ were proposed historically (Stratford 
et al. 1996) in practice much smaller differences are observed in clinical trials.  
A meta-analysis of large physiotherapy trials of LBP observed mean between 
group differences of 0.8 and 1.87 points in the RMDQ at three months (Ellard 
et al. 2017) and in a LBP study of yoga, a difference of 1.48 points lower was 
observed at six months (95% CI, 0.33 to 2.62 points) and 1.57 points lower 
was observed at 12 months (95% CI, 0.42 to 2.71 points) on the RMDQ score 
(Cox et al. 2010).  In a review of treatments for LBP including acupuncture, 
a difference of 2 - 4 on the Roland-Morris disability questionnaire was 
reported to be significant (Chou et al. 2007).  UKBEAM (2004) observed 1.6 
points improvement at three months and 1.0 point at 12 months.  While they 
note it is a small to moderate clinical benefit, it was suggested that this benefit 
in outcome might lead to large economic effect due to the high cost of LBP 
in society (UKBEAM, 2004). 
This pilot study will plan to observe and consider a planned minimum 
clinically important difference on the RMDQ for a full-scale study.  A 
difference of 1.5 points on the RMDQ was selected as a prospective figure 
due to the observed differences seen in previous trials. 
Modified Oswestry Disability Index (MODI):  The MODI questionnaire was 
selected as a secondary condition specific measure for this study, to compare 
the results of the two measures and consider it as a potential alternative 
measure for a full scale study.   
The Oswestry Disability index was first developed as a validated 
questionnaire in 1980 (Fairbank et al. 1980) and was reviewed and modified 
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to become the MODI in 2001 (Fritz et al. 2001) it was argued to be the gold 
standard of functional outcome measures for LBP (Fairbank et al. 2000). 
It is a self-reported scale of the functional disability of LBP, including ten 
subjects (pain, lifting, self-care, walking, sitting, sexual function, standing, 
social life, sleep, travel).  Each subject has a question with six multiple-choice 
options to select as answers, which follow a scale of difficulty.  Each question 
is scored from 0 to 5, with 0 = no difficulty and 5 = maximum difficulty (each 
score is multiplied by two for a score of 0 – 100).  Overall scores range from 
0 – 20 = minimal disability, 21 – 24 = moderate disability, 41 – 60 = severe 
disability, 61 – 80 = crippling back pain, 81 – 100 = either bed bound or 
exaggerating their symptoms (BPS, 2019).   
The Oswestry Disability Questionnaire (ODQ) has been suggested to be most 
useful in a trial in which disability is likely to remain relatively high 
throughout a trial (e.g. chronic low back pain) and is more suited to a more 
specialist clinical care setting (Deyo et al. 1998).  It consists of ten questions 
with six response options to give a range of severity; it is completed to 
represent a patient’s condition at the time of completion (Smeets et al, 2011).  
The MODI has been shown to be a reliable measure, with high test-retest 
reliability (intra-class correlation coefficient 0.84 (95% CI, 0.73 – 0.91) and 
it was reported it to be one of the most reliable measures (with SF-36 and 
QS), having appropriate width scale to reliably detect improvement and 
deterioration in participants symptoms (Davidson et al. 2002) and having a 
smaller measurement of error compared to the RMDQ (Chiarotto et al. 2016).  
This finding was supported across the literature with test-retest reliability 
reported as high, ICC values range = 0.83 to 0.99 and measurements varied 
in relation to time intervals, with the greater interval between assessments 
seeing a lower score (Miekisiak et al. 2013; Grotle et al. 2012; Davidson et 
al. 2002; Fairbank et al. 2000; Roland et al. 2000). 
MODI has good to high internal consistency across studies (Cronbach’s 
a = 0.71 to 0.90) (Miekisiak et al. 2013; Grotle et al. 2012; Fairbank et al. 
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2000; Roland et al. 2000) though no difference between the internal 
consistency of MODI and the RMDQ were seen (Chiarotto et al. 2016). 
MODI’s responsiveness to detect change (‘area under the receiver operating 
characteristic curve >0.76) was consistently found across all the four studies 
(Frost et al. 2008; Davidson et al. 2002; Beurskens et al. 1996; Stratford et al. 
1994), and Frost et al. (2008) reported the ODI to be a more responsive 
measure to change in disability overall (large effect size -0.88 to 1.00 
(improved group) & moderate effect size 0.61 to 1.16 (deteriorated group) 
comparative to the RMDQ (moderate effect sizes -0.70 to -0.74 & 0.69 to 
1.25) and the Patient Specific Activity Questionnaire (PSAQ) (large effect 
size 1.08 to 1.31 & small effect size -0.16 & -0.26). 
The MODI was also reported to have a moderate to large correlation with 
other PROMS, e.g. RMDQ and the Quebec scale (QS) (Cohen, 1992).  Its 
performance was measured against the RMDQ and it was found to be a 
potential alternative measure to the RMDQ for LBP (Chiarotto et al. 2016; 
Fairbanks, 2014; Vianin, 2008). 
There are some limitations to the MODI.  It is time consuming to complete 
with ten questions each having a multiple-choice response, this also adds an 
element of complexity and thus some participants may require support in 
completion of the measure. (BPS, 2019; Smeets et al. 2011).  The ten 
functional subject areas included may not be the most significant to the 
participants, and the questionnaire has no applicability beyond LBP (BPS, 
2019).  Additionally as with the RMDQ the participants were asked to 
complete the questionnaire based on how they feel that day, which as 
discussed for the RMDQ, limits the potential clinical presentation and 
account of the episodic variation of a participants LBP, which may result in 
the estimate of effect being diluted or reduced, and could impact upon 
achieving the minimum entry threshold into a trial, the adequacy of the score 
reported and the accuracy of scores between the study time-points. 
Minimum clinically important difference (MCID):  A minimum clinically 
important difference on the MODI was reported to be 11 points, in their 
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assessment of LBP PROMS (Lauridsen et al. 2006) whereas a comparison of 
the MODI and the QS for physical therapy for LBP, reported a MCID of 6 
points on the MODI (Fritz et al. 2001). 
In a study of acupuncture compared to usual care for LBP a mean difference 
of 6.1 (3.5, 8.7) points was observed on the MODI (Nicolian et al. 2019).  A 
study comparing back rehabilitation with spinal surgery, a mean difference of 
11.75 was reported as minimal detectable change on the MODI (Johnsen et 
al. 2013), and a study of back schools for LBP observed a reduction in mean 
difference in the MODI of 13.49 ± 0.59 (P<0.001) (Sahin et al. 2011). 
Research has identified the minimum clinically important difference to range 
of between 6 – 13.49 points on the MODI.  It is evident that further research 
is required to establish a recommended MCID for the MODI. 
Summary:  Both the RMDQ and the MODI were selected for this study to 
allow their comparison, to review their use in a study for acupuncture and 
manual therapy for LBP, and to inform a full-scale study which was the most 
appropriate measure to utilise. 
In addition to the RMDQ and MODI, other PROMS (SF12, EQ5D, VAS and 
a ‘Costs’ questionnaire) were also selected for this pilot to assess their use, 
completion and appropriateness for a future full scale RCT.  The SF12 was 
selected as a quality of life measure, the EQ-5D-3L was selected as a measure 
of health assessment, the VAS was selected as a measurement of pain, and a 
healthcare utilisation questionnaire was selected as a measure of healthcare 
utilisation.  These additional PROMS are detailed below: 
Short Form 12 (SF12):  The SF12 is a quality of life assessment 
questionnaire, consisting of 12 questions, each having five possible answers 
ranging from poor to excellent.  The answers to the questions are weighted to 
create two scales, providing a mental health composite score and physical 
health composite score for a participant.  It was developed as a shorter version 
of the SF36 to aid researchers to restrict the length of surveys while still 
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maintaining the minimum standards of precision (Utah, 2001; Ware et 
al.1995). 
The SF12 has been widely studied and used as a valid measure of health-
related quality of life for a variety of populations.  The internal consistency 
for the individual subscales was good at approximately 0.8 or higher (Turk 
and Melzack, 2011).  The test-retest reliability was report by Huo et al. (2018) 
to be good with intra-class correlation coefficients (ICC) of 0.61 for the PCS 
component of the questionnaire and 0.57 for the MCS component of the 
questionnaire and by Turk et al. (2011) to range from 0.71 and 0.89.  It was 
seen to have linear correlations when compared to the SF36 for both the PCS 
and the MCS components (R = 0.86 to 0.93; P< 0.0001) for both sensitivity 
and reliability (Singh et al. 2006) this result was also supported by the 
findings Pezzilli et al. (2006). 
It is reported that the scoring can be quite time consuming and subject to 
participant error, unless expensive software is used.  The measures scales 
have few ranges of responses limiting the interpretation and scores are 
multiplied up to 0-100.    It is suggested that due to the physical and mental 
components of the questionnaire being very closely correlated at high scores 
they should be used with caution, and the concurrent validity of the mental 
component may only be adequate and thus not valid for use (Turk et al. 2011).   
EQ-5D-3L: The EuroQol group, developed the EQ-5D-3L in 1987 as a 
standardised measure of health status, with the aim of providing a simple, 
generic measure of health for clinical and economic evaluation (Reenen and 
Janssen, 2015).   The EQ-5D-3L is recommended for ‘Health Technology 
Assessment’ by NICE in the UK, and by the NHS PROMS Group; it is 
influential in its use to inform economic evaluations and can be used for a 
wide range of conditions (BPS, 2019).   
It is a widely used measure; the first section is a qualitative assessment of 
health, with questions covering five areas of well-being (mobility, self-care, 
usual activities, pain / discomfort and anxiety / depression). Each area 
consists of statements of ability of three levels for each question, it is easy to 
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complete, with the participants place an x in a box corresponding to their 
circumstance.  The second section is a VAS measure of overall health to 
measure their health status from 0 – 100 (BPS, 2019; Balestroni and 
Bertolotti, 2012).   
The EQ-5D-3L was found to have reasonable test-retest reliability ICC of 
0.70 (Fransen and Edmonds, 1999), values of <0.01 to 0.92 (Varatharajan and 
Chen, 2012) and Cohen’s k test-retest reliability range of 0.29 to 0.61 (Luo et 
al. 2003) and a higher reliability was associated with an improved health 
status (BPS, 2019).  It was shown to be responsive to change (Payakachatt, 
Ali and Tilford, 2016), have construct validity, and was found to correlate 
similarly with the SF-36 for musculoskeletal diseases (Picavet and 
Hoeymans, 2004). 
In a systematic review it was concluded the EQ-5D-3L demonstrated 
evidence of responsiveness for several conditions and was an appropriate 
measure for economic evaluation and health technology assessment 
(Payakachatt et al. 2016).   
The EQ-5D-3L is less sensitive to change than the SF12 (Johnson and Coons 
(2017) and for some conditions it demonstrated a mixed level of 
responsiveness and it was recommended it should be used alongside 
additional measures for such conditions (Payakachatt et al. 2016).  It is often 
used for economic evaluations, but it has been reported that being a generic 
measurement it may not be sensitive enough and may not fully cover disease 
symptomology e.g. fatigue, concentration, appetite (Priedane et al. 2018).  
Fransen et al (1999) also reported concerns regarding the difference in 
patient’s self-evaluation and the derived societal utility tariffs as a concern, 
in addition to a lack of discriminative sensitivity for participants with 
moderate morbidity.   
The wording for some questions has also been suggested to be ambiguous e.g. 
“walk about….” without clarity of distance or location, thus the mid-range 
responses can be difficult for participants to select (Janssen et al. 2012).  
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Additionally it asks participants to report ‘how they feel today’ and as 
discussed for the previous PROMS, this limits the account of the episodic 
variation of a participant’s symptoms.  
Visual Analogue Scale (VAS):  The VAS is a pain rating scale and was one of 
the first PROMS, used by Hayes and Patterson in 1921.  The VAS is a 
validated, subjective measure of pain and is used most frequently as a uni-
dimensional measure of pain.  It is easy to use, requiring participants to mark 
or ‘x’ placed along a horizontal 10cm line to indicate level of pain along the 
continuum (line) from no pain to worst pain (0 – 4mm = no pain, 5 – 44mm 
= mild pain, 45 – 74mm = moderate pain, 75 – 100mm = severe pain, however 
these values are imposed by the assessor and do not necessarily reflect the 
participants meanings (PRS, 2019; Delgado et al. 2018).  The participant 
completes the questionnaire based on how they feel in the previous 24 hours 
and is reported to be and sensitive to small changes (Streiner and Norman, 
1989). 
The VAS is versatile and can be used for a variety of pain conditions.  The 
same scale can also be adapted to measure other variables (mood, sleep, 
function) and is quick to complete, requiring no training (PRS, 2019). 
The test-retest reliability was shown to be good for the VAS with intra-class 
correlation coefficients (ICC) of 0.97 (95% CI, 0.96 to 0.98) and 90% of pain 
ratings being reproducible (Bijur et al. 2001), Alghadir et al. (2018) supported 
this finding also reporting ICC of 0.97 and concluding the VAS had excellent 
test-retest reliability. 
The construct validity of the VAS was good; with it being highly correlated 
other scales and was also reported to be more sensitive to small changes than 
other measures (5-point Verbal descriptive scale, Numeric Rating Scale) 
(Gould et al. 2001; Joos et al. 1991)  
The measure is only useful for uni-dimensional measures and is limited to a 
single subject i.e. pain in the information provided (PRS, 2019).  A higher 
distributional use of the mid-point on the VAS scale has also been raised as a 
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concern with it being selected 2.8 - 4.8 times more than other points. While it 
was shown to be less of an issue with a mid-point indicator, radio button or 
number removed from the scale, there did appear to be a draw of participants 
to the mid-point (Couper, Tourangeau and Conrad, 2006).  Additionally while 
the VAS appears a useful measure of pain, it was reported not to perform as 
effectively when used for disability.  Its validity for assessing disability was 
classified as poor due to a weak correlation with other PROMS (SF-36, 
RMDQ & VAS for pain) (Boonstra et al. 2008). 
Health Utilisation Questionnaire:  The healthcare utilisation questionnaire is 
a bespoke set of questions designed to collect information on health care 
utilization, developed by the York Trials Unit.  It aims to give an indication 
of healthcare utilisation of individuals within the study.  It may be a useful 
addition to a full-scale study to indicate any differences between groups or 
with the cohort participants in healthcare utilisation throughout the cohort 
study period. 
The included questionnaires will be reviewed for their completion rates and 
ease of use, to determine their appropriateness and clinical usefulness for 
inclusion in a full-scale study. 
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4.6 A Pilot Cohort Study with Nested Factorial RCT design 
The pilot study design proposed, follows a novel cohort recruitment design, 
in which the pragmatic factorial RCT will be nested within a cohort study.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Flow diagram of the cohort and RCT recruitment process 
(adapted from Dascanio et al. 2011) 
Participants were recruited to a cohort study and were advised they may be 
selected for recruitment to a nested RCT during the cohort study period, as 
detailed in figure 4.1.  This allowed for cohort participants who conformed to 
the study requirements only (returned their three month questionnaires) to be 
recruited and randomised into the RCT, thus aiming to reduce post 
randomisation attrition (Relton et al. 2010). 
Identification of participants from GP practice 
Eligible participants enrolled into cohort study 
Consented to be in cohort and RCT 
 
RMQD > 4: enter RCT & 
Randomised 
Follow Up at Three Months  
Participants who return their questionnaires to be assessed for eligibility 
 
 
RMQD < 4: Remain in cohort 
 
 
Consented to Cohort only 
 
Follow Up at Six Months  
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4.6.1 Cohort design 
Participants were selected from two GP practices, using coded databases 
searches.  Those individuals aged between 18-65 years who had consulted 
their GP in the preceding 18 months with low back pain were identified.  The 
study inclusion criteria used during the searches are detailed in table 4.2 and 
the study exclusion criteria used during the searches are detailed in table 4.3. 
All potentially eligible participants were sent an information pack from their 
GP practice, which contained an invitation letter; a participant information 
sheet and a study consent form (appendices C4, C5). 
It was explained to participants in the information sheet that during the course 
of the cohort, a treatment trial would occur, and cohort participants would be 
given the opportunity to take part in the RCT.  Those who indicated they did 
not wish to take part in a future RCT on their consent form would continue in 
the cohort study only.   
All participants who consented to enter the cohort only were went a baseline 
questionnaire.  Those participants who consented to enter the cohort and be 
contacted about an RCT study were then sent a second participant information 
sheet, a second consent form and a baseline questionnaire to complete and 
return to the University of York.  Those who returned their completed 
baseline questionnaire (and consent forms for those consenting to the RCT) 
were all registered for the cohort.   
Throughout the cohort study the individuals were monitored using 
questionnaires at three monthly intervals.  Participants received information 
explaining that they were forming part of a cohort study and would be 
monitored regularly (i.e. three monthly) via postal questionnaire, to 
investigate their LBP over an 18-month period, however this thesis 
considered participant data to the six-month time point only. 
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Inclusion Criteria: Rationale for Inclusion: 
Individuals aged between 18 – 65 
years 
Inclusive of a wide population sample 
Individuals registered with a GP 
practice participating within the trial 
Restricted to GPs inducted into the 
study 
Individuals able to converse in English Limited funds of a Pilot for translators 
Individuals who have consulted their 
GP with mechanical or simple LBP in 
the preceding eighteen months 
LBP reported within the preceding 18 
months if still ongoing would be 
constitute chronic or recurring LBP 
Individuals suffering with LBP for 
between six weeks and eighteen 
months 
Restricted to more than six weeks, due 
to prior would be considered acute and 
likely resolve.  Limited to an 18 month 
history, due to increased chronicity 
changing the presentation of LBP 
Individuals with referred pain into the 
leg will be included in the study (if 
there was no indication of any serious 
neurological conditions when assessed 
by their GP) 
Leg pain is common with LBP 
sufferers and often benign and caused 
by referral from mechanical structures 
of the LBP e.g. nerves, muscles, discs. 
Individuals with pain present on 
assessment and pain that is persistent 
in nature (i.e. occurring at least once 
daily for eighty percent of the days in 
the history of their recent painful 
episode) 
Due to the need to differentiate 
between those with minor and more 
severe LBP.  The condition needs to be 
present for a substantial period of time 
to allow the interventions to take place 
Individuals who agree to avoid 
physical treatments other than the 
study interventions for the ten to 
twelve week period of the pilot study 
(active treatment participants only) 
Other treatments at the same time as 
the intervention treatment could 
impact and alter the participants 
response 
Individuals with a score of four or 
more on the Roland-Morris disability 
questionnaire at baseline (UKBEAM 
2004) 
To enable there to be scope for a 
change in the outcome measure 
(RMDQ) 
Table 4.2: Study inclusion criteria and rationale (adapted from Dascanio, 2015) 
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Exclusion Criteria: Rationale for Exclusion: 
Individuals who were below 18 years 
of age 
Children were not considered for this 
study as they required specialized 
services 
Individuals who were above the age of 
65 years 
Due to the increased risk of co-
morbidities 
Individuals with clinical indications of 
serious spinal or neurological 
pathology, as assessed by their GP 
As would constitute LBP caused by a 
specific pathology.  This study is 
focused on non-specific LBP 
Individuals with a history of spinal 
surgery 
As may alter the clinical presentation 
of LBP and clinical outcome 
Pregnant women or those who have 
given birth in the last twelve weeks 
As this may alter the clinical 
presentation of LBP clinical outcome 
Individuals who had received manual 
therapy or acupuncture in the 
preceding three months 
As this may alter clinical outcome and 
may provide an inaccurate measure of 
treatment effect 
Individuals with blood disorders, 
receiving anti-coagulants or anti-
platelets 
As this is a relative contraindication to 
acupuncture 
Individuals who are immuno-
compromised 
As this is a relative contraindication to 
acupuncture 
Individuals with metal allergy As this is a relative contraindication to 
acupuncture 
Individuals who are unable to provide 
consent 
Due to limitations of this pilot 
individuals only who can consent to 
participate are able to be included 
Individuals with a history of psychosis 
or alcohol abuse Due to difficulty in assessing outcome 
Individuals who have a needle phobia, 
unless individual chooses to participate 
in the non-acupuncture part of the study 
Due to acupuncture being part of the 
study 
Individuals with valvular heart disease 
or pacemakers 
As an absolute contraindication to 
acupuncture 
Table 4.3: Study exclusion criteria and rationale (adapted from Dascanio, 2015) 
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The cohort study provided a recruitment base for the nested trial, however the 
cohort participants (not willing or eligible to be part of the nested trial) 
continued to be monitored in the study and provide cohort data for LBP over 
the six month period.  The data collected from this group of individuals would 
provide information on a cohort of individuals with LBP who were not 
included in the trial.   
Box 4.1 details a summary of the participant information process. 
Box 4.1: Participant information summary 
• A letter invited the patient to join the cohort study (if they 
are currently still experiencing their LBP) by returning the 
completed forms to the University of York  
• The participant invitation letter explained to the participant 
that there would be a future treatment trial within the cohort 
and if they wished to also take part in the treatment trial to 
express that wish on the consent form in the allocated box 
• Those participants who consented to the cohort and the 
treatment trial were then sent a second information pack 
containing the participant information sheet two, consent 
form two and the baseline questionnaire 
• Participants who consented to the cohort only received the 
baseline questionnaire booklet but were not be entered into 
the treatment trial or randomised 
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4.6.2 Nested factorial trial design 
Participants from the cohort study were assessed for their eligibility to enter 
the nested trial; they were required to meet the criteria set prior to 
commencing the study: 
• Participants who consented to both the cohort and nested trial  
• Participants who returned their completed consent form and baseline 
questionnaire  
• Participants who subsequently returned their three monthly 
questionnaire   
• Participants with a score of four or more on the Roland Morris 
Disability Questionnaire(RMDQ) as the minimum entry requirement 
Figure 4.2 shows the flow diagram of the participants’ pathway through the 
pilot cohort and nested RCT. 
Individuals who scored four or more, on the three-month RMDQ 
questionnaire, were considered to have significant symptoms to differentiate 
between those with functional or dysfunctional state (Stratford and Riddle, 
2016).  Symptoms associated with a score of four or more may potentially 
trigger a referral to physiotherapy via routine contact with their GP as part of 
a usual care pathway, thus a score four or more on the RMDQ was used as 
the entry threshold for the RCT.  
As shown in figure 4.2, those participants who scored less than four on the 
RMDQ at three months were excluded from the nested RCT, as their 
symptoms of LBP were considered minimal and below the threshold to 
differentiate between those with a functional and dysfunctional state 
(Stratford et al. 2016).  In standard routine care these participants would be 
managed by their GP with medications and advice, onward referral to 
physiotherapy would rarely be indicated.  These participants were not 
considered severe enough for further treatment and may well be less 
responsive to a course of treatment or may be too healthy to demonstrate a 
true effect of treatment interventions within an RCT.  While this study was a 
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pilot and was not planned to determine a treatment effect, the objective was 
to keep the trial as similar to an anticipated full-scale trial as possible. 
 
  
Figure 4.2: Flow diagram of Cohort study with nested RCT (Dascanio, 2015d) 
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The Roland Morris Disability Questionnaire (RMDQ) was selected as the 
main treatment outcome measure for this study primarily due to its extensive 
use within research studies of LBP; as discussed (section 4.5) it has been 
shown to provide a measurable, valid, reliable outcome measure (BPS, 2019: 
Pawar et al. 2017. Chiarotto et al. 2016; Stevens et al. 2015; Smeets et al. 
2011; Spanjer et al. 2011; Bishop et al. 2010; Brouwer et al. 2004).   
The Modified Oswestry Disability Index (MODI) Questionnaire was selected 
as a secondary measure of back pain, as discussed (section 4.5) to investigate 
its performance as a measure against the RMDQ and consider it as a potential 
alternative measure (BPS, 2019; Chiarotto et al. 2016; Fairbank, 2014; 
Miekisiak et al. 2013; Grotle et al. 2012; Vianin, 2008; Frost et al. 2008; 
Davidson et al. 2002).   
Acceptability and use of the RMDQ and MODI measures were considered by 
analyzing response rates and results, which aimed to help determine which 
back pain measure should be the primary measure for a full-scale trial.  The 
specifics of the objective measure tools are detailed in this chapter in section 
4.5, discussion of their use and comparative results from the pilot study are 
presented in chapter five. 
A nested pragmatic factorial pilot trial design was used. The factorial trial had 
four groups: 
 Treatment ‘O’   = Usual Care 
 Treatment ‘A’   = Acupuncture  
 Treatment ‘B’   = Manual Therapy 
 Treatment ‘AB’ = Acupuncture and Manual therapy 
In this pilot and a potential full-scale trial, this design would allow us to 
analyse the effectiveness of the two interventions at the same time, while 
maintaining a comparative control arm, and would increase the efficiency of 
the trial (Finlay et al. 2003; Byth and Gebski, 2004).  In addition, it would 
allow the investigation of the effects of the two treatments when given in 
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isolation and compared head to head and if their effectiveness is changed 
when provided in combination (table 4.4). 
This trial design allows more than one research question to be addressed as 
efficiently as possible without the generation of additional cost of another 
study (Byth et al. 2004).  
The design assumes no interaction between acupuncture and manual therapy 
and the pilot is not powered to detect such an interaction.  If the interaction 
effects of the two treatments were to be assessed in a definitive trial this would 
require a significant increase in the total sample size to account for interaction 
(i.e. 4 times that needed to look at the main treatment effects). 
 
A
c
u
p
u
n
c 
t
u
r
e 
Manual Therapy 
 B (Yes) O (No) Margin 
A (Yes) 
Acupuncture and 
manual therapy        
(cell AB) 
Acupuncture        
(cell AO) 
All A  
(cells AB & AO) 
O (No) 
Manual therapy 
(cell BO) 
Usual GP Care 
(cell OO) 
All non-A 
(cells BO & OO) 
Margin All B                      (cells AB & BO) 
All non-B 
(cells AO & OO) 
 
Table 4.4: Factorial design of pilot RCT 
Treatment effects and potential indications of interactions will be monitored, 
and appropriate clinical outcomes determined to inform an appropriately 
powered trial, aiming to investigate the effectiveness of the treatments 
individually and in combination.  A full-scale trial would aim to look at the 
combined treatment effect of acupuncture and manual therapy using the 
factorial approach.   
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A pragmatic trial was proposed to allow the interventions to be delivered in 
line with current clinical practice.  It is a more acceptable approach to 
clinicians and affords greater clinical autonomy, external validity and 
generalizability with more real life treatments (Relton et al. 2010; Ross et al. 
1999). 
4.7 Trial interventions 
The detailed procedural processes of each trial intervention are detailed 
below.  A TIDieR checklist and guidance (Hoffmann et al. 2014) was used to 
provide comprehensive and repeatable information. 
Usual GP care intervention group (Treatment 0): 
Usual care for this study constituted ‘usual GP care’ i.e. as participants would 
receive usually under the supervision of their GP or other health professionals 
as appropriate, and as would be routine in clinical practice, i.e. the same as if 
they were not involved in the study.  All participants received usual GP care. 
Usual care also involved the provision of the ‘Back Book’ (Burton, Main and 
Cantrall (2002); this is a self-help book for LBP frequently distributed by 
health care professionals.  These participants were not provided with manual 
therapy or acupuncture throughout the study period.  Data was collected on 
all patients during the cohort period. 
Trial interventions: 
Information pertaining to all trial intervention groups is detailed below: 
All intervention treatments took place at a local private physiotherapy clinic 
and was provided in face-to-face individual treatments by the recruited 
Chartered physiotherapists only (see section 4.10), each physiotherapist was 
appropriately qualified in the techniques they delivered, either acupuncture or 
manual therapy or both.  
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Participants were screened and assessed by the chartered physiotherapist 
using a health-screening questionnaire (appendix C10) and a physiotherapy 
LBP assessment form (appendix C11) prior to commencing the trial 
intervention.  This was conducted as a second screening process to ensure the 
participants were safe to receive their allocated interventions and that no red 
flags of health concerns were present.  This process is standard procedure and 
in line with the professional standards expected of all Chartered 
Physiotherapists when receiving a new patient to ensure the health of the 
patient is appropriate for receiving physiotherapy.  If any concerns were 
raised regarding a participant the physiotherapist would contact the trial 
coordinator to report the concern, discussion between the two would occur 
and a decision made regarding the participants safety and eligibility to 
continue in the trial. 
All usual standards of care, protocols and practices continued to be observed 
for all intervention groups.  Participants were also provided with usual GP 
care as required, including the provision of the ‘Back Book’ (Burton et al. 
2002) as would be expected were they not involved in a trial. 
Acupuncture intervention group (Treatment A):   
Acupuncture has its history in Chinese medicine and is one of the oldest forms 
of therapies available.  It involves the insertion of fine needles into the body 
and aims to take a holistic (whole body) approach to treatment.  In Chinese 
philosophy illness is considered an imbalance of energy sources in the body 
and acupuncture strives to recreate this balance and harmony within the body 
(Vera et al. 2018; Chong et al. 2015).  In western medicine acupuncture is 
considered to stimulate blood flow and nerve activity (Kim et al. 2016; Li et 
al. 2013; Uchida and Hotta, 2008; Inoue et al. 2005) and stimulate specific 
areas of the brain to release chemicals that have pain-relieving responses (Jin 
et al. 2016; He et al. 2015; Bradnam 2011; Lewith, et al. 2005).  Specially 
trained professionals can deliver acupuncture, these include: acupuncturists, 
physiotherapists, osteopaths, doctors, nurses, and chiropractors.  Chartered 
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physiotherapists only were recruited to this study to deliver the interventions 
(see section 4.10). 
A group of experienced musculoskeletal physiotherapists with acupuncture 
training were recruited and inducted into the trial.  They met prior to 
commencement, to discuss guidelines for the expected best practice standards 
and agreed a consensus for the treatment of LBP using acupuncture 
principles.  These included discussion of any other physiotherapy 
interventions (though this could not include any manual therapy techniques) 
they would routinely have provided in addition to acupuncture for individuals 
with LBP, so this may be standardized to all participants.  The STRICA 
guidelines of reporting trials of acupuncture were adhered to (MacPherson et 
al. 2002). 
Participants allocated to this intervention followed a programme of 10 x 30 
minute acupuncture treatment sessions, which occurred weekly if possible, 
over a ten to 12 week period.  This was in line with the recommendations 
from the NICE LBP guidelines (2009). 
Acupuncture point selection and needling treatment was delivered as deemed 
appropriate by the physiotherapist, following the pre-agreed trial guidance 
(see below) and following their professional governance as required by their 
professional organisation and standards.   
Acupuncture point location, size of needle and depth of needling was applied 
as detailed in the ‘Color Atlas of Acupuncture’ (Hecker et al. 2001). It was 
agreed and anticipated eight to twelve acupuncture needles would be used per 
acupuncture session for each participant, with a mixture of local and 
peripheral points used.  Points were selected based on their prescription use 
for LBP and pain as indicated by TCM theory (as detailed in Hecker et al. 
2001). 
All acupuncture points used for each participant for each session would be 
recorded in a table by the physiotherapist and documented as part of the 
participants medical notes at the physiotherapy practice. 
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Acupuncture 
point 
Bilateral / 
Unilateral 
Depth of 
needles 
De Qi 
stimulated 
Time period 
of needling 
Adverse 
events 
     
     
Table 4.5: Recording of acupuncture treatments 
Achieving the sensation of De Qi (a deep aching) was an objective at each 
acupuncture point, in line with the theory of acupuncture core teachings, as is 
described in TCM (Hecker et al. 2001).  If a participant experienced any 
significant discomfort deemed outside normal expectations of acupuncture 
(i.e. sharp pain at the site of a needle), the needle would be removed, and the 
participant’s sensation documented.  This was in line with the routine process 
of acupuncture treatment in clinical practice by Chartered Physiotherapists.  
An alternative needle location would then be selected to continue the 
participant’s treatment. 
Single disposable needles were used for all treatments; these were package as 
one needle to one guide tube in strips of five needles.  Needles within their 
expiry date only were used and all needles were disposed of in a sharps bin, 
in accordance with the physiotherapy practices sharps policy. 
It was not permitted for the physiotherapists to provide any form of manual 
therapy for this intervention group. 
Manual Therapy intervention group (Treatment B): 
Manual therapy is a form of therapy that involves a therapist’s hands to 
deliver mobilization, massage or manipulation of joints or soft tissues in the 
body.  Specially trained professionals can deliver manual therapy including; 
physiotherapists, osteopaths, doctors or chiropractors (NICE, 2009) chartered 
physiotherapists only were recruited to this study to deliver the interventions 
(see section 4.10). 
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Participants allocated to this intervention followed a programme of 10 x 30 
minute acupuncture treatment sessions, which occurred weekly if possible, 
over a ten to 12 week period.  The NICE LBP guidelines (2009) 
recommended 9 sessions of manual therapy over a ten to 12 week period but 
in the interest of equipoise between interventions in the study, 10 sessions 
were offered for both acupuncture and manual therapy. 
The physiotherapists provided the manual therapy intervention as they 
deemed appropriate to their participant, following the pre-agreed guidance of 
best practice established for the trial and following their professional 
governance as required by their professional organisation and standards.  The 
physiotherapists used their hands to deliver the manual therapy interventions 
to the participants (manual therapy techniques included: massage, joint 
mobilisation, soft tissue mobilisation, frictions, manipulation, stretching, 
mobilisations with movement) and all treatments were documented as part of 
the participant’s medical notes at the physiotherapy practice.   
If a participant experienced any significant discomfort deemed outside 
normal expectations of manual therapy (i.e. sharp pain) at the site of 
treatment, the treatment would be ceased, and the participant’s symptoms 
documented.  This was in line with the routine processes of manual therapy 
treatment in clinical practice by Chartered Physiotherapists.  An alternative 
manual therapy technique would be selected to continue the participant’s 
treatment. 
It was not permitted for the physiotherapists to provide acupuncture to this 
intervention group. 
Combined Acupuncture and Manual Therapy intervention group: 
A discussion occurred with the recruited physiotherapists to agree the format 
for providing manual therapy and acupuncture within the same treatment 
session.  The same physiotherapist delivered both interventions in the 
combined group; they had training in both acupuncture and manual therapy.  
For the combined manual therapy and acupuncture intervention group, it was 
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anticipated that the participants would receive a 50% longer treatment session 
to allow for both interventions to be completed effectively. 
Participants allocated to this intervention followed a programme of 10 x 45 
minute acupuncture treatment sessions, which occurred weekly if possible, 
over a ten to 12 week period. 
The acupuncture was delivered in exactly the same way as detailed above for 
the acupuncture intervention group, and the manual therapy intervention was 
delivered in exactly the same way as detailed above for the manual therapy 
intervention group, but they were delivered one after the other within the same 
treatment session.   
Treatment was delivered as the physiotherapist deemed appropriate following 
the pre-agreed trial guidance provided prior to the trial and following their 
professional governance as required by their professional organisation and 
standards. 
4.8 Study Documentation 
All pilot study documentation was subject to the scrutiny of the Multicentre 
Research Ethics Committee (MREC) at the University of York and the ‘York 
and Humber ethics committee’ 11/YH/0028.   The project was registered with 
the NIHR CSP - R&D IRAS project code: 57218. 
Initial documentation required modification following the initial ethics 
review, by the ‘York and Humber ethics committee’.  The committee 
considered it potentially too confusing for participants to receive information 
about the cohort study and the nested treatment RCT together in the 
information pack and at the same time.  Thus a dual consenting process within 
this study was implemented as an amendment, to fulfil the pilot study 
recommendation from the ‘York and Humber ethics committee’ (appendix 
C1).   
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The initial consenting process was adapted and separated, and the information 
sheets and consent forms were redesigned, and two separate consent and 
information forms were provided for each part of the study.  It was decided 
that distribution of the baseline questionnaire was to occur with the second 
consent and information sheets.  However it was unknown at this stage of the 
impact, adding an additional layer of documentation to the process would 
have upon the study.  All final study documentation with appropriate version 
numbers was reviewed and approved by the ‘York and Humber ethics 
committee’. 
Samples of the participant recruitment pack were tested internally at the 
University of York by a number of individuals, prior to the recruitment packs 
being distributed to participants.  Clarity, ease of completion, acceptability to 
the respondent and the identification of any frequently unanswered questions 
were assessed in this process and any appropriate adjustments made. 
Participants capable of conversing with a physiotherapist in English as 
detailed in the inclusion criteria were included.  As this was a PhD pilot study 
questionnaires will be available in English versions only.  There are financial 
constraints of a PhD project attached to this study; no provision for translators 
or additional physiotherapy time that would be required for non-English 
speaking participants was afforded.  For this reason, one of the criteria was a 
sufficient grasp of the English language.  Patients who are ineligible or who 
are taking part in other research were excluded.  An explanation letter was 
sent to patients who consented but did not meet the inclusion / exclusion 
criteria. 
Once the pre-test of documentation was complete, initially one GP practice 
was invited to participate and selected as a recruitment and document test site.  
The rational for this, was to test initial recruitment rates and documentation 
packs with an initial number of participants, allowing for any modifications 
to be made to minimal baseline documentation only, if required. 
A second letter was mailed to participants, once the initial consent forms 
(appendix C5) were received by the University.  This included a second 
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information sheet (appendix C6) a consent form (appendix C7) and the 
baseline (case report form) questionnaires (appendix C8) for those patients 
who had consented to receive additional information about the nested RCT.  
Participants not consented to the RCT were sent the baseline questionnaire 
only. 
4.9 General Practice (GP) Recruitment 
The GP practices within the York region were identified through an online 
search of the Primary Care Trust (PCT) and NHS Choices websites in May 
2011.  A restructure of the NHS in April 2013 saw PCT’s replaced by Clinical 
Commissioning Groups (CCG), which occurred during the period of this 
study.  An aim of identifying ten GP practices was planned, with preliminary 
investigations into the practice size, locality and involvement within research 
with the University of York previously being conducted to:  
• Determine the size of the GP practice would assist the trial 
coordinator in the estimation of how many GP practices would be 
required   
• The locality of each practice was important to ascertain for feasibility 
of participant travel to any potential intervention at the physiotherapy 
practices 
• Previous involvement in research with the University of York was 
important to consider; to establish experience of working with trials 
but also importantly not to over burden one individual practice with 
multiple trial involvement requests 
The above information was collected to establish and confirm the suitability 
of the GP practice for the proposed pilot trial prior to making contact. 
Initially five of the ten GP practices were selected based on their locality and 
travel feasibility for participants to the identified physiotherapy practices. 
Initially only five practices were invited to participate due to: 
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• An unknown response rate of the GP practices 
• The unknown number of participants to be recruited from each GP  
practice 
• The study being a pilot investigation with limited resources 
It was aimed to recruit 2 – 3 GP practices initially.  The identified GP 
practices were invited by letter (appendix C2) to participate within the study.  
The invitation letter included information regarding the cohort study and 
nested RCT, and an expression of interest form was included. Interested 
practices returned their expression of interest forms to the chief investigator 
at the University of York.   
A confirmation letter was then sent to the GP practice (appendix C3) and a 
discussion and induction meeting was arranged with the GP practices, to gain 
formal consent and to deliver the participant information packs (containing 
participant invitation letters, consent forms, a copy of the information sheets, 
and baseline assessment questionnaires) to the practices.  The process of 
inducting the GP practice was commenced; this involved myself as chief 
investigator providing a short presentation of the trial, and a question and 
answer session with key staff members and a discussion session. 
At an agreed time, the GP database search was conducted by myself, as chief 
investigator with a practice representative present to identify a list of eligible 
patients, and the participant information packs were mailed to all the 
identified potential participants at the time of the search.  The invitation packs 
were labeled and sent by myself, by post directly from the GP practice, which 
ensured researchers did not have access to patient data unless a patient 
expressed an interest in taking part in the study.   
Following the successful recruitment of the first GP practice participant 
recruitment, a second practice was planned for recruitment.  If sufficient 
participants numbers for the purpose of the pilot study were achieved from 
the two GP practices no further practices were planned to be recruited, if 
participant recruitment was not sufficient, a further one to eight practices were 
planned to be invited to join the study.  If recruitment exceeded expectation 
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and participant numbers were higher than required, a two to one allocation 
method was planned, there by twice the number for participants randomised 
to the control group than the treatment groups.  
Previous trials have shown good recruitment using a GP database recruitment 
method.  A yoga trial for LBP demonstrated a response rate of 12% (994 
patients responded from 8,638) (Cox et al. 2010) and an acupuncture trial for 
Irritable bowel syndrome demonstrated a response rate of 15% (247 
responded from 1651) (Reynolds, Bland and MacPherson 2008).   
 
Figure 4.3: Flow Diagram of GP recruitment to participant identification 
It was anticipated the recruitment of the required sample size of participants 
would take between ten and twenty weeks for completion. 
4.10 Justification for choosing chartered physiotherapists 
Establishing a professional group to take the lead in delivery of prompt and 
effective care for LBP, is inherently determined by the intervention type, the 
effectiveness of the professional group and its cost of delivery.  I published a 
paper justifying the use of Chartered Physiotherapists for the delivery 
acupuncture (Dascanio 2015b), (see appendix A2) which is referenced where 
appropriate throughout this chapter. 
A multidisciplinary approach is often adopted for LBP (Salerno et al. 2002) 
however professional autonomy within the UK has allowed a more integrative 
approach with crossover of roles and thus a reduction of the number and cost 
of staff members.  Chartered physiotherapists and other medical professionals 
GP	Practices	identified	via	online	search
Initial	contact	via	expression	of	interest	form
Recruitment	of	GP	practice	and	induction
GP	Database	search	conducted
Paricipants	identified	and	mailed	information	packs
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are able to extend their roles (with additional training) and they are able to 
undertake treatments that would previously have been considered outside 
their scope of practice (Dascanio 2015b). 
Chartered physiotherapists are potentially well placed to help provide a 
solution and lead on the delivery of interventions for LBP.  In the UK there 
are in excess of 55,000 physiotherapists working across the country, who 
work at the forefront of healthcare (CSP, 2014a).  Chartered physiotherapists 
are regulated by the Health Care Professions Council (HCPC) and are 
autonomous holistic practitioners. They have a variety of appropriate skill 
sets; they have the opportunity to extend their scope of practice and are well 
established and integrated into the health service with care pathways available 
to support them.  Additionally early referral to physiotherapy for LBP has 
been shown to reduce the risk of additional healthcare consumption and cost 
(Fritz et al. 2012). 
With reference to the treatment recommendations in the NICE (2009 and 
2016) LBP guidelines, many chartered physiotherapists are already 
specialised and able to deliver the recommended interventions and the NICE 
recommendations and physiotherapy input are listed below: 
Advice on self-care: Physiotherapists routinely offer advice on self-care and 
self-treatment for LBP, supported by aids such as ‘The Back Book’ (Burton 
et al. (2002) and other patient advice material. They also offer advice on 
posture, correctional movements for activities of daily living and work.  
Those with additional training are also able to offer ergonomic advice for 
workstations, seating and car seating (Association of Chartered 
Physiotherapists in Occupational Health and Ergonomics, 2015). 
Exercise (individual & group sessions) – including aerobic activity, 
movement instruction, muscle strengthening, postural control and stretching: 
This is a core skill for physiotherapists: they can offer comprehensive 
exercise programmes on individual and group programmes – incorporating 
aerobic activity, movement instruction, muscle strengthening, postural 
control, stretching, Pilates, and yoga.  They also often undertake additional 
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training to advance these skill sets (The Association of Chartered 
Physiotherapists in Sport and Exercise Medicine, 2017). 
Manual Therapy (including spinal mobilisation, spinal manipulation and 
massage techniques): This is a core skill for physiotherapists; they routinely 
offer manual therapy – including spinal mobilisation, spinal manipulation and 
massage techniques. Additional training is encouraged to further develop and 
specialise in advanced techniques in this area (Musculoskeletal Association 
of Chartered Physiotherapists, 2017). 
Combined physical and psychological treatment programmes: As part of 
multi-disciplinary teams and with additional training in interventions such as 
Cognitive Behavioural Therapy (CBT), physiotherapists are involved in 
treatment programmes and pain management groups nationally, both in the 
NHS and private sector (Brunner et al. 2013). 
Pharmacological therapies: Physiotherapists with additional training have 
had supplementary prescribing rights since 2005, however an application for 
full independent prescribing responsibilities was under review for ten years 
and in July 2012 physiotherapists were awarded full independent prescribing 
rights.  This skill requires additional training, but places physiotherapists well 
for prescribing medications and providing a complete and comprehensive 
service for patients with LBP (CSP, 2012). 
Acupuncture (Recommended NG88 2009, not recommended NG59 2016): 
Currently chartered physiotherapists are the largest group of healthcare 
professionals delivering acupuncture within the UK with over 12% (<6500) 
of physiotherapists already trained in western medical acupuncture, they 
deliver acupuncture treatments routinely in the NHS and private sector 
(Dascanio, 2015a). 
Other interventions not currently recommended by NICE included traction, 
lumbar supports, injection therapy and electrotherapy modalities (including 
laser therapy, interferential, therapeutic ultrasound and transcutaneous 
electrical nerve stimulation TENS).  Though these treatments are not 
currently nationally recommended they have been historically used for LBP 
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and can all be provided by chartered physiotherapists if required. They may 
carry some benefit on an individual case basis, for example, while not 
routinely recommended using a lumbar support belt for heavy gardening as a 
preventative measure but not during routine daily life may be appropriate for 
some individuals.  Many of these interventions are often still requested by 
doctors and supported by some research (Muller, 2009; Watson, 2008; 
Watson, 2000), though the thresholds of evidence are not sufficient for 
national guideline recommendation. 
Treatment recommendations do change over time with new research 
published frequently, popular treatments in 2017 may not be considered 
effective in the future, so it is important health professionals remain current 
with up to date research and adaptive to change within clinical practice.  Many 
chartered physiotherapists have extended their roles, adapt well to change and 
would be well placed to deliver interventions for LBP patients.  In addition 
physiotherapists have chartered status, protected titles, have clinical 
autonomy and are regulated by the HCPC, some professions do not offer this 
depth of protection to the public.  While GPs, nurses, physiotherapists and 
other healthcare professionals have qualified in the use of acupuncture and 
other interventions (Dascanio, 2015b), due to their routine knowledge, care 
and treatment of low back pain and for all the stated reasons, and for clarity 
and consistency chartered physiotherapists only were used for all intervention 
delivery for the pilot study for this thesis. 
4.11 Physiotherapy practice recruitment 
An online search via the Chartered Society of Physiotherapy was conducted 
of private physiotherapy practices within the York region.  It was important 
the physiotherapy practice would be easily accessible geographically for 
future participants within the trial from the recruited practices.  These 
practices were selected and contacted by telephone. 
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An aim of identifying five physiotherapy practices was planned, with 
preliminary investigations into the practice size, locality and involvement 
within research with the University of York being conducted:  
• Determining the size of the physiotherapy practice and number of 
physiotherapy staff available for the study would assist the trial 
coordinator in the estimation of how many practices would be 
required   
• The locality of each practice was important to ascertain for feasibility 
of participant travel to any potential intervention, considering the 
recruited GP practice regions 
• Previous involvement in research with the University of York was 
important to consider; to establish experience of working with trials 
but also importantly not to over burden one individual practice with 
multiple trial involvement requests 
The above information was to be collected to establish and confirm the 
suitability of the physiotherapy practice for the proposed pilot trial prior to 
making contact.  Private physiotherapy practices only were to be approached 
for this study, due to the limited time frame for completion of the pilot study 
and the additional timely layer of ethics involved in recruiting NHS 
departments and the large department sizes.  It would be planned for NHS 
departments to be incorporated into a full-scale trial.  
Initially three of the five practices were selected based on their locality and 
travel feasibility for participants.  Initially only three practices were planned 
to be invited to participate due to: 
• An unknown response rate of the physiotherapy practices 
• The unknown number of participants each practice would be able to 
accommodate  
• The study being a pilot investigation with limited resources 
The identified physiotherapy practices were invited by telephone and letter to 
participate within the study.  The invitation letter included information 
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regarding the cohort study and nested RCT, and an expression of interest 
form.  Interested practices returned their expression of interest forms to the 
chief investigator at the University of York.   
A discussion and induction meeting was planned with the physiotherapy 
practices, to gain formal consent and to provide information and 
documentation to the practices.  It is important that more than one 
physiotherapist delivered the interventions to avoid any bias of the results 
being introduced due to a single therapist's expertise.   
Recruited physiotherapists were required to be qualified in manual therapy or 
acupuncture or both.  Due to the factorial nature of the nested RCT the same 
practitioner was required to deliver both interventions in the combined trial 
arm and for consistency the same type of professional practitioners were 
required to deliver the interventions to all groups.  Chartered physiotherapists 
were selected for this role due to their ability to deliver both acupuncture and 
manual therapy (Dascanio, 2015b) justification for this decision is discussed 
in section 4.10.  No traditional acupuncture practitioners were recruited for 
this pilot. 
 
Figure 4.4: Flow Diagram of Physiotherapy practice recruitment process 
It was anticipated the recruitment of the required physiotherapists would take 
between two to six weeks for completion.  Following the successful 
recruitment of the physiotherapy practices, training and induction of all 
physiotherapy staff was to be conducted at the physiotherapy practices, by 
myself as trial coordinator. 
PhysiotherapyPractices	identified	via	online	search
Initial	contact	via	expression	of	interest	form
Recruitment	of	Physiotherapy	practice	and	induction
Training	and	induction	of	physiotherapy	staff
Commencement	of	paricipants	randomised	trial	interventions
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4.12 Randomisation process 
Participants eligible for the nested RCT study were given an identification 
number.  Participant eligibility was determined by: 
• Participants consented to the cohort study 
• Participants consented to be part of the nested RCT 
• Participants consented to receive the trial interventions  
• Participants completed the baseline questionnaire 
• Participants completed the three monthly questionnaire 
• Participants who scored 4 or more on the RMDQ 
When a group of participants were found to be eligible for the nested RCT, 
their identification numbers only were sent to the University of York’s Trials 
Unit Director.  The Trials Unit Director acted as the independent data 
manager and undertook the planned independent random allocation.  
Randomisation was conducted using the randomization function in SPSS 
software, such that equal numbers were allocated to the arms within each 
block. The allocation was not stratified, and the characteristics of the 
individual participants were unknown to the Director undertaking the 
allocation procedure (Dascanio et al. 2014).  The process was conducted in 
this way to avoid the possibility of subversion bias.  
Randomisation of the participants occurred in a block that was equal to the 
size of the group.  Randomisation occurred when approximately ten 
participant forms were returned and randomisation was repeated every time a 
new batch of questionnaires were received.  It was anticipated that by 
randomising in this way, it would allow time for the participants to commence 
their allocated treatment without delay and not overwhelm the physiotherapy 
practices with a high volume of participant numbers simultaneously 
(Dascanio et al. 2014).   
The size of the control group depended upon the numbers recruited to and 
from the cohort, but it was to be at least as large as the intervention groups.  
It was planned that if recruitment to the cohort and thus the RCT was greater 
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than anticipated, the usual care group would be larger than the treatment 
groups; to enable an unequal allocation ratio favoring the control group 
compared with the intervention groups.  This would afford the trial to have 
greater power through an increased sample size and be more efficient. The 
number of participants recruited determined the allocation ratio.  If 
recruitment meant that more patients were available for the study than could 
be treated in the intervention groups, then the rationale of putting more into 
the control group means that the total sample size can be increased to improve 
the power of the study.   
Prior to randomisation participants were asked which treatments they would 
consider for their low back pain.  If a participant expressed an unwillingness 
to receive one or all of the specific treatments (i.e. manual therapy or 
acupuncture), they would still be included in the study, but randomised to 
usual care or the remaining intervention that they did not express an aversion 
to.  Participants who did not wish to receive any intervention would be 
followed up in the observational cohort study and would not be randomised.  
4.13 Methods for preventing bias 
Randomisation within the RCT, if conducted effectively, will eliminate 
selection bias and an intention to treat analysis principle was used as it is the 
most robust analysis technique for preventing the introduction of bias 
(Torgerson and Torgerson 2008). 
As discussed in chapter three, the majority of attrition occurs within the first 
follow-up period of an RCT and is a major threat to internal validity of a study 
(Relton et al. 2010).  Using a cohort design with nested RCT will allow a 
‘run-in period’ to occur, allowing for the collection of baseline data and a set 
of three-month outcome data to be collected, prior to randomisation.  Only 
participants returning their three-month questionnaire were eligible for 
randomisation.  Therefore subsequent attrition post randomisation was 
expected to be minimal.  Further attempts to reduce attrition were planned 
through the provision of comprehensive explanation of the study and regular 
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contact in the form of questionnaires to maintain regular contact with the 
participants throughout the study (Dascanio, 2015d). 
Other potential sources of bias are dilution effects (i.e. some participants, 
randomised to intervention fail to accept the allocated treatment) and patient 
preference, however it is anticipated this will be low due to nature of the 
cohort recruitment design methods in offering an element of choice in the 
early phase of recruitment (Brewin et al. 1989).  As participants were entering 
a cohort and aware that they may be approached to take part in a trial, but 
aware that only a small portion of participants may be offered treatment, 
informative explanations were provided to the participants (Torgerson, 
Kaber-Moffett and Russell, 1996).  
As this was a pragmatic study, it was not possible to blind the participants or 
the clinicians to the allocated interventions.  Those allocated to the usual care 
group however were not advised of their allocation, only that they were 
continuing within the cohort, thus limiting resentful demoralisation within 
this group.  Both the participant and their GP were advised if they were 
assigned to one of the treatment groups.  As the final outcome assessment was 
provided by the participant no blinding of the outcome measurement occurred 
(Dascanio, 2015d). 
4.14 Duration of treatment period 
The treatment period for the trial interventions was between ten and twelve 
weeks.  The allocated treatment intervention aimed to be conducted once per 
week for a period of ten weeks; however a two week threshold to twelve 
weeks allowed the ten allocated treatment sessions to be completed if any 
delayed or missed treatment sessions occurred due to sickness or other reason.  
This timescale was in line with the recommendations from the NICE 
guidelines for LBP (NICE, 2009). 
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4.15 Outcome measurement and follow-up 
On entering the study each participant completed a baseline assessment 
delivered via a postal questionnaire, which included RMDQ and MODI, 
(detailed in section 4.5).  This was then followed up by a postal questionnaire 
at three months.  On completion of the three-month questionnaires, eligible 
and consented participants were randomised to one of the four trial arms. 
Follow-up then occurred at six months via postal questionnaire; this timing 
coincided with the completion of treatment for the active treatment 
intervention groups.  Further follow up via postal questionnaires occurred at, 
9, 12, 15 and 18 months, however this thesis only considered the data to the 
six-month follow up period, figure 4.5 demonstrates the flow diagram of 
participants through the study. 
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Figure 4.5: Flow diagram of participants through the study (Adapted from Dascanio, 2015d) 
Consent forms returned to the University of York  
Consented to cohort only or cohort and treatment trial 
 
Randomisation (N = 80+) 
Eligible participants will be randomised by the independently to one of the four 
groups 
 
Usual Care 
Treatment ‘O’ 
 
 
Acupuncture 
Treatment A 
Manual therapy 
Treatment B 
Acupuncture & 
Manual therapy 
Treatment AB 
Baseline questionnaires sent to all participants 
Consent forms also sent to participants who consented to the treatment part of the study (the RCT) 
 Consented to be in both cohort and RCT 
 
RMQD > 4: enter RCT 
Consented to Cohort only 
 
Follow Up at Six Months 
Participants will be sent a questionnaire  
Follow Up at Three Months  
Participants who return their questionnaires to be assessed for eligibility 
 
 
RMDQ score >4 at Six Months 
Can then enter the RCT 
 
RMQD < 4: Remain in cohort 
 
 
Identification of participants and contact from GP practice  
Potential eligible participants identified, consent forms and information packs sent to participants 
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4.16 Data Collection 
Participant baseline data was collected and inputted into an excel 
spreadsheet by the trial coordinator; each participant was issued with a trial 
participant ID number.  When the baseline, three and six questionnaires 
were received, the receipt of these was recorded onto an excel spreadsheet 
using the participant ID numbers to ensure all appropriate questionnaires 
had been received. 
All baseline and follow-up data were collected on paper questionnaires 
called Case Report Forms (CRFs) and identified solely by the trial 
Participant ID.  The CRFs were returned by post to the University of York 
where they were scanned, using Teleform data capture software, into a 
bespoke data management system.  The data were error checked and 
validated to ensure accuracy.  The paper CRFs were held securely in a 
controlled access area in locked cabinets but separate from the consent 
forms. 
4.17 Missing Data Follow-Up 
If postal questionnaires were not returned at three months or subsequently, 
it was planned to send an initial text reminder to the participant at ten days, 
followed by a reminder telephone call at two weeks and a further follow-
up telephone call was also planned at four-weeks.   
If missing data were evident on the case report form questionnaires, 
participants would be contacted by telephone in an attempt to retrieve the 
data, by asking the questions to the participant over the telephone in order 
to support the participants if they found difficulty completing the 
questionnaire.  A second follow-up call was planned if the first contact 
attempt was unsuccessful.  In a deviation from this protocol the process for 
collecting missing data was only applied for the RMDQ and the MODI, as 
these data were analysed immediately following the completion of the pilot 
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study.  No attempt was made to collect missing data from all the ancillary 
data (SF-12, EQ-5D-3L, VAS, Health Utilisation Questionnaire) due to the 
missing data for these data sets only being reviewed when the statistical 
analysis was conducted a considerable time (several years) after the pilot 
study was completed. 
4.18 Sample size calculation 
This pilot study was not planned to determine or compare effectiveness 
between groups, and not powered to do so, as is common practice for pilot 
studies (Lancaster et al. 2004).  Sample size estimation for a pilot study is 
not straightforward, as the outcomes of a pilot study tend to be process 
measures rather than quality of life or clinical outcome measures.  Though 
this study will collect outcome data to inform a full-scale study. 
Potential recruitment of 16 participants for each intervention group would 
be acceptable; as this exceeds the minimum recommended number of 12 
per group for a pilot trial, as is routinely recommended (Whitehead et al. 
2016; Moore et al. 2011; Julious 2005) and if aiming to power the study, 
would enable the study to have an 80% power with a significance level of 
0.05 to observe a 1 standard deviation difference between the two groups, 
if a difference were to exist (Bland, 2000). 
In the proposed pilot study no formal sample size calculation was 
conducted.  However it was planned to recruit a sample size of a minimum 
of 16 participants per group.  Allowing for any attrition and the pragmatic 
nature of the trial, recruiting 16 - 20 participants to each arm of the trial, 
therefore a sample size of 64 - 80 will be a conservative target and 
achievable within the limitations of the pilot (Whitehead et al. 2016; 
Moore et al. 2011).   
While the objective was not to consider effectiveness, the target sample 
size planned would allow an observation of 1 standard deviation difference 
between the usual care and treatment groups, powered to 80% (Dascanio, 
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2015d) this would assist in determining the data requirement for a sample 
size calculation to inform a full-scale study and also to mirror a planned 
full-scale study as closely as possible. 
An anticipated recruitment rate was not established prior to the study.  The 
actual study recruitment rate would be used to provide information to 
establish an anticipated recruitment rate for the planning of a full-scale 
study. 
4.19 Anticipated problems with treatment compliance 
A treatment compliance rate of 90% was anticipated for the interventions 
within this pilot study.  Evidence from the UKBEAM trial demonstrated 
compliance of 92% for the manipulation intervention group (UKBEAM, 
2004) and a similar compliance rate of 91% was seen for the acupuncture 
intervention group in a trial of LBP (Leibing et al. 2002).  Participants 
within this study attendance was planned for one weekly treatment 
sessions and in the combined treatment group the treatment occurred at the 
same time, a similar compliance rate for this study was expected. 
4.20 Minimising loss to follow up 
A 20% loss to follow up rate was anticipated for this study as is in line 
with other similar studies. There was 24% attrition in an acupuncture trial 
of LBP (Leibing et al. 2002) trial over a nine-month follow-up period and 
33% was lost in the UKBEAM trial (2004) over a twelve-month period. 
However the cohort study design with a nested pragmatic factorial RCT 
has been selected for this pilot to consider and review its effectiveness in 
minimizing trial attrition, therefore a lower rate of attrition was potentially 
expected. 
If a participant wished to withdraw from their intervention at any time they 
were asked if they were happy to complete the appropriate questionnaires 
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for our analysis using the intention to treat principle, the participants were 
free to accept or decline this request. 
4.21 Methods of analysis  
The CONSORT guidelines for randomised control trials will be used for 
the reporting of this study and data analysis (Moher et al. 2001).  An 
intention to treat (ITT) principle will be applied: therefore all participants 
will be included and analysed in their original randomised groups, 
regardless of completion of their intended intervention (Torgerson and 
Torgerson 2008).   
Data will be collected at three monthly intervals, with a single principal 
analysis occurring at six months, following the trial interventions. 
4.21.1 Primary analyses 
The results for this pilot study are largely descriptive and reflect upon the 
study design for implementation of a full-scale trial and they focus upon: 
• An analysis of the recruitment rates of GP practices to the study  
• An analysis of the recruitment of physiotherapy practices and 
practitioners to the study 
• An analysis the number of participants recruited to the cohort study 
from each GP practice 
• An analysis of recruitment rates of participants from the cohort 
study to the nested factorial RCT 
• An analysis of the participant consent rates and acceptance of the 
study interventions 
• An analysis of the success of delivering combined interventions by 
the practitioners 
• An analysis of the attrition rates of participants, pre and post 
randomisation within the cohort and nested RCT 
• A review of baseline characteristics of the study participants 
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• A descriptive analysis of the use of the design methodology for 
evaluating individuals suffering with LBP 
• A sample size calculation for a full scale study 
4.21.2 Sub-analyses 
The planned preliminary investigation involved estimating the effect of: 
• Acupuncture alone versus usual care  
• Manual therapy alone versus usual care  
• Combined acupuncture and manual therapy versus usual care 
• Combined intervention compared to each of the single treatments  
The estimation of effect was considered for both the RMDQ score and 
MODI score at six months (three months post randomisation) to determine 
the standard deviations for calculating a sample size, to enable the 
comparison of the outcome measures and to observe if any directions of 
effect or associations were evident to inform a full-scale study.   
For each comparison, analysis of covariance was employed adjusting for 
the score reported immediately prior to randomisation (at three months) 
(hereafter referred to as the “screening score”) to obtain treatment 
estimates with 95% confidence intervals.  The trial was not powered to 
detect a specific difference between intervention groups and all analyses 
therefore were exploratory only to inform a full-scale study.  Participants 
identified who were unwilling to accept randomisation to all interventions 
were excluded from any comparison analysis between acupuncture and 
manual therapy (alone or in combination). 
Continuous data are to be summarised as mean and standard deviation 
(SD) and categorical data as frequency (%), with adjustment for screening 
scores. 
Sub-analysis included: 
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• An analysis of the use and completion rates of Roland Morris 
disability questionnaire (RMDQ) and Modified Oswestry 
Disability Index (MODI) 
• A regression analysis of mean scores will be performed adjusting 
for baseline assessment for the Roland Morris Disability 
Questionnaire – (an estimate of standard deviations will be 
calculated and combined with acceptance and attrition rates for a 
future sample size calculation) 
• A regression analysis of mean scores will be performed adjusting 
for baseline assessment for the Modified Oswestry Disability Index 
• A regression analysis will compare the three treatment groups to 
the control group.  Analysis of differences between the combined 
treatment group compared to the single treatment groups. The 
study is of relatively low power to demonstrate any difference, any 
results will be treated with caution and are primarily intended to 
inform the design of a future study 
• Comparison of the characteristics of the two outcome measure 
tools (RMQD and MODI) to assess which would be most 
appropriate for a full-scale trial 
4.22 Economic data 
The NICE guidelines (2009) calculated the additional cost to the nation of 
implementing acupuncture for the treatment of LBP would be 
£24,366,000, however this estimation failed to consider the use of services 
already in place in the NHS, for example within physiotherapy 
departments, and the estimation was based on the introduction of new staff 
and services.  The potential additive benefits of combining two treatments, 
was also not considered by NICE (2009; 2016). 
This pilot study will aim to inform a full-scale trial if the incorporation of 
acupuncture into an already existing physiotherapy session is a viable 
option.  
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4.23 Ethics and governance 
Prior to the commencement of the trial, ethics approval and research 
governance was sought from the MREC (Multicentre Research Ethics 
Committee) at the University of York Health Sciences Committee and the 
York and Humber ethics committee.  The study commenced once all 
approvals were in place as detailed in section 4.8. 
4.24 Data protection and confidentiality   
All participant documentation is kept in line with the Data Protection Act 
(1998) and paper copies will be retained for 7 years after the completion 
of the trial.  All electronic data was password protected on secure 
computers. 
All personal information remained confidential and was anonymised 
through the use of coding as appropriate. 
4.25 Monitoring of adverse events and safety protocol 
A data and safety monitoring committee was formed to monitor the trial 
and any adverse effects that occurred.  The committee included myself as 
trial coordinator, the trials unit director (DT) and another trials unit staff 
member (LC).  A safety reporting protocol was established in accordance 
The York Trials Unit, Standard Operating Procedures (SOP) (version 2.0) 
and with the NIHR clinical trials tools kit (NIHR, 2017b), and followed in 
the event of any safety concerns or adverse events (appendix C12). 
The treating chartered physiotherapists were professionally responsible, 
trained and competent to determine the level of a safety issue or adverse 
event, if any occurred and thus make a clinical judgement for the 
appropriate procedure, as expected within their professional code of 
conduct.   The trial coordinator would be informed of any incident and a 
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report made to the data and safety monitoring committee, for any actions 
or recommendations to be made.  
Acupuncture and manual therapy are rarely reported to cause adverse 
effects (White, 2006; White et al. 2001: MacPherson et al. 2001).  
However, adverse events or safety issues can happen to participants and 
practitioners in trials.  During the trial, if any occurred to the participants, 
the physiotherapist assessed them for the seriousness and the nature of the 
incident i.e. was it related to the intervention and was it serious, and then 
the individual was treated locally or referred to the appropriate location, 
i.e. A&E, local hospital or GP, as per the seriousness of the incident.  If a 
physiotherapist experienced an adverse event or safety issue i.e. a needle 
stick injury, physiotherapists were required to assess themselves, to 
determine the seriousness and nature of the incident.   
The seriousness of a reaction determined the action taken e.g. a needle 
stick injury would require attendance at A&E, a participant experiencing 
considerable pain following an intervention would require a GP referral.  
It was planned for the trial coordinator to follow up any individuals who 
experienced adverse events or safety concerns, and detailed information 
and any treatment delivered was documented and reported to the safety 
monitoring committee. 
In the event of minor reactions, such as feeling faint (commonly 
experienced with acupuncture) participants would be treated locally as 
appropriate by the treating therapist until symptoms resolved and the GP 
and the data and safety monitoring committee would be kept informed of 
any concerns (Dascanio, 2015d). 
All centres providing acupuncture were registered and approved by their 
local health authority.  Sharps policies and Health and safety polices were 
in place.  A needle stick injury protocol was also in operation (MacPherson 
et al. 2004). 
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4.26 Informed consent 
Participation in the study was entirely voluntary.  Written informed 
consent was required from all participants.  Entry into the cohort or RCT 
was not permitted without informed consent.  
A clear and easily understandable participant information sheet (appendix 
C4) was provided to all consented potential participants.  It stated not 
entering the trial, withdrawal of consent or withdrawal from the trial at any 
time in no way affected their present or future quality of care.  It aimed to 
provide an unbiased explanation of the treatment interventions 
investigated, including any potential benefits and known risks (Dascanio, 
2015d). 
4.27 Dissemination of findings 
Debriefing and sharing of the study results and findings with study 
participants who wished to know the outcome of the study is standard 
practice via the University of York website.  However the Research 
Government Framework published by the Department of Health (DoH, 
2001) outlined that sharing of the study outcomes and also information 
regarding a participants’ individual treatment allocation and their outcome 
should be standard procedure in clinical research.  Further consideration 
and input in this matter would be required for a full-scale RCT, as 
individual participant data was not available to distribute from this pilot 
study. 
Dissemination of this study aimed to be extensive to help raise awareness 
of the potential need for research in this area.  Findings of the study were 
presented through peer-reviewed publications and conferences (local, 
national and international).  A single piece of research may not in itself 
change practice however it aimed to initiate discussion and therefore 
interest in the area, potentially attracting future funding for a full-scale trial 
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that may provide clarity of the NICE guidelines and pathways for LBP 
(Dascanio et al. 2014). 
It is intended for the findings of the study to be presented in high impact 
peer-reviewed publications, which are accessed as many health 
professionals and policy makers as possible.  The results of the study will 
be submitted for presentation, as an abstract or poster presentation at 
conferences working in the field of LBP, acupuncture and manual therapy 
in the UK and internationally as appropriate (Dascanio, 2015b, c, d).  All 
active contributors will be credited in the main report and publications. 
4.28 Discussion 
The planned study aimed to pilot a relatively new design methodology, 
which had not previously been used for the musculoskeletal disorder of 
LBP.  The study considered the role of a cohort design to aid recruitment 
to a nested RCT and evaluate the amenability of participants following the 
methodology.   
The key objectives of the pilot study were to investigate the practicality of 
it being run as a full-scale trial, to pilot the use of the cohort methods to 
recruit and retain participants to the trial, to establish appropriate outcome 
measures, review recruitment and retention, to investigate the value and 
functioning of the factorial methodology, and to assess the achievability of 
combining two treatments within a single treatment session.  A factorial 
design was used to consider the efficiency of running two trials within one. 
It is the intention of a full-scale trial to maximise generalizability of the 
study while maintaining strength within its internal validity and 
contributing to the research base for care pathways for LBP.  The pilot 
study aimed to aid future decisions for a full-scale trial with information 
and knowledge gained from the running of the pilot study. 
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The strengths and weaknesses of this study will be discussed in the final 
chapter of the thesis.  The following chapter will present the results of the 
conducted cohort study with nested factorial RCT. 
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5 Results of the Pilot Study 
5.1 Introduction 
In chapter two, I discussed the need for more evidence to ascertain the 
effectiveness of acupuncture in order to reduce uncertainty and inform 
guideline developers and clinical practice.  In chapter three I demonstrated 
why a cohort study with nested factorial RCT had features that would 
provide robust evidence in an efficient way for a study of acupuncture and 
manual therapy for LBP.  In chapter four I presented the methods of the 
planned pilot study. 
In this chapter, I report the results of the pilot study and critically examine 
the implementation of the processes of the pilot study.  I will report: 
recruitment rates of participants to a cohort study from GP practices, and 
of participants from the cohort study to a nested RCT, rates of consent to 
participate and acceptance of the interventions by participants and delivery 
by therapists, and attrition rates of participants pre and post randomisation.  
I also report on the use of factorial RCT design for a population with low 
back pain.  I will report on the use of the outcome measurement tools, 
which will include an updated exploratory analysis of the outcome tools 
(RMDQ and MODI) used within the study and these will be presented and 
discussed to inform a full-scale trial.  I will also present the results from a 
range of outcome measures: the SF12, the EQ-5D-3L, the VAS pain scale 
and the health utilisation questionnaire. 
Some of the results for this pilot study have been published (Dascanio 
2014, appendix A6 and updated in A6b), and is referenced where 
appropriate throughout this chapter. 
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5.2 Recruitment 
5.2.1 General Practice (GP) recruitment 
A total of ten potential GP practices were identified within the York area 
as presented in chapter four.  An initial five practices were selected from 
the ten GP surgeries identified, based on their locality and travel feasibility 
for participants to the identified physiotherapy practice. 
GP Practice one:  GP practice one was based York and had a practice list 
of 17,564 patients.  A meeting was arranged with the first GP practice Data 
Quality Manager on the 27th July 2011 and the practice was successfully 
recruited.  The GP practice was inducted, the database recruitment process 
was established and a timescale for the start of participant recruitment was 
identified and agreed.  
The GP practice operated the ‘Synergy database’ system to store patient 
information.  Although older than other databases, the synergy database 
system was comparable to that used in other practices and permitted group 
searches of participants to be conducted.   The patient population was 
17,564 at the time of recruitment.  275 (1.6%) of the total patients were 
identified as eligible for the study and invited by letter (appendix C4) to 
participate.  25 (9%) of the invited participants were recruited from the 
first practice over a three to twelve week period, as shown in figure 5.1. 
 
Figure 5.1: Patient recruitment from GP Practice one  
GP Practice Two:  GP practice two was based in York and had a practice 
list of 13,538 patients.  The GP practice experienced a change in personnel 
during the preliminary discussions and after a period of uncertainty about 
GP:	Patient	Population17,564
Identified	eligible	patients275	(1.6%)
Recruited	Patients25(9%)
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their continued involvement in the trial, a meeting was arranged with the 
Research Liaison Manager at the practice on the 18th October 2011 and the 
practice were recruited.  The same induction process for practice one was 
used for practice two and a timescale for the start of participant recruitment 
was identified and recruitment commenced.  
The second practice operated the EMIS LV clinical system software.  The 
patient population was 13,538 at the time of recruitment.  570 (4%) of all 
patients were identified as eligible for the study and invited by letter to 
participate in the study.  100 participants (18%) were recruited from the 
second practice over a shorter time scale of a one to six week period, as 
shown in figure: 5.2.  
Figure 5.2: Patient recruitment from GP Practice two  
In figure 5.3 the GP practice recruitment process for this study is 
illustrated.  Following the successful recruitment of 125 participants from 
the two initial GP practices and a limited time frame for recruitment, it was 
decided not to expand the invitation to any further GP practices. 
GP:	Patient	Population13,538
Identiefied	eligible	patients570	(4%)
Recruited	Patients100(18%)
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Figure 5.3: GP practice recruitment flow diagram 
5.2.2 Physiotherapy practice recruitment 
Five private physiotherapy practices were identified.  Three of the five 
physiotherapy practices were local to the area of the University of York.  
In figure 5.4 the recruitment process of physiotherapy practices is 
illustrated. 
Private physiotherapy practices were approached to participate in this 
study, due to the limited time frame for completion of the pilot trial.  Of 
the three invited physiotherapy practices, one consented to participate, one 
declined to participate after initial interest, and one had recently closed 
down for business.   
The participating practice employed eight physiotherapy staff, five were 
qualified to practice acupuncture, and sufficient staffing was therefore 
considered to be in place to conduct the study at a single practice.  By the 
start of the RCT recruitment however, the physiotherapy staffing level had 
fallen from eight to three members of staff, two of whom were acupuncture 
10	GP	Practices	Identified
GP	Practice	117564	patients275	identified25	recruited	to	the	study
GP	Practice	213538	patients570	identified100	recruited	to	the	study
GP	Practice	3Failed	to	respond	to	follow	up	contact	and	contact	ceased
2	did	not	respond 5	GP	Practices	were	invited	to	participate	
3	GP	Practices	returned	expression	of	interest	forms	
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trained.  While the practice were still able to participate in the study their 
staff numbers had significantly reduced, and time did not permit the 
recruitment of any further physiotherapy practices to the pilot. 
 
 
Figure 5.4: Physiotherapy practice recruitment flow diagram 
5.2.3 Participant recruitment 
Recruitment of participants to the study occurred between July and 
December 2011 from the two recruited GP practices.  Participants who had 
reported to their GP with LBP within the preceding 18 months were 
identified on each GP database system; the exclusion criteria were 
implemented during the selection process to provide potentially eligible 
participants, as displayed within table 5.1.  The details of all the exclusion 
criteria and their rationale are detailed in table 4.3 (chapter four). 
  
5	Physiotherapy	Practices	Identified
Physiotherapy	Practice	18	Physiotherapists	with	manual	therapy	skills,		5/8	were	also	qualified			in	acupuncture	
1	practice	had	recently	closed
1	Practice	declined	to	be	involved	in	the	study
3	Physitherapy	Practices	were	invited	to	participate	
2	Physiotherapy	Practices	expresed	interest
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 GP Practice 1 GP Practice 2 
Number of patients at GP 
practice prior to exclusions 17564 13538 
Reporting LBP & between the 
ages of 18 to 65 years, excluding 
pregnant ladies 
293 
(1.7%) 
757 
(5.6%) 
After excluding: - - 
- Rheumatoid arthritis, 
ankylosing spondylitis, immune 
compromised, anti-coagulants, 
heparin, anti-platelets 
280 
(1.6%) 
642 
(4.7%) 
- Metal allergy or needle phobia 
279 
(1.6%) 
639 
(4.7%) 
- With psychosis, bi-polar, drug 
and alcohol abuse 
277 
(1.6%) 
577 
(4.3%) 
- Valvular heart disease, 
demand pacemakers 
275 
(1.6%) 
576 
(4.3%) 
- Neurological conditions, MS, 
Parkinson’s, meningioma 
(excluded in group 
searching system prior 
to 293 start figure) 
574 
(4.2%) 
-  Those unable to consent 
(excluded in group 
searching system prior 
to 293 start figure) 
570 
(4.2%) 
Total eligible following 
exclusions 
275 
(1.6%) 
570 
(4.2%) 
Table 5.1: Results from GP database search, applying exclusion criteria  
A total of 845 (2.7%) of potential participants were identified.  I sent a 
letter as the lead researcher to all 845 patients from the GP practice on the 
same day as the searches were conducted. 
In figure 5.5 below the CONSORT flow diagram of participants through 
the study from invitation to the six-month time point is illustrated, further 
discussion also follows in the narrative. 
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Figure 5.5: CONSORT flow diagram (adapted from Dascanio et al. 2014)
Potentially eligible patients identified from two 
GP practices 
Consent form (for cohort study only) and 
baseline questionnaire sent to 845 participants 
Consent to cohort study only Consent to cohort study and 
treatment trial 
Participants enter 
cohort 
1 consent form returned to the University of York 124 consent forms returned to the University of York 
1 baseline questionnaire returned to the University of York 87 baseline questionnaires returned to the University of York 
1 participant decided not 
to be considered for the 
treatment trial 
Followed-up at three 
months (n=2) 
1 
participant 
withdrew 
Followed-up at three 
months (n=85) 
 
RMDQ ≥ 4 = enter RCT 
Randomised (n=57) 
 
RMDQ ≥ 4 = eligible but 
decided to remain in 
cohort (n=2) 
RMDQ ≤ 4 = remain in 
cohort (n=26) 
Combined 
(n=12) 
Manual 
therapy 
(n=16) 
Acupunc
ture 
(n=14) 
Usual 
care 
(n=15) 
Followed-up at six 
months (n=30) 
Followed-up at six months 
(n=57) 
59 Participants RMDQ ≥ 4 = enter RCT Randomised (n=2) 
 
Combined 
(n=13) 
Manual 
therapy 
(n=16) 
Acupunc
ture 
(n=14) 
Usual 
care 
(n=16) 
28 cohort only 
Participants 
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5.2.4 Recruitment rates to the cohort from GP practices 
Participants consenting:   
125 consent forms were returned between August and November 2011, 
from the 845 patients invited.  Yielding a response rate of 15% via a GP 
database recruitment process. 
Of the 125 patients, one patient consented to enter the cohort study only, 
and did not wish to be considered for the treatment trial.  124 patients 
consented both to participate in the cohort study and to receive further 
information about the treatment trial.  
Participants returning baseline questionnaires:   
88 of the 125 consented patients returned their baseline questionnaire; a 
response rate of 70%.  Consented patients who did not return their baseline 
questionnaire were not followed up and not entered into the cohort study.  
Information regarding any differences between those who did and did not 
return their questionnaires was not investigated in this study; this is 
discussed further in chapter eight (section 8.3). 
Of the 88 patients who returned their baseline questionnaires and trial 
consent forms, one additional patient decided not to be considered for the 
treatment trial and choose only to continue in the cohort study.  Therefore 
two participants were eligible for the cohort study only and a further 86 
were eligible for the cohort study and available for the nested RCT.  Four 
weeks after their consent, but prior to the three monthly questionnaires 
being distributed one additional participant decided to withdraw from 
study completely, reporting they were pain free. 
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Participants returning three monthly questionnaires:   
At the three-month time point the 87 participants were sent a questionnaire.  
In my nested study design this is the time point at which the cohort 
participants became eligible to enter the RCT, thus providing the run-in 
period within the recruitment process.  All 87 participants, (100%) 
returned their questionnaires fully completed.  
Of the 85 potentially eligible participants who had consented to be part of 
the nested RCT, a further two opted to remain only within the cohort study 
prior to randomisation, therefore four participants in total remained in the 
cohort only.  
26 other participants scored less than four on the RMDQ and were 
ineligible for the nested trial so continued in the cohort study only.  This 
corresponded to a 30% loss of potential participants from the cohort 
population.  
30 participants continued in the cohort study and continued to complete 
their questionnaires; only one participant contacted the investigator to 
enquire when they would be entered into the treatment study.  Involvement 
in a cohort study remained acceptable to this group of participants 
reporting low levels LBP on the RMDQ. 
5.2.5 Recruitment rates from the cohort to the nested RCT 
Participants entering the nested RCT:   
The remaining 57 participants scored four or above on the RMDQ and 
were subsequently recruited to the treatment trial.  The participants were 
allocated randomly to one of four groups using the randomisation function 
within SPSS (detailed in chapter four). 
At the six-month time point, 11 of the 26 cohort participants who were 
previously ineligible to participate in the trial (because of their low RMDQ 
scores) returned their questionnaires with a score of 4 or more on the 
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RMDQ.  The increase in their RMDQ score rendered them now eligible 
for participation and randomisation into the nested RCT. 
Two of these 11 eligible participants were invited and entered the trial at 
the six-month stage.  Nine were not invited to enter the treatment trial due 
to their six-month time point occurring too late in the process and therefore 
they remained within the cohort study.   
A total of 59 participants, therefore, were randomised into the treatment 
trial and remained in the trial, (57 participants were recruited from the 
cohort into the nested RCT at three months and two entered at the six 
month time period). 
16 participants were allocated to usual care, 14 participants were allocated 
to the acupuncture arm, 16 participants were allocated to the manual 
therapy arm and 13 participants were allocated to the combined 
acupuncture and manual therapy arm as shown in table 5.2. 
The minimum recruitment of 12 participants per group recommended for 
a pilot trial (Julious, 2005) was achieved for this pilot.  However, the 
study’s sample size target of 16-20 participants per group (total sample 
size 64-80) was not achieved. 
 
A
c
u
p
u
n
c 
t
u
r
e 
Manual Therapy 
 B (Yes) O (No) 
A  
(Yes) 
13 
Acupuncture and manual therapy 
(cell AB) 
14 
Acupuncture 
(cell AO) 
O  
(No) 
16 
Manual therapy 
(cell BO) 
16 
Usual GP Care 
(cell OO) 
Table 5.2: Participant allocation to trial intervention groups 
 
250 
 
Summary of participant recruitment:   
• An initial patient pool of 31,102 were registered at two GP 
practices 
• 845 patients were identified with LBP and invited to participate    
• The initial response rate of returned consent forms was 15% 
(125/845)  
 
Figure 5.6: GP participant recruitment (pooled data) 
• 70% (88/125) of consented patients returned their baseline 
questionnaire and entered the cohort  
• Of the initial 845 patients, 10% (88/845) entered the cohort study 
 
Figure 5.7: Participant recruitment to the cohort study 
• Recruitment from the cohort study to the nested pilot treatment trial 
yielded a 65% (57/88) recruitment rate at the three month time 
point.   
• Two participants requested to remain in the cohort only  
• One participant withdrew from the cohort study (prior to 
randomisation)  
• 30 participants were recruited into the cohort study only, at the six 
months, none of the 30 participants had withdrawn 
• 26 previously ineligible participants became eligible to recruit 
from the cohort to the RCT at the six month time point 
GP:	Patient	Population31,102
Identiefied	eligible	patients845	(2.7%)
Recruited	Patients125	(15%)
Consenting	patients125/845	(15%)
Returned	baseline	Questionaires88/125	(70%)
Successful	recruitment	into	the	cohort88/845	(10%)
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• Two of the 26 consented participants entered the trial at six months 
• 28 participants remained in the cohort only at the conclusion of 
this phase of the study  
• Of the initial 845 patients mailed from GP practices, 7% (57/845) 
entered the nested RCT via the cohort study 
5.2.6 Consent and acceptance of trial interventions 
97% (82/85) of cohort participants consented to the nested trial and to all 
the treatment interventions.  A high acceptance and consent rate to the trial 
interventions: acupuncture and manual therapy was observed. 
Of the 85 participants, two were unwilling to receive acupuncture and so 
they were randomised to either usual care or manual therapy only.  One 
participant was unwilling to receive manual therapy and they were 
randomised to usual care or acupuncture only.  These participants self-
excluded from acupuncture or manual therapy, they were able to be 
randomised to the available two groups and remain within the trial.  The 
three participants were not included in any statistical comparisons 
conducted between acupuncture and manual therapy, alone or in 
combination. 
All participants allocated to an intervention treatment group completed 
their course of ten treatment sessions, one participant required 13 weeks to 
complete his 10 sessions due to a holiday and sickness, but was able to 
complete the course with additional time.  Thus there was a 100% 
attendance rate, demonstrating a very high level of compliance and 
treatment acceptance. 
The chartered physiotherapists were able to deliver all the interventions 
and successfully combined acupuncture with manual therapy within a 
single treatment session for all the required sessions. 
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5.2.7 Attrition rates of participants pre and post randomisation 
Figure 5.8 illustrates the flow and attrition rate of participants throughout 
the study from consent to the six-month time point. 
 
Figure 5.8: Attrition throughout the study, flow diagram 
Prior to randomisation 70% of consented patients returned their baseline 
questionnaires, a loss of 37 potential participants.  Attrition from the 
baseline questionnaire to the time point just prior to randomisation (three-
125	cohort	consent	forms	returned
57	participants	completed	their	course	of	allocated	intervention	and	completed	their	six	month	questionnaire
1	participant	consented	to	the	cohort	study	only
1	participant	withdrew	completely
Randomisation	
occurred
1	participant	changed	his	consent	to	cohort	study	only	
28	participants	remained	in	cohort	only	due	to	ineligibility	for	trial	(<4RMDQ)
2	particiapnts	elected	to	remain	in	the	cohort,	though	eligible	for	the	pilot	trial
88	trial	consent	forms	and	baseline	questionnaires
87	potential	trial	participants	completed	their	three	monthly	questionnaire	
57	participants	entered	the	trial	and	were	allocated	to	one	of	the	four	intevention	groups
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month time point) was low at 1%, with one participant withdrawing 
completely from the study (87 participants remained in the study).  One 
additional participant elected to remain in the cohort only; both decisions 
were made prior to randomisation. 
Of the 30 participants eligible for the cohort only, all 30 remained at the 
six-month time point.  Zero attrition for the cohort between the three and 
six month time periods occurred. 
Of the 57 participants who were randomised into the treatment trial at three 
months none withdrew from the trial at the six-month follow-up time point, 
post randomisation (95% CI for attrition 0.0% to 6.3) (Dascanio et al. 
2014).  Providing a zero post randomisation attrition rate for this nested 
RCT design. 
5.3 Baseline characteristics 
Baseline characteristics are described at the time point for entering the 
nested RCT, at three months following the run in period within the cohort 
study. 
5.3.1 Baseline characteristics of the participants 
As shown in table 5.3, screening demonstrated the mean (SD) age of 
participants of the cohort study was 46.3 (9.6) years.  At randomisation for 
the trial participants it was also 46 (12) years, with a range 19-64 years.   
Any differences occurring between the intervention groups in the trial 
should be random as they were allocated randomly and reflects the small 
numbers involved, but it is of interest to view these differences at baseline 
to observe any potential anomalies and identify if future stratification at 
randomisation may be required. 
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Characteristic 
Cohort study 
only 
(N=30) 
Nested RCT 
only 
(N=57) 
Whole  
study 
(N=87) 
Age, years Mean 
(SD) 
46.3 
(9.6) 
46.5 
(12) 
46.4 
(13.7) 
Male 
(%) 
8 
(29%) 
23 
(39%) 
32 
(37%) 
Table 5.3: Age and Sex demographics at baseline, of cohort only, nested 
RCT only and whole study  
As shown in table 5.4 participants in the combined intervention group are 
observed to have a mean age approximately 5 years older than patients in 
the cohort and other trial arms. Participants in the manual therapy group 
were slightly younger (<2years) compared to the other groups. 
Characteristic 
Cohort 
study 
(N=30) 
Usual care 
 
(N=16) 
Acupuncture 
 
(N=14) 
Manual 
therapy 
(N=16) 
Combined 
 
(N=13) 
Age, years 
Mean 
(SD) 
46.3 
(9.6) 
46.3 
(11.3) 
45.6 
(11.9) 
43.9 
(13.7) 
50.1 
(9.3) 
Male 
(%) 
8 
(29%) 
5 
(31%) 
4 
(29%) 
9 
(56%) 
5 
(38%) 
Table 5.4: Age and Sex demographics of cohort only and allocated trial 
intervention groups (N= including those randomised at three and at six months) 
Within the intervention groups, the manual therapy group were observed 
to have almost double the proportion of male participants (56%) compared 
to the cohort and other three intervention groups, which were 
approximately one third male (29%, 31%, 29% & 38% respectively).  
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5.3.2 Baseline characteristics for RMDQ and MODI 
Table 5.5 shows that the cohort participants had lower RMDQ and MODI, 
with a mean score of 1.8 and 11.6 respectively, compared to the nested 
RCT group with a combined score of 8.8 and 28.5.   
Objective measure Cohort only Nested RCT only 
Roland Morris  Disability 
questionnaire  
(0-24, 0=best1) 
1.8 
(2.6) 
8.8 
(4.2) 
Modified Oswestry 
Disability Index 
(0-50, 0=best2) 
11.6 
(9.7) 
28.5 
(12.3) 
Table 5.5: Mean score of outcome measures at baseline of cohort and 
nested RCT (1RMDQ questionnaire rating scale, 2 MODI questionnaire rating scale) 
With minimum entry level into the RCT set a 4 or above on the RMDQ, 
but no minimum entry level for the cohort group, the cohort presented with 
a considerably lower score than the minimum eligibility level score for the 
RCT.   
Table 5.6 shows the usual care group had the highest score for the RMDQ 
with a mean score of 11.4.  The usual care group equally had very close to 
the highest score for the MODI of 29.5.  The combined intervention group 
had the lowest RCT group score for the RMDQ and the MODI at 7.0 and 
19.2 respectively. 
A between-group difference of more than four points on the RMDQ (7.0 – 
11.4) and more than ten points on the MODI (19.2 – 29.6) was observed. 
The Acupuncture and manual therapy group had very similar scores on the 
RMDQ of 8.8 and 8.0 respectively, but a 5.6 difference in the MODI of 
29.6 and 24.0 respectively.   
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Quality of life 
measure 
Cohort study 
(N=30) 
Usual care 
(N=16) 
Acupuncture 
(N=14) 
Manual 
therapy 
(N=16) 
Combined 
(N=13) 
Roland Morris 
questionnaire  
(0-24, 0=best) 
1.8 
(2.6) 
11.4 
(5.2) 
8.8 
(4.3) 
8.0 
(4.4) 
7.0 
(2.6) 
Modified 
Oswestry  
(0-50, 0=best) 
11.6 
(9.7) 
30.3 
(14.9) 
29.6 
(12.2) 
24 
(13.6) 
19.2 
(8.0) 
Table 5.6: Mean score of outcome measures at baseline of cohort and 
allocated trial intervention groups (N= including those randomised at three and at six months) 
The Acupuncture group scored 8.8 on the RMDQ, 2.6 points lower than 
the usual care group, but held the highest MODI score at 29.6.  Only the 
acupuncture group demonstrated a variation between its RMDQ and 
MODI scores. 
 
Figure 5.9: Baseline RMDQ and MODI group scores  
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2025
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Cohort Usual	care Acupunct
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RMDQMODI
257 
 
5.4 Exploratory analysis 
A preliminary investigation into the effectiveness of the two interventions 
(acupuncture and manual therapy) was conducted.  Exploratory regression 
statistical analysis was conducted using two-sided significance at the 5% 
level on an intention-to-treat basis to consider any noteworthy findings. 
For the two participants who were randomised at six months from the 
cohort study, their six-month score has been classed as their screening 
score; their three (nine actual) month follow-up data was not available 
within the time frame of this thesis. 
5.4.1 Pre and post-test correlation of Roland Morris Disability 
Questionnaire  
Figure 5.10 shows a scatterplot of pre and post-test values and correlation 
of the RMDQ scores. 
 
Figure 5.10: Pre and post-test correlation of Roland Morris Disability 
Questionnaire (RMDQ) (Dascanio, 2014) 
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Figure 5.10 plots the screening scores at three months (trial entry time 
point) against the scores three months later at six months (primary 
analysis).  It also shows regression lines for the cohort only group (far left) 
and for each of the trial intervention arms.  The lines represent best fit for 
the cohort and each of the randomised groups.  The vertical line at four 
represents the trial eligibility entry level on the RMDQ, as participants had 
to cross this threshold to be eligible for the treatment trial.  
A 45-degree line shows where 3month and 6 month scores are the same 
(no change in symptoms).  The lines with a gradient below 45 degrees 
show improvement (six month scores are less than the three month scores).  
A higher score of the RMDQ indicates a worse outcome.  Lines of positive 
gradient (>0°) indicate that, in general, the higher a participant scored at 
month three the higher their score at month six (e.g. a participant who 
scored 10 at month three tended to score higher at month six than someone 
who scored 5 at month three).  All the regression lines have a positive 
gradient.  The regression line for the cohort has a gradient that appears to 
be almost 45° indicating that within this group participants’ low back pain 
scores tended to be fairly consistent at three and six months.  For the 
randomised groups, the usual care line is the steepest (i.e. less 
improvement in symptoms) whilst the combined therapy line is the 
shallowest (greatest improvement in symptoms).  This means that for 
every unit increase in month three score the increase in predicted month 
six score was smaller for patients allocated to the combined therapy group 
than for those allocated to the acupuncture group, the manual therapy 
group, or the usual care group. 
259 
 
5.4.2 Exploratory analysis - Roland Morris Disability Questionnaire 
(RMDQ) 
Quality of life 
measure Usual care Acupuncture Manual therapy Combined 
Roland Morris 
questionnaire  
Baseline 
11.4 
(5.2) 
(N=16) 
8.8 
(4.3) 
(N=14) 
8.0 
(4.4) 
(N=16) 
7.0 
(2.6) 
(N=13) 
Roland Morris 
questionnaire  
Follow-up 
9.5 
(6.3) 
(N=14) 
6.8 
(4.5) 
(N=13) 
4.6 
(4.0) 
(N=15) 
5.4 
(4.8) 
(N=11) 
Table 5.7: Mean outcome measure scores at baseline and follow-up   
(N= at baseline includes participants randomised at three and six months; N= at 
follow-up excludes those randomised at six months, three selective participants 
not included in analysis and one incomplete data set) 
Observations at baseline and follow-up (table 5.7) show all arms improved 
in the RMDQ.   
In table 5.7 a variation in participant numbers is observed from baseline 
(59 participants) to the follow up (53 participants). There are three 
plausible explanations for this.  Firstly due to two participants being 
unwilling to receive acupuncture and thus were randomized only to either 
usual care or manual therapy and one participant being unwilling to receive 
manual therapy and thus randomized only to either usual care or 
acupuncture. The data from these three participants were excluded from 
any exploratory comparisons between acupuncture and manual therapy 
(alone or in combination).  Secondly two patients were randomised to the 
trial later in the study at the 6 month time point, their 6-month score has 
been classified as their screening score; this means however that their 
follow-up data for these participants is not available.  The final participant 
data lost from this observation occurred due to incomplete section of the 
participants questionnaire, attempts to contact the participant to retrieve 
this data were made by telephone however the data was not retrieved. 
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Table 5.8 shows the results of regression analysis of treatments for low 
back pain at three months post randomisation time point.  The analysis of 
covariance estimates are adjusted for screening score and highlight the 
differences between groups and also additional difference attributed over 
usual care.  Negative differences represent a favourable outcome for the 
relevant intervention over usual care. 
Exploratory analysis of the efficacy of the trial interventions showed that 
the Roland Morris questionnaire scores improved across all the groups. 
QoL 
measure 
Usual care 
(UC) 
Acupunctu
re 
Additional 
difference 
attributed to 
acupuncture 
over usual 
care 
(95% CI) 
Manual 
therapy 
Additional 
difference 
attributed 
to manual 
therapy 
over usual 
care 
(95% CI) 
Combined 
Acupuncture 
and manual 
therapy 
Additional 
difference 
attributed 
to 
combined 
therapy 
over usual 
care 
(95% CI) 
RMDQ 
9.3 
(6.3) 
N=14 
6.8 
(4.5) 
N=13 
0.3 
(-2.9, 3.5) 
P=0.85 
4.6 
(4.0) 
N=15 
-1.4 
(-3.8, 1.0) 
P=0.24 
5.4 
(4.8) 
N=11 
0.01 
(-4.3, 4.3) 
P=1.00 
Table 5.8: Regression analysis results for RMDQ at 6 months (3/12 post 
randomisation) 
Table 5.8 indicates the manual therapy group produced the largest benefit 
over usual care at three-months.  In the ‘additional difference’ columns 
negative differences reported represent a favourable outcome for the 
relevant intervention over usual care due to the change achieved. 
The manual therapy group achieved the greatest negative difference 
(additional reduction in RMDQ relative to usual care) of -1.4 (95% CI -
3.8, 1.0, P=0.24) and thus a favourable outcome above usual care at three 
months was seen, although statistical significance was not achieved. 
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Positive numbers reported in the additional difference columns (table 5.8) 
represent no difference to usual care; a favourable outcome over usual care 
was not seen.  Acupuncture was reported at 0.6 (p=0.78) and combined 
therapy at 0.01 (p=1.00).  Statistical significance was not achieved.   
No additional benefit in mean RMDQ score was observed in the 
acupuncture and combined therapy arm at three months over the usual care 
group, statistical significance was not achieved due to the low power of 
the trial to detect such a change, though this was not the objective of the 
pilot study. 
Compared to baseline scores participants in the combined intervention 
group experienced an increase on average a 1.4-point (95% CI -1.5 to 4.4, 
p=0.31) in Roland Morris score than the manual therapy group, though 
statistical significance not achieved. 
Compared to baseline scores participants in the combined intervention 
experienced a 0.9-point (95% CI: -2.9 to 4.7, p=0.63) greater improvement 
than the acupuncture group after adjusting for screening scores.  Statistical 
difference was not achieved between the combined and acupuncture 
comparison. 
Analysis of an interaction within the factorial design was not conducted 
for this pilot due to low participant numbers, but a full analysis would be 
planned for a full-scale trial. 
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5.4.3 Exploratory analysis - Modified Oswestry Disability Index 
Quality of life 
measure Usual care Acupuncture Manual therapy Combined 
Modified 
Oswestry 
Baseline 
30.3 
(14.9) 
(N=16) 
29.6 
(12.2) 
(N=14) 
24 
(13.6) 
(N=16) 
19.2 
(8.0) 
(N=13) 
Modified 
Oswestry 
Follow-up 
29.2 
(21.0) 
(N=13) 
25.4 
(12.0) 
(N=13) 
18.3 
(11.1) 
(N=15) 
16.7 
(10.9) 
(N=11) 
Table 5.9: Mean outcome measure scores at baseline and follow-up 
(N= at baseline includes participants randomised at three and six months; N= at follow-up excludes those 
randomised at six months, three selective participants not included in analysis and two incomplete data sets) 
Observations at baseline and follow-up in table 5.9 show that the MODI 
improved in all arms.  A variation in participant numbers is observed from 
baseline (59 participants) to the follow up (52 participants).  Three 
explanations are presented in section 5.4.2, however one additional 
participant data was incomplete for the MODI questionnaire, thus missing 
data for two participants in total.  Attempts to contact the participants to 
collect this data were made by telephone without success. 
Table 5.10 shows the results of regression analysis of treatments for low 
back pain at three months post randomisation time point.  Highlighting the 
differences between groups and also additional differences attributed over 
usual care.  In the additional difference columns within table 5.10, negative 
differences reported represent a favourable outcome for the relevant 
intervention over usual care. 
The exploratory analysis of the efficacy of the trial interventions after 
adjusting for baseline screening score showed (as with the RMDQ), that 
the modified Oswestry (MODI) scores, the greatest difference was 
observed in the Manual therapy (additional improvement to usual care of 
-5.0 points (95% CI -13.3, 3.3, P=0.23) (Table 5.10) though statistical 
significance was not achieved. The study was not powered to be able to 
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find statistically significant differences.  The difference observed for the 
manual therapy group appeared consistent across the MODI and the 
RMDQ. 
QoL 
measure 
Usual care 
(UC) 
Acupunc-
ture 
Additional 
difference 
attributed to 
acupuncture 
over usual 
care 
(95% CI) 
Manual 
therapy 
Additional 
difference 
attributed to 
manual 
therapy over 
usual care 
(95% CI) 
Combined 
Acupuncture 
and manual 
therapy 
Additional 
difference 
attributed 
to 
combined 
therapy 
over usual 
care 
(95% CI) 
MODI 
29.2 
(21.0) 
N=13 
25.4 
(12.0) 
N=13 
-1.9 
(-9.9, 6.1) 
P=0.63 
18.3 
(11.1) 
N=15 
-5.0 
(-13.3, 3.3) 
P=0.23 
16.7 
(10.9) 
N=11 
2.1 
(-6.5, 10.6) 
P=0.62 
Table 5.10: Regression analysis results for MODI at 6 months (3/12 post 
randomisation) 
Acupuncture achieved a negative difference of -1.9 (p=0.63) and thus a 
favourable outcome above usual care, though statistical significance was 
not achieved.   
For the combined treatment group no substantial differences were 
observed after the three month time period, after adjusting for baseline 
screening score a positive score of 2.1 (-6.5, 10.6. P=0.62) was observed 
(table 5.10). Positive numbers reported in the additional difference 
columns within table 5.10 show no favourable outcome over usual care. A 
difference attributable above usual care was not observed for the combined 
intervention.  Statistical significance was not observed due to the low 
power of the trial. 
The combined arm experienced on average a 2.2 points (95% CI: -4.8, 9.3; 
P = 0.52) increase in MODI than the manual therapy group and a 0.5point 
(95% CI: -7.7, 8.7; P = 0.10) increase over the acupuncture arm after 
adjusting for screening scores, statistical difference was not achieved.  
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Both differences in the MODI favour the individual intervention rather 
than the combined group. 
Analysis of an interaction within the factorial design was not conducted 
for this pilot due to low participant numbers, but a full analysis may be 
planned for a full-scale trial. 
5.4.4 A comparison and analysis of the RMDQ and the MODI outcome 
measure tools  
Both outcome measures are frequently used in research and both have been 
shown to be valid and reproducible, however they each have strengths and 
limitations in different aspects (Longo et al, 2010).   
Both measures were completed fully by 97% of participants returning their 
questionnaires and all participants appeared happy to complete both the 
measures, suggesting it is possible for two outcome measures to be used 
within a trial. 
The objective measure tools were compared to each other (see table 5.11). 
No significant differences between the two outcome measures data were 
observed in this pilot study.  Both measures were consistent in showing 
that the manual therapy intervention arm was superior to the other arms; 
this result was not statistically significant however.  
With the RMDQ being scored out of 24 and the MODI scored out of 50 
the observed difference between four points and ten points is effectively 
very similar in observed measurement on the objective measure tools 
across the study arms, generally indicating the alignment of the outcome 
measurement scores, showing comparability at baseline.  Comparison of 
the scores using standardised mean differences is shown in section 5.4.5 
and would need to be conducted if considered for a full-scale trial. 
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QoL 
measure 
Usual care 
(UC) 
 
Acupunc-
ture 
Additional 
difference 
attributed to 
acupuncture 
over usual 
care 
(95% CI) 
Manual 
therapy 
Additional 
difference 
attributed to 
manual 
therapy over 
usual care 
(95% CI) 
Combined 
Acupuncture 
and manual 
therapy 
Additional 
difference 
attributed 
to 
combined 
therapy 
over usual 
care 
(95% CI) 
RMDQ 
9.3 
(6.3) 
N=14 
6.8 
(4.5) 
N=13 
0.3 
(-2.9, 3.5) 
P=0.85 
4.6 
(4.0) 
N=15 
-1.4 
(-3.8, 1.0) 
P=0.24 
5.4 
(4.8) 
N=11 
0.01 
(-4.3, 4.3) 
P=1.00 
MODI 
29.2 
(21.0) 
N=13 
25.4 
(12.0) 
N=13 
-1.9 
(-9.9, 6.1) 
P=0.63 
18.3 
(11.1) 
N=15 
-5.0 
(-13.3, 3.3) 
P=0.23 
16.7 
(10.9) 
N=11 
2.1 
(-6.5, 10.6) 
P=0.62 
Table 5.11: Regression analysis results, three months post randomisation 
of interventions and difference attributable over usual care for LBP  
5.4.5 Differences between the two objective measures 
As this was a pilot study, both of the above measures were used to 
investigate which would be the more informative measure to use in a future 
full-scale study of LBP.    
A comparison of the two questionnaires performances to assess their 
reliability to each other as similar measures for LBP showed some 
similarities and differences.   
All groups improved for both measures.  Both measures performed 
comparably for the manual therapy intervention group with an attributed 
difference above usual care, both providing a negative result within table 
5.11.  By dividing the negative result (-1.4, -5.0) by the SD the 
standardised difference can be observed between the two measures.  The 
RMQD thus has a standardised measure of 0.35 and the MODI 
standardised measure is 0.45, showing minimal difference between the two 
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measures, with the MODI being slightly more sensitive, however this 
study was not powered to test for a statistical difference between the 
measures.  
Comparing the results a negative value = a positive effect.  Negative values 
were achieved for the manual therapy group for both measures (RMDQ -
1.4, MODI -5.0).  However participants in the acupuncture group had a 
greater improvement on the MODI measure than the RMDQ.  A negative 
value was achieved for the MODI measure (-1.9) but was not achieved for 
the same participants completing the RMDQ (0.3). 
After adjusting for screening scores, consideration of the RMDQ only 
would suggest the manual therapy group could be effective comparatively, 
with a small difference in favour of acupuncture and the combined group.  
Consideration of the MODI only would also indicate the manual therapy 
group to be superior, with the acupuncture group achieving a difference 
attributable over usual care and no additional difference observed in the 
combined therapy group over usual care.   
While the results of the pilot are not powered to detect differences it is 
interesting to observe a different emphasis between the two measures with 
RMDQ = favouring Manual therapy and the MODI = favouring Manual 
therapy and acupuncture.  Statistical significance was not achieved for 
these comparisons. 
5.4.6 Ancillary data 
Descriptive data for the outcome measures SF12, EQ5D, VAS pain scale 
and the cost analysis questionnaire are presented below.  StataSE (64-bit) 
was used to analyse the results. Mean and standard deviations (or 
percentage measures) are shown. 
For the SF12 (PCS (5.12) and MCS (5.13) analysis), EQ5D (THERM) and 
the VAS pain scale a loss of one to two participants’ data was observed 
across the trial groups for all the analyses, this derived from incomplete 
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sections of the participant questionnaires.  The recovery of missing data 
for these outcome measures was not conducted due to the time lapse for 
analysis of these measures for this PhD, it would be useful in a future trial 
to plan for the collection of any missing data. 
Table 5.12 below shows the PCS scores for the quality of life measure 
SF12 at baseline (three months) and follow-up (six months). 
SF12 
PCS 
Quality of life 
measure 
Cohort Usual care Acupuncture Manual therapy Combined 
  Baseline - 
three months 
Pre-randomisation 
Screening score 
Mean (SD) 
52.8 
(4.96) 
N=27 
42.6 
(8.68) 
N=16 
43.4 
(9.18) 
N=14 
46.5 
(12.68) 
N=16 
48.1 
(4.53) 
N=13 
    Follow up - 
six months 
Mean (SD) 
51.3 
(5.95) 
N=25 
41.9 
(10.43) 
N=15 
43.7 
(8.73) 
N=13 
48.5 
(12.0) 
N=14 
51.9 
(6.7) 
N=12 
Table 5.12: SF12 PCS mean score (SD) at baseline (three months) and six 
months of the cohort and allocated trial intervention groups 
Minimal changes in the data are observed from baseline to follow up for 
the PCS of the SF12.  For the combined group an increase of 3.8 points 
was observed and for the manual therapy group an increase of 2 points was 
observed.  A 0.3 point increase was observed for the acupuncture group 
and the usual care and cohort groups decreased by 0.7 and 1.5 respectively.  
A small improvement was observed in the combined and manual therapy 
groups and a small deterioration was observed in the usual care and cohort 
groups; however the sample size was small thus limiting any interpretation 
from the results. 
Table 5.13 shows the MCS scores for the quality of life measure SF12 at 
baseline (three months) and follow-up (six months). 
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SF12 
(MCS) 
Quality of life 
measure 
Cohort Usual care Acupuncture Manual therapy Combined 
  Baseline - 
three months 
Pre-randomisation 
Screening score 
Mean (SD) 
50.7 
(8.57) 
N=27 
43.7 
(11.13) 
N=16 
43.9 
(9.89) 
N=14 
47.3 
(12.49) 
N=16 
52.6 
(7.16) 
N=13 
    Follow up - 
six months 
Mean (SD) 
52.0 
(7.99) 
N=25 
45.2 
(10.1) 
N=15 
50.8 
(9.06) 
N=13 
51.1 
(8.59) 
N=14 
49.9 
(7.94) 
N=12 
Table 5.13: SF12 MCS mean score (SD) at baseline (three months) and 
six months of the cohort and allocated trial intervention groups 
The greatest increase was observed in the acupuncture group, with a 6.9 
point score increase.  While the other groups observed a more modest 
increase of 3.8 points for the manual therapy group, a 1.5 points for the 
usual care group and a 1.3 points increase for the cohort group.  The 
combined group observed a decrease in score of -2.7 points suggesting a 
deterioration in MCS score, however the sample size was small thus 
limiting any interpretation from the results.   
Table 5.14 shows the scores for the quality of life measure EQ5D at 
baseline (three months) and follow-up (six months). 
For the EQ5D, no difference was observed for the cohort and usual care 
groups at baseline and follow up.  A 1.5 point increase was observed in the 
acupuncture group, a 1 point increase in the combined group and a 0.5 
point increase in the manual therapy group, with an increase in the score 
showing a mild improvement from baseline to follow up, however the 
sample size was small thus limiting any interpretation of the results. 
The THERM data showed a reduction in score for the cohort and usual 
care group of 4.6 and 2.4 points respectively.  However an increased score 
was observed for the acupuncture (10.2 points) manual therapy (7.4 points) 
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and the combined group (1.5 points) suggesting a deterioration of the 
THERM score for participants, however the sample size was small thus 
limiting any interpretation of the results. 
EQ5D 
Quality of life 
measure 
Cohort study Usual care Acupuncture Manual therapy Combined 
  Baseline - 
three months 
Pre-randomisation 
Screening score 
Mean (SD) 
0.8 
(0.18) 
N=27 
0.6 
(0.28) 
N=16 
0.6 
(0.21) 
N=14 
0.8 
(0.14) 
N=16 
0.7 
(0.10) 
N=13 
THERM Scale 
(0-100, 0 =best) 
Mean (SD) 
84.3 
(8.56) 
N=26 
69.5 
(13.92) 
N=15 
60.5 
(19.35) 
N=14 
68.3 
(18.64) 
N=16 
77.7 
(10.14) 
N=13 
    Follow up - 
six months 
Mean (SD) 
0.8 
(0.12) 
N=26 
0.6 
(0.32) 
N=15 
0.75 
(0.13) 
N=13 
0.85 
(0.12) 
N=15 
0.8 
(0.23) 
N=12 
THERM 
(0-100, 0 =best) 
Mean (SD) 
79.7 
(16.5) 
N=26 
67.1 
(18.27) 
N=14 
70.7 
(16.92) 
N=13 
75.7 
(20.93) 
N=15 
79.2 
(19.4) 
N=12 
Table 5.14: EQ5D mean score (SD) at baseline (three months) and six 
months of the cohort and allocated trial intervention groups 
A considerable improvement of pain rating on the VAS scale was observed 
for the manual therapy group with a reduction from 33.7 to 14.6 points 
across the time points, a reduction of 19.1 on the scale.  A reduction of 8.6 
points for the acupuncture group, 5.4 points for the combined group and 
1.4 points for the cohort were observed.  An increase in pain score was 
observed in the usual care group of 4.7 points. 
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Table 5.15 below shows the scores for the VAS (Visual analogue scale) 
for Pain at baseline (three months) and follow-up (six months).  
VAS 
Pain Scale 
(0-100 
100 = worst) 
Cohort  Usual care Acupuncture Manual therapy Combined 
Baseline - three 
months   
Pre-randomisation 
Screening score 
Mean (SD) 
27.4 
(20.39) 
N=26 
48.3 
(21.4) 
N=15 
38.1 
(18.54) 
N=13 
33.7 
(22.0) 
N=16 
29 
(15.34) 
N=13 
Follow up - six 
months 
Mean (SD) 
26 
(21.91) 
N=25 
53 
(16.4) 
N=13 
29.5 
(20.54) 
N=13 
14.6 
(11.65) 
N=15 
23.6 
(22.5) 
N=11 
Table 5.15: VAS of pain, mean score (SD) at baseline (three months) and 
six months of the cohort and allocated trial intervention groups 
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Resource use data: Table 5.16 and table 5.17 below show the results of the 
EcoCost questionnaire at baseline (three months) and follow-up (six 
months), mean score (number of visits) and SD’s (or percentages) are 
presented.  
Eco Cost 
Questionnaire at  
3 months 
Cohort 
study Usual care Acupuncture 
Manual 
therapy Combined 
1) Care from GP in the last three months 
Own or other GP 
Mean (SD) 
0.8 
(1.31) 
N=27 
1.5 
(2.53) 
N=15 
1.4 
(1.98) 
N=14 
0.9 
(1.11) 
N=16 
0.9 
(1.11) 
N=13 
Practice nurse 
Mean (SD) 
0.2 
(0.5) 
N=27 
0.6 
(0.86) 
N=13 
0.7 
(1.18) 
N=13 
0.4 
(0.63) 
N=15 
0.2 
(0.40) 
N=11 
Physiotherapist 
Mean (SD) 
0.1 
(0.42) 
N=27 
0 
(0) 
N=13 
0.4 
(0.99) 
N=12 
0.6 
(1.59) 
N=15 
0.4 
(0.92) 
N=11 
Other 
Mean (SD) 
0 
(0) 
N=25 
0.6 
(1.28) 
N=14 
0 
(0) 
N=10 
0.2 
(0.59) 
N=13 
0.4 
(0.92) 
N=11 
Other detail - 
1x Counsellor 
1x Nurse 
specialist 
1x Sports 
therapist 
- 
1x Health care 
assistant 
1xMES clinic 
1x Chiropractor 
1x MRI scan 
1x physiotherapist 
Other 
Mean (SD) 
0 
(0) 
N=25 
0.25 
(0.86) 
N=12 
0 
(0) 
N=10 
0 
(0) 
N=13 
0 
(0) 
N=10 
Other detail - 1x Podiatrist - -  
2) Care from NHS Hospital - In last three months as an emergency 
Yes 
(%) 
1 
(3.7) 
1 
(6.25) 
0 0 0 
(No of admissions)  1    
No 
(%) 
26 
(96.3) 
15 
(93.75) 
14 
(100) 
16 
(100) 
13 
(100) 
3) Care from NHS hospitals - In last three months non-emergency 
Yes 
(%) 
2 
(7.4) 
1 
(6.25) 
0 0 0 
(No of admissions) 2 1 - - - 
No 
(%) 
25 
(92.6) 
15 
(93.75) 
14 
(100) 
16 
(100) 
13 
(100) 
4) Care from NHS hospital by a doctor in outpatient clinic 
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Doctor 
Mean (SD) 
0.11 
(0.42) 
N=27 
0.06 
(0.25) 
N=16 
0 
(0) 
N=14 
0.36 
(0.84) 
N=14 
0.15 
(0.37) 
N=13 
5) Care from NHS hospitals –In last three months from any other health professional 
Physiotherapist 
Mean (SD) 
0.48 
(1.19) 
N=25 
0 
(0) 
N=15 
0.5 
(1.4) 
N=14 
0.94 
(2.17) 
N=16 
0.23 
(0.6) 
N=13 
Other 
Mean (SD) 
0.19 
(0.69) 
N=26 
0.53 
(1.24) 
N=15 
0.08 
(0.28) 
N=12 
0.13 
0.35 
N=15 
0 
(0) 
N=11 
Other detail 1x Dietician 
1x Counsellor 
1x Nurse 
specialist 
1x Podiatrist 
1x MRI 
pelvic scan 
1x Podiatrist 
1x Urologist 
- 
Other 
Mean (SD) 
0 
(0) 
N=25 
0 
(0) 
N=14 
0 
(0) 
N=12 
0.13 
(0.51) 
N=15 
0 
(0) 
N=11 
Other detail - - - 1x Consultant Urologist - 
6) Private treatments –In the last three months have you been admitted to a private hospital 
Yes 
(%) 
1 
(3.7) 
1 
(6.25) 
0 0 0 
No. of admissions 1 1 0 0 0 
No 
(%) 
26 
(96.3) 
15 
(93.75) 
14 
(100) 
16 
(100) 
13 
(100) 
7) In the last three months how often have you consulted a private healthcare professional 
Doctor 
Mean (SD) 
0.38 
(0.19) 
N=26 
0.63 
(1.63) 
N=16 
0 
(0) 
N=14 
0 
(0) 
N=15 
0 
(0) 
N=12 
Physiotherapist/ 
Chiropractor/Osteopath 
Mean (SD) 
1 
(3.16) 
N=27 
0.33 
(1.29) 
N=15 
0.57 
(2.14) 
N=14 
0.25 
(0.77) 
N=16 
0.69 
(1.18) 
N=13 
Other 
Mean (SD) 
0.25 
(0.73) 
N=24 
0.2 
(0.77) 
N=15 
0.41 
(1.44) 
N=12 
0 
(0) 
N=14 
0.08 
(0.28) 
N=13 
Other detail 
1x 
Occupational 
health 
Physiotherapist 
2x Dentist 
1x Surgeon 
1x Sports 
therapist 
1x Chinese 
acupressure - 
1x MRI scan 
knees 
Table 5.16: Eco cost questionnaire mean score (SD) and percentage 
results at baseline (three months) of the cohort and allocated trial 
intervention groups 
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Table 5.17 below show the results of the EcoCost questionnaire at follow-
up (six months), mean score (number of visits) and SD’s (or percentages) 
are presented. 
Eco Cost 
Questionnaire at 
6 months 
Cohort  Usual care Acupuncture Manual therapy Combined 
1) Care from GP in the last three months 
Own or other GP 
Mean (SD) 
0.57 
(0.95) 
N=26 
1.07 
(1.70) 
N=13 
0.84 
(1.21) 
N=13 
1.35 
(1.69) 
N=14 
0.57 
(1.62) 
N=12 
Practice nurse 
Mean (SD) 
0.73 
(1.93) 
N=23 
0.33 
(0.49) 
N=12 
0.27 
(0.65) 
N=11 
0.1 
(0.62) 
N=10 
0 
(0) 
N=11 
Physiotherapist 
Mean (SD) 
0.66 
(3.1) 
N=21 
0 
(0) 
N=11 
1.36 
(3.1) 
N=11 
0.36 
(1.20) 
N=11 
3.6 
(5.39) 
N=11 
Other 
Mean (SD) 
0.1 
(0.44) 
N=20 
0.1 
(0.31) 
N=10 
0 
(0) 
N=11 
0.25 
(0.46) 
N=8 
0.13 
(0.35) 
N=8 
Other detail 1x Osteopath 1x Consultant - 
1x asthma check 
1x Health care 
assistant 
1x Eye consultant 
Other 
Mean (SD) 
0 
(0) 
N=17 
0 
(0) 
N=10 
0 
(0) 
N=9 
0.71 
(1.89) 
N=7 
0 
(0) 
N=7 
Other detail - - - No detail - 
2) Care from NHS Hospital - In last three months as an emergency 
Yes 
(%) 
1 
(3.85) 
1 
(7.14) 
0 0 0 
(No of admissions) 1 1    
No 
(%) 
25 
(96.15) 
13 
(92.86) 
13 
(100) 
15 
(100) 
12 
(100) 
3) Care from NHS hospitals - In last three months non-emergency 
Yes 
(%) 
1 
(3.85) 
1 
(7.14) 
0 0 0 
(No of admissions) 1 1 - - - 
No 
(%) 
25 
(96.15) 
13 
(92.86) 
13 
(100) 
15 
(100) 
11 
(100) 
4) Care from NHS hospital by a doctor in outpatient clinic 
Doctor 
Mean (SD) 
0.23 
(0.82) 
N=26 
0.08 
(0.28) 
N=12 
0.15 
(0.38) 
N=13 
0.6 
(1.12) 
N=15 
0.25 
(0.62) 
N=12 
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5) Care from NHS hospitals –In last three months from any other health professional 
Physiotherapist 
 Mean (SD) 
0.53 
(2.74) 
N=26 
0.28 
(1.06) 
N=14 
0.23 
(0.83) 
N=13 
1.54 
(2.57) 
N=13 
0.24 
(1.44) 
N=12 
Other 
Mean (SD) 
0.87 
(0.29) 
N=23 
0.38 
(1.12) 
N=13 
0.09 
(0.3) 
N=11 
1.1 
(1.49) 
N=10 
0 
(0) 
N=9 
Other detail 
1x 
Gynaecologist 
1x 
Hypnotherapist 
1x Consultant 
Gynae 
1x Counsellor 
1x Consultant 
Rheumatologi
st 
1x Clinical 
psychologist 
1x 
Gastroenterology 
1x Medical 
elective 
1x Moxiofacial 
1x X-ray nurse 
- 
Other 
Mean (SD) 
0 
(0) 
N=22 
0 
(0) 
N=11 
0.09 
(0.30) 
N=11 
0.25 
(0.46) 
N=8 
0 
(0) 
N=9 
Other detail - - 1x Gastroscopy 
1x MRI nurse 
1x Pain clinic 
- 
6) Private treatments –In the last three months have you been admitted to a private hospital 
Yes 
  (%) 
1 
(3.85) 
1 
(6.67) 
0 
1 
(6.67) 
0 
No. of admissions 1 1 0 1 0 
No 
(%) 
25 
(96.15) 
14 
(93.33) 
13 
(100) 
14 
(93.33) 
12 
(100) 
7) In the last three months how often have you consulted a private healthcare professional 
Doctor 
Mean (SD) 
0.12 
(0.33) 
N=25 
0.07 
(0.26) 
N=14 
0 
(0) 
N=12 
0.64 
(2.13) 
N=14 
0.38 
(1.06) 
N=8 
Physiotherapist/ 
Chiropractor/Osteopath 
Mean (SD) 
0.29 
(0.8) 
N=24 
0.28 
(1.07) 
N=14 
1.64 
(3.2) 
N=11 
0.71 
(2.67) 
N=14 
3.72 
(4.17) 
N=11 
Other 
Mean (SD) 
0.25 
(0.74) 
N=24 
0 
(0) 
N=14 
1.27 
(3.13) 
N=11 
0 
(0) 
N=11 
0.11 
(0.33) 
N=9 
Other detail 
1x 
Acupuncture 
2x Chiropodist 
1x Sports 
massage 
- 2x Acupuncture - 
1x Eye 
consultant 
1x no detail 
Table 5.17: Eco cost questionnaire mean score (number of visits), (SD) 
and percentage results at six month follow up of the cohort and allocated 
trial intervention groups 
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This study was intended to pilot the collection of data from the resource 
use questionnaires, thus limited information can be determined from the 
differences between time points due to the small sample size.  
Resource use reported in tables 5.16 and 5.17 was observed to be low, 
across all groups and across both time points.  No notable values were 
observed in the variables data across the tables. 
Under the care from GP section, resource use of accessing a GP use 
increased marginally for the manual therapy group (from 0.9 (1.11) three 
months, to 1.35 (1.69) six months), but decreased for all other groups from 
baseline to follow up.  
Resource use of accessing a physiotherapist went up across the 
acupuncture (0.4 to 1.36) and combined (0.4 to 3.6) intervention groups at 
six months, this occurred due to some individuals mistakenly including 
their trial intervention sessions on the resource use section of the 
questionnaire.  Individuals indicated they had received 10 physiotherapy 
sessions, these individuals were contacted by telephone, where possible, 
to confirm if they had identified the trial interventions on the questionnaire 
and these were corrected where confirmation was possible.  If follow up 
by telephone was unsuccessful, further follow up was not conducted and 
data was not corrected.  A future study would plan to avoid this inaccuracy 
in reporting resource use. 
Additional resource use across the groups varied but at three months, nine 
additional contacts in the “other section” where made and included the 
usual care group accessing a counsellor, nurse, sports therapist and a 
podiatrist.  The manual therapy group accessing health care assistants, the 
MES clinic, and the combined therapy group accessing chiropractors, MRI 
scans, physiotherapists.  At six months, six additional contacts were made 
including the cohort accessing an osteopath, the usual care group accessing 
a consultant, the manual therapy group accessing an asthma check and a 
health care consultation and the combined group accessing an eye 
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consultant.  The Acupuncture group did not access any additional care in 
the recorded “other” sections at three or six months. 
Hospital use both emergency and non-emergency across the groups was 
minimal with only one or two participants from the cohort and usual care 
group only accessing services, at both baseline and follow up. 
Variation in completion rates were seen throughout the questionnaire in 
the resource use section; a loss of one to four participants data was 
observed across the groups for the analysis at six months, this derived from 
incomplete sections of the participant questionnaires i.e. all questionnaires 
were returned but not every question was complete.  This figure rose to the 
loss of up to ten participants data for the sections titled ‘other’, participants 
completed part 1,2,3 of the question but left the section ‘other’ blank.  
Retrieval of missing data was not conducted. 
5.4.7 Effectiveness of the design for evaluating a population with LBP 
The design methodology of this study worked effectively in the assessment 
of interventions for LBP.  The details and a discussion of the design will 
be presented in chapter six. 
The factorial design was effective for assessing the use of acupuncture and 
manual therapy in comparison and in combination while maintaining a 
control arm.  A full-scale trial of this pilot would incorporate the two 
interventions concurrently and is likely to be a more cost effective trial in 
its approach, than conducting two separate trials.   
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5.5 Proposed full-scale study sample size calculation 
5.5.1 Calculations to inform sample size calculation 
5.5.1.1 Calculation of Standard Deviation (SD): 
The SD for the sample size to inform a full-scale study was calculated for 
the RMDQ score at six months (three months post randomisation) using 
StataSE (64-bit).  
Calculation from this pilot: Standard deviation = 5.0 
5.5.1.2 Important difference on RMDQ score 
A difference of 1.5 points on the Roland-Morris disability questionnaire 
would be anticipated for a future study of LBP, this decision was made 
based on consensus from published literature.   
Ellard et al. (2017) observed mean between group differences of 0.8 and 
1.87 points in the RMDQ at three months in their meta-analysis of large 
physiotherapy trials of LBP using the RMDQ.  UKBEAM (2004) observed 
a 1.6-point improvement at three months and 1.0 point at 12 months.  
While they note it is a small to moderate clinical benefit, it was suggested 
that this benefit in outcome might lead to a large economic effect due to 
the high cost of LBP to society (UKBEAM, 2004).  A similar finding was 
found for the pilot study conducted for this thesis for the manual therapy 
group, the additional reduction in RMDQ relative to usual care was 1.4 
points (95% CI: -1.0, 3.8. P = 0.24) at three month follow up, though as it 
was a small pilot the results were not statistically significance (Dascanio 
et al. 2019). 
Chou et al (2007) in their review of treatments for LBP including 
acupuncture, found a difference of 2 - 4 on the Roland-Morris disability 
questionnaire to be significant in the reviewed articles.  In a study of yoga 
for LBP, a difference of 1.48 points lower (95% CI, 0.33 to 2.62 points) 
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was observed at six months and 1.57 points lower (95% CI, 0.42 to 2.71 
points) was observed at 12 months on the RMDQ score (Cox et al. 2010).  
The selection of a difference of 1.5 points also equates for the calculation 
of the planned effect size of 0.3 (section 5.5.1.3).  With a planned mean 
difference of 1.5, divided by the six-month standard deviation for this pilot 
of 5.0, equalling 0.3 for the effect size:   
    1.5 / 5.0 (SD) = 0.3 
A mean difference of 1.5 points on the Roland-Morris disability 
questionnaire was therefore used as the mean difference worth being able 
to detect as statistically significant for the sample size calculation for a 
potential full-scale study of this pilot.   
5.5.1.3 Estimation of effect size: 
The effect size is often used for reporting and interpreting effectiveness 
(Coe, 2002).  As this was a pilot study it was not the intention to estimate 
an effect size from the data collected; with a small sample size the 
precision of any estimates of effect were of course low.  However the 
calculations have been conducted for exploratory reasons and presented 
below for interest.  The six-month data set has been used, selecting the 
mean RMDQ score from the acupuncture (for the purpose of this 
calculation) and usual care groups (table 5.8). 
Effect Size =  (Mean of experimental group) – (Mean of control group) 
                       -------------------------------------------------------------------- 
 Standard Deviation 
 
Effect size = (6.8 Acupuncture) – (9.3 Usual care) 
                        --------------------------------------------------------   = -0.5   
          5.0 (SD) 
An effect size of 0.5 was estimated, this calculation was based on the six-
month data set for this study (table 5.8). 
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An effect size of 0.3 is recognised as a medium effect (Cohen, 1992), and 
I decided to use this to calculate the sample size for a future trial of this 
study, as it is more conservative. The rationale for selecting a medium 
effect size of 0.3 is based on the recognised use of a medium effect size 
for RCTs (Cohen, 1992) and published literature reporting their effect 
sizes.   
Rothwell, Julious and Cooper (2018) reported the median standardised 
target effect size across the studies was 0.30 (interquartile range: 0.20 – 
0.38) from 107 RCTs included in their study.  UKBEAM (2004) reported 
an effect size of 0.39 at three months and 0.25 at 12 months for the 
manipulation group on the RMQ.  MacPherson et al (2014) reported effect 
sizes of 0.17 (95% CI: 0.11, 0.23) and 0.43 (95% CI: 0.01, 0.85) for the 
effect of acupuncture versus sham penetrating and non-penetrating needles 
comparatively across 29 high quality RCTs.  Linde K, Niemann K and 
Meissner K (2010) reported effect sizes of 0.43 (95% CI: 0.01, 0.85) and 
-0.37 (95% CI: -0.70, 0.04) for the effect of acupuncture versus sham 
penetrating and non-penetrating needles comparatively across 61 RCTs.   
After consideration of the reported effect sizes in the literature, the effect 
size calculated from this pilot (above) and the planned mean difference of 
1.5 on the RMDQ (section 5.5.1.2) an effect size of 0.3 was considered 
appropriate to select, to calculate the sample size for a future full-scale 
RCT. 
5.5.1.4 Power 
A 90% power was selected for calculating the study sample size required 
to have a high probability of detecting the difference as statistically 
significant if a difference exists between the interventions.   
Conventionally it is recommended to have power of 80% to 90% for an 
RCT (Hickey et al. 2018), however 90% power requires an increase in 
sample size of around 30% (Wittes, 2002). 
280 
 
5.5.1.5 Summary of calculations to inform sample size 
calculation 
In summary a mean difference of 1.5 points on the Roland-Morris 
disability questionnaire would be appropriate for future calculations, with 
an effect size of 0.3, assuming the standard deviation of 5. 
5.5.2 Sample size calculation 
A sample size calculation was performed to inform a full-scale trial; using 
PS Power and sample size calculation version 3.1.2.  A future full-scale 
study would be planned to follow a continuous response variable of 
independent control and experimental participants.   
The pilot was planned to observe a response from each trial group of 
normal distribution, with a standard deviation of 5, which was observed 
from the study.  If the true difference in the experimental and control 
means was 1.5, 234 experimental participants and 234 control participants 
would be needed to be able to reject the null hypothesis; that the population 
means of the experimental and control groups are equal with probability 
(power) 0.9.   
The type I error probability associated with this test of this null hypothesis 
is 0.05.  Translating this power calculation into a four group factorial 
design, would relate to 117 participants in each of the four groups of the 
RCT. As the comparison of active treatment is with usual care, a 
comparative treatment group and a combined treatment group. 
468 participants would therefore be required to detect an effect size of 0.3 
with statistical significance at the 5% level for a full-scale randomised 
controlled trial of this pilot.   
While the pilot study observed a post randomisation attrition rate of zero, 
it is good practice in research to allow for 10% loss due to attrition, the 
sample size would be inflated by an anticipated attrition rate of 10%.  468 
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/ 0.9 = 520 participants, this would allow 130 in each of the four trial arms.  
520 participants would therefore be required for recruitment and random 
allocation to one of the four trial groups within a future full scale RCT. 
If the cohort recruitment design with nested RCT were to be adopted for 
the full scale study, based on the pilot study conducted, these numbers 
would need to inflated by 30%, as 30% of the participants who consented 
to the study failed to return their baseline questionnaire or subsequently 
left the study, therefore: 520 / 0.7 = 743.  This would allow for recruitment 
to the cohort and for the loss of participants during the first three month 
time period, prior to randomization to the RCT, as seen for this pilot and 
described in section 5.2.4 and 5.2.5. 
30% of the cohort participants in the pilot were also ineligible to enter the 
nested RCT at the three-month time point due to a low score on the 
RMDQ, as they did not score the entry threshold of 4.  If the design 
remained the same and a minimum RMDQ score was not applied to cohort 
entry, then a further 30% (743 / 0.7 = 1061) inflation of participants would 
be required to allow for participants in the cohort being ineligible for the 
RCT.   
Therefore, based on the information derived from this pilot and utilizing 
the same study design, a target of 1064 participants would be required for 
recruitment to a future cohort study in order to achieve a target of at least 
520 of those participants entering, and 468 completing the nested RCT.  
• 468 / 0.9   = 520   
• 520 / 0.7  = 743  
• 743 / 0.7  = 1064 (1061 round up to full group numbers) 
Therefore a sample size of 1064 participants would be required for a full-
scale study of this pilot. 
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5.5.2.1 Interaction and additive effects 
A future full-scale trial with a factorial design is unlikely to be planned to 
test for interaction and / or additive effects of the assessed treatment 
interventions, due to the considerable increase in sample size required.  
These numbers are shown below for illustrative purposes. 
Interaction: (also known as effect modification) occurs when the 
effect of one variable (intervention) on an outcome is modified 
according to the level of a second variable (intervention) (Altman 
and Bland, 2003). 
Additive effects: occur when two factors or variables 
(interventions) have an additive effect on each other, adding to 
the others outcome of effect, without interaction. (Small, Volpp 
and Rosenbaum, 2011) 
To test for interaction and additive effects then the RCT sample size would 
need to be inflated by a further multiple of 4, to power the study to 
effectively. 
• 520 x 4     = 2080 
If nested within a cohort design, based on the findings of this pilot, further 
inflation of 30% to allow for a cohort design and to account for loss pre 
randomisation. 
• 2080 / 0.7 = 2971 
Additional loss when recruitment from the cohort to the RCT for 
randomisation, thus a further inflation of 30% would be required to 
account for ineligibility within the cohort prior to entry into the RCT 
• 2971 / 0.7 = 4245  (full-scale sample size calculation) 
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Therefore 4245 participants would be required for a full-scale study of this 
pilot for the additional power to test for interaction and additive effects of 
the interventions. 
5.6 Projected full scale study calculation 
Based on the pilot study results to achieve a cohort participant rate of 1064 
(section 5.5.2) for a future full-scale study, a more extensive trial 
infrastructure would be required:  
GP recruitment:   
A future trial would require inviting 20 – 25 GP practices to allow for the 
successful recruitment of at least 15 of those practices. The number of 
registered patients would need to be in excess of 262,703 across 9 
practices, if a similar identified eligible patient rate of 2.7% and a 
participant response rate of 15% was projected, to achieve the number of 
participants required.   
From the information gained from the pilot, a mail out to at least 7093 
patients would be anticipated to achieve the required 1064 participant 
numbers, over a six to nine month time period. 
Physiotherapy recruitment:  
On the basis of recruiting physiotherapy practices similar to the one in the 
pilot study, if each physiotherapy practice had three physiotherapists, (at 
least two of whom were qualified to practice acupuncture) and each 
practice being able to receive and treat 84 participants: nine physiotherapy 
practices would be required for a future trial.  However as was the case 
with the physiotherapy practice in the pilot it is anticipated that the 
physiotherapy practices would be able and willing to accommodate 
additional participants, the pilot physiotherapy practice reported being 
available to accept at least 135 participants over the course of this trial and 
they were a relatively small private practice.  On the basis of the 
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information provided from this pilot, five – six physiotherapy clinics 
would need to be recruited for a future trial. 
Therefore 15 physiotherapy practices would need to be contacted and 
invited to achieve the successful recruitment of five to six.  I anticipate that 
at least two of the recruited practices would be NHS outpatient clinics to 
provide a balance of NHS and private practice input into the study.   
Participant recruitment:   
Alongside GP database recruitment, local advertising of the trial should be 
considered including notices at private clinics, local groups and sports 
centres to access those individuals who do not report their LBP to their 
GP.  This would provide further information regarding the population 
suffering with LBP and provide guidance on the extent of under reporting 
that occurs within society (Papageorgiou, 1991). 
Additionally to achieve a participant sample more ethnically and socially 
diverse and in line with the UKs general population, a multi-regional trial 
would need to be considered, using at least two regions of the UK (e.g. 
York and Leeds), this would allow for a potentially more inclusive 
participant population.  
Recruitment from cohort study to nested RCT:   
A 65% recruitment rate from the cohort to the treatment trial is a useful 
figure for informing future studies.  It is also a significantly high rate of 
recruitment comparative to the observed recruitment of two previous 
studies of between 12 – 15%, who also used GP database recruitment 
methods but recruited directly into their trial (Cox et al. 2010, Reynolds et 
al. 2008).  An even higher rate of trial recruitment may also have been 
achieved if the 30% of the cohort who were ineligible for the study had 
scored higher on the RMDQ, the consideration of having a minimum entry 
level of the RMDQ to the cohort for a future study may aid a greater cohort 
to nested trial recruitment rate. 
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Box 5.1: Summary of key study findings 
Key findings 
• The design was effective for recruiting particiapants from 
GP to the cohort study 
• The design followed a novel methodology and the cohort 
was useful for recruiting participants from to the nested 
RCT 
• Consent and intervention acceptance rates were 97% 
• This observational cohort study with a nested factorial 
RCT demonstrated zero attrition post randomisation 
• This design with factorial RCT was appropriate for 
evaluating acupuncture and manual therapy for LBP 
• The outcome measure tools were appropriate for LBP  
 What this adds to what is known:  
• The design has not been previously used in the study of 
LBP and is an appropriate design for this population  
• Acupuncture and manual therapy can be combined by 
physiotherapists safely; it is achievable and potentially 
effective in combination 
• Participants willingly accept acupuncture and manual 
therapy as interventions for LBP 
 What is the implication, what should change now:  
• When evaluating novel interventions in chronic 
musculoskeletal problems, trials should consider using a 
cohort design with a nested factorial randomised 
controlled trial 
• Cost effective delivery of combining interventions should 
be considered to reduce cost to the NHS 
(Dascanio, 2015d) 
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5.7 Summary 
The aim of this study was to conduct a pilot study to investigating the use 
of a novel trial design; an observational cohort study with a nested factorial 
randomised controlled trial, for a population suffering from LBP. The 
methodology of a cohort study with a nested RCT for participant 
recruitment would be focused upon.   
The pilot study recruitment and attrition rates and the acceptability of 
acupuncture and manual therapy as a treatment for people with LBP were 
the key objectives.  The results of the study have been presented within 
this chapter and the design was found to achieve the objectives of the 
study.  
With the sample size and the study not planned to establish effectiveness 
differences, the differences noted in the study are small to moderate, 
however on a larger scale we would expect to see further differences across 
the groups and analysis.  
Discussion of the above results analysis and the pilot RCT are presented 
in chapter six. 
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6 Discussion of the Pilot Study 
6.1 Introduction 
In this chapter I discuss the pilot study (chapter four) and the results 
presented in chapter five.  I consider the aims and objectives of the study 
and how these were achieved.  I review the results presented and discuss 
the strengths and weaknesses of the pilot study design. 
The aim was to conduct a pilot to investigate the use of an observational 
cohort study with a nested factorial RCT methodology, for evaluating 
acupuncture and manual therapy for LBP.  Recruitment, retention and 
attrition rates and the acceptability of acupuncture and manual therapy as 
a treatment were the key objectives for the study and these will be 
discussed further as part of this analysis.  Conclusions will be formed, 
discussing any implications for a future full-scale trial. 
The reporting of data for this study constitutes the data from 
commencement of the study to the six-month data time point and will 
inform this discussion.  Data beyond the six-month time point is outside 
the remit of this PhD and does not form part of this thesis. 
6.2 Recruitment 
6.2.1 General Practice (GP) recruitment 
Of the five GP practices invited two were recruited over a four-month 
period.  The recruitment of the GP practices was conducted via email, mail, 
telephone and face-to-face meetings and the time taken to recruit the two 
GP practices took nearly as long as recruiting the participants to the study.  
The delays in GP recruitment occurred in part due to unavailability of 
required personnel, changes in personnel during the process and 
administrational requirements of the NHS organisations.  The paperwork 
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involved in the GP recruitment, recording of patients contacted and those 
recruited was time consuming and working towards an automated 
recording system for a larger trial would be preferential. 
As discussed in section 5.6, inviting between 20 – 25 GP practices and 
recruiting a minimum of 15 GP practices would be required for a full-scale 
study.  The planning for the logistics of this and setting a time frame for 
recruitment would need to be factored into the planning of a future study. 
6.2.2 Physiotherapy practice recruitment   
During the recruitment process one physiotherapy practice was recruited 
to this pilot trial.  At the time of recruitment, the single physiotherapy 
practice employed eight physiotherapy staff at the practice, five were 
acupuncture trained, providing a variety of physiotherapy clinicians to 
accommodate all the potential trial participants.  Though only one practice 
was recruited the staffing levels were considered sufficient for the pilot 
trial.   
Subsequently however by the time of the commencement of the trial 
interventions, the practice faced some unexpected external contract 
changes and staff redundancies, leaving three staff members remaining, 
two that were able to practice acupuncture. Though this was a relatively 
small number of therapists and a greater number would have been 
preferable, having three therapists did reduce the risk of the results being 
dependent upon a single therapist's expertise and any practitioner effect 
bias would have been eliminated.   Therefore, it was determined at this 
stage, that this was still adequate to accommodate the trial participants for 
the purpose of this pilot study. 
For a full-scale trial a greater ratio of physiotherapy staff would be 
intended, desirable and best practice to deliver the interventions.  It is 
important to have more than one physiotherapist to deliver the trial 
interventions to eliminate any risk of the results being dependent upon a 
practitioner or therapist effect and the introduction of bias.  
289 
 
The recruitment of more physiotherapy practices to limit the effects of any 
staff changes at the private practices impacting on the trial would be 
planned.  It would also be appropriate to use both NHS and private practice 
physiotherapy services for a future full-scale study to more closely reflect 
societal norms.  Confidence that one could recruit sufficient physiotherapy 
practices can be gained from various studies.  UKBEAM (2004) scaled up 
their feasibility study successfully and used both the NHS and private 
practitioners concurrently for their study of manipulation and exercise for 
LBP.  Vickers et al. (2002) reported acupuncture is widely used in both 
private practice and the NHS.  A mapping survey of acupuncture services 
in the UK estimated four million acupuncture sessions are conducted 
annually, 330 practitioners responded (29% Doctors, 29% 
physiotherapists, 15% nurses, 27% acupuncturists) of these 68% provided 
services in the private setting and 42% practiced in the NHS (Hopton et al. 
2012).  As discussed in section 5.6 having a minimum of five 
physiotherapy practices (with at least two NHS sites) with multiple staff 
in each would be recommended for a full-scale study. 
Additional ethics approval would be needed for any included NHS sites.  
Further consideration of participant logistics (access, parking at NHS sites) 
would need to be considered.  NHS physiotherapists’ may have a 
requirement for additional training, resource provision, available time for 
trial participants and diary availability, (i.e. diary availability for 
rebooking participants at follow-up within one week) due to their often 
overstretched caseloads within NHS sites.  The pilot study only 
demonstrated the successful recruitment of one physiotherapy practice and 
consideration would need to be given to recruit additional practices.  The 
national Primary Research Networks would be a useful resource for 
supporting the recruitment of NHS physiotherapy sites, and advertising 
and direct contact with geographically suitable private practices would be 
planned.  Further discussion of scaling up the pilot study, the recruitment 
of physiotherapists and the inclusion of NHS sites are provided in section 
8.6. 
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6.2.3 Participant recruitment 
Recruitment of participants occurred over a six-month period from the two 
GP surgeries.  This was a reasonable time frame for sufficient recruitment 
of participants to the pilot cohort study.  A greater time frame would need 
to be considered to accommodate a larger scale study and there would need 
to be consideration of the benefit of additional GP practices if it increased 
the recruitment period substantially.  It may be that with a wider 
geographical site and additional physiotherapy practices, more than one 
GP practice and recruitment could be conducted simultaneously.  Only 
having one physiotherapy practice for this study limited the number of 
participants that could be admitted at one time. 
6.2.4 GP database recruitment 
The difference between the total of identified potential participants across 
the two recruited GP surgeries was notable.  GP practice one; with a greater 
population of 17564, yielded 275 (1.6%) potentially eligible LBP 
participants in their search, whereas GP practice two with a significantly 
smaller population of 13538 identified 570 (4%) potentially eligible LBP 
participants. There was a distinct difference between the percentages of 
recruitment of participants with LBP between the two GP practices at with 
the smallest practice generating a significantly greater number of potential 
participants.  2.7% of patients on the total GP databases were recorded to 
have LBP. 
Further consideration as to whether this was due the GP database software 
systems and their algorithms to identify potential participants or whether 
the characteristics of the population of the practice differed are unclear 
from this small sample.  An exploratory investigation to gain knowledge 
and understanding of the identification process of all the GP database 
systems in the area would be useful to inform future researchers, to enable 
the maximisation of results from this recruitment model.  It would enable 
the identification of the most effective systems to utilise, the provision to 
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guide expectations, and also indicate the number of GP surgeries required 
for future recruitment in studies.   
The divergence in numbers identified across the two practices may also 
have been due to the differing demographics of the population in each GP 
region reporting LBP.  There is little to suggest any differing demographics 
of the York regions used or any vast difference in the cultural norms.  
However due to the demographics of the York region there was generally 
limited cultural diversity amongst the participants within this pilot study.  
Extending the region would need to be a consideration for a full-scale trial, 
to ensure the trial population is representative and generalisable to the 
whole of the UK.   
Additional examination of the area demographic facilities may have been 
of value prior to the study.  Demographic factors may have influenced the 
numbers of participants reporting LBP to their GPs.  In some area’s 
patients may seek private treatment directly or have access to a direct 
access to physiotherapy via a self-referral pathway without ever consulting 
their GP regarding their LBP.  The presence of an effective private 
therapist in the region or direct access to physiotherapy may influence 
reporting processes and conversely these services may not be available in 
some areas.   
As discussed in chapter one, LBP is a vastly under reported condition with 
only approximately 20% of sufferers reportedly consulting their GP 
(Papageorgiou, 1991).  More recent epidemiological data on the reporting 
of LBP to a GP is presently unavailable, a UK National Pain Audit was 
published in 2012 (Price et al. 2012) but no further information on GP 
reporting rates was provided.  It may be that LBP is significantly under 
reported at some GP practices compared to others.  Recruitment of 
participants via other methods, through advertising, employers and from 
other local therapists would need to be a consideration.  Further 
demographic planning and discussion would aid and inform a future study.   
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6.2.5 Recruitment rates of participants to the cohort form GP practices 
Participants consenting 
An initial response rate to the cohort from the invited participants was 15% 
for this study of those invited.  125 patients of an invited 845 returned the 
consent forms.  This was broadly in line with and anticipated response rate 
of 12 – 15% previously observed in two studies using similar GP database 
recruitment methods.  One study recruited to a yoga trial for LBP (12%, 
994 of 8638) (Cox et al. 2010) and another recruited to an acupuncture trial 
for irritable bowel syndrome (15%, 247 of 1651) (Reynolds et al. 2008).  
Participant returning baseline questionnaires:   
Following consent, 88 of the 125 consented patients returned their baseline 
questionnaire, providing a response rate of 70% of those who had agreed 
to be in the study.  
A 30% loss of potential participants at this stage of the study was 
disappointing, but this was an intrinsic part of what the design was planned 
to advise.  Having the consenting process and the baseline questionnaire 
completion as separate mail outs would have allowed for drop out prior to 
any substantial work being completed by the researchers or participants 
and thus may be preferable in a future trial. Attrition within trials is poorly 
reported (Dumville et al. 2006) and previous trials reporting attrition in 
their trial generally report it at each data collection period, there is no data 
available to guide the figures of attrition rate between the consent process 
and completion of the initial baseline questionnaire.  The breakdown of 
figures for this early dropout rate information is currently unavailable from 
other studies and maybe useful data to collect to inform future study 
planning. 
Due to the limited resources of this PhD, participants not returning their 
baseline questionnaires were not followed up or entered into the cohort.  
While with greater resources this may be a consideration, one of the key 
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elements considered for this study was attrition.  Having a multi-layer 
administrational process for entry to the study may inadvertently cause 
those who would have left the study at a later date, to leave earlier, due to 
the effort required to complete the questionnaires.  It could be considered 
that chasing participants to enter the study at this early stage may not 
actually be beneficial to a study in the long term, in regard of attrition and 
their long term commitment to the study. 
Participants returning three monthly questionnaires:   
At the three-month time point 100% of the 87 participants who were sent 
their three-month questionnaires, returned their questionnaires fully 
completed.  The 100% response rate is suggestive that the study design, 
methods and paperwork were appropriate for achieving a reduction in 
attrition.  This further validates the previous point with the early multi-
layered recruitment producing early attrition in the pre-randomisation 
phase of the pilot and the participants remaining showing long-term 
commitment. 
In this nested study design, this is the time point at which the cohort 
participants became eligible to enter the RCT, thus providing the run in 
period within the recruitment process.  Potentially making it a very valid 
design methodology for the recruitment of conforming, committed 
participants. 
Recruitment rate of participants from the cohort to the nested RCT 
A 65% recruitment rate from the cohort to the treatment trial was achieved 
for this pilot, which demonstrates the nested design as being a highly 
effective recruitment model for this RCT.   However any additional 
increase in potential cohort recruitment was significantly limited in this 
study by the number of participants who scored less than four on the 
RMDQ.  Rendering them ineligible for the nested treatment trial.  The 30% 
loss of potential participants at this later stage was greater than anticipated, 
regression to the mean would have occurred demonstrating significant 
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levels of individuals with mild LBP as is evident in society as discussed in 
chapter one. 
The intention of this cohort design was to provide a pool of potentially 
eligible participants.  It is surprising such a significant proportion (30%) 
failed to achieve the entry requirement of the nested RCT.  It may be a 
consideration to have a minimum entry requirement of RMDQ baseline 
score to the cohort study in addition to the nested RCT.  This would assist 
in preventing a repeat of such a high total of ineligible participants within 
the cohort study.  Alternatively lowering the eligibility level to be inclusive 
of participants suffering with low levels of LBP may need to be 
considered, though this would reduce the value for money of improvement 
as the participants would have less pain.  Thus a separate study of mild 
LBP may also be indicated. 
It is of interest that the participants ineligible for the nested RCT 
demonstrated a significant proportion of the study population (30%).  
These participants considered their LBP significant enough to enter a 
research study but only scored between 0 – 3 on the outcome measurement 
tool (RMDQ).  The mean RMDQ score for those who remained in the 
cohort for the duration of the study was 1.8.  Were this proportion of 
ineligible individuals reduced through a redesign, the sample size would 
not require such over inflation (see section 5.6). 
This study uncovered significant numbers of participants with low levels 
of LBP.  Further investigation to ascertain knowledge of these individuals 
would be useful.  Are members of society functioning with low level LBP 
that impact upon them?  Or is the RMDQ not sensitive enough to measure 
and report the significance of LBP in its totality?  Does LBP have a greater 
impact on everyday life than we currently understand or are able to 
measure?  These are all areas that would aid knowledge of LBP as a 
condition and facilitate research into the area.  With additional knowledge 
using a comparable research design methodology for a future study may 
provide solutions to these questions.  It may be possible in a future planned 
study to have an additional RCT within the cohort to investigate 
295 
 
characteristics and appropriate interventions of those with low levels of 
LBP.    
The study’s conservative sample size target of 16 - 20 participants per 
group (total sample size 64 - 80) was not achieved.  This was primarily 
due to the significant loss of participants prior to randomisation from the 
cohort study (who were ineligible for entry into the trial due to a score 
below four on the RMDQ), so limiting the potential pool of eligible 
participants from the cohort and the trial numbers. 
6.3 Consent and acceptance rate of interventions   
124 /125 (99%) participants consented to participate in both the cohort 
study and nested RCT.  Demonstrating a high consent and acceptance rate 
to the study. 
Of the 124 patients that expressed an interest in being offered one of the 
trial treatments, only three people expressly stated they would not consider 
one of acupuncture or manual therapy, indicating a high level of 
acceptability of the treatments (97%).   
The three participants who were selective regarding their treatments were 
still able to be randomised and remain in the study, they were just 
randomised to either usual care or acupuncture, or usual care or manual 
therapy, depending upon which they consented to.  As previously stated, 
these participants were excluded from any comparator analyses between 
acupuncture and manual therapy (alone or in combination).  
All participants allocated to an intervention completed their course of 
treatment, delivering a 100% attendance rate and demonstrating a very 
high level of treatment acceptance.  It would be of interest to assess if a 
high attendance rate would be repeated with treatments based within an 
NHS physiotherapy department.  It may be possible attendance was higher 
than expected due to participants holding a high valued opinion of the 
private practice locally and / or knew and valued the cost of the treatment 
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they were receiving.  Delivery occurring within a private physiotherapy 
practice setting may have impacted attendance (with convenient access, 
free parking etc.) or it may have been the design methodology of simply 
nurturing attuned participants.  Further consideration and investigation 
should be afforded to this area. 
The physiotherapists were able to deliver the appropriate interventions to 
the participants and were able to combine acupuncture with manual 
therapy for the combined intervention arm for 100% of the sessions 
required.  Demonstrating the ability of physiotherapists to be able to 
combine the interventions safely and deliver them.  This has the potential 
to save the NHS time and money through the provision of combined 
interventions in the future.  
6.4 Attrition rates, pre and post participant randomisation 
One objective of this cohort study with a nested RCT design was to try to 
limit attrition and resentful demoralisation as far as possible in the early 
stages of the study.  Through the multiple consenting layers and the run in 
period of the cohort (described in chapter four) occurring prior to 
randomisation to the treatment trial, it was anticipated the majority of 
attrition would occur prior to participants entering the nested trial. 
As previously discussed in Chapter three (3.3.4) attrition rates are poorly 
reported in RCTs.  Some reports have suggested that attrition can be 
estimated between 4 – 28% (Hewitt et al. 2010) and 7 – 67% (Dumville et 
al. 2006; Leon et al. 2006) with the majority of attrition within an RCT 
suggested to occur during the first of the follow-up periods (MRC/BHF, 
2002; Klaber-Moffett et al. 2006).  Therefore, due to the three-month ‘run-
in’ period of this cohort study it was anticipated that attrition subsequent 
to randomisation in this trial would be minimal.   
The initial up take and consent to the cohort study was very favourable at 
15% of the GP mail-out.  The second mail-out of the initial baseline 
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questionnaire saw a 30% attrition rate to the study, which was substantial 
at this stage. 
Initially participants considered a letter, information sheet and signed a 
consent form, a relatively modest activity level.  However on receiving the 
more arduous task of completing the initial baseline questionnaire 12 page 
booklet, some may have considered this to be extensive or did not have the 
time to commit to its completion.  It may be that completion of the initial 
baseline questionnaire would be more appropriately completed at the time 
of consent, so potential participants were aware of the level of input 
required and able to make an informed decision.  It may be that the 12-
page case report form questionnaire is too extensive and would need 
consolidating for a full-scale study.   
Though a sizeable attrition rate was seen initially, the attrition occurred 
before the participant or researcher on the study completed any ‘substantial 
work’.  This could be considered a positive time for participants to leave 
the study if they were likely to drop out subsequently at a later stage.  
However, such extensive attrition was unusual at this stage, and did reduce 
the number of available participants quite considerably for this pilot study.  
If the trial design were to remain unchanged an inflation of any future 
sample size would need to be considered to account for this stage of 
attrition.  
The dual mail-out consenting process was an unplanned change to this 
study, introduced as a condition of the ‘York and Humber Ethics 
Committee Review Board’, at the ethical review of the study.  The 
committee considered it potentially confusing for participants to receive 
information at the initial contact point regarding the cohort study and the 
nested RCT.  They advised separate information sheets and mail-outs; 
which were hence incorporated into the induction process. 
It may have been that this dual consent process led to early attrition due to 
participant confusion and possibly a lack of managing the patients’ 
expectations.  Alternatively the additional information provided to them 
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with the second information sheet and questionnaire may have allowed 
them to make a more informed decision on their non-participation.  No 
data or information from the participants was collected on this, to gain 
feedback for participant reasons for not wishing to participate in the study.  
Further investigation into early participant attrition may be useful 
knowledge to gain and to consider the opportunity for feedback being 
designed into the methods of a future trial.  The process of consent for this 
study would require redesign and consideration to ensure consented 
patients are fully informed of the study requirements and expectations, 
prior to launching a full-scale study. 
Attrition between the second consent phase and randomisation for the RCT 
was extremely low at 1% for this study, with only one patient withdrawing 
from the trial completely and one patient requesting to remain in the 
cohort.  The additional level of the consenting process may have increased 
early attrition or perhaps brought attrition that would have occurred later 
forwards within the process.  If it were the later, this provides valuable 
information into the necessity of a cohort study or run in period being used 
within studies to minimise participant attrition.  An alternative future trial 
design methodology maybe to consider the incorporation of additional 
levels or separating paperwork into separate mail-outs to function in the 
facilitation of early attrition prior to actual recruitment or randomisation.  
Such a methodology may reduce the need or additional cost and time of 
using a nested cohort study or a trial run in period. 
6.4.1 Zero attrition:   
A low (in this case zero) attrition rate post randomisation is a significant 
and aspirational result for this study.  Achieving such low attrition within 
research studies maybe unrealistic on a larger scale, however working 
towards it would provide more reliable results, improve the validity of 
trials and reduce bias within studies.  It would also significantly reduce the 
overall cost of research, aiding funding for future studies.  
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Zero attrition and 100% response rate of paperwork (with 95% completion 
rate) and attendance post randomisation demonstrated the effective 
methodology and appropriate design for this study.   
Such a low attrition rate post randomisation was not predicted and provides 
useful information on a desirable and valid design for future investigations 
and compares extremely favourably with other back pain trials.  For 
example, three trials (UKBEAM, a CBT trial for low back pain, and a trial 
of yoga for low back pain) had attrition rates of 25%, 22% and 13% 
respectively (UKBEAM, 2004; Lamb et al. 2010; Tilbrook et al. 2011); all 
of these exceed the upper 95% confidence interval limit of 6% for attrition 
(Dascanio et al. 2014). 
6.5 Baseline characteristics of the participants 
Differences were seen in baseline characteristics of the participants in this 
pilot study, which would not be expected in a larger full-scale trial.  
Identifying such a difference in female to male ratio between the groups 
was unusual following randomisation, however such imbalances are not 
unexpected with a small sample size.  There were a significantly greater 
number of females than males across the whole study and within each trial 
arm.  It is documented that females are more likely to enter trials than their 
male counterparts (Kennedy-Martin et al. 2015).  This may have 
contributed to the overall higher proportion of women in this pilot.   
The age demographic of the pilot study had a mean score of 46.4 in the 
study, which appear to be in-line with the age demographic of individuals 
who suffer with LBP and those who enter trials (Nordeman et al. 2016; 
Kennedy-Martin et al. 2015). 
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6.5.1 Baseline characteristics for RMDQ and MODI 
The baseline score for the cohort participants was significantly lower than 
that of the nested RCT for both the RMDQ and the MODI.  This was 
primarily due to the minimal entry score of four for the nested RCT.  It 
was not anticipated that a minimal entry score for the cohort study would 
be a requirement, as participants who scored zero; one or two on the 
RMDQ were not expected to wish to enrol in a study of LBP.  However 
many participants scoring less than four enrolled in the study and further 
consideration needs to be given as to why this occurred.   
The RMDQ measure records a participant’s symptoms on the day they 
complete the questionnaire and it may be for some that on that day their 
back was less symptomatic, or it may be that the RMDQ may not have 
been sensitive enough to measure what the participants consider LBP 
symptoms that are significant to them.  These need exploring further. 
A full-scale study may wish to incorporate a minimum entry level score of 
participant to the cohort study, or may wish to collect information upon 
this group of individuals who function with low levels of LBP. 
It was observed that those allocated to the usual care group recorded the 
highest RMDQ scores compared to those who had been randomly 
allocated to the active treatment groups.  It was also observed the 
combined intervention group had the lowest scores on the RMDQ and the 
MODI at 7.0 and 19.2 respectively at baseline.  These between group 
variations were random and baseline scores were adjusted for in the 
analysis, therefore the anomalies observed would not have impacted upon 
the study results. 
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6.6 Exploratory regression analysis 
6.6.1 Roland Morris Disability Questionnaire (RMDQ) 
Analysis of the RMDQ scores showed an improvement in all trial arms.  
This might reflect regression to the mean, the placebo effect and/or the 
natural history LBP and not necessarily the effectiveness of any treatment 
modality. The analysis suggested that the manual therapy alone group 
intervention showed greater improvement in symptoms compared to the 
acupuncture alone group and the combined intervention group for the 
RMDQ, though statistical significance was not achieved.   
This pilot study was not powered to detect any interaction or additive 
effects, which may have been occurring within the combined treatment 
group of this pilot study.  A future study is not planned to assess for 
interaction and / or additive effects, however further consideration for 
interpreting interaction effects or additive effects via a regression / 
ANCOVA analysis would need to be contemplated for planning a full-
scale well-powered trial.  The indication from the pilot is suggestive of a 
limited benefit in combining the two interventions studied, however given 
the small sample size this needs to be interpreted with caution, the pilot 
was designed to investigate the practicality of combining the interventions 
within the study and not powered to assess efficacy. 
As previously discussed, (section 4.5) when the RMDQ was developed, 
Roland and Morris (1983) noted that one of the difficulties in conducting 
LBP research, was a lack of suitable outcome measure, and thus they 
developed one.  They developed the RMDQ questionnaire to be short, 
simple, sensitive, and reliable, advocated for its use in future trials.  It has 
become one of the most commonly used LBP measures in research (Longo 
et al. 2010).  
However, in conditions such as low back pain, patients’ symptoms vary 
daily and weekly; a participant could have had seven days of severe pain 
followed by less painful days.  One of the limitations of the RMDQ is that 
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patients complete the questionnaire based on how they feel on that day 
only. With varying conditions of LBP, this may not give an accurate 
reading of a participant’s standard level of back pain over time.  These 
concerns should be consistent across all the randomised groups limiting 
any bias; however it remains a limitation of the questionnaire, regarding 
entry level to trials, adequacy of scoring and accuracy of scores between 
the study time-points. 
6.6.2 Modified Oswestry Disability Index 
The regression analysis of the MODI scores showed an improvement 
across all trial arms, with the manual therapy arm (seeing the greatest 
improvement) and the acupuncture arm achieving improvement over usual 
care.  This was not the case in the combined intervention arm, with no 
improvement over usual care. 
The MODI showed a greater difference in participants in the manual 
therapy arm, however statistical significance was not achieved, and the 
pilot study was not powered to detect this.   
6.6.3 A comparison and analysis of the RMDQ and the MODI outcome 
measurement tools 
There is a requirement for the outcome measures for any trial to be valid, 
reliable and sensitive and both these outcome measures have been shown 
to achieve this within research studies (Morris et al. 2015). 
The participants completed both outcome measures in the pilot and 
appeared happy to complete them (97% completion rates), suggesting it is 
possible for two outcome measures to be used within a trial.  The use of 
two outcome measures may give greater scope to a trial, a primary measure 
would need to be identified however a second measure may aid data 
collection (Streiner and Norman, 2008). 
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While the observations are not inferential in this pilot, both outcome 
measures appeared to perform consistently to each other with no 
significant differences between them, improvements were seen in all trial 
arms by both measures.  The results show some sensitivity to change for 
both measures, but it is not large enough to determine which measure 
should be used over the other.  Using both measures for a full-scale trial 
analysis with a greater sample size would be useful in understanding the 
differences between these measures.  This would be supported by a recent 
systematic review which concluded there was no defining reason to choose 
one of these measures above the other, they both were valid and reliable 
and further high quality research was required to determine any superiority 
(Chiarotto et al. 2016). 
Another study compared the outcome measure results of 11 LBP trials 
(Morris et al. 2015).  Each trial used at least two of the seven identified 
back pain measures in their studies, highlighting the use of two outcome 
measures as a norm.  The study concluded that data gained from different 
outcome measures should not be pooled for meta-analysis due to the lack 
of agreement and differing results between the measures (Morris et al. 
2015).  This has implications for the way trial results can be interpreted via 
systematic reviews and pooling of data for meta-analyses.  The use of two 
outcome measures in all trials may assist in pooling data across studies. 
It would be useful for the research community to investigate and agree 
upon a small set of appropriate outcome measurement tools for LBP. 
Standardising outcome measurement tools would allow for meaningful 
comparisons and a greater capacity of pooling data.  However if the 
evidence base did not support the convergence of practice and consensus, 
then further research may be required before an agreement can be achieved 
(Skrabanek, 2003). 
While I had planned to compare the two outcome measure (RMQD and 
MODI) to assess which would be most appropriate tool for a full-scale 
trial, insufficient data was available from this pilot study.  Any 
observations seen and described (section 5.4.4 and 5.4.5) were from a very 
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small sample of participants and thus the small sample size prevented any 
meaningful analysis.  Specific criteria to compare and analyses the 
outcome measures in a future trial would need to be planned and specified 
in advance of conducting a full-scale study. 
Future research should give consideration to the ability and sensitivity of 
the individual outcome measures to assess the condition being analysed 
and also the interventions being studied.  While extensive research has 
been conducted into the performance of outcome measures, the research 
of outcome measures predominantly focuses upon the patient’s 
experiences and the condition being studied.  Differences may exist in the 
sensitivity of the measures, which make some more suitable or not for use 
with complex interventions.  Further research in this area would add to the 
research knowledge base. 
6.7 Ancillary data 
Completion rate of the SF12, EQ5D, VAS scale and resource use 
questionnaires were good at 85% but were not as high as the RMDQ and 
MODI.  Further consideration would need to be given to the length of the 
12 page questionnaire booklets and if further guidance may be required for 
this to be improved in a future study. 
In the resource use section of the questionnaire some inaccurate data was 
identified, with some individuals indicating the trial intervention sessions 
they had received on the forms.  Future use of this questionnaire would 
require further instruction to participants and clarification not to include 
their trial intervention sessions on the resource use forms thus preventing 
skewing of data. While these individuals were contacted by telephone 
where possible, due to limited resources further follow up was not 
possible, any future study should plan for additional time and resources to 
follow up participants to collect missing data and check any potential 
inaccurate data inputted.  Additionally in the “other sections” on the 
resource use questionnaire, it was repeatedly left blank, if participants did 
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not have any information to input, further participant instruction or the 
option to select ‘none for these’ would considerably reduce the missing 
data in these areas.  Alternatively the research team may discuss and agree 
a plan for recording uncompleted ‘other’ sections in the resource use i.e. a 
box left blank indicating no use of ‘other’ resources.  
A future study would need to have a comprehensive plan for addressing 
missing data and uncompleted sections of the questionnaires including the 
resource use section, time and resources to follow up any missing or 
questionable data. 
6.8 Sample size calculation for a full trial 
Recruitment from the cohort to the nested RCT and the potential of 
participant ineligibility would need to be considered and planned for in a 
sample size calculation of a full-scale trial.  Within this pilot 87 
participants were recruited to the cohort study, but only 57 were recruited 
to the nested RCT due to ineligibility of 28 participants and 4 participants 
not consenting.  This resulted in the study objective of recruiting 16 
participants to each group not being achieved, however the recommended 
minimum of 12 for a pilot study (Julious, 2005) was exceeded in all 
groups. 
Using the factorial trial design with analysis “at the margins” means that 
evidence of efficacy can be obtained from fewer participants than would 
be required if acupuncture and manual therapy were tested individually in 
two independent trials (Finlay et al. 2003).  However, in a full-scale trial a 
greater number of participants would be required to investigate the 
effectiveness of interventions proposed and even more so to test for 
additive effects and interactions between the interventions (see section 
5.5.2.1). 
Trials are notorious for not achieving their recruitment objectives with 
many failing to reach their recruitment targets (Huang et al. 2018), for 
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example; a study comparing acupuncture with conventional therapy, 
conducted and reported their RCT with 186 participants, while reporting 
that a sample size of 380 was required to reach sufficient power 
(Molsberger et al. 2002).  They did not achieve their recruitment aim; thus 
the study’s statistical power and reliability were reduced.  The failure to 
reach planned recruitment is substantial amongst trials, and has significant 
implications to the scientific validity of trial results, as well as consequence 
to the financial, ethical, policy makers and stakeholders of trials.   
A future full-scale trial of this pilot would need to ensure the recruitment 
of sufficient number of GP surgeries and recruitment outside the database 
recruitment model to ensure individuals who did not report to their GP also 
had the opportunity to partake in the study.  A comprehensive plan would 
be needed to ensure the sample size recruitment objective was achieved 
for a future full-scale trial of this pilot. 
6.8.1 Appropriateness of the design for evaluating a population with 
LBP 
The cohort model proved to be an efficient method of recruitment to the 
nested factorial trial, with no post randomization attrition rate in this pilot 
study.  The information from this pilot trial provides a useful knowledge 
for informing a full-scale design and is evidence for further use of this 
design methodology, as it provided a significantly higher rate of 
recruitment comparative to recruitment directly into similar trials. 
Particularly notable is the compliance of the participants recruited to the 
nested RCT from the cohort study.  As discussed, this pilot achieved a high 
response rate and commitment following randomisation.  Indicating its use 
for the recruitment of participants who are compliant for future studies. 
Accomplishing this across RCTs would provide greater accuracy and 
validity of trial results and reduce the risk of errors. 
The study methodology conducted for this pilot differed from original 
nested cohort design proposed by Relton et al. (2010).  In the original 
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Relton design participants are not specifically told about the possibility of 
future treatment options available.  The difficulty of this approach was that 
failure to alert the participants at the outset, may mean a refusal to take up 
the treatment offered later, which might lead to treatment dilution.  In this 
study the possibility of future treatments was presented in the initial stages 
to avoid this problem (Dascanio et al. 2014). 
6.8.2 New findings with this design: 
This was the first time this study design was used for a study of LBP and 
it was seen to be appropriate and effective.  The nature of this nested cohort 
study following participants with remitting and relapsing conditions over 
a period of time, provided two new opportunities not previously 
considered for the recruitment to this pilot study.  These benefits had not 
been described by previous research studies using this design (Dascanio et 
al. 2014).   
Firstly, by including the cohort of low symptom patients we could, if the 
trial had been large enough, have supplemented the randomised analysis 
by including the cohort participants in a regression discontinuity analysis 
(Dascanio et al. 2014).  This would give the opportunity for an analysis of 
individuals more generalisable to the population suffering with LBP, 
inclusive of the whole cohort not just those willing to enter a trial.  Further 
consideration of this analysis would need to be given for a future full-scale 
trial. 
Secondly, using the design for remitting and relapsing chronic LBP 
conditions, allowed some participants, who initially were not eligible due 
to low symptom scores, to become eligible later in the trial, and thus could 
be randomised.  In a typical randomised trial design these patients would 
have been lost from being included in the randomisation and the trial data.  
The ability to recruit participants from the cohort at varying time points 
through a trial may prove beneficial to future trial design to maximise 
recruitment. 
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In this pilot we were able to offer the opportunity to two of the participants 
at their six-month time point, both subsequently joined the trial and were 
randomised for entry into the RCT at six-months.  The time constraints of 
this pilot study prevented further entry into the trial following the 
recruitment deadline and thus the further nine participants who became 
eligible to enter the study at their six-month time point later in the study 
were not able to be admitted. 
Considering this trial design and how the time continuum of recruitment 
could be developed further to include those participants with fluctuating 
conditions should be a priority for research studies.  There is also random 
variation that occurs on a daily basis of the measurements from the 
outcome measures tools, thus participants may be missed.  A possible 
longer term cohort monitoring of the condition prior to the trial to gain 
additional understanding of the nature of the condition would be useful, 
followed by several recruitment time points over an extended time period 
would be beneficial to develop knowledge in this area.  An extended 
follow up may also provide more informed evidence into how to 
effectively manage LBP as a condition in the longer term. 
The nested factorial RCT combined acupuncture with manual therapy and 
this was shown to be an effective way of analysing the interventions, 
assessed on a larger scale, effects of interactions and additive effects would 
also be able to be seen with this model.  
6.9 Strengthens and weaknesses of the pilot study 
The study design was shown to be achievable and effective, however if it 
were to be scaled up there would be additional work and cost for the 
researchers to follow-up the non-randomised cohort.  It is possible that this 
would not be a cost-effective use of research resources unless information 
from the non-randomised group was used. A value of information analysis 
could be used to explore this and inform future decision-making (Claxton, 
Sculpher and Drummond, 2002).  The non-randomised cohort may 
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improve recruitment for the study of LBP, as some patients may become 
eligible who previously were not.  As mentioned in 6.7.1, in a larger study 
the trial based analysis can be supplemented with a regression 
discontinuity analysis, which would improve study inference.  However, 
arguably the resources spent to obtain these benefits may be better used to 
increase the overall sample size of the participants who could be 
randomised.  Consequently, it might be more cost effective to modify the 
design to not follow up the ineligible participants (Dascanio et al. 2014).  
Analysis can be planned to inform the cost benefit of this and aid the design 
of an efficient study (Claxton et al. 2002). 
The limitations of this study mainly occur due to the limited sample size 
and the lack of ability to achieve statistical significance in the data 
collection.  However, this was a pilot study that never planned to be 
powered to detect a difference between the trial groups and thus the results 
were exploratory to inform a full-scale study (Dascanio et al. 2014).   
Another significant weakness of the pilot study was the limited process 
evaluation conducted for the study.  No detailed analysis of the recruitment 
processes, or the fidelity of the participant or therapist journeys of 
involvement in the study was conducted.  The pilot study did not consider 
or provide detailed analysis of the implementation of the trial 
interventions, if any causal mechanisms were occurring, or if any 
contextual factors were at play during the pilot study (see section 8.3 for 
further discussion).  A future full-scale study would need to incorporate all 
of these factors into its analysis, providing a ‘study of a study’ approach 
(Moore et al. 2015; MRC, 2008; Craig et al. 2008) to generate knowledge, 
help interpret the study and inform implementation and future research. 
6.10 Implications 
This pilot study of a cohort design with a nested, factorial RCT, provided 
useful information to inform a future study design for a full-scale RCT.  
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Several aspects from this pilot require further consideration when 
designing a full-scale study, as outlined below. 
Further thought would need to be given as to how to access those potential 
participants in the population who live with the relapsing and remitting 
condition of LBP but do not access their GP.  Investigating the reasons 
why they choose not to report their condition, i.e. possibly due to previous 
experiences, mismanagement of their condition in the past, lack of support, 
access to direct treatment, self-management; this would be useful 
knowledge gain for future research in this field.  
Further consideration would need to be given regarding a minimum entry 
level on the RMDQ for entry to the cohort study, aiming to limit the 
number of potentially ineligible trial participants.  However as discussed 
this would have excluded those participants who became eligible at a later 
time point. An alternative may be to lower the entry-level score to the 
RCT.   Four or more on the RMDQ maybe too high for many individuals 
experiencing LBP, as demonstrated within the pilot. 
Discussion of the need for a cohort model is also required.  If the cohort is 
primarily to be used as a way to reduce attrition, then the inclusion of 
several layers of paperwork may be sufficient to achieve the early attrition 
within the trial.  If the cohort model were to be used as a recruitment tool 
to the trial with participants entering the trial at different time points 
throughout the trial, then it would be a useful to include the cohort as part 
of a future design.  Though adequate consideration would need to be given 
to the cost and additional workload it would add to a trial. 
Using this research design in large treatment trials of interventions for 
musculoskeletal conditions would be recommended from this pilot study 
(Dascanio et al. 2014). The most appropriate methodological design 
should be considered e.g. a factorial trial design, for investigating complex 
interventions.  The comparison of treatment interventions with one another 
and in combination in research studies may be an opportunity to find 
advancement in the management of LBP.  This study design has the 
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potential to aid the establishment of preferential treatments and guide any 
additional benefits of offering additional or combined treatments for LBP 
(Gleiss, 2017). 
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7 Systematic Review: Acupuncture Versus Manual 
Therapy for LBP 
7.1 Introduction 
Thus far I have discussed the impact of LBP upon society and reviewed 
the international guidelines and the NICE guidelines in the UK, identifying 
the need for further RCTs.  I have identified limitations and bias within 
RCT designs and proposed a pilot cohort with nested factorial RCT study 
design for a study of acupuncture and manual therapy.  I have conducted 
the study, informed by a review of literature undertaken in March 2010.  
The results of the pilot study have been presented and discussed in chapter 
five and six of this thesis. 
In this chapter I will present a systematic review and meta-analysis 
conducted in July 2017, which builds on and extends the review of 
literature in chapter two.  Following the results of the pilot study presented 
in chapter five and discussed in chapter six, there is an indication for 
further study in this area.  Prior to conducting a full-scale study, 
undertaking a systematic review to provide the most current evidence base 
available to inform a trial is indicated and would be considered best 
practice.   
7.2 Indication for a systematic review 
A lot of research is being published and systematic reviews are 
fundamental tools for aiding clinicians, health care providers and policy 
makers to remain up-to-date and implement best practice.  Systematic 
reviews allow evidence to be summarised accurately and reliably and are 
more easily accessible to clinicians and policy makers in times of limited 
resource (Grimshaw et al. 2012; Liberati et al. 2009).  Systematic reviews 
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have been suggested as a vital mechanism for getting research into clinical 
practice (Carrasco-Labra et al. 2015). 
Furlan et al. (2005) suggested that the use of acupuncture as an adjunct to 
other interventions for chronic LBP should be considered.  A recent review 
of systematic reviews of acupuncture for LBP supported this view stating: 
“Systematic reviews of variable quality showed that acupuncture, 
either used in isolation or as an adjunct to conventional therapy, 
provides short-term improvements in pain and function for 
chronic LBP.  More efforts are needed to improve both internal 
and external validity of systematic reviews and RCTs in this 
area.”  
(Liu et al. 2015) 
A study of acupuncture and manual therapy interventions and their 
combination for LBP would be a useful addition to the current research 
knowledge base and perhaps provide some clarity on the efficacy of 
acupuncture and combining interventions as a method to alleviate the 
chronic issue of LBP within society. 
From previous searches I have conducted, it is clear that RCTs combining 
acupuncture and manual therapy in a factorial design or other design do 
not currently exist (other than the pilot study for this thesis).  While this 
lack of evidence is suggestive of the need for a new study alone, it remains 
important to fully review all literature systematically comparing 
acupuncture and manual therapy for LBP as a measure to fully inform any 
future study.  
Adding to the knowledge base for the treatment and prevention of LBP 
would aim to inform improvements in care and a reduction of LBP, 
potentially saving societies in the UK and internationally.  There remains 
considerable deliberation as to whether acupuncture is effective and cost 
effective provision for the treatment of LBP.  The research currently does 
not conclusively guide policy makers and is open to interpretation, as was 
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evident from the variation in clinical practice guidelines discussed in 
chapter two.  
The UK NICE LBP guidelines (2009) recommended acupuncture and 
manual therapy (amongst other interventions), however the updated NICE 
LBP guidelines (2016) removed the recommendation of acupuncture 
citing lack of robust evidence (discussed in chapter two).  NICE’s decision 
was in contrast to the American guidelines, who recommended 
acupuncture and other interventions as first line treatments in favour of 
medication, to the updated LBP guidelines  (Qaseem et al. 2017).   
Completing a systematic review comparing acupuncture with manual 
therapy for the treatment of LBP would provide an understanding of the 
scope of the current evidence base.  Its aim was to investigate the most 
effective and potentially cost effective method of the two treatments for 
LBP, understand any uncertainties and gain insight into previous study 
designs and recommendations.  It would also be intended to add the results 
of the pilot RCT conducted for this thesis into a meta-analysis to view a 
larger data set to investigate if any further insight can be gained. 
In addition to informing a future study, the results of this systematic review 
would aim to provide a focused conclusion to aid practising manual 
therapists (i.e. physiotherapists, osteopaths, chiropractors), acupuncturists 
and health-care decision makers in guiding funding and treatment selection 
for individuals with LBP (Manheimer, 2012). 
The aim of this systematic review was to determine the strength of 
evidence for a recommendation of acupuncture and manual therapy for 
LBP for the benefit of patients and policy makers. 
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7.3 Objectives 
The objectives of the systematic review were: 
• To determine the effectiveness of acupuncture versus manual 
therapy for LBP 
• To determine the availablity of literature for acupuncture and 
manual therapy for LBP 
7.4 Methods 
This systematic review was conducted based on the Preferred Reporting 
Items for Systematic reviews and Meta-Analysis (PRISMA) Statement 
(Liberati, 2009) to ensure the provision of transparency and completeness, 
of the reporting of the review and meta-analysis.  It also used GRADE  
(Grading of Recommendations Assessment, Development and evaluation) 
a transparent framework to develop and present a summary of the 
evidence, establish the strength of the evidence and to propose a systematic 
approach to clinical recommendations (Schümenann, 2013; Guyatt et al. 
2013; Guyatt et al. 2011).   
This systematic review included a PRISMA flow diagram, figure 7.1 and 
aimed to ensure it was reproducible and provide confidence in the results.  
The study criteria were established in advance and followed a protocol 
(appendix E0) (however the SR protocol was not registered with 
PROSPERO or published prior to commencing the review); the recording 
of all decisions with explanations was conducted at each stage of the 
review (appendix E). 
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7.4.1 PICOS study inclusion and exclusion 
The inclusion of published studies was based on the requirement to fulfil 
the following PICOS criteria for selection: 
• Population: People suffering low back pain 
• Interventions: Acupuncture and manual therapy 
• Comparators: Acupuncture vs manual therapy with or   
•   without an additional control group 
• Outcome:  Reduction of pain, improvement in function 
• Study design: Randomised controlled trials 
(GRADE, 2013. Stone, 2002) 
Population: 
Age demographic: As per the protocol, studies of adult participants of all 
genders aged between 18 - 65 years with a diagnosis of ‘non-specific’ LBP 
were included, however in a deviation from the protocol the age 
demographic was expanded (as detailed below) due the revisions of the 
NICE guidelines. 
LBP is less common in people below the age of 18 and the management 
of children with LBP differs from the adult population, it would be 
inappropriate to review these two population sets together.  However, 
within the time frames of this thesis the recent NICE LBP guidelines 
(2016) updated their parameters to consider individuals from the age of 16 
years within their guidelines and thus any future planned study would 
follow the NICE guideline format.  Therefore, in a deviation from the 
protocol for this systematic review, any studies inclusive of an age range 
from 16 years were considered and included.  Studies of those below the 
age of 16 years were excluded.     
Individuals over the age of 65 years are more likely to suffer from serious 
spinal pathology and co-morbidities that may affect their response to low 
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back treatment (UKBEAM, 2004) and thus would be inappropriate to 
consider.  The updated NICE LBP guidelines (2016) however, considered 
individuals above the age of 65 years.  Any future planned study would 
follow the NICE guideline format, therefore in a deviation from the 
documented protocol for this systematic review, any studies inclusive of 
individuals above the age of 65 years were considered; conditional to the 
provision of information outlining their age range and any serious spinal 
pathology or comorbidities suffered.  Studies of those over 65 years were 
excluded if serious spinal pathology or comorbidities impacted upon the 
study group or if serious spinal pathology or comorbidities were not 
reported. 
Non-Specific LBP: Studies where a diagnosis of ‘non-specific’ LBP of the 
population was determined by a General Practitioner (GP) or other 
healthcare practitioner (Physiotherapist, Osteopath, Chiropractor, Nurse 
practitioner) only were included to ensure appropriate screening had been 
conducted and an accurate diagnosis determined. 
‘Non-specific’ Low Back Pain; = a musculoskeletal problem, not 
attributable to a specific pathology (Milczarek, 2009). 
Specific LBP: Studies where a diagnosis of ‘specific’ LBP of the 
population was determined by a General Practitioner (GP) or other 
healthcare practitioner (Physiotherapist, Osteopath, Chiropractor, Nurse 
practitioner) were excluded.   
‘Specific’ Low Back Pain: = infection, cancer, rheumatic disease, 
osteoporosis, post-operative or nerve root involvement. 
(Milczarek, 2009) 
Studies not specifying the type of LBP studied were excluded, unless the 
reviewers could establish the LBP type from the reported information. 
Time frame: Trials investigating any one or more of acute (one to six 
weeks), sub-acute (six to twelve weeks) and chronic LBP (more than 
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twelve weeks) (Milczarek, 2009) were included, to be representative of the 
population of LBP sufferers. 
Following these criteria ensured greater external validity of this review 
than the planned protocol, and enabled the study to be generalisable to a 
population between the ages of 16 – 65 years or older without 
comorbidities who suffer with non-specific LBP. 
Interventions and Comparators: 
RCTs comparing the use of acupuncture with manual therapy for the 
treatment of LBP were selected for this review. 
Both the acupuncture and manual therapy interventions in any selected 
studies were required to be conducted by a suitably qualified health care 
professional, trained in their respective field.  Each intervention would act 
as a control to the other, with or without an additional control group. 
Acupuncture was restricted to ‘real acupuncture’ defined as the insertion 
of an acupuncture needle into specific acupuncture points (WHO, 2002).  
The style of acupuncture was not limited for this review to ensure 
completeness of trial information.  If more than one type of acupuncture 
or two acupuncture arms was studied, they were included if an appropriate 
comparator arm was also apparent.   
Studies of acupuncture with non-penetrating needles, acupressure and 
laser acupuncture were excluded. 
Some acupuncture trials may have considered manual therapy / 
physiotherapy as ‘usual care’ or as a control arm; RCTs using this design 
were considered for the review if the intervention included the use of 
manual therapy. 
Manual therapy; incorporates mobilisation, therapeutic massage and 
manipulation treatments, all these interventions were included under the 
classification of manual therapy: 
319 
 
• Mobilisation; Joint and soft tissue movement within normal range 
• Massage; Manual manipulation or mobilisation of soft tissues 
• Manipulation; Low amplitude, high velocity movement taking 
joints beyond normal range      
(NICE guidelines, 2009) 
Studies of all these types of manual therapy were included.  Studies using 
mechanical devices to deliver manual therapy or light touch / sham manual 
therapy techniques were excluded. 
Outcomes: 
Studies were included if a primary outcome measure focused on ‘Pain 
Intensity’, ‘Quality of Life’, ‘Functional Status’ or ‘Occupational Status’.  
These are considered to be key areas of focus in the discipline of LBP and 
are important areas of attention for patients with LBP (Chiarotto et al. 
2018; Maughan and Lewis, 2010; Furlan et al. 2008).   
Primary outcomes: 
• Quality of Life: e.g. EQ5D, SF-36, SF-12, Patient self-efficacy 
questionnaire (PSEQ) 
• Functional status; e.g. Roland Morris disability scale, Oswestry 
disability index, Quebec back pain disability scale, SF-36, Sickness 
impact profile, Patient Specific Functional Scale (PSFS) 
• Occupational status; e.g. Return to work status, number of sick 
days off work 
• Pain intensity; would be included if used in combination with one 
of the above measures e.g. Visual analogue scale (VAS), Numerical 
pain rating scale, Numerical Rating Scale (NRS), McGill pain 
inventory 
(Chiarotto et al. 2018; Maughan and Lewis, 2010; Resnik and 
Dobrzykoski, 2003; Furlan et al. 2008) 
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The outcome measures are useful tools and their objective is to provide the 
researcher, clinician and patient with a change in the measurement that 
parallels with a meaningful clinical change (Hägg, Fritzell and Nordwall, 
2003). 
Other outcomes were not considered for this review; e.g. economic 
outcomes, patient satisfaction, adverse reactions, negative consequences 
of the interventions, side effects, recurrence, fear avoidance behaviours, 
medication, depression e.g. Hamilton depression rating scale (HAMD).  If 
a primary outcome did not measure quality of life, functional status, pain 
intensity, or occupational status, they were excluded.  Other measures not 
listed above were only considered if they were appropriate to LBP and 
evidenced to be reliable, accurate and valid. 
While the collection of data on adverse events was not initially planned at 
protocol stage, when actually conducting the review I did include 
information on adverse events to ensure completeness and in order to 
provide the information required for clinical relevance. This addition was 
a deviation from the protocol. 
Study Design: 
All randomised control trials that meet the inclusion criteria were included 
in this review.  Only RCTs were selected as they provide the strongest 
form of evidence, they are the most robust in their design to ensure they 
control for selection bias, regression to the mean and temporal changes.  
Randomisation minimises biases in the allocation of participants to each 
arm of the trial and helps ensure the internal validity is robust (Torgerson 
and Torgerson, 2008). 
RCTs are required to have documented adequate randomisation e.g. 
computer generated, sealed envelopes, independent allocation.  Studies 
without adequate or documented adequate randomisation were included in 
the narrative analysis of this systematic review but excluded from any 
meta-analysis due to the risk of bias in the studies. 
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Quasi-experiments were not included in this study.  They can be inherently 
biased and are vulnerable to temporal changes, regression to the mean and 
subversion bias, questioning the internal validity and results of the study 
(Torgerson and Torgerson, 2008).  Inclusion of results with inherent 
limitations could bias the results of this systematic review.  All other forms 
of study design were also not considered sufficiently rigorous in their 
design and may be subject to biased results and thus were not considered 
for this review. 
7.5 Language selection 
Only studies in the English language were included.  Studies with an 
English language translation were included and considered as part of this 
review.  The potential increased cost implication to this review of non-
English studies; in terms of the time, resources and translation services was 
not possible for this systematic review as part of this PhD project. 
It is recognised that the inclusion of English only papers may potentially 
introduce bias and affect the validity of the review (Moher et al. 1998).  
However having no language restriction may also lead to concerns over 
publication bias, especially in the field of acupuncture and complimentary 
medicine, where a majority of study and evidence is based in Asia; 
publications in Asian journals have been reported to be of low quality and 
it is suggested only positive results are published (Ernst, 2016).  Vickers 
et al. (1998) have demonstrated in their review that some countries publish 
only positive results, they reported no trial published in China or Russia 
found an investigated treatment to be ineffective.  They also reported a 
very strong tendency towards the publication of positive results (China 
99%, Russia 97%, Japan 89%, England 75%).  Accessing negative 
findings from China and Russia may not be possible and would create 
further increased resource, time and translation costs with potentially 
limited success.   
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All papers were carefully considered, adhering to the inclusion criteria to 
ensure eligibility and quality of included trials.  Searches for unpublished 
material were implemented in an attempt to ensure publication bias did not 
impact this review. 
7.6 Search methods for the identification of studies: 
A computerised literature search with English language restrictions 
including all publications to July 2017 was conducted using the following 
databases:  
• EBSCOhost included; 
• AMED - 1985 to July 2017 
• CINAHL database -1981 to July 2017 
• CINAHL Plus with full text - 1937 to July 2017 
• CSP Online Library Catalogue – 1937 to July 2017 
• MEDLINE – to July 2017 
• SPORTDiscus – to July 2017 
The search strategy used for EBSCOhost is documented under appendix 
E1. 
• ProQuest Dialog Healthcare included; 
• British Nursing Index - 1994 to July 2017 
• Allied & Complementary Medicine - 1985 to July 2017 
• DH-DATA: (Health Administration, Medical Toxicology & 
Environmental Health) 1983 – July 2017 
• MEDLINE 1946 to July 2017 
• EMBASE 1947 to July 2017 
• EMBASE Alert – July 2017 
The search strategy used for ProQuest is documented under appendix E5. 
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Grey literature was searched through SIGLE (System for information on 
Grey Literature in Europe) and HSRProj (Health Services Research 
Projects in Progress). 
Other databases searched included: 
• Unpublished databases – System for Information on Grey 
Literature in Europe (SIGLE) 
• Unpublished databases - National Research Register; Health 
Services Research Projects in Progress (HSRProj) 
• CENTRAL, the Cochrane Library 
• ACULARS (Acupuncture Literature Analysis and Retrieval System) 
• Acubriefs.com to July 2017 
• The Clinical Trials Register and the ISRCTN Registry 
A search strategy was performed following the Cochrane Back Review 
Group (CBRG) guidelines (Furlan et al. 2015), it was adapted for our 
search as we were searching for trials with comparator treatments 
(acupuncture versus manual therapy) and not placebo or drug comparators 
alone.  Specific terms for LBP were used, though terms for conditions 
considered as ‘Specific LBP’ were adapted for our search.  The search 
strings for ‘EBSCO’ and ‘ProQuest’ are provided (appendices E1, E5) and 
these search terms were adapted for the other databases as appropriate to 
ensure the key components, terms and mesh headings were correct for each 
database. 
All reference lists and bibliographies from systematic reviews and all 
selected original articles were reviewed for any additional studies.  All 
duplicate articles were logged and excluded.   
Hand searching was conducted for a small number of journals e.g. 
Acupuncture in Physiotherapy (previously the Journal of the Acupuncture 
Association of Chartered Physiotherapists) and publications held by the 
Chartered Society of Physiotherapy.  Hand searching was performed due 
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to these journals historically not being well covered by electronic 
databases (appendix E9d). 
The above search strategy was implemented to aim to ensure a 
comprehensive and thorough search.  Every effort to find unpublished and 
papers with negative findings was made in an attempt to reduce the 
possibility of publication bias affecting the results of this review. 
7.7 Data collection and analysis 
7.7.1 Selection of Studies 
For this review the first reviewer (VCD) generated the electronic search 
strategies for EBSCOhost, ProQuest Dialog Healthcare and the other 
databases (appendices E1, E5).  
The database searches and searches of other sources were then conducted 
by the first reviewer.  Once the search results were completed, both 
reviewers conducted the identification of potential studies independently.  
The two reviewers (VCD and AWG) screened the titles and abstracts of 
all studies using the previously piloted study eligibility form (appendix 
E12) and either excluded (reasons for exclusion were documented; 
appendices E2, E6, E10a,b,c,d) or selected as full text for review. 
Selected full texts studies were independently reviewed (VCD and AWG), 
observing the inclusion and exclusion criteria.  Study eligibility forms 
were independently completed (appendix E12), providing reasons for any 
exclusion (appendices E3, E7).   
Reasons for excluding studies were provided to ensure transparency of the 
selection process and to limit any bias within the review process.  
Consensus was used for any discrepancies; and arbitration by a third 
independent reviewer used to resolve any disagreement.   
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7.7.2 Data extraction  
Both reviewers piloted the data extraction form (appendix E13) to ensure 
consistency, the extraction was appropriate, no errors occurred, and biases 
were excluded. 
After piloting, the two reviewers independently extracted data from the 
selected studies.  The data extraction incorporated authors, year of 
publication, language, setting, country, study information, methodology, 
study population, study interventions, study comparisons, study outcomes, 
randomisation, blinding, data analysis, data to assess risk of bias, results, 
attrition and funding sources.  Data on adverse events was also collected.  
The objective of two independent reviewers was to reduce the risk of 
mistakes, data input errors and any relevant information being missed, 
reducing the introduction of bias (Edwards et al. 2002). 
Data extraction was recorded on data extraction forms to ensure 
transparency of information, consistency, and reproducibility, 
consequently reducing any risk of bias in this review.  If any discrepancy 
could not be resolved through discussion arbitration by a third independent 
reviewer was conducted, and they had the concluding decision. 
An attempt to retrieve any missing data was planned, by contacting the 
study’s authors. 
If multiple publications of the same study existed, all appropriate 
information was extracted, but the data was treated as one study and 
analysed once. 
Measurement bias can arise due to differences in outcome measurements.  
High quality trials provide full descriptions of the criteria for measuring 
outcomes and reduce the risk of bias.  All selected studies were reviewed 
for their reporting of the measurement outcomes, to assess the quality of 
the studies (appendix 14). 
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7.7.3 Assessment of methodological quality  
Moher et al. (1998) highlighted how the quality of the design, conduct and 
analysis of a trial can affect the estimate of the efficacy of the assessed 
intervention, it is therefore imperative to assess if a study is robust. 
The assessment of methodological quality including the risk of bias was 
assessed for this review using the 12 criteria recommended by the 
Cochrane Back Review Group (CBRG) (Furlan et al. 2015; Furlan et al. 
2009; Bombardier, Esmail and Nachemson, 1997) and considered design, 
quality of methodology, consistency of results, sufficient data, 
generalizability and risk of bias.  This is considered a comprehensive tool 
in the field of LBP (appendix E14) and relates to the Cochrane risk of bias 
tool. 
Prior to assessing the selected studies, a pilot process of assessing the 
criteria was performed by both reviewers independently to identify and 
address any opportunity for misinterpretation or disagreement.  Any 
disagreements were resolved through discussion and any unresolved 
discrepancies were resolved through arbitration with a third reviewer, who 
had the concluding decision.  Results were recorded on a risk of bias 
assessment form for transparency of decisions and guidance notes are 
provided for each reviewer to ensure consistency of decisions.  
The 12 criteria were scored as ‘yes’, ‘no’ or ‘don’t know’ and reported 
with reasons for each decision to demonstrate transparency of the 
decisions.  For this review an RCT was considered at ‘low risk of bias’ of 
high quality if it meets criteria ‘A’ (randomisation), ‘B’ (allocation 
concealment), ‘C5’ (outcome assessor blinding) and a minimum of three 
other criteria. 
Due to the nature of many acupuncture and manual therapy RCTs being 
pragmatic and blinding of clinicians and patients to treatment intervention 
being unrealistic in many studies, criteria ‘C3’ (patient blinding) and 
criteria ‘C4’ (clinician blinding) was interpreted as the clinician and patient 
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not being informed of the outcome of their intervention in relation to the 
study objectives until after analysis of the whole study. 
The two reviewers assessed the methodological quality and risk of bias of 
the selected studies independently to ensure accuracy, consistency and 
transparency of the review, reducing any risk of bias.  This assessment was 
conducted to ensure any studies with serious flaws were excluded from 
any meta-analysis, (e.g. exceptionally high attrition rates, or trial 
conclusions not supported by the reported statistical results), and also to 
grade the quality of the trials from low too high to guide the strengthen of 
the evidence presented (Low quality studies with a high risk of bias 
fulfilled six or less of the criteria, high quality studies with a low risk of 
bias fulfilled seven or more criteria) attrition rate was also considered for 
the risk of bias assessment. 
Studies with low risk of bias were included in any pooling or meta-analysis 
of the results, any studies of low quality and a high risk of bias were 
considered further before any inclusion or rejection from pooling or meta-
analysis, a sensitive analysis may be considered if appropriate (Bland, 
2000).  
7.7.4 Adequacy of interventions 
The adequacy of interventions within the selected studies is a subjective 
analysis therefore both reviewers agreed on the adequacy in delivery of the 
intervention for each included study.  The reviewers both held extensive 
knowledge and experience in acupuncture and manual therapy and were 
well informed to assess the adequacy of an intervention.   
Each intervention was judged as adequate, moderate or inadequate for the 
studies; if any interventions were deemed to be inadequate in their delivery 
of the intervention the studies were excluded from pooling of the results in 
a meta-analysis.  Adequacy included consideration to the type of treatment, 
the length of session, the number of treatment sessions, the period of time 
they were delivered over and the therapist delivering the intervention.   
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Detailed explanations were provided of the reviewer’s views of any studies 
excluded for inadequate interventions.  If studies were considered of 
moderate adequacy, they were given further consideration in relation to 
quality and the other parameters of the systematic review to decide if they 
were appropriate or not for pooling in a meta-analysis, with explanations 
provided. 
7.7.5 Clinical relevance 
An assessment of clinical relevance of the studies was performed using an 
adapted version of the assessment guide for clinical relevance (appendix 
E15) developed by the Cochrane Back Review Group (Furlan et al. 2015; 
Furlan et al. 2008). 
7.7.6 Data analysis 
Descriptive data was used to summarise the main characteristics and 
conclusions of the studies and these were presented.   
The quality of the studies was established as recommended by the CBRG 
(Furlan et al. 2008); with focus upon study design, quality of methodology, 
consistency of results, sufficient data, generalisability and low risk of bias, 
and a meta-analysis was considered for good quality studies.  A meta-
analysis is regarded as useful tool for a systematic review as it provides a 
clear picture of the evidence, provides a common effect of the study data 
by pooling the data, and summarises the results of several studies into one 
single estimate of treatment effect. 
The meta-analysis would consider the interventions comparative to each 
other to consider any differences within the study results.  Sub-group 
analyses were not anticipated as a requirement for this review. 
To perform a meta-analysis of the studies for continuous data, the mean, 
standard deviation and sample size were required for each trial for analysis 
to occur.  If data from a study were inadequate for analysis, the authors 
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were contacted to request further information (Singh et al. 2017; Bland, 
2000). 
For continuous data outcomes, mean difference and standard deviations 
were presented.  Any data presented with alternative measurements was 
converted into standard deviations for the pooling of the data for meta-
analysis.  Any dichotomous data present was reported as risk ratios or odds 
ratios and their 95% confidence intervals.  Inverse variance methods 
(Mantel-Haenszel method) were used for pooling of data where 
appropriate (Bland, 2000). 
The software package RevMan 5.3 was used for the meta-analysis.  A 
common estimate of the mean and standard deviation was used, and data 
presented in other forms was converted to mean values and standard 
deviations for each study to provide a common study denominator.   
Chi-squared was calculated as: 
 Q = sum of (study estimate – common estimate / standard error)2 
Heterogeneity between the studies would be assessed using I2.  The I2 is 
the percentage of variation across the RCTs that are due to heterogeneity 
rather than chance (Higgins and Thompson, 2002).  I2 was calculated as: 
I2  = (Q – df) / Q 
If heterogeneity / I2 were below 50% a meta-analysis would be performed 
to pool the data using the fixed effects model, as 50% or below would be 
considered as low to moderate heterogeneity.  If heterogeneity fell between 
50 - 75% then a meta-analysis would be performed using a random effects 
model, as this would be considered as high heterogeneity.  If heterogeneity 
rose above 75%, pooling of the results was not recommended as it would 
be invalid to pool the results into a single summary and a narrative analysis 
would be provided  (Singh, 2017; Gagnier et al. 2012; Bland, 2000).   
If any data was inadequate for analysis, the trial was excluded from any 
pooling of the results and presented descriptively.  The extent of attrition 
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bias and the use of the intention to treat (ITT) analysis to reduce the risk 
of attrition bias were considered for each trial (Torgerson and Torgerson, 
2008).  Trials using ITT were included, trials not using ITT may indicate 
bias and low quality, these trials were considered for quality, and attrition 
levels were assessed prior to pooling of any data for a meta-analysis. 
A sensitivity analysis may be performed if weaker (low quality or very 
small) studies looked to be influencing the results; this was assessed 
considering outlying results or substantial differences to other studies.  A 
sensitivity analysis without these studies was an efficient way to consider 
the influence of quality.  An analysis of the stronger evidence may be 
useful, to see if the results differ, giving an indication of the influence of 
strength of research.  If questionable studies exist in the review, an analysis 
was performed without them to assess their influence on the results.  If any 
treatments were assessed as inadequate, a sensitivity analysis to investigate 
the impact of their exclusion was conducted to ensure the reviewer’s views 
had not biased the results. 
Outcome measurements were analysed together at their primary outcome 
measurement time point.  If the continuous outcome measures were not 
measured on the same outcome scale the standardised mean difference 
(SMD) was used.  The weighted mean difference (WMD) would be used 
to provide a standard unit of measurement for the meta-analysis for 
pooling data.  They are weighted by how informative each study is.  
Studies would be weighted to reflect their importance, the greater the 
sample size the greater the weighting of the trial for the meta-analysis 
(Bland, 2000).  Forest plots were presented for the results of meta-analysis 
conducted. 
7.7.7 GRADE methods 
The GRADE framework was used for this SR to assess the quality and 
strength of evidence, and to make recommendations based on the 
assessment. 
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The GRADE certainty (strength of evidence) assessment considered risk 
of bias, inconsistency, indirectness, imprecision and other considerations, 
detailed below and the results of the certainty assessment influenced the 
quality rating (table 7.1) (Zhang et al. (19) 2018). 
• For risk of bias: a judgement was made regarding whether the risk 
of bias in the individual studies was large enough that confidence 
in the estimated treatment effect was reduced. 
• For inconsistency: examination of whether the studies showed 
consistent results was conducted. 
• For indirectness: consideration was given to whether the studies 
directly compared the interventions of interest in the population of 
interest, and outcomes where reported. 
• For imprecision: the GRADE approach focuses on the 95% 
confidence intervals (CIs), i.e. confidence in estimates of effect, 
and this was reviewed for the included studies.   
• Other considerations: the transparency of reporting of adverse 
events in the studies was conducted for this assessment. 
For the summary of findings: the quality level of the evidence was 
determined for this assessment by the GRADE criteria, which has four 
levels of evidence for its quality rating (table 7.1).  
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 Quality  What it means 
 High  The authors have a lot of confidence that the true effect is similar to the estimated effect 
 Moderate The authors believe that the true effect is probably close to the estimated effect 
Low The true effect might be markedly different from the estimated effect 
Very Low The true effect is probably markedly different from the estimated effect 
Table 7.1: GRADE – levels of evidence (adapted Zhang et al. 2019;Guyatt et al. 2013) 
For relative importance: the GRADE classification of relative importance 
of outcomes (table 7.2) (GRADE, 2013; Schünermann et al. 2013). This 
review was assessed using the GRADE criteria, with consideration to the 
importance of health benefits and potential harms of the interventions.   
GRADE Rating Scale 
1 2 3 4 5 6 7 8 9 
Of Limited importance for 
making a decision 
(not included in the evidence 
profile) 
Important, but not critical for 
making a decision 
(not included in the evidence 
profile) 
Critical, for making a decision 
(included in evidence profile) 
Table 7.2: GRADE relative importance rating scale (adapted from GRADE, 2013) 
Strength of recommendation: a GRADE strength of recommendation was 
provided with justifications, based on the quality of the evidence assessed 
following the GRADE framework. 
7.8 Search strategy results 
The electronic searches of the databases listed in section 7.6 was conducted 
on the 4th July 2017 (appendices E1, E5, E9), the results of the selected 
studies from the systematic review searches are detailed in section 7.9 and 
in the PRISMA flow diagram below in figure 7.1. 
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Figure 7.1: PRISMA flow diagram of identified articles via literature 
search 
The results revealed from the individual search engines are detailed in 
table 7.3 and presented as totals in the PRISMA diagram (figure 7.1). 
 
76 studies rejected from title and abstract review 
Exclusions due to: not RCT (39); Inappropriate intervention (13); 
Inappropriate comparator (12); Inappropriate condition (10); 
Inappropriate outcome (1); Long term follow-up (1) 
 
References checked of 5 eligible studies 
 
13 studies rejected from full text review 
Exclusions due to: not RCT (6); Inappropriate intervention (1); 
Inappropriate comparator (3); Inappropriate condition (1); Long 
term follow-up (1); Inappropriate outcome (1); Conference paper(1) 
 
4 Articles assessed 
for eligibility 
 
5 Studies selected for inclusion in this review 
 
1 study found from reference lists (duplicate of 
previously included study) 
93 studies were identified from database search 
 
1 additional study uncovered 
from review of a conference 
paper and included 
 
17 Articles considered for full text 
review 
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Search Engine Search results Excluded Studies Included Studies 
EBSCOhost 48 45 3 
ProQuest 32 31 1 
Grey Literature 
SIGLE 5 5 0 
Grey Literature 
HSRProj 6 6 0 
Hand Searching 1 1 0 
Reference List 
Search 1 1 0 
Review of 
Conference paper - - 1 
Table 7.3: Individual search engine results of database search 
As the PRISMA flow diagram presents, of the 93 studies found, the review 
of titles and abstracts resulted in 76 studies being rejected on the basis of 
not fitting the parameters of the systematic review: 39 studies were 
rejected for not being RCTs, 13 studies reviewed different interventions, 
12 studies had inappropriate comparators, ten studies had inappropriate 
conditions, one was a long term follow-up of an included study with 
duplicate results, one study had an inappropriate outcome with no outcome 
data provided (appendices E2, E6, E9, E10, E11). 
17 studies were selected for full text review (figure 7.1).  13 studies were 
excluded for not fitting the parameters of the systematic reviews; six 
studies were excluded for not being RCTs, one had an inappropriate 
intervention, three inappropriate comparators, one an inappropriate 
condition, one study had inappropriate outcomes, one study was a long 
term follow up of an included study with duplicate data, and one study was 
a conference abstract paper with no reported data (however further follow-
up of the conference paper uncovered an additional paper for potential 
inclusion) (appendices E3, E7, E11). 
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Four studies (Kumnerddee, 2009; Giles et al. 2003; Cherkin et al. 2001; 
Giles et al. 1999) were included from the original search, plus one 
uncovered paper (Dascanio et al. 2014) from a conference study paper, 
which resulted in five studies remaining for inclusion.   
The reference lists of the five studies were checked and one duplicate study 
was found, and had been included.  Therefore five studies matched the 
criteria for this systematic review and were selected for inclusion (figure 
7.1).  The narrative break down of each individual search conducted is 
detailed in appendix E11. 
7.9 Selected studies 
As the PRISMA flow diagram (figure 7.1) highlights, five studies met the 
inclusion criteria and were included within this review.  No unresolved 
disputes between the two independent reviewers existed.  Table 7.4 details 
the studies selected for inclusion within this systematic review. 
Title, authors and date 
Participants 
/conditions 
Intervention 
Dascanio, VC. Birks, Y. Torgerson, 
D. (2014) Low back pain 
Acupuncture, manual therapy and 
usual care 
Kumnerddee, W. (2009) Back pain 
Massage 
Acupuncture 
Giles, LGF. Muller, R. (2003) Chronic spinal pain 
Medication, acupuncture, and 
spinal manipulation 
Cherkin, DC. Eisenberg, D. 
Sherman, KJ. Barlow, W. Kaptchuk, 
TJ. Street, J. Deyo, RA. (2001) 
Chronic low 
back pain 
Acupuncture, Therapeutic 
massage and self-care 
Giles, LGF. Muller, R. (1999) Chronic spinal pain syndromes 
Acupuncture, a non-steroidal anti-
inflammatory drug, and spinal 
manipulation 
Table 7.4: Selected studies included within the systematic review 
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7.10 Description of included studies 
This systematic review included five randomised controlled trials, detailed 
in table 7.5; two were pilot trials (Dascanio et al. 2014 – (the study 
conducted for this thesis); Giles et al. 1999), two were full-scale trials 
(Cherkin et al. 2001. Giles et al. 2003) and one was a small trial with 
preliminary findings reported (Kumnerddee, 2009).  
All the studies were published in English language between the years of 
1999 and 2014.  531 participants were included across the five studies.  All 
studies clinically assessed each participant as having low back pain, four 
with a sub-acute (six to twelve weeks) or chronic (more than twelve weeks) 
nature and one (Kumnerddee, 2009) with acute (zero to six weeks) or sub-
acute (six to twelve weeks) nature.   
One of the studies (Giles et al. 2003) and one pilot (Giles et al. 1999) 
considered spinal pain, however separate results for data sets on back pain 
and neck pain were provided, to enable the selection of the back pain data 
only, for the purpose of this systematic review. 
All studies compared the effectiveness of the two identified interventions 
(acupuncture and manual therapy) against each other; Kumnerddee (2009) 
compared Chinese acupuncture against Thai traditional massage.  Giles et 
al. (2003) trial and Giles et al. (1999) pilot trial compared acupuncture with 
spinal manipulation, Cherkin et al. (2001) trial compared Chinese 
acupuncture with massage and Dascanio et al. (2014) pilot trial compared 
Western acupuncture with manual therapy.   
In addition to the identified interventions; Giles et al. (2003, 1999) also 
included a medication arm; Cherkin et al. (2001) included a self-care arm 
and Dascanio et al. (2014) had a usual care arm and an arm combining 
acupuncture with manual therapy.  Kumnerddee (2009) did not have an 
additional arm. All studies reported on pain or function as the main 
primary outcome. 
337 
 
Table 7.5: Summary of included studies (RMDQ = Roland Morris Disability Questionnaire, ODI = Oswestry Back Pain Disability Index, RDS = Roland Disability Score) 
Study  No of part   -icipants 
Pain 
Duration Interventions 
Outcome 
Measurement 
No. in each trial 
arm & Lost to 
follow-up 
Timing of Primary 
Outcome & Analysis Results Trial Conclusions 
   
Dascanio 
et al. 
(2014) 
UK 
Pilot trial 
        59 
6 weeks      
or more 
(Sub-acute 
- chronic) 
Usual care  
10 x Acupuncture 30minutes 
 10 x Manual Therapy 
30minutes 
10 x Combined A and 
MT 45minutes 
Weekly 
Roland Morris 
Disability 
Questionnaire 
Modified Oswestry 
Disability Index 
Usual care - 14 
Acupuncture - 13 
Manual Therapy - 
13 
Combined – 12 
(0 lost) 
12 weeks 
(3 months) 
(after initial treatment) 
Analysis of Covariance 
RMDQ: 
Mean (SD)  
Usual care 9.5 (6.3) 
Acupuncture 6.8 (4.5) 
Manual therapy 4.6 (4.0) 
Combined 5.4 (4.8) 
Combined acupuncture and 
manual therapy had the 
greatest effect.  
Statistically significance not 
achieved 
Kumnerd
dee 
(2009) 
 Thailand 
     18 
3 months 
or less 
(acute –   
sub-acute) 
5 x Acupuncture 
5 x Thai Massage 
1 hour 
Every 2 days 
Thai McGill pain 
questionnaire  
Visual Analogue 
Scale (VAS) 
Acupuncture - 9 
Thai Massage - 8  
(1 lost) 
10 days 
(after initial treatment) 
Paired T-test 
McGill: 
Mean (SD)  
Acupuncture 2.11 (2.21) 
Thai Massage (10.25 (11.02) 
Significant difference shown 
for acupuncture post 
treatment 
Improvement across all other 
time points, not statistically 
significant 
Giles et 
al. (2003) 
 Australia 
115 
6 weeks      
or more  
(Sub-acute 
- chronic) 
Manipulation  
20minutes 
Acupuncture  
20minutes 
Medication 
2 x Weekly 
Oswestry  
Disability 
Questionnaire 
VAS 
 Manipulation – 35  
(2 lost) 
 Acupuncture – 34  
(2 lost) 
Medication - 40 
9/52  
(after initial treatment) 
Wilcoxon signed-rank 
test 
ODI: 
Mean (interquartile ranges)  
Manipulation 12 (0-29) 
Acupuncture 24 (11-36) 
Medication 32 (11-46) 
Manipulation had greater 
short-term effect than 
acupuncture.  
The data does not support 
single use intervention. 
Cherkin 
et al. 
(2001) 
USA 
262 
6 weeks      
or more 
 (Sub-acute 
- chronic) 
10 x Acupuncture 
10 x Massage 
Self-care 
Weekly 
Modified Roland 
Disability Scale 
Acupuncture - 94 
Massage - 78 
Self-care – 90 
(5% (13) lost, no 
between group 
figures provided) 
10 weeks 
(after initial treatment) 
ANCOVA 
RDS Mean (95% confidence 
intervals) 
Acupuncture 7.9 (6.5-9.3) 
Massage 6.3 (5.1-7.5) 
Self-care 8.8 (7.4-10.2) 
Massage effective for LBP 
 Acupuncture relatively 
ineffective 
Giles et al 
(1999) 
 Australia 
Pilot trial 
77 
 13 weeks   
or more  
(chronic) 
Manipulation  
20 minutes 
Acupuncture  
20 minutes 
Nonsteroidal anti-
inflammatory drug 
 6 treatments in 4 weeks 
Oswestry 
Disability 
Questionnaire 
VAS 
 Manipulation – 36 
 Acupuncture – 20 
Medication -21 
(49 lost, above no 
remaining, no 
between group 
figures provided 
4/52  
(after initial treatment) 
Post intervention minus 
pre intervention 
measurements 
ODI: 
Median (interquartile ranges)  
Manipulation 28 (14.5-41.5) 
Acupuncture 24 (18.5-35.5) 
Medication 20 (14.5-39.5) 
Spinal manipulation superior 
to acupuncture and 
medication 
Statistical significance 
achieved for the 
manipulation group results 
only 
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7.11 Study summary details 
Dascanio et al. (2014): piloted a cohort study with a nested RCT.  59 
participants aged 18 – 65 with a GP diagnosis of LBP were randomised to 
one of four groups.  Randomisation was conducted via an SPSS computer 
programme and ITT was adopted (14 Acupuncture, 16 Manual Therapy, 
13 Acupuncture combined with Manual therapy, 16 Usual GP care).  The 
baseline characteristics and outcome data are presented in table 7.6. 
Parameters 
Manual Therapy 
N = 16 
Acupuncture 
N = 14 
Usual-care 
N = 16 
Combined 
N = 13 
Age (years) 
(SD) 
43.9 
(13.7) 
45.6 
(11.9) 
43.8 
(11.7) 
50.1 
(9.3) 
Male (%) 56 29 31 38 
Onset (years) - - - - 
Roland Morris 
at baseline 
(SD) 
8.0 
(4.4) 
8.8 
(4.3) 
11.4 
(5.3) 
7.0 
(2.6) 
Modified 
Oswestry Score 
(SD) 
24.0 
(13.6) 
29.6 
(12.2) 
29.5 
(15.4) 
19.2 
(8.0) 
Roland Morris 
at outcome 
(SD) 
4.6 
(4.0) 
6.8 
(4.5) 
9.5 
(6.3) 
5.4 
(4.8) 
Modified 
Oswestry Score 
(SD) 
18.3 
(11.1) 
25.4 
(12.0) 
29.2 
(21.0) 
16.7 
(10.9) 
Table 7.6: Baseline characteristics and outcome data (Dascanio et al. 2014) 
A group of musculoskeletal physiotherapists with appropriate additional 
training delivered the trial interventions.  Ten weekly treatment sessions 
were delivered, treatment sessions of individual interventions were 30 
minutes in duration. 
The Roland Morris Disability Questionnaire (RMDQ) and the Modified 
Oswestry Disability Index (MODI) Questionnaire was used.  Analysis of 
covariance (ANCOVA) was conducted to obtain treatment effects.  A zero 
attrition rate was achieved with no dropouts following randomisation.  The 
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study was not powered to detect a significant difference; however the 
manual therapy intervention group gained the most improvement across 
the time points (statistical significance was not achieved). 
Kumnerddee (2009): conducted a randomised comparative study to 
provide preliminary data.  Their subjects were 18 male Thai Military 
personnel aged 20 - 40 years, who had experienced myofascial back pain 
in the preceding three months.  No information regarding the 
randomisation technique was provided.  (9 Thai massage, 9 Acupuncture). 
The baseline characteristics and outcome data are presented in table 7.7. 
Parameters 
Thai Massage 
N = 8 
(mean ± SD) 
Acupuncture 
N = 9 
(mean ± SD) 
P-Value 95% CI 
Age (years) 
26.25 
± 6.84 
29.00 
± 6.84 
0.42 -0.43, 9.83 
Male (%) 100 100 - - 
Onset (weeks) 
12.78 
± 22.71 
14.81 
± 22.73 
0.86 -21.49, 25.55 
McGill scores 
At baseline 
16.13 
±8.94 
15.78 
± 8.41 
- - 
VAS (mm) 
At baseline 
4.56 
± 1.37 
4.19 
± 2.70 
- - 
McGill scores 
At outcome 
10.25 
± 11.02 
2.11 
± 2.11 
0.02 (TM) 
0.002 (A) 
1.01, 10.74 
6.91, 20.42 
VAS (mm) 
At outcome 
2.15 
± 2.61 
0.45 
± 0.71 
0.03 (TM) 
0.003 (A) 
0.32, 4.50 
-2.63, 1.88 
Table 7.7: Baseline characteristics and outcome data (Kumnerddee, 2009) 
The interventions included; a) Traditional Thai Massage (TTM), which is 
a form of deep massage said to manipulate the local and peripheral tissue. 
One hour of treatment was provided with a qualified therapist.  b) 
acupuncture delivered seven set points plus additional points as the 
therapist felt appropriate to the patient.  No information was provided on 
the length of treatment or needle type or point location.  A single 
acupuncturist was used to deliver the intervention.  Five sessions were 
delivered every two – three days over a ten-day period. 
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Blind measurements were collected at baseline, day three, day eight and at 
the end of treatment.  The Thai version of the short form McGill pain 
questionnaire and a visual analogue scale (VAS) were used, descriptive 
statistics were provided, and a paired T-test was used.  One participant 
dropped out of the TTM group of the study, no information regarding ITT 
analysis was given.  Results reported a statistically significant 
improvement post intervention in the acupuncture group.  A trend of 
improvement for both interventions and at all time points was noted but 
not statistically significant. 
Giles et al. (2003): conducted an RCT comparing medication, acupuncture 
and spinal manipulation for individuals over the age of 17 years, suffering 
spinal pain for more than 13 weeks.  115 spinal participants were recruited 
from a hospital multidisciplinary spinal unit.  Randomisation occurred via 
150 well-shuffled envelopes. 
Two acupuncturists and one chiropractor provided the interventions, 
which were delivered for 20 minutes twice weekly, for a maximum of nine 
weeks. For acupuncture 8-10 needles were used, manipulation involved 
high thrust techniques and medication included non-steroidal anti-
inflammatory medication. 
The Oswestry scale was used as the main outcome measure. The results 
were separated into cervical and lumbar spine pain, therefore data set for 
the lumbar spine pain only could be used for this review. Attrition was 
high, out of the 115 spinal patients randomised; only 69 reached the study 
end point.  Additionally 36 participants changed treatment during the trial 
due to feeling their intervention was ineffective or due to side effects, 
though an ITT analysis was used.  Pre and post intervention changes were 
analysed using the paired Wilcoxon signed-rank test and comparisons 
between the groups were analysed using the Mann-Whitney U test.  The 
manipulation group gained greater improvement for lumbar pain 
participants.  The baseline characteristics and outcome data are presented 
in table 7.8. 
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Table 7.8: Baseline characteristics and outcome data (Giles et al. 2003) 
Cherkin et al. (2001): conducted a randomised trial of 262 participants, 
comparing the effectiveness of acupuncture, therapeutic massage and self-
care education for back pain.  Participants were invited to participate six 
weeks after a consultation in primary care for LBP.  693 consent forms 
were returned, but only the first 262 20 - 70 year olds were enrolled.  
Randomisation was conducted via computer assisted telephone interview 
(94 Acupuncture, 78 Massage, 90 Self-care).  The baseline characteristics 
and outcome data are presented in table 7.9. 
Parameters 
Manipulation 
N = 35 
Acupuncture 
N = 34 
Medication 
N = 40 
P-Value 
Age (years) 38 35.1 36.7 0.66 
Male (%) 51.4 55.9 57.5 0.86 
Onset (years) 8 6.5 7.3 0.77 
Oswestry 
Disability 
Index – median 
at baseline 
24.0 
(10 - 36) 
27 
(11 - 36) 
32 
(23 – 49) 
0.06 
VAS (mm) 
Median at 
baseline 
5.0 
(4 - 8) 
6 
(4 – 8) 
32 
(3 – 8) 
- 
Oswestry 
Disability 
Index – median 
at outcome 
12 
(0 – 29) 
P = 0.01 
24 
(11 - 36) 
P = 0.02 
0.0 
(11 – 46) 
P = 0.22 
- 
VAS (mm) 
Median at 
outcome 
-2.5 
CI -5, -21 
P = 0.0001 
4 
CI -1, +2 
P = 0.33 
5 
(2 – 7) 
P = 0.77 
- 
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Parameters 
Massage 
N = 78 
Acupuncture 
N = 94 
Self-care 
N = 90 
P-Value 
Age (years) 
(SD) 
45.7 
(11.4) 
45.3 
(11.5) 
43.8 
(11.7) 
- 
Male (%) 31 48 44 - 
Onset (years) - - - - 
Roland Morris 
at baseline 
(SD) 
11.8 
(4.4) 
12.8 
(5.3) 
12.0 
(5.3) 
- 
Roland Morris 
at outcome 
(95% CI) 
6.3 
(5.1 – 8.1) 
7.9 
6.5 – 9.3 
8.8 
7.4 – 10.2 
0.001 
(adjusted) 
Table 7.9: Baseline characteristics and outcome data (Cherkin et al. 2001) 
12 massage therapists and seven acupuncturists were used for the study, 
massage followed a protocol of soft tissue massage for the massage group 
and basic TCM needling techniques with electrical stimulation, cupping, 
heat and exercise prescription were permitted for the acupuncture group.  
The self-care group received a book and two professional videos of self-
care of LBP. 
The Roland Disability Scale was used as a primary functional measure. An 
intention to treat analysis was used, using analysis of covariance 
(ANCOVA) 80% power to detect a 2.5 difference.  The massage 
intervention was favoured after ten-weeks, statistical significance was 
achieved comparing massage to acupuncture and self-care. 
Giles et al. (1999): piloted a three-armed study of spinal pain, comparing 
acupuncture, a nonsteroidal anti-inflammatory drug and spinal 
manipulation.  They recruited 77 participants from a hospital spinal unit; 
the participants were required to be of 18 years of age and suffered spinal 
pain for at least 13 weeks. Participants were randomised to one of the three 
groups, randomisation occurred via 150 well-shuffled envelopes (32 
manipulation, 16 Acupuncture, 20 Medication).  The baseline 
characteristics and outcome data are presented in table 7.10. 
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Parameters 
Manipulation 
N = 32 
Acupuncture 
N = 18 
Medication 
N = 19 
P-Value 
Age (years) 42 44 3 0.19 
Male (%) 53 35 37.5 0.38 
Onset (years) 8 6.5 7.3 0.77 
Oswestry 
Disability 
Index – median 
at baseline 
28.0 24 20 - 
VAS (mm) 
Median at 
baseline 
5.0 4.3 3.5 - 
Oswestry 
Disability 
Index – median 
at outcome 
-8.5 
CI: -14, -4 
P = 0.0004 
+0.5 
CI: -8, +11.8 
P = 0.77 
0.0 
CI: -4, 0 
P = 0.71 
Note: 
change seen 
= (before 
minus after 
intervention
) 
VAS (mm) 
Median at 
outcome 
-2.5 
CI -5, -21 
P = 0.0001 
+0.8 
CI -1, +2 
P = 0.33 
+0.3 
CI -2, +0.2 
P = 0.34 
Note: 
change seen 
= (before 
minus after 
intervention
) 
Table 7.10: Baseline characteristics and outcome data (Giles et al. 1999) 
Interventions were described and participants received either six 15 – 20 
minute treatments of Manipulation over a three to four week period, or six 
20-minute treatments of acupuncture over a three to four week period.  (8-
10 needles were used, and electrical stimulation was applied).  Or in the 
medication group, non-steroidal anti-inflammatory medications were 
prescribed.  Four acupuncturists were used for acupuncture intervention 
and one resident chiropractor was used for manipulation intervention. 
The Oswestry scale was used as a primary functional measure, and an 
unpaired Kruskal-Wallis test was used.  The results were separated into 
cervical and lumbar spine pain, therefore data for the lumbar spine only 
could be used for this review.  Dropout rate was high in this study and 
varied across groups (26% Manipulation, 50% Acupuncture, 20% 
Medication) but all participants were followed up by telephone.  The spinal 
manipulation group only achieved a statistically significant improvement. 
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7.12 Adverse events 
Table 7.11 summarises the adverse events reported across the included 
studies.  Only minor adverse events were reported, which encompassed 
post treatment soreness (Kumnerddee (2009); Cherkin et al. 2001), with 
no major adverse events reported.  Some minor side effects were also 
reported in the medication arms of two trials (Giles et al. 1999; Giles et al. 
2003). 
Study Sample size 
Methods 
used to assess 
adverse events 
Adverse 
events 
assessed 
Reported adverse events 
Dascanio et 
al. (2014) 59 Not reported 
All adverse 
events No adverse events reported 
Kumnerddee 
(2009) 18 Self-reported 
All adverse 
events 
One minor adverse effect 
considered not serious: 
One participant dropped out 
of the massage group due to 
post massage soreness 
Giles et al. 
(2003) 115 Self-reported 
All adverse 
events 
No serious adverse events 
reported 
No minor adverse effects 
reported in acupuncture or 
manipulation arms.  Seven 
minor side effects reported in 
the medication arm 
Cherkin et al. 
(2001) 262 Self-reported 
All adverse 
events 
No serious adverse effects 
reported, some minor effects 
occurred:  
11% acupuncture group and 
13% massage participants 
reported significant 
discomfort during or shortly 
post intervention 
Giles et al. 
(1999) 77 Self-reported 
All adverse 
events 
No serious adverse events 
reported 
No minor adverse effects 
reported in acupuncture or 
manipulation arms.  Three 
minor side effects reported in 
the medication arm 
Table 7.11: Adverse events reported across the included studies 
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It was unclear across all the studies if registration of the adverse events 
was systematic.  Uncertainty exists therefore on the reliability of the 
reporting of adverse incidents. 
7.12.1 Methodological quality including the risk of bias in the included 
studies 
The results of the methodological quality and risk of bias assessment are 
presented in table 7.12.  The CBRG 12 criteria forms (appendix E14) were 
used to calculate the quality and risk of bias (Furlan, 2015). 
Study No of Subjects 
Randomisation 
method 
Bias 
assessment 
score 
Risk of 
Bias Quality 
Dascanio 
et al. 
(2014) 
59 Computer generated A + B + 11/12 Low risk High 
Kumnerd
dee 
(2009) 
18 
Randomised (no 
information 
reported) 
6/12 High risk Low 
Giles et 
al. (2003) 115 
Shuffled 
envelopes A + B + 9/12 Low risk Medium 
Cherkin 
et al. 
(2001) 
262 Computer generated A + B + 9/12 Low risk High 
Giles et 
al. (1999) 77 
Shuffled 
envelopes A + B + 6/12 
High 
risk Medium 
Table 7.12: Results of methodological quality and risk of bias assessment 
Table 7.12 shows Kumnderddee’s (2009) study was of high risk of bias 
and low quality.  It was a very small-scale study of men only, with a poor 
methodological quality.  No information was provided for the 
randomisation and allocation concealment process, it considered pain of 
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three months or less duration (acute – sub-acute), its primary outcome 
assessment occurred at 10 days following the first of five intervention 
treatments, no control arm was used, it used pain scales for its outcome 
measures and its subject numbers did not achieve the minimum of 12 
required for a pilot study (Julious, 2005).  Due to the poor methodological 
quality including the differing time scales, the outcomes measurements 
used, and the high risk of bias, this study was excluded from the planned 
meta-analysis pooling of data.   
Table 7.12 shows one study was high risk of bias and medium quality 
(Giles et al. 1999).  One study was of low risk of bias and medium quality 
(Giles et al. 2003).  Two studies were low risk of bias with high quality 
(Cherkin et al. 2001; Dascanio et al. 2014).   
All five studies were randomised. One study provided no information of 
the randomisation process (Kumnderddee, 2009).  Envelope concealment 
randomisation was used in one of the studies and one pilot (Giles et al. 
2003; Giles et al. 1999). Two studies used computer-conducted 
randomisation (Dascanio et al. 2014; Cherkin et al. 2001). 
None of the trials were blinded due to the pragmatic nature of the trials.  
Blinding of the outcome was reported in all five of the studies. 
Giles et al. (1999) and (2003) also reported very high attrition and 
crossover rates, which was not observed in the other studies, however ITT 
analysis was used.  One pilot study presented an attrition rate of zero post 
randomisation, (Dascanio et al. 2014). 
Four studies were assessed to be of medium and high quality (Dascanio et 
al. 2014; Giles et al. 2003; Cherkin et al. 2001; Giles et al. 1999), all using 
a functional outcome measure and therefore these studies were included in 
the meta-analysis. 
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7.13 Adequacy of interventions 
In all studies selected for this review the interventions were considered 
adequate for the population they targeted.  Table 7.13 shows the 
interventions provided for each of the selected studies. 
It was the view of both reviewers that the interventions across all the 
studies were delivered by appropriately qualified practitioners (Chartered 
physiotherapist, acupuncturist, chiropractor, massage therapist) and 
provided effective intervention types (e.g. manual therapy, massage, 
manipulation, acupuncture), with suitable numbers of treatment (e.g. 10, 
12, 6 & 5), appropriate length of treatment sessions (30-45minutes, one 
hour, 20minutes) and appropriate treatment techniques delivered. 
Regarding the time period the treatment was delivered for however, one 
study did not fit within the time frame of the others.  Kumnerddee’s (2009) 
intervention was delivered over a ten-day period, which was considered a 
very short intervention period by both reviewers and the third reviewer.  It 
was considered that minimal outcomes would be understood over such a 
short treatment parameter, which did not reflect current clinical practice.  
The other four studies (Dascanio et al. 2014; Giles et al. 2003; Cherkin et 
al. 2001; Giles et al. 1999) treatment period ranged from 4 weeks to 12 
weeks, which was considered more in line with standard clinical practice. 
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Table 7.13: Adequacy of interventions 
Study No of Subjects Interventions Intervention details Adequacy 
Dascanio et al. 
(2014) 
 
 
59 
 
 
Acupuncture 
Manual Therapy 
Combined A 
and MT 
Usual care 
Ten weekly sessions over a maximum of twelve weeks. Delivered by experienced physiotherapists 
Western acupuncture was delivered incorporating some traditional principles 30 minute sessions 
Manual therapy 30 minute sessions 
Combined A & MT received 45 minute sessions 
No details provided 
High 
adequacy 
Kumnerddee 
(2009) 18 
Thai Traditional 
Massage 
Acupuncture 
Five sessions delivered over a ten-day period. One-hour massage was delivered, 
Chinese acupuncture for myofascial pain. No information on treatment time for acupuncture.  
7 needles used as protocol plus additional needles no information provided. 
Moderate 
adequacy 
Giles et al. 
(2003) 
 
 
115 
 
 
Manipulation 
Acupuncture 
Medication 
Maximum of nine weeks of treatment 
Manipulation occurred twice weekly high-velocity, low-amplitude trusts to spinal areas 
Acupuncture sessions occurred twice weekly 8-10 needles for 20 minutes plus 5 needles for five minutes 
Medication two visits to physician prescribed Celebrex (200-400mg, doses at the discretion of the physician) 
High 
adequacy 
Cherkin et al. 
(2001) 262 
Acupuncture 
 
Massage 
 
Self-care 
 
Acupuncturists and massage therapists were able to schedule up to ten sessions over ten weeks. 
TCM acupuncture was used, decisions of number and location of needles was left to the provider, thought he 
acupuncturists established a treatment protocol with the trial consultants. 
A protocol of massage was developed by the masseurs and consultants, acupressure and shiatsu were not 
permitted but all other styles of massage were permitted. 
The self-care group received high quality information including a back book and two self-management 
videotapes. 
High 
adequacy 
Giles et al. 
(1999) 77 
Manipulation 
Acupuncture 
Medication 
Manipulation = 6 treatments over 3 -4 weeks, 15 – 20 minute appointments 
Acupuncture = 6 treatments over 3 -4 weeks, 20 minute appointments,  
8-10 needles were used, electrical stimulation was also applied 
Medication = non-steroidal anti-inflammatory, no further details provided 
Moderate 
adequacy 
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7.13.1 Clinical relevance 
The interventions selected within this review are commonly used 
interventions for LBP within clinical practice; therefore determining their 
clinical relevance, effectiveness and indication for use would be very 
useful.  Table 7.14 highlights the findings of clinical relevance assessment 
for each study.   
Item Dascanio et al. (2014) 
Kumnerddee 
(2009) 
Giles et al. 
(2003) 
Cherkin et 
al. (2001) 
Giles et al. 
(1999) 
Based on the data 
provided, can you 
determine if the 
results will be 
clinically relevant? 
Yes Yes Yes Yes Yes 
Are the patients 
described in detail so 
that you can decide 
whether they are 
comparable to those 
that you see in your 
practice? 
Yes Yes Yes Yes Yes 
Are the interventions 
and treatment settings 
described well enough 
so that you can 
provide the same for 
your patients? 
Yes Yes Yes Yes Yes 
Were all clinically 
relevant outcomes 
measured and 
reported? 
Yes No Yes Yes Yes 
Is the size of the effect 
clinically important? 
No No Yes Yes No 
Are the likely 
treatment benefits 
worth the potential 
harms? 
Yes Yes Yes Yes Yes 
Table 7.14: Clinical relevance assessment 
All five studies provided data, participant information and appropriate 
details of the intervention parameters and settings to allow the 
interpretation of relevance to practice.  Kumnerddee’s (2009) study only 
reported pain scales, which have been shown to be subjective and less 
reliable as an outcome tool, comparative to functional measures outcomes 
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(British Pain Society, 2019), the other four studies reported using 
functional outcome measures.   
The effect size was not considered clinically important in Kumnerddee 
(2009) study and the two pilot studies (Dascanio et al. 2014; Giles et al. 
1999) primarily due to lack of power to detect a difference within the 
studies (Schober et al. 2018). 
All five studies reported treatment benefit (though not statistically 
significant for the three smaller studies (Dascanio et al. 2014; 
Kumnerddee, 2009; Giles et al. 1999) and as presented in section 7.12 none 
of the studies reported any serious adverse events. 
The evidence from this systematic review was limited primarily due to the 
small study sizes, therefore it is not possible to provide distinct 
recommendations of clinical relevance.  However the meta-analysis results 
of the included studies indicated manual therapy showed an advantage 
over acupuncture. 
7.14 Meta-analysis 
Four of the five RCTs were selected for the meta-analysis (tables 7.15, 
7.16, 7.17, 1.18).  The data required conversion into means and standard 
deviations through statistical calculation for the Giles et al. 1999 and Giles 
et al. 2003 studies (appendix E16).  Different outcome measures (RMDQ 
and ODI) were used, therefore pooled estimates of effect were provided as 
standardised mean differences for the analysis. 
Outcome measure Intervention Mean (SD) Sample size 
RMDQ Acupuncture 7.9 (6.86) 94 
RMDQ Massage 6.3 (7.36) 78 
Table 7.15: Mean (SD) scores for Cherkin et al. (2001) 
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Outcome measure Intervention Mean (SD) Sample size 
RMDQ Acupuncture 6.8 (4.5) 14 
 Manual therapy 4.6 (4.0) 16 
MODI Acupuncture 25.4 (12.0) 14 
 Manual therapy 18.3 (11.1) 16 
Table 7.16: Mean (SD) scores for Dascanio et al. (2014) 
Outcome measure Intervention Mean (SD) Sample size 
MODI Acupuncture 24 (8.21) 18 
MODI Manual therapy 28 (20.77) 32 
Table 7.17: Mean (SD) scores for Giles et al. (1999)  
(Interquartile range converted into SD’s, using the normal distribution model (Bland, 2000) (Appendix E16). 
Outcome measure Intervention Mean (SD) Sample size 
MODI Acupuncture 24 (19.40) 34 
MODI Manipulation 12 (17.91) 35 
Table 7.18: Mean (SD) scores; Giles et al. (2003) 
(Interquartile range converted into SD’s, using the normal distribution model (Bland, 2000) (Appendix E16). 
7.15 Meta-analysis results 
The meta-analysis combined the results of four of the included studies 
comparing acupuncture with manual therapy, using continuous outcomes.  
One study was not included (Kumnerddee, 2009) due to major flaws in the 
study.   
All meta-analyses are presented as summary effect estimates for 
acupuncture versus manual therapy, with standardised mean difference 
and 95% confidence intervals.  Inverse Variance (IV) weighting was used 
across all the meta-analyses, to give each study a weighting determined by 
352 
 
how informative each study was (affected by the size of each study and the 
standard deviation of the outcome).  
The results of the first meta-analysis are plotted in figure 7.2.  I2 was 
calculated at 45% thus a fixed effects meta-analysis model was used.   
 
 
Figure 7.2: Forest plot of comparison: Acupuncture versus Manual Therapy for 
LBP (Outcome measures; RMDQ – Dascanio & Cherkin; ODI – Giles & Giles) 
Figure 7.2 shows the fixed effect estimate for a between group comparison 
of acupuncture versus manual therapy, with a favourable effect towards 
manual therapy (0.27, 95% CI 0.05, 0.49), (P = 0.02) for this outcome. 
Giles et al. (1999) was an outlier comparative to the other studies within 
the analysis, it is a pilot study of medium quality with a high risk of bias 
therefore a sensitivity analysis was conducted without this study (figure 
7.3).   
Figure 7.3 shows the results of the fixed effect estimate for a between 
group comparison of acupuncture versus manual therapy meta-analysis 
without Giles et al. (1999).  The confidence interval of the pooled estimate 
(the diamond) is reduced in the forest plot and the overall combined effect 
size was 0.36 (95% CI 0.12, 0.60) (P = 0.004), in favour of manual therapy.  
I2 was calculated at 8% thus a fixed effects meta-analysis model was used. 
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Figure 7.3: Forest plot of comparison: Acupuncture versus Manual Therapy for 
LBP (Sensitivity analysis minus Giles et al. 1999) (Outcome measures RMDQ 
Dascanio. Cherkin. ODI Giles et al. 2003) 
In the previous analyses (figure 7.2 and 7.3) both Dascanio and Cherkin 
used the RMDQ as their primary outcome measure and Giles et al. (2003 
& 1999) used the Oswestry disability index.  Dascanio et al. (2014) used 
both the RMDQ and the MODI in their study, therefore a sensitivity 
analysis was able to be conducted using the MODI for Dascanio et al. 
(2014), thus three Oswestry measures and one Roland-Morris, to assess if 
any differences were seen with the use of a different outcome measure 
(figure 7.4 and 7.5). 
 
Figure 7.4: Forest plot of comparison: Acupuncture versus Manual Therapy for 
LBP (Outcome measure; RMDI – Cherkin; ODI – Dascanio & Giles & Giles) 
Figure 7.4 shows the fixed effect estimate for between group comparison 
of acupuncture versus manual therapy, with a significant overall effect 
0.28 (95% CI 0.06, 0.50) favourable to manual therapy, however the 
average effect size is slightly smaller and closer to zero / line of no effect 
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than seen in the previous forest plots.  Statistical significance was achieved 
(p = 0.01) and I2 was calculated at 49%, thus a fixed effects meta-analysis 
model was used. 
Due to Giles et al. (1999) being an outlier in the analysis, a sensitivity 
analysis excluding the study was also conducted and is shown in figure 
7.5. 
 
Figure 7.5: Forest plot of comparison: Acupuncture versus Manual Therapy for 
LBP (Sensitivity analysis minus Giles et al. (1999) (Outcome measures; RMDQ - Cherkin; ODI – Dascanio 
& Giles et al. 2003) 
Figure 7.5 shows the fixed effect estimate for between group comparisons 
of acupuncture versus manual therapy, with a significant overall effect 
0.37 (95% CI 0.13, 0.61) (P = 0.003) favourable to manual therapy, the 
average effect size is larger than seen in the previous forest plots.  I2 was 
calculated at 18%, thus a fixed effects meta-analysis model was used. 
7.16 GRADE quality of evidence 
The GRADE quality of evidence assessment was used to assess the 
strength of evidence.  I assessed two outcomes the functional status 
outcome measure and adverse events.  The evidence profile, the certainty 
assessment, summary of findings, and relative importance for each 
outcome are detailed in table 7.19.  The PICOS criteria (section 7.4.1) were 
used for the identified research and the effect sizes were established from 
the meta-analysis (figure 7.2).  
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7.16.1 GRADE certainty assessment 
The GRADE analysis (table 7.19) for this SR included four randomised 
controlled studies in the assessment (Cherkin et al. 2001; Dascanio et al. 
2014; Giles et al. 2003; Giles et al. 1999). 
Risk of bias: For risk of bias the rating was downgraded to ‘serious’ for 
both outcomes (table 7.19) due to the limitations of the included studies, 
the small sample size (due to the reduced precision of any estimated 
treatment effect) and two of the studies being pilot studies (Zhang et al. 
(19) 2018).  The GRADE criteria gives a combined summary assessment 
for the risk of bias and thus a different risk of bias rating to that reported 
for the CBRG criteria in table 7.10. 
Inconsistency:  For inconsistency the rating was not downgraded for either 
outcome (table 7.19) and considered not serious, as there was relative 
consistency in the reported treatment effects across the studies and 
heterogeneity was considered low to moderate (I2 45% figure 7.2) (Zhang 
et al. (20) 2018; Guyatt et al. 2011b). 
Indirectness:  For indirectness the rating was not downgraded for either 
outcome (table 7.19) and considered as not serious, as all the included 
studies: included a population of LBP, directly compared the relevant 
interventions and reported their outcomes (Zhang et al. (19) 2018; Guyatt 
et al. 2011c). 
Imprecision:  For imprecision the rating was not downgraded for either 
outcome (table 7.19) and considered as not serious.  Certainty is reduced 
and a rating down of the quality occurs, if clinical choice would differ if 
the true effect were at the upper versus the lower end of the confidence 
interval (Zhang et al. (20) 2018; Guyatt et al. 2011d), which was not 
considered to be the case. 
Other considerations:  No other considerations or concerns were raised for 
the certainty assessment for the functional status outcome (table 7.19).  
However for the adverse events outcome the rating was downgraded to 
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‘serious’ (table 7.19), as there was a lack of transparency and information 
regarding the systematic reporting of adverse events across the included 
studies (Zhang et al. (20) 2018). 
7.16.2 GRADE summary of findings 
321 participants were included across the four studies. The overall effect 
size derived from the meta-analysis was 0.27 (95% CI 0.05, 0.49) (table 
7.19).   
The quality level of the evidence, for this review, was determined by the 
GRADE criteria.  The quality was rated as moderate for the functional 
status outcome (table 7.19), this was due to one of the criteria form the 
certainty assessment (risk of bias; explanations given as footnotes) being 
downgraded to serious, therefore following GRADE’s criteria the quality 
rating was moved down one level from high to moderate (GRADE, 2013; 
Schünemann et al. 2013). 
For the adverse events outcome it was rated as low quality, this was 
primarily due to two ratings being downgraded to serious on the certainty 
assessment (risk of bias and other considerations; explanations given as 
footnotes, table 7.19), therefore following GRADE’s criteria the quality 
rating was moved down two levels from high to low (GRADE, 2013; 
Schünemann et al. 2013). 
7.16.3 GRADE relative importance 
Consideration was given to the importance of the health benefits and 
potential harms of the therapies prior to making the decision and a rating 
of four out of nine was given on the GRADE rating scale (table 7.2), thus 
it was considered important but not critical for decision making (GRADE, 
2013; Schünemann et al. 2013).  
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7.16.4 GRADE strength of recommendation 
Based on the quality of evidence assessed with the GRADE strength of 
recommendation framework (Andrews et al. 2013), a weak 
recommendation can be given in favour of manual therapy over 
acupuncture.  This recommendation was due to uncertainty remaining 
regarding the benefits outweighing the harms and the quality assessment 
rated as moderate and low (Andrews et al. 2013).  Limitations in the 
primary research and the analysis prevent a strong recommendation from 
being given, and it is not possible to say from this review that all persons 
would choose manual therapy based on the current evidence base 
(Andrews et al. 2013; Cochrane, 2013; GRADE, 2013; Schünemann et al. 
2013). 
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Table 7.19: GRADE evidence profile and summary of findings: acupuncture versus manual therapy for LBP 
1 Limitations in the studies design exists due to small sample sizes and two of the four studies being pilot investigations 2 Lack of transparency and information regarding systematic reporting of events 
Outcome Certainty Assessment Summary of Findings Relative Importance 
  No. of         Studies  Study design 
 Risk of  
bias Inconsistency Indirectness Imprecision 
Other 
Considerations 
No. of 
Patients Effect Quality  
Functional 
status 
Acupuncture 
Vs Manual 
Therapy for 
LBP 
4 
Randomised 
Control 
Trials 
Serious1 Not Serious Not Serious Not Serious None 321 0.27 (0.05, 0.49) 
ÅÅÅ 
Moderate 1 
4/9 
(Important but 
not critical) 
Adverse 
Events 
Acupuncture 
Vs Manual 
Therapy for 
LBP 
4 
Randomised 
Control 
Trials 
Serious1 Not Serious  Not Serious Not Serious Serious 
2 321 Nil adverse events 
ÅÅ 
Low 1,2 
4/9 
(Important but 
not critical) 
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7.17 Discussion 
Five studies engaging 531 participants were included in this systematic 
review.   The methodological quality of the selected studies was high for 
three studies and low for two studies, however none of the studies are large 
scale recent RCTs.  The selected studies were heterogeneous in their 
selection of study population, manual therapy and acupuncture 
intervention administered, number of intervention arms and controls, 
outcome measures, follow up time points and the presentation of the 
results. 
While manual therapy is considered a global term for a variety of hands on 
treatment for LBP (NICE, 2009) in practice this led to heterogeneity within 
this review, with three differing types of manual therapy delivered 
(massage, manual therapy, manipulation), however for the purpose of this 
systematic review they were considered similar enough to combine the 
results and for a meta-analysis.   
In addition the global term acupuncture is considered as ‘the insertion of 
needles’ (WHO, 2002) and thus a variety of acupuncture intervention 
techniques were delivered across the studies, though heterogeneity existed, 
for the purpose of this systematic review they were considered similar 
enough to combine the results and for a meta-analysis.   
If a greater number of research studies had existed in this area of study, 
sensitivity analyses could have been used to account for variation in 
manual therapy and acupuncture techniques and thus inform the results 
further. 
The time frame of the condition was another area for consideration for this 
review.  Four of the included studies selected participants with sub-acute 
and chronic low back pain; and within this patient group there appears to 
be some evidence to suggest manual therapy is superior to acupuncture 
across these studies, and this was supported by the meta-analysis results.  
360 
 
One of the smaller trials considered pain of three months or less therefore 
considering acute and sub-acute LBP (Kumnerddee, 2009), however as it 
was a preliminary data trial very small sample size of 18 participants were 
included in the study.  No control arm was included in this study and the 
analysis was conducted at ten days, therefore regression to the mean may 
have played a role in any improvement seen in the participants within this 
study (Torgerson and Torgerson, 2008).  While acute LBP is included in 
various guidelines it is also reported that acute and sub-acute LBP often 
resolves spontaneously for the majority of individuals (Qaseem et al. 
2017).  While this author was contacted for further information or a follow-
up study, no response was received at the time of writing.  Minimal 
conclusions could be drawn for acupuncture versus manual therapy for 
LBP in its acute phase from the Kumnerddee (2009) study. 
The meta-analysis and forest plots all presented a favourable effect 
towards manual therapy, with consistent average effect sizes (0.27, (95% 
CI 0.05, 0.49), 0.36 (95% CI 0.12, 0.60), 0.28, (95% CI 0.06, 0.50), 0.37, 
(95% CI 0.13, 0.61)).  The meta-analysis results are consistent with the 
findings of the four individual studies. 
Caution is required in interpreting the results of the meta-analysis as 
though the studies were of good or medium quality, they were small 
studies with two being pilot investigations (one a high risk of bias (Giles 
et al. 1999) and three of the studies being over 15 years old (Giles et al. 
2003; Cherkin et al. 2001; Giles et al. 1999). 
The GRADE assessment offered only a weak recommendation in favour 
of manual therapy, due to limitations and uncertainty in the primary 
research, and due to a low to moderate quality assessment.  Further high 
quality, large full-scale studies and analysis are required to draw firm 
conclusions in this area of research. 
Limitations: 
A number of limitations exist within this systematic review.  Principally 
the review protocol was not registered or published prospectively, this 
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occurred primarily due to limitations and time scales of this PhD.  While 
considerable effort was made to ensure the integrity of the review, lack of 
publication leaves it subject of criticism due to lack of transparency, and 
the questionable opportunity to deviate from the original protocol exists.  
The opportunity for conscious or subconscious influences on the review 
from the data extracted could not be refuted (PROSPERO, 2019), limiting 
this review comparative to the rigorous standards expected of systematic 
reviews.  Registration of protocols reduces the potential for bias, including 
outcome and reporting bias.  It allows transparency of the planned review 
including a public record of the inclusion criteria and intended outcomes, 
and in addition it also avoids duplication of systematic reviews (Misra and 
Agarwal, 2018; Stewart, Moher and Shekelle, 2012). 
Additionally this systematic review planned only to consider primary 
outcomes using pain and function for selection for the review, it did not 
plan to collect data on economic outcomes, patient satisfaction, adverse 
reactions, negative consequences of the interventions, side effects, 
recurrence, fear avoidance behaviours, medication, depression.  This 
limited the potential knowledge gained from this systematic review and 
limited the author’s ability to make informed decisions regarding the 
included studies.   
In order to complete the review effectively information regarding adverse 
events was required for the clinical relevance analysis and GRADE’s 
summary of findings analysis.  Thus the authors deviated from the original 
planned protocol to collect data on adverse events, allowing informed 
decisions on whether the treatment benefits were worth any treatment 
harms, (table 7.11) and to grade the level of evidence (table 7.19).  
Deviation from the original protocol is not ideal, however detail of why 
and how this was conducted is provided to ensure transparency.   
The protocol inclusion criteria specified an age range of 18 to 65 years, 
however in a deviation from the protocol it was decided if a publication 
included individuals from the age of 16 years or over the age of 65 years 
who were not suffering comorbidities then these studies would not be 
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excluded based on their age specification but considered for inclusion.  
This decision was made based on a change in the age demographics in the 
update of the NICE LBP guidelines (2016).  No other deviations from the 
planned protocol were undertaken. 
The limited number of RCTs available with a low risk of bias in this area 
is a limitation of this study, as is the ambiguity surrounding the impact of 
publication bias, both noteworthy limitations but those which are perhaps 
inherent to many studies. Significant effort was made to find all published 
and unpublished RCTs, however some studies may have been missed due 
to the databases searched being predominantly UK based and the English 
language only.  Further consideration would need to be given to not having 
a language restriction for future systematic reviews in this area.  
Additionally the restriction of search strategy strings inputted for this 
systematic review may not have been comprehensive enough and limited 
the studies isolated, thus limiting the review.   
The heterogeneity across the included studies was another limitation of 
this review; while every careful consideration was given to the inclusion 
criteria of each study it was not an issue that could be resolved for this 
systematic review.  The data collected from the included studies was also 
limited to a twelve-week outcome measurement post intervention 
completion, therefore limitations to the report of long-term effects of 
acupuncture or manual therapy for patients with LBP are apparent, long-
term follow-up of studies should be considered for future reviews in this 
area.  If any future studies were discovered this review would be updated. 
7.18 Implications for clinical practice and future research 
There is some evidence from this systematic review and meta-analysis to 
indicate manual therapy is superior to acupuncture, however with only a 
weak recommendation in favour of manual therapy from the GRADE.  The 
conclusions are constrained by the limitations of the primary research 
studies available for the review.  Minimal research was uncovered through 
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this systematic review; with only five studies investigating acupuncture 
versus manual therapy found and two of those were pilot studies and one 
a very small-scale preliminary study with limited power to establish 
effectiveness.  Only three of the five studies were of high methodological 
quality and one of these studies was a pilot.  Participant numbers were low 
across the studies and attrition across three studies was high (Giles et al. 
1999; Giles et al. 2003; Kumnerddee, 2009), heterogeneity was significant 
with varying techniques used across the studies and three out of the four 
studies were more than 15 years old. 
It is, therefore, not possible to reach a convincing conclusion to inform 
clinical practice and healthcare commissioning in this area of study, 
without conducting further high quality research to provide a more 
definitive insight. 
Further investigation into the effectiveness of the various types of manual 
therapy available would be useful. Major differences existed in this 
systematic review between various types of manual therapy used from 
therapeutic massage of tissues through to manipulation of joints; further 
specification of the techniques would be a useful area for future study to 
establish the appropriate levels of effectiveness for each type of technique 
for research and clinical practice. 
Additionally investigation into the range of acupuncture intervention 
styles would be useful, across this systematic review the intervention 
ranged from western medical acupuncture, traditional Chinese medical 
acupuncture (TCM), and Chinese acupuncture.  The number and depth of 
needling, frequency and duration of sessions varied greatly, with some 
studies being prescriptive, others allowing the acupuncture provider to 
decide on needle location and one study using half prescribed points and 
half provider choice.  Consideration of all these areas through research 
would be useful to inform future research studies and clinical practice. 
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7.19 Conclusions 
This review provides evidence for manual therapy being superior to 
acupuncture for LBP, however as previously discussed caution is required 
in interpreting the results of the review due to the limitations of the 
included studies within the review.  Additionally this review has 
determined that there is a significant lack of research in this area 
comparing acupuncture with manual therapy. 
The evidence available from this systematic review does not support 
revising the guidance from the current NICE guidelines for LBP (2016). It 
is not clear whether acupuncture is effective for LBP or if it should be 
added to manual therapy, and if so, whether to recommend manual therapy 
or acupuncture first.   
Further research is therefore required to reduce the uncertainty and inform 
decision-making.  Serious consideration should be given to further 
investigation into appropriate and timely interventions for LBP.  
Uncertainty surrounding the efficacy of acupuncture for LBP remains and 
a future study of acupuncture versus manual therapy would be useful in 
this area of research. 
A large multi-centered trial would assist in supporting the knowledge base, 
to advise on comprehensive treatment programs and appropriate care 
pathways.  A large full-scale trial would aim to assist in providing clarity 
for the use of acupuncture for LBP.  
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8 Discussion of the Thesis 
8.1 Introduction 
The aim of this thesis was to investigate acupuncture and manual therapy 
in the treatment of LBP, and consider if further investigation of their use 
individually or in combination as a treatment package was a viable and 
effective option for clinical practice.  Together with this, and in respect of 
the issues that surround the quality of previous research in this field (SAR, 
2018), I wanted to establish whether a specific RCT design would be 
preferable for the evaluation of acupuncture and manual therapy which 
would satisfy guideline developers.  
In this chapter I will discuss the research and: 
• Summarise and consider the key findings of this thesis 
• Evaluate the limitations of this thesis and the conducted study, 
identifying the strengths, weaknesses and challenges of their 
completion 
• Highlight what this thesis has contributed to the research 
knowledge base 
• Relfect upon future research potentials identified from this thesis 
• Consider what a future trial, guided by this thesis may look like 
• Establish conclusions of the thesis 
8.2 Summary of the thesis 
Chapter one: 
In chapter one I introduced LBP and its non-specific nature.  I described 
LBP’s epidemiology, its impact and economic burden, its causes and 
prognosis.  I presented current treatments available for LBP and outlined 
the complexities of assessing complex interventions such as acupuncture 
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and manual therapy, for a complex condition like LBP.  I concluded with 
key research questions, which I considered throughout this thesis. 
It has been well documented that LBP is the principal cause of global 
disability, and that further research to improve understanding of LBP in a 
variety of settings is required to improve the knowledge base (Buchbinder 
et al. 2018; Hoy et al. 2014).  As I identified in this chapter, the lack of 
diagnostic clarity of LBP may well be impeding therapeutic strategies.  
Patients present in clinic with substantially different LBP symptoms; 
however they are often grouped together for diagnostic and research 
purposes.  The one size fits all model has thus not aided information, 
recovery or prevention of long term LBP. 
Further understanding of the subsets or types of LBP would be useful, 
separated into their anatomical cause if possible. Continuing to use the 
broad term LBP to diagnose so many, may adversely impact upon the 
success and development seen in research.  Further investigation should 
be conducted into diagnostics of LBP to aid our understanding.  Greater 
understanding of this multi-faceted condition may then inform appropriate 
treatments and management.  Despite extensive research into the treatment 
of LBP, debate remains surrounding which interventions are appropriate, 
and which may constitute a long-term solution to the problem (Foster et 
al. 2018). 
Identifying which causes and risk factors lead LBP to establish as chronic 
condition, remains a real need and challenge for the research and clinical 
community (NICE, 2016).  Better understanding of the risks (as the new 
NICE guidelines recommend) through the use of assessments such as 
STarT Back screening tools and stratified care (Foster et al. 2014; Hill et 
al. 2011) may help future understanding.  Through chapter one I presented 
the many unknowns of LBP and where research focus is required to reduce 
the impact of LBP and inform clinical practice. 
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Chapter two:  
In chapter two I conducted a literature review of systematic reviews of 
acupuncture and manual therapy for LBP and the research comparing or 
combining acupuncture and manual therapy.  I also reviewed the 
systematic reviews of international clinical practice guidelines for LBP. 
The international guideline recommendations for acupuncture and manual 
therapy were summarised and I examined their varying recommendations. 
I also reflected upon how they compared to the UK NICE guidelines and 
the changes that have occurred over time.    The NICE LBP guidelines 
from 2009 and 2016 were reviewed and compared, with specific analysis 
of the evidence base for manual therapy and acupuncture.  The removal of 
acupuncture from the recent 2016 NICE guidelines and uncertainty 
surrounding its provision was discussed, and I considered if acupuncture 
and manual therapy were appropriate interventions for LBP. 
One of the significant themes discussed within this chapter was how the 
same international evidence, was interpreted differently in each country 
which produced guidelines and their guideline committee members.  Thus 
producing divergent national clinical practice guideline recommendations.  
I found differing interpretation of the evidence and how it was applied to 
the guidelines.  The choice between efficacy and effectiveness of 
interventions in the assessment processes of the guidelines was evident, 
particularly for acupuncture recommendations in the UK. 
A House of Lords science and technology report in the UK gave a criterion 
for the evidence needed for clinical practice, it stated that: 
“…any discipline whose practitioners make specific claims…to 
treat specific conditions should have evidence … above and 
beyond the placebo effect”  
(House of Lords (HoL), 2000)  
The evidence for acupuncture was interpreted differently by the NICE 
2009 GDC and the NICE 2016 GDC.  NICE (2009) GDC considered non-
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placebo RCTs including research comparing acupuncture to usual care and 
other interventions. However, with a change of GDC personnel for NICE 
2016 and a change to the accepted value of the Minimal Clinically 
Important Difference (MCID) to 1.0 above sham.  The GDC determined 
that the acupuncture studies were not able to satisfy the MCID or the 
House of Lords criterion (2000) to produce evidence above and beyond 
the placebo effect, and thus NICE (2016) withdrew acupuncture from its 
recommendations.  However, as discussed in chapter two and chapter 
three, it may be that acupuncture is merely an effective placebo or it may 
be that there is evidence and recommendation for not comparing 
acupuncture to sham controls in trials, but using an alternative 
effectiveness trial.  Additionally the potential bias of individuals and their 
specialities on guideline development committees remains a criticism of 
the committees.  More needs to be done to develop a framework and 
agreement on the interpretation of the international evidence and assessing 
all evidence with the same framework and expectations, for a more 
consistent approach to the future development of clinical practice 
guidelines. 
I reported a significant lack of high quality research for acupuncture and 
manual therapy from the literature reviews and clinical practice guidelines 
I reviewed.  I established that further high quality robust research was 
required to establish the effectiveness of both acupuncture and manual 
therapy for LBP. 
Chapter three: 
In chapter three I reviewed the strengths and weaknesses of RCT design 
methodology and its relevance to a study of acupuncture and manual 
therapy.   
Following a critique of the quality of past literature (many low and medium 
quality research studies) for acupuncture and manual therapy, I discussed 
the type of trial design, which could be most appropriate for a complex 
condition (LBP) with complex interventions (acupuncture and manual 
therapy).  I considered various types of trial design, including a discussion 
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on previous placebo trial designs of acupuncture and manual therapy used 
to inform the NICE (2016) guidelines, to establish which design could be 
robust and potentially reduce the biases seen within the previous trials. 
I presented the rationale for the selected use of a cohort design with a 
nested factorial RCT for acupuncture and manual therapy.  Exploring its 
use for recruitment and retention in trials and giving justification for the 
use of an active control group rather than a placebo arm, thus providing a 
robust design with the potential for a high quality methodological study.  
While this design did not satisfy the House of Lords criterion (2000)  (due 
to not including a placebo comparator, as detailed above), until a true inert 
placebo intervention can be developed for acupuncture, comparing 
interventions to one another, in combination and to usual care, within one 
RCT may provide a robust solution.  
Having an appropriate comparator as an alternative in effectiveness trials 
equally requires consideration.  If a comparator arm is less favoured and 
leads to resentful demoralisation then an imbalance of attrition could 
occur, and potentially lead to an inaccurate reporting of the treatment effect 
within those trials if not analysed appropriately.  Exercise for example has 
questionable use as a comparator for evaluating the effectiveness of 
interventions for LBP, as a trend of indifference, reduced compliance, and 
higher attrition in the exercise arm has been demonstrated.  Exercise by its 
nature takes additional effort for a participant compared to a treatment 
delivered within a clinic, and thus needs careful consideration before being 
used as a comparator for future studies of acupuncture or other complex 
interventions. 
In chapter three I highlighted the need for further robust research of 
acupuncture and manual therapy for LBP, and proposed the use of a cohort 
study with a nested factorial RCT as the most appropriate trial design for 
a pilot study for this thesis.   
Chapter four: 
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In chapter four I gave justification for the development of a pilot study and 
detailed the aims, objectives, methods and procedures of the planned pilot 
cohort with nested factorial RCT.  The key objectives of the pilot study 
were to provide knowledge to inform and to investigate the practicality of 
conducting a future full-scale trial.  
Explanations for the selected objective measures and the use of only 
chartered physiotherapists in the pilot study were also given.  The 
recruitment rate targets, study documentation, study population, and 
inclusion and exclusion criteria with justifications were presented.  The 
randomisation process, trial interventions, monitoring of participants and 
methods of analysis were all outlined.  I published the protocol for this 
study in a peer reviewed journal (appendix A3) and the planned pilot study 
was delivered. 
The Limitations of the pilot study are discussed below in section 8.3. 
Chapters five and six: 
In chapter five I reported the results of the pilot RCT and the use of the 
cohort study, providing a descriptive review of the results, the participant 
data gained and the outcomes of the trial.  In chapter six I discussed the 
presented results. 
While many opportunities exist to reduce attrition, shifting attrition to a 
pre-randomisation phase would aid the reliability and internal validity of 
studies, as it would potentially lead to less attrition once randomisation and 
the study had commenced, as was seen in the pilot for this study. 
Meeting the expectations of participants is important and, while the 
participants who moved beyond three months in the study completed all 
paperwork and had excellent attendance rates, further communication with 
participants to inform them of the required input for the study at the 
consent point would have been useful.  A telephone call following initial 
consent, for example, may have encouraged and supported potential 
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participants to enter the study and may also have provided the opportunity 
to collect qualitative information as part of a process evaluation.   
The conducted pilot study demonstrated: 
• Recruitment rates from GP practices to the cohort study was an 
effective recruitment method 
• Recruitment rates from the cohort study to the nested factorial RCT 
was an effective method of recruitment to the nested trial  
• Randomisation occurring at three months reduced post 
randomization attrition to zero and facilitated an attuned cohort of 
participants   
• Consent and acceptance of trial interventions was 97% 
• Acceptance of therapist conducting the interventions was 100% 
• The design with factorial RCT was appropriate for evaluating 
acupuncture and manual therapy for LBP 
• The use of the outcome measures was appropriate 
• A suggestion of the manual therapy intervention being superior 
• The study parameters to inform a sample size calculation and 
projected study parameters for a full-scale study 
It was the first time this study design had been used to evaluate the 
complex condition of LBP and it would appear to be an efficient and 
appropriate design for this musculoskeletal condition.  The results 
indicated the study design of this pilot to be promising, and thus should be 
given consideration for future research studies. 
Chapter seven:  
In this chapter I presented a systematic review of studies comparing 
acupuncture with manual therapy for LBP and its results, including a meta-
analysis.  This systematic review differed from the literature review 
presented in chapter two, as it focused upon primary research of 
acupuncture versus manual therapy or their combination, not SRs of 
acupuncture and manual therapy.  It was also conducted systematically 
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following the PRISMA guidelines and used GRADE to assess the 
evidence.  No studies examined the combination of acupuncture and 
manual therapy apart from the study conducted for this thesis.  The 
systematic review and meta-analysis were conducted following the 
completion of the pilot RCT for this thesis, to enable the inclusion of its 
results and data.   
The systematic review ensured all research was considered to inform a 
potential full-scale trial in this area.  The results of this systematic review 
and meta-analysis indicated manual therapy might be more effective than 
acupuncture, however the quality of the included studies was limited.  The 
lack of studies in this area of research and the results of this review and 
meta-analysis were further suggestive of the need for a large, multi-
centred, full-scale well-conducted RCT of the presented pilot study or 
study in this area. 
8.3 Limitations of this thesis 
Duration of the PhD:  The length of time, from start to finish of this PhD, 
presented a number of challenges, which limited the research.  The primary 
research pilot study planned in 2010 was stimulated as a result of the 
publication of the original 2009 NICE LBP guidelines, which 
recommended acupuncture and manual therapy for LBP.   
I designed and conducted this pilot trial because I felt an opportunity had 
been missed within the 2009 guidelines to offer a combined intervention 
of acupuncture and manual therapy, potentially saving the NHS money and 
possibly increasing the effectiveness of the treatments delivered.  NICE 
(2009) recommended offering acupuncture or manual therapy and if one 
of the interventions was not effective to offer the other, thus potentially 
costing the NHS the expense of delivering two separate treatment courses 
and the cost of setting up acupuncture services throughout the NHS.  
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However, given the extended duration of the PhD period (due to working 
part time as a PhD student and extensions due to maternity leave and 
subsequent personal and family illness), more research was generated, and 
the NICE LBP guidelines were updated and published in 2016 removing 
acupuncture from their recommendations, after my research pilot study 
had been completed.  The thesis therefore had to be adapted to take this 
into account and multiple sections updated.   
The new NICE LBP (2016) guidelines added further uncertainty about 
acupuncture for LBP due to its withdrawal from their recommendations.  
This reversal of NICE’s recommendation was then shortly followed by the 
American clinical practice guidelines which, in contrast, strongly 
promoted acupuncture for LBP in 2017 (Qaseem et al. 2017).   
While the extended duration of the PhD work was a limitation, it did in 
itself present an opportunity to incorporate the new NICE guideline 
recommendations and advice into the discussions and compare both 
guidelines and their journey over time.  The outcome of the updated NICE 
guidelines reinforced the importance of further research in this area and 
my trial design and pilot study remain appropriate.  It lays the foundation 
for future research, which would be of the required high quality, to be 
considered by NICE.   
I found the interpretation of evidence and its application to guidelines 
differed over time, both nationally and internationally.  The choice 
between efficacy and effectiveness of interventions was key, especially for 
acupuncture recommendations in the UK.   
Not conducting an interview or an in depth documentary of the different 
guideline approaches and how different decisions were arrived at from the 
same body of literature, is a limitation of this thesis.  It would be a 
significant consideration for further study in this area and would be 
recommended to fully inform future research.  
My review of acupuncture and manual therapy systematic reviews 
conducted in chapter two did not use a structured tool, such as AMSTAR 
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or ROBIS (Gates et al. 2018), for appraising the systematic reviews.  This 
was a limitation of the review and a structured plan incorporating the use 
of an appraisal tool would need to be included into future reviews.  
It is common practice to conduct a systematic review in advance of 
undertaking an RCT and thus completing only a review of the literature 
prior to my trial was a limitation.  Conducting a systematic literature 
review later in the PhD following the completion of the pilot study enabled 
me to include the results of my pilot study to further inform the research.  
The completion of my SR towards the end of my PhD also ensured my 
thesis was more up to date with the passage of time and thus became a 
strength of my thesis. 
I updated all areas of the thesis to maintain its relevance and status with 
the updated literature and guidelines, and I needed to rise to the challenge 
of maintaining the story of the thesis over the period of time and my 
journey on this PhD. 
Pilot study: This thesis reports on the assessment of a cohort design with 
a nested factorial RCT in its pilot form for a six-month period.  The study 
design has therefore not been tested in a full-scale trial over an extended 
follow-up period, thus limiting the information on long-term follow-up 
that can be realised and the impact of this pilot study and thesis.   
The lack of a long-term follow up limited the degree to which the results 
adequately informed the planned long-term study, as it could not assess 
attrition levels or participant commitment passed the six-month time point.  
A full-scale study would plan to have a two-year cohort and follow-up 
period.  Additionally it is unknown whether the effectiveness of the 
treatments would diminish with time and how this might differ between 
treatment groups.  While a longer term study was initially planned for this 
pilot study, delays during the early part of the PhD and lengthy ethics and 
recruitment processes determined this PhD could only evaluate the study 
to the six-month time point, limiting any longer-term conclusions being 
drawn. 
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The pilot study engaged a GP database recruitment system, which limited 
its scope, only capturing individuals who had attended their GP within the 
preceding 18 months.  It could not incorporate individuals who self-
managed their LBP or who sought private healthcare without attending 
their GP.  For a full-scale trial, consideration to a wider recruitment method 
to ensure inclusivity would be important.  It has been suggested that LBP 
is significantly more widespread than is currently recorded (Greenberg et 
al. 2005); wider recruitment to include untreated or unreported cases of 
LBP would aid generalisability of the final study. 
The generalisability of the pilot study is also limited as only adults between 
the ages of 18 – 65 years old were included.  It would have been useful to 
extend the parameters of the study, as LBP becomes more prevalent in the 
aging population, therefore an opportunity was missed to gain information 
on this population type.  The 2016 NICE guidelines consider individuals 
above 16 years without an upper age limit.  Extending the age demographic 
and including LBP and sciatica for a full-scale study to fall in line with the 
new NICE (2016) recommendations would be valuable. 
Due to the location of the PhD in the city of York and limited funds, the 
pilot study was conducted locally.  York is a predominantly white area of 
the country with few very deprived populations and lacks the diversity of 
some other parts of the UK.  A full-scale study would need to incorporate 
a more diverse population closely representing the population of the UK.  
A multi-regional study would be preferable to allow wider generalisability, 
and this would also need to make provision for non-English language 
speaker/reader participants. 
The recruitment of only one physiotherapy practice remained a limitation 
of the study delaying the time frames achievable, and with no NHS 
provision represented.  Future research would look to incorporate both the 
NHS provision and additional physiotherapy clinics. 
While a pilot study was always planned, if we had achieved the sample 
size planned for and had the multiple trial sites envisaged it would have 
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aided the studies strength and conclusions, by providing more precise 
estimates for a full-scale study and greater generalisability of the results. 
Limited participant preference was afforded in this trial and following the 
recommendations within the NICE (2016) guidelines participant 
preference should be incorporated into any future trial to mirror patient 
choice encouraged within practice. 
Due to the factorial design of the pilot study, chartered physiotherapists 
conducted all interventions.  In clinical practice there may be differences 
in clinical delivery of acupuncture and manual therapy if delivered by 
other therapists i.e. acupuncturists, osteopaths, chiropractors or masseurs.  
This study fails to consider other professional input, however great 
consideration was afforded to the profession selected to lead in this trial. 
Loss of potential participants from the cohort for the nested RCT was 30% 
and this limited the pool of available participants to the RCT, due to many 
scoring below four on the RMDQ outcome measure.  Further consideration 
would need to be given for a full-scale trial, as to whether this minimum 
entry level on the RMDQ should also be set for entry to the cohort study, 
to limit the number of potentially ineligible trial participants.  Alternatively 
consideration of whether a score of four or more on the RMDQ is too high 
as an entry level for the treatment trial when so many scored lower, is 
required. 
This pilot study lacked full transparent criteria for the analysis to compare 
the two objective measures tools, limiting the information gained, this 
would need to be addressed for an informative assessment in full-scale 
study. 
Limited resource use data was collected as part of this pilot study; a full-
scale trial would need to include a full economic evaluation to inform 
commissioners and advise on the costs of intervention delivery on a 
national scale.  Incorporating a complex intervention as a service, such as 
acupuncture into LBP care provision as was recommended by the 2009 
NICE LBP guidelines was estimated to cost £24,366,000 if delivered by a 
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newly funded service with acupuncturist practitioners (NICE, 2009b).  
However, incorporating a service such as acupuncture into the NHS, 
through an already funded and established physiotherapy musculoskeletal 
or pain service, within the NHS could easily be delivered with minimal 
additional cost (training, time and acupuncture needles being required, 
(Dascanio, 2015b) by physiotherapists, nurse practitioners or doctors.  
This lower cost delivery option was not considered by the NICE Guideline 
Development Group (GDG) in the 2009 or 2016 LBP NICE guidelines.  
“The GDG considered the potentially considerable cost impact 
for the NHS if acupuncture was recommended and this would 
need to be underpinned by a strong evidence base of clinical and 
cost-effectiveness, which the GDG did not feel had been 
demonstrated.”       
(NICE, 2016, page 498) 
Providing full cost delivery details and economic data in a full-scale study 
would be essential to guide future guidelines and studies. 
The conducted pilot was planned to pilot the study design for a full-scale 
study however there were elements of this pilot, which could have fitted 
into the bracket of a feasibility study.  It may have been wise to extend the 
scope of this pilot to combine the intention of the pilot with a feasibility 
study to have better informed a full-scale study. 
Process Evaluation: The very limited process evaluation conducted for the 
cohort study and the nested RCT for acupuncture and manual therapy was 
a limitation of this study, further analysis of the processes would have been 
informative.  The limited process evaluation in the conducted pilot study 
simply considered the process of GP and physiotherapy recruitment, 
participant recruitment to the cohort and the nested RCT, the completion 
rates of the questionnaire case report forms, the success of the 
physiotherapists to conduct the sole and combined interventions and if any 
adverse events were reported.  No detailed analysis however was collected 
on the processes of participant recruitment, ease of completion of the 
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questionnaires or how the interventions were delivered and if any 
deviations from the planned methods were undertaken.  All this 
information would have been useful to generate knowledge to inform the 
planning of a full-scale trial. 
To have included the collection and analysis of qualitative data; for 
example, the analysis of the processes of running the whole study would 
have highlighted more in depth the strengths and weaknesses of the study 
to further inform a future study. 
Process evaluation information regarding the fidelity of participant 
journey could have further aided planning of a future trial.  Feedback from 
potential participants on their experience of the consent process, the 
information sheets, the pre-screening questionnaires, and overall 
communication from the study, would have helped further inform 
decisions regarding the duel consent process and if the administration 
commitment of the trial was realistic for participants.  A telephone 
interview could have been introduced to gain information regarding 
participant’s experience of engaging with the different stages of the study 
and how these could have been improved for a future study.   
The process and experience of; participants moving from the cohort to 
RCT, participants attending for their allocated intervention, seeing the 
therapist and their interaction with the interventions, would have been 
useful.  Additionally information from participants not contacted to take 
part in the RCT and remaining in the cohort only and their experience.  
Gaining an understanding of participant responses and feedback would 
have aided preparation for planning a full-scale RCT and the process 
evaluation of the participants journey would need to be incorporated into 
a full-scale study of this pilot.   
Process evaluation information from this thesis was limited in determining 
how the interventions were implemented in clinic by the recruited 
therapists.  It is therefore not expressly known if what was intended, was 
actually delivered.  Analysis of the range of manual therapy techniques 
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used or the choice of point selection for acupuncture treatments (including 
depth, needle size and point justification) was not planned or collected.  
Specific treatments may have been perceived as effective and thus selected 
by the therapists.   Therapists may have selected techniques and 
acupuncture points they felt comfortable using, and thus patterns of 
treatment perhaps specific to therapists may have emerged.  Information 
on any adaptation’s therapists may have been required to make to 
accommodate their patients was not collected, patients’ weight, fitness, 
perception of pain, concerns or tolerance of treatment may have all 
effected the patient and therapists’ journey.  All this information would 
have supported a future study on the potential use or requirement for a 
treatment protocol or part protocol, to ensure evidence of consistency and 
equity in the delivery of the interventions across the groups.    
Further information on the fidelity of the therapist experience of delivering 
the interventions, especially in the combined intervention group, would 
have been useful to establish if any limitations to delivering a dual 
intervention existed.  It would have been useful to know if the therapists 
felt they were delivering the interventions in the combined group as 
effectively as they felt they were delivering them in the solo intervention 
groups.  How the participants were divided up amongst the therapists 
would have been useful to know, while the participants were allocated to 
their intervention independently, once the referral was sent to the clinic, 
the administrator determined which therapist the participant saw.  Further 
information on the individual therapists may provide answers on whether 
a ‘therapist effect’ bias may have taken place.  Further understanding 
would have aided planning and would need to be planned into a future full-
scale study of this pilot. 
A ‘study’ of ‘this study’ to evaluate the conducted processes further and 
how it could have been improved at each stage would have been useful to 
plan to run alongside this study (Moore et al. 2015; MRC, 2008; Craig et 
al. 2008).  This process evaluation information would have aided the 
information derived from this study, and more extensive process 
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evaluation should be incorporated into a full-scale study to fully inform 
how the design met the objectives, the outcomes of the research and further 
guide future research in the area. 
8.4 What this PhD contributes to knowledge 
The research presented in this thesis contributes to key areas of the current 
research knowledge base: of RCTs nested within cohorts, of piloting a 
novel design, of RCTs using a factorial design to compare acupuncture to 
manual therapy, the combination of acupuncture and manual therapy by 
physiotherapists, in providing information to inform a full-scale RCT, in 
providing information of a preferred design for future RCTs of 
acupuncture and in providing current information on the research base 
through a systematic review and meta-analysis.  I highlight below the 
original and significant contributions to knowledge made: 
• It was the first study to use a cohort study with nested RCT for 
acupuncture and manual therapy for LBP, and a factorial RCT to 
consider the combination of acupuncture and manual therapy for 
LBP, and to demonstrate it was an effective study design for the 
recruitment and retention of attuned participants.   
• It showed that the cohort design with nested RCT was an 
appropriate design for future musculoskelatal studies  
• It provided insight into the current research base of acupuncture 
and manual therapy for LBP by conducting the first systematic 
review in this area and highlighted a lack of research on this 
question 
• It established participants willingly accept acupuncture and 
manual therapy and their combination as an intervention for LBP 
• It demonstrated acupuncture and manual therapy can be combined 
and delivered safely by chartered physiotherapists 
• It piloted a study, determined study parameters and informed a 
potential full-scale trial 
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The original journal articles I have published so far from this PhD are 
presented in appendix A. 
8.5 Implications for future research 
While there has been extensive investigation of LBP over the years, few 
trials have been able to understand and manage the fluctuating condition 
of LBP.  Further research should focus on the examination and diagnosis 
of LBP, what causes and triggers LBP, how LBP differs across a variety 
of settings and what the predictors are for translating an acute episode of 
LBP into a chronic condition. 
NICE LBP guidelines (2016) in their recent publication moved away from 
“acute, sub-acute and chronic” categories and as an alternative considered 
back pain as a continuum, primarily due to many acute LBP episodes 
exhibiting symptoms that could be predictors of chronicity and show risk 
of exacerbation.  A new way of thinking for LBP is thus emerging, clinical 
practice and research requires adaptation.  Clinical practice will need to 
invest in the assessment and support of LBP in the acute stages for those 
who are identified as at risk of chronicity.  Research will need to be 
undertaken to assess if our measurements of chronicity risk are accurate 
and if the interventions being delivered are effective at limiting chronicity. 
Real world therapy includes multiple treatments; RCTs and guidelines 
would be more useful if they reflected a combined approach in order to 
provide more effective guidance on clinical treatment pathways.  In line 
with the research, clinical guidelines currently recommend either / or 
scenarios.  Consideration of an RCT with an inclusive combined approach 
(e.g. acupuncture, manual therapy, exercise, self-care, CBT, medication) 
would be advantageous to reflect an integrated care package for LBP.  This 
integrated approach is supported by the recent NICE guidelines for LBP 
(2016). 
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The American guidelines (Qaseem et al. 2017) recommendation not 
offering drug therapy initially as first line treatment (recommending 
acupuncture and other interventions); this is long way from primary care 
we see practiced in the UK today.  A transition period is required from 
guidelines to clinical practice and the incorporation of any change into 
medical care and General Practice is required.  It will be interesting to see 
if the change in drug therapy recommendations will be incorporated 
internationally or remain specific to the USA.  The reliance upon 
pharmacology however is becoming less desirable for many individuals 
within society. 
Assessing the effectiveness of acupuncture in a high quality study and its 
use in combination with other interventions would be valuable to reduce 
uncertainty.  It is repeatedly reported that a combined intervention 
approach combining acupuncture with another intervention provides 
additional benefit and could be more effective than current practice (Liu et 
al. 2015; Furlan et al. 2005).  The study design presented within this thesis 
was effective at assessing acupuncture and could improve the quality of 
acupuncture research, it should thus be considered so a decision upon the 
effectiveness of acupuncture can be adequately determined. 
Further research on GP database recruitment would be useful in order to 
understand differences in database system software and how they impact 
on selection and thus the recruitment process.  Investigation and 
understanding of the underreporting of LBP and reasons for not consulting 
ones GP would be useful to the research community.  Additionally 
recruitment of these individuals to future studies would need to be a 
consideration. 
Further investigation into the use of the cohort study is required, 
consideration regarding a delay period at the start of trials, or multi-levels 
of administrational tasks may design out any significant levels of attrition, 
prior to randomisation and also before substantial trial work has been 
conducted, thus potentially negating the need for the cohort study.  
Reducing attrition in trials would improve the reliability of results and help 
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reduce the number of participants required for studies, whether this could 
be more effectively conducted via a cohort nested RCT design or a delay 
period and multi-level administrational design needs to be evaluated. 
Investigation of the cohort of participants functioning with mild LBP 
(three or less on the RMDQ) would be useful to that population of 
individuals, and examination of the course of LBP through an extended 
cohort would be useful for long-term understanding of LBP. 
A review of effectiveness studies using exercise, as comparators would be 
of interest to the research base, as attrition rates in exercise interventions 
are suggested to be higher and thus may give an overestimation of 
treatment effects of the comparative intervention.  Further investigation 
into appropriate comparators for effectiveness studies would be useful for 
future research. 
8.6 A potential future full-scale trial informed by this thesis 
The pilot study demonstrated the cohort with nested factorial RCT design, 
to be feasible and effective for evaluating acupuncture, manual therapy and 
their combination for LBP. As presented in section 5.6 to scale-up this 
pilot study to a full-scale study would be achievable and there is a real need 
for further research in this area.  The provision of more conclusive answers 
regarding the effectiveness of acupuncture for LBP would support 
knowledge, and also add to the limited knowledge base of acupuncture and 
manual therapy for LBP.  Promoting the use of the pilot trial design, may 
improve the quality of research in this field; there are multiple aspects 
learned from conducting the pilot to take into consideration prior to 
planning a future full-scale RCT. 
Scaling up the study:  Scaling up any pilot study to a full-scale trial has 
challenges and repeating anything on a larger scale entails greater 
resources, logistics and organisation.  Further explanations on the scaling 
up of recruitment and logistics of this pilot are also detailed in section 5.6.  
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Within this pilot for example, only two GP practices were used for 
recruitment, this would need to be scaled up considerably, identifying 20 
– 25 GP practices, to recruit at least 15 GP practices to allow for adequate 
recruitment (as discussed in section 5.5), this would incur additional 
workload, logistics and cost.  Enlisting primary care research networks 
would be a useful resource for supporting the recruitment of GPs and NHS 
physiotherapy practices.  While there are some financial incentives for GPs 
to partake in research studies, and the trial comes with the benefit of 
providing many GP patients an intervention for their LBP, other ideas for 
attracting additional GPs would need to be considered for a full-scale trial.  
UKBEAM (2004) successfully scaled up their feasibility study from two 
to 14 GP practices for their full-scale study, and effectively combined the 
use of NHS and private practice providers to deliver the trial interventions. 
Recruitment of participants with LBP as discussed (section 5.6) would 
need to be expanded to include non-GP practice recruitment, due to the 
high non-reporting rates of LBP patients (Greenberg et al. 2005; 
Papageorgiou, 1991).  This could be done through advertising, social 
media platforms, recommendation, information available at private clinics, 
local groups, sports clubs, at other medical practices and through the NHS.   
The scope of participants would be a consideration for a future study and 
including participants from the age of 16 years with no upper age limit 
(once comorbidities were excluded) would bring any future study of LBP 
in line with the scope of the NICE LBP guidelines (2016) and thus be 
recommended for a future study to ensure it was as generalisable as 
possible. 
The interventions delivered for this pilot were conducted at one private 
physiotherapy practice, and with them working in close proximity, this 
allowed communication and consistency to be easily managed.  Scaling up 
to multiple practices in varied cities would require a larger team to manage 
the logistics, training, monitoring of consistency and communication, 
using the national Primary Research Networks would help support this.  A 
prescriptive intervention protocol or a partial prescriptive intervention 
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protocol, using the TIDieR checklist (Hoffmann et al. 2014) would be 
advisable to implement for therapists, if the study were scaled up, this 
would aid a large multi-centred full-scale study to ensure consistency, 
quality and equity across all the intervention groups. 
Additionally incorporating NHS sites into a future study would bring with 
it the requirements as for other private practice sites, but in addition further 
NHS ethical approval at all sites would be required, logistics for 
participants getting to and from hospital sites and parking would need to 
be considered, participant perception of attending an NHS centre or a 
private practice would need to be considered and data collected to 
investigate any impact of this.  As discussed previously some participants 
may consider treatment in private practice to be more valuable and this 
would be useful knowledge to explore further in the process evaluation 
analysis of a future study.  UKBEAM (2004) did not find any significant 
difference in the effectiveness of interventions delivered in either private 
practice or the NHS, however no qualitative information was collected or 
analysed in their study.   
Additional training and resource provision would be required within the 
NHS to the therapists and the support staff, ensuring recruited practitioners 
had adequate availability and provision within their diaries to 
accommodate weekly follow-up appointments.  This would be essential to 
ensuring participants received the prescribed intervention in a timely 
manner.  Ensuring practitioners were afforded adequate time within their 
busy schedules to ensure they could commit fully to the study and to treat 
its participants would be important, due to the already overstretched 
caseload of many NHS therapists.  Consistent communication and 
additional support for therapists in the NHS may be required to fully 
support them.   
These additional requirements and costs would all need to be factored into 
a future plan and budget for a full-scale trial.  Due to the implication of 
additional costs it would be appropriate for a ‘value of information 
analysis’ to be completed, to estimate if the cost of conducting the future 
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research was worthwhile.  A ‘value of information analysis’ is a 
quantitative process, which aims to estimate the ‘return on investment’ of 
proposed research studies, giving a value to the expected knowledge 
gained.  It is a useful tool, which can be conducted alongside an economic 
evaluation in a trial and can also assess cost effectiveness of projects 
(Wilson, 2015).  
Cohort study: The use of the cohort study should be considered; while 
recruitment to a cohort has previously been suggested as a potential 
limitation of this design (section 3.47) this pilot demonstrated it to be an 
effective recruitment mechanism for an RCT, with attrition occurring 
during the early stages of the cohort prior to randomisation to the RCT. 
There was an indication from the pilot that having a run-in period and/or 
multiple admin layers may possibly serve to reduce attrition in a way 
similar to the cohort model.  This would potentially reduce the additional 
cost and work associated with the cohort study.  The cohort does however 
serve the purpose of inducting participants into the study and having a 
cohort of individuals with LBP who could also be monitored and included 
in potential analysis.   
In addition the cohort also supported the study through the reduction of 
resentful demoralisation, as those allocated to the usual care arm were not 
informed of their allocation and continued as though they were in the 
cohort potentially awaiting the trial.   
The cohort design also served the purpose of allowing multiple recruitment 
time points during the study.  This could be expanded upon further in a 
full-scale study, allowing for entry into the trial at a later time when 
participants’ symptoms had changed.  If further recruitment to the trial was 
required, additional participants could be recruited from the cohort at a 
later time point.   
The cohort recruitment model has only been piloted in this area of study 
and it would be useful to research to see it conducted in a full-scale study.  
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A full-scale cohort style recruitment model for a study of LBP would 
support research in this area. 
Entry level to cohort study: Some alterations to the process would be 
recommended to reduce the loss of participants through the process of the 
cohort due to their ineligibility.   
Introducing a minimal score of two on the RMDQ to enter the cohort 
would reduce the number of participants with very low-level back pain and 
exclude those who scored zero or one.  This would streamline the 
recruitment to the cohort and potentially improve the number of eligible 
participants for the nested RCT.  
Entry level to RCT: Reducing the entry level to the RCT from four to three 
would be indicated to reduce the number of individuals being ineligible for 
the study because they scored below four on the RMDQ.   With the 
minimally clinically important difference planned to be a mean change of 
1.5 on RMDQ, reducing the RMDQ score to three would still allow for 
change to occur and be recognised. 
It was not clear if multiple low scorers on the RMDQ were due to it being 
less sensitive for the individuals with low level LBP, or if many individuals 
suffer with low levels of LBP and feel their back pain substantial enough 
to enter a study, even though they only scored minimally on pre-screening.  
Process evaluation and feedback would be planned to gain this information 
from a future study.   
It could be argued that the cohort and the RCT should have the same entry 
score, however LBP varies across time and those who scored two at 
baseline may have a change in score at follow-up.  This approach would 
accommodate some of those participants with persistent low levels of back 
pain.  There would also be a differentiation between the cohort and the 
RCT for investigation regarding those individuals. 
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Factorial design:  From the information gained from the pilot study a 
factorial trial design would be desirable in a future full-scale trial for a 
variety of reasons.  It allows for the simultaneous comparison of more than 
one intervention to be compared to usual care, thus costing less than two 
separate effectiveness trials (Sedgwick, 2014), and it allows the study of 
the effect of two or more interventions conducted alone or in combination 
(NephJC, 2017).  When designing and applying for funding for a potential 
future full-scale study of this pilot, it will need to be considered that time 
has passed, and guidelines have progressed and thus research priorities 
may also have changed.  It may be decided for a future study that to attract 
funding for a trial a wider scope of LBP interventions to further reflect the 
NICE guidelines may need to be considered.  The inclusion of a 
medication, exercise, other interventions and / or incorporating patient 
preference (as recommended by NICE 2016) would be desirable, and these 
would all be possible through a factorial design and it would allow some 
flexibility to the planned full-scale study to ensure funding was achievable.   
Using a factorial design allows researchers to understand the effect of two 
or more independent variables upon a single dependent variable such as 
LBP.  A standard RCT usually compares a single intervention with a 
control to establish effectiveness, if investigating several interventions in 
different trials, this would be statistically inefficient, with extensive time 
and work spent on participant recruitment and the burden of greater costs 
of running separate trials (Sedgwick. 2012).  The factorial design also 
differs and has advantages over a multiple arm trial due to its design and 
statistical methods.   
A factorial design allows the effectiveness of several interventions to be 
compared to usual care and also to all arms not including that specific 
intervention, the factorial design is therefore more efficient and versatile 
than running parallel arm trials (Sedgwick, 2012).  Thus it has powerful 
statistical processes that allow for the analysis of the compared multiple 
treatments while only using one control arm, and for all participants to be 
included in the analyses of both investigations.  Using a regression analysis 
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model principally provides an average of two differences, weighted 
according to sample size.  The primary analysis is a comparison of the 
margins of a 2 x 2 table (see table 3.1) and the effect of each intervention 
is adjusted for the other interventions and any covariates.  The adjustments 
improve the accuracy of the analysis to obtain precise estimates of effect 
and their standard errors (Montgomery, Peters and Little, 2003).   
The factorial design is considered a ‘versatile experimental design’ as it 
allows the opportunity for researchers to examine whether the combination 
of interventions can affect their effectiveness.  No other design allows for 
such information to be acquired (Sedgwick, 2012). 
Factorial RCTs are most frequently powered to detect the main differences 
and the effects of interventions in trials; as to adequately power a factorial 
study to detect plausible interactions requires a significantly enlarged 
sample size (Montgomery et al. 2003).  If research did not attract extensive 
cost and there was no financial implication when designing trials, then 
conducting a full-scale cohort with a nested factorial RCT, powered to 
assess interaction would be ideal.  However the cost of scaling up a 
factorial study to test for interaction in this circumstance would be four 
fold (Montgomery et al. 2003), for this study, 4245 participants would be 
required to power it, as oppose to 1064 for a study not testing for 
interaction (as discussed in section 5.5.2.1), a considerable expense on an 
already costly study.  From knowledge of funding awards for trials, it 
would be unlikely that funding would be granted for such a large-scale 
study, where costs had increased by four simply to consider the interaction 
of interventions, of which the effect of some was still uncertain.  
Maintaining the use of the factorial design (but not powering to detect 
interaction) would additionally give the flexibility of scaling up the 
planned study with future studies (following correct adaptation 
procedures) to potentially include the power for interaction in the future, 
if there was indication from the full-scale study for the need to testing this 
area further.  The results of the full-scale study could thus be added to 
future investigations in the area, an example of combining the results from 
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research studies was conducted by MacPherson et al (2014), they 
performed a secondary analyse of the results from 29 acupuncture trials 
for a variety of conditions to explore the influence of the control group on 
the effect size of the interventions. 
The pilot study demonstrated the factorial design to be a robust design for 
assessing complex interventions for a complex condition, providing a 
pragmatic inclusive approach, which can closely map clinical practice.  
The factorial design has only been piloted comparing acupuncture with 
manual therapy for LBP and it would be useful to research to see it 
conducted in a full-scale study.  Using the factorial design RCT nested 
within the cohort would be advocated for a full-scale study of this pilot. 
Long-term effects: Understanding long-term effects of interventions within 
research, is crucial to advocating their use and justifying their cost.  
Ensuring a full-scale trial considered long-term effects and incorporated 
long-term follow-up would be important to this area of research.  In 
Macpherson et al. (2017b) meta-analysis they attempted to provide 
answers regarding the length of time the effects of acupuncture persist.  
They concluded the effects of acupuncture did not appear to reduce 
importantly at twelve months for chronic pain, with their central estimate 
suggesting approximately 90% of the benefit of acupuncture remained 
compared to the control interventions. In their recommendations they 
advocated for additional trials to measure long-term outcomes of 
acupuncture to at least 12 months follow-up and ideally beyond.  Therefore 
long-term analysis for a full-scale study would be planned to follow-up 
outcomes at 12, 18 and 24 months, as this would aim to contribute new 
knowledge and information in this area of research. 
Economic evaluation: As discussed in section 8.3 (pilot study limitations), 
the limited resource data collected, and the lack of economic evaluation 
conducted for this pilot was a limitation.  Therefore a full economic 
evaluation of a future full-scale study would be planned and implemented.  
Enabling economic data to be collected from the study to inform therapists, 
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commissioners and guideline developers of the economic value of the 
investigated interventions for LBP. 
Process evaluation: As discussed in section 8.3, process evaluation would 
be required to provide additional information and answers not provided 
within this pilot study.  The intentions of the process evaluation of the 
study would intend to inform researchers, policy makers and practitioners 
of the processes of conducting the RCT and the assessed complex 
interventions.  Aiming to giving insight into why some interventions are 
effective and why some are not, it may simply be an intervention is just 
not effective or it may be due to lack of equipoise or implementation in the 
study.  If there were reasons some interventions were not seen to be 
effective, the process evaluation would aim to assess how the interventions 
and their delivery could be improved.   
A future process evaluation would focus upon 1) Intervention 
implementation - what was actually implemented in practice and why it 
was done as such, were any adaptations to the intervention or its delivery 
required or conducted, and did the actual implementation of the 
interventions impact the effectiveness. 2) Causal mechanisms - close 
scrutiny of causal mechanisms to aid the establishment of more effective 
interventions and the transferability of the findings to other settings and 
populations.  3) Contextual factors – to understand the factors external to 
the intervention, which may improve or hinder the intervention (Moore et 
al. 2015; Moore et al. 2014).   
A process evaluation of the study would be fully implemented through a 
study of the ‘study’ approach (Moore et al. 2015; MRC, 2008; Craig et al. 
2008) as discussed in section 8.3 (process evaluation).  A future study 
would use the MRC process evaluation framework for complex 
interventions, with focus upon planning, design, conduct, reporting and 
appraisal of the process evaluation of the interventions (Moore et al. 2015). 
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Summary: It would be proposed to undertake a full-scale cohort study with 
a nested factorial RCT, similar to the one undertaken for this pilot, 
however with significant changes implemented.  Expansion of recruitment 
and intervention sites (including the NHS) would be conducted.  The age 
demographic would be expanded. The entry level for the cohort would be 
set to a minimum of two; the minimum entry into the RCT would be 
lowered to three.  The factorial design would be used to allow for analysis 
of multiple interventions but would not be powered to test for interaction 
due to the excessive cost implication.  Additional training and support 
would be provided and a prescriptive or part prescriptive intervention 
protocol would be implemented.  Long-term outcomes would be 
measured, a full economic evaluation would be conducted, and a full 
process evaluation of the study would be undertaken.  These changes 
would aim to ensure a robust and comprehensive, high quality, full-scale 
study of the effectiveness of acupuncture and manual therapy, and their 
combination for LBP was conducted. 
8.7 Conclusion 
A robust evidence base is required to inform the treatment provision and 
policy on LBP within the UK and globally.  As previously discussed, LBP 
is a widespread, costly and significant problem for individuals, healthcare 
and industry (Clark and Horton, 2018; Cholangitis 2018).  There is a real 
need for high quality research evidence to provide more extensive and 
conclusive answers to the condition.  It is apparent that time for a new 
approach to LBP is upon us, with early intervention and less reliance upon 
medication (NICE, 2016; Qaseem et al. 2017). 
There is a significant and clear need for long-term longitudinal research 
into LBP and its symptomology over time.  Gaining a greater 
understanding of predictors, the number of episodes, duration of pain, 
severity of disability and recovery would provide insight, to provide 
appropriate and timely interventions (Hoy et al. 2014). 
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Providing a more inclusive approach to LBP, by incorporating a variety of 
interventions to present a more real life experience and understanding the 
effectiveness of treatment combinations to reflect current clinical practice 
would be valuable to the area of study (Salerno et al. 2002).  Perhaps 
similar to the combinations used in the UKBEAM (2004) study, where one 
intervention arm delivered manipulation followed by a course of exercise.  
Implementing clinical practice into research and thus informing current 
guidelines of a more complete approach could facilitate patients and the 
health services more effectively and may ultimately provide more 
conclusive results (Salerno et al. 2002).  
There is a clear need for further research into the clinical effectiveness and 
the clinical necessity of current treatments for LBP.  The uncertainty 
surrounding the use of acupuncture remains and advice on its inclusion 
continues to vary internationally (Qaseem et al. 2017; Wong et al. 2017; 
NICE, 2016; Nijs et al. 2015; Koes et al. 2010).   
A large full-scale well-conducted multi-centred trial is required within this 
area of study.  It would assist to reduce the uncertainty surrounding 
acupuncture and also provide further insight into the effectiveness of 
manual therapy and/or other interventions for the long-term benefit of 
patients with LBP. 
I have demonstrated through the journey of this PhD and thesis, the RCT 
conducted, its results, the results of the systematic review and meta-
analysis, and through the discussions and the conclusions, that the thesis 
aims have been achieved and this thesis has contributed to the knowledge 
base for acupuncture and manual therapy for LBP. 
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